AI assistant
Standard Chartered PLC — Audit Report / Information 2025
Feb 24, 2026
4648_rns_2026-02-24_87a056a4-3e47-4ed3-b6f6-c4fb3f5dea8c.pdf
Audit Report / Information
Open in viewerOpens in your device viewer

Pillar 3 Disclosures Report 2025
Incorporated in England and Wales with registered number 966425 Registered Office: 1 Basinghall Avenue, London, EC2V 5DD, England
Contents
1. Introduction
- 1 1.1. Purpose
- 1 1.2. Highlights
- 2 1.3. Key prudential metrics
- 3 1.4. Regulatory disclosure framework
- 4 1.5. Risk management
- 5 1.6. Accounting and regulatory consolidation
- 6 1.7. Significant subsidiaries
- 6 1.8. Comparison of accounting balance sheet and exposure at default
2. Capital
- 11 2.1. Capital management
- 11 2.2. Capital resources
- 15 2.3. Minimum requirement for own funds and eligible liabilities
- 22 2.4. Countercyclical capital buffer
- 24 2.5. Capital requirements
- 28 2.6. Leverage ratio
3. Credit risk
- 32 3.1. Internal Ratings Based Approach to credit risk
- 32 3.2. Standardised Approach to credit risk
- 33 3.3. Internal Ratings Based models
- 54 3.4. Credit risk quality
- 61 3.5. Risk grade profile
- 78 3.6. Credit risk mitigation
- 81 3.7. Standardised risk weight profile
- 83 3.8. Securitisation
4. Traded risk
- 91 4.1. Market risk
- 95 4.2. Counterparty credit risk
5. Operational risk
6. Interest rate risk in the banking book
7. Liquidity risk
112 7.1 Encumbered and unencumbered assets
8. Remuneration
9. Forward looking statements
Annex 1 Standard Chartered Significant Subsidiaries
- 150 Acronyms
- 151 Glossary
- 157 Prudential disclosure reference table
- 176 Summary of differences between the Pillar 3 Disclosures and the Risk and capital review sections of the Annual Report
Tables
- 2 1. Key metrics template (UK KM1)
- 3 2. Key metrics TLAC requirements (KM2)
- 5 3. Regulatory consolidation
- 6 4. Outline of the differences in the scopes of consolidation (UK LI3)
- 7 5. Differences between accounting and regulatory scopes of consolidation and the mapping of financial statement categories with regulatory risk categories (UK LI1)
- 9 6. Main sources of differences between regulatory exposure amounts and carrying values in financial statements (UK LI2)
- 10 7. Prudent valuation adjustments (PVA) (UK PV1)
- 11 8. Reconciliation between financial total equity and regulatory CET1 before regulatory adjustments
- 12 9. Composition of regulatory own funds (UK CC1)
- 14 10. Reconciliation of regulatory own funds to balance sheet in the audited financial statements (UK CC2)
- 16 11. TLAC composition for G-SIBs (TLAC1)
- 17 12. Resolution entity creditor ranking at legal entity level (TLAC3)
- 18 13. Standard Chartered Bank creditor ranking (TLAC2)
- 19 14. Standard Chartered Bank (Hong Kong) Limited creditor ranking (TLAC2)
- 20 15. Standard Chartered Bank Korea Limited creditor ranking (TLAC2)
- 21 16. Standard Chartered Bank (Singapore) Limited creditor ranking (TLAC2)
- 22 17. Standard Chartered Bank (China) Limited creditor ranking (TLAC2)
- 23 18. Geographical distribution of credit exposures relevant for the calculation of the countercyclical buffer (UK CCyB1)
- 23 19. Amount of institution-specific countercyclical capital buffer (UK CCyB2)
- 25 20. Overview of risk weighted exposure amounts (UK OV1)
- 26 21. Movement analysis for RWA
- 26 22. RWEA flow statements of credit risk exposures under the IRB approach (UK CR8)
- 27 23. RWEA flow statements of CCR exposures under the IMM (UK CCR7)
- 27 24. RWA flow statements of market risk exposures under the IMA (UK MR2-B)
- 28 25. Leverage and CRR Leverage Ratio
- 29 26. LRSum: Summary reconciliation of accounting assets and leverage ratio exposures (UK LR1)
- 30 27. LRCom: Leverage ratio common disclosure (UK LR2)
- 31 28. LRSpl: Split-up of on balance sheet exposures (excluding derivatives, SFTs and exempted exposures) (UK LR3)
- 35 29. IRB approach Back-testing of PD per exposure class for central governments or central banks (fixed PD scale) (UK CR9)
- 36 30. IRB approach Back-testing of PD per exposure class for institutions (fixed PD scale) (UK CR9)
Contents
- 37 31. IRB approach Back-testing of PD per exposure class for corporates – other (fixed PD scale) (UK CR9)
- 38 32. IRB approach Back-testing of PD per exposure class for corporates – specialised lending (fixed PD scale) (UK CR9)
- 39 33. IRB approach Back-testing of PD per exposure class for corporates – SME (fixed PD scale) (UK CR9)
- 40 34. IRB approach Back-testing of PD per exposure class for retail other – non SME (fixed PD scale) (UK CR9)
- 41 35. IRB approach Back-testing of PD per exposure class for retail other – SME (fixed PD scale) (UK CR9)
- 42 36. IRB approach Back-testing of PD per exposure class for retail – secured by real estate property – non SME (fixed PD scale) (UK CR9)
- 43 37. IRB approach Back-testing of PD per exposure class for r retail – secured by real estate property – SME (fixed PD scale) (UK CR9)
- 44 38. IRB approach Back-testing of PD per exposure class for retail – qualifying revolving (fixed PD scale) (UK CR9)
- 45 39. IRB Backtesting of probability of default (PD) for central governments or central banks (UK CR9.1)
- 47 40. IRB Backtesting of probability of default (PD) for institutions (CR9.1)
- 49 41. IRB Backtesting of probability of default (PD) for corporates (CR9.1)
- 51 42. IRB Backtesting of probability of default (PD) for corporates – specialised lending (CR9.1)
- 53 43. IRB Backtesting of probability of default (PD) for corporates – SME (CR9.1)
- 55 44. Performing and non-performing exposures and related provisions (UK CR1)
- 56 45. Maturity of exposures (UK CR1-A)
- 57 46. Changes in the stock of non-performing loans and advances (UK CR2)
- 57 47. Credit quality of forborne exposures (UK CQ1)
- 58 48. Credit quality of performing and non-performing exposures by past due days (UK CQ3)
- 59 49. Quality of non-performing exposures by geography (UK CQ4)
- 60 50. Credit quality of loans and advances to nonfinancial corporations by industry (UK CQ5)
- 62 51. IRB Credit risk exposures by exposure class
- 63 52. Internal ratings mapping to external ratings
- 64 53. IRB approach Credit risk exposures by exposure class and PD range for central governments or central banks (UK CR6)
- 65 54. IRB approach Credit risk exposures by exposure class and PD range for institutions (UK CR6)
- 66 55. IRB approach Credit risk exposures by exposure class and PD range for Corporates (UK CR6)
- 67 56. IRB approach Credit risk exposures by exposure class and PD range for Corporates – other (UK CR6)
- 68 57. IRB approach Credit risk exposures by exposure class and PD range for corporates – specialised lending (UK CR6)
-
69 58. IRB approach Credit risk exposures by exposure class and PD range for corporates – SME (UK CR6)
-
70 59. IRB approach Credit risk exposures by exposure class and PD range for retail (UK CR6)
- 71 60. IRB approach Credit risk exposures by exposure class and PD range for retail – secured by real estate property – SME (UK CR6)
- 72 61. IRB approach Credit risk exposures by exposure class and PD range for retail – secured by real estate property – Non SME (UK CR6)
- 73 62. IRB approach Credit risk exposures by exposure class and PD range for retail – qualifying revolving (UK CR6)
- 74 63. IRB approach Credit risk exposures by exposure class and PD range for retail – SME (UK CR6)
- 75 64. IRB approach Credit risk exposures by exposure class and PD range for retail – Non SME (UK CR6)
- 76 65. Scope of the use of IRB and SA approaches (UK CR6-A)
- 77 66. Specialised lending and equity exposures under the simple riskweighted approach (UK CR10.2)
- 78 67. CRM techniques overview: Disclosure of the use of credit risk mitigation techniques (UK CR3)
- 79 68. Standardised approach Credit risk exposure and CRM effects (UK CR4)
- 80 69. IRB approach Effect on the RWEAs of credit derivatives used as CRM techniques (UK CR7)
- 80 70. IRB approach Disclosure of the extent of the use of CRM techniques (UK CR7-A)
- 82 71. Standardised approach (UK CR5)
- 86 72. Securitisation exposures in the non-trading book (UK-SEC1)
- 87 73. Securitisation exposures in the trading book (UK-SEC2)
- 88 74: Securitisation exposures in the non-trading book and associated regulatory capital requirements – institution acting as originator or as sponsor (UK-SEC3)
- 89 75. Securitisation exposures in the non-trading book and associated regulatory capital requirements – institution acting as investor (UK-SEC4)
- 90 76. Exposures securitised by the institution Exposures in default and specific credit risk adjustments (UK-SEC5)
- 92 77. Market risk regulatory capital requirements
- 92 78. Market risk under standardised approach (UK MR1)
- 93 79. IMA values for trading portfolios (UK MR3)
- 93 80. Market risk under the internal Model Approach (IMA) (UK MR2-A)
- 94 81. 2025 Backtesting chart for Internal Model Approach regulatory trading book at Group level with hypothetical profit and loss (P&L) versus VaR (99 per cent, one day) (MR4))
- 94 82. 2025 Backtesting chart for Internal Model Approach regulatory trading book at Group level with actual profit and loss (P&L) versus VaR (99 per cent, one day) (MR4)
- 96 83. Composition of collateral for CCR exposures (UK CCR5)
- 97 84. Analysis of CCR exposure by approach (UK CCR1)
- 98 85. Exposures to CCPs (UK CCR8)
- 98 86. Credit derivatives exposures (UK CCR6)
Contents
- 98 87. Transactions subject to own funds requirements for CVA risk (UK CCR2)
- 99 88. Standardised approach CCR exposures by regulatory exposure class and risk weights (UK CCR3)
- 100 89. IRB CCR exposures by exposure class
- 100 90. IRB approach CCR exposures by exposure class and PD scale for central governments or central banks (UK CCR4)
- 101 91. IRB approach CCR exposures by exposure class and PD scale for institutions (UK CCR4)
- 101 92. IRB approach CCR exposures by exposure class and PD scale for corporates (UK CCR4)
- 102 93. IRB approach CCR exposures by exposure class and PD scale for corporates – specialised lending (UK CCR4)
- 102 94. IRB approach CCR exposures by exposure class and PD scale for corporates – SME (UK CCR4)
- 103 95. Operational risk own funds requirements and risk-weighted exposure amounts (UK OR1)
- 105 96. Quantitative information on IRRBB (UK IRRBB1)
- 107 97. Liquidity Coverage Ratio (LCR) (UK LIQ1)
- 109 98. Net Stable Funding Ratio (UK LIQ2)
- 111 99. Total eligible high-quality liquid assets (HQLA)
- 112 100. Encumbered and unencumbered assets (UK AE1)
- 113 101. Collateral received and own debt securities issued (UK AE2)
- 114 102. Sources of encumbrance (UK AE3)
- 115 103. Remuneration awarded for the financial year (UK REM1)
- 116 104. Special payments to staff whose professional activities have a material impact on institutions' risk profile (identified staff) (UK REM2)
- 117 105. Deferred remuneration (UK REM3)
- 119 106. Remuneration of 1 million EUR or more per year (UK REM4)
- 119 107. Information on remuneration of staff whose professional activities have a material impact on institutions' risk profile (identified staff) (UK REM5)
- 121 108. Capital resources of significant subsidiaries
- 122 109. Composition of regulatory own funds (UK CC1) – Solo consolidation
- 124 110. Reconciliation of regulatory own funds to balance sheet in the audited financial statements (UK CC2) – Solo consolidation
- 125 111. Geographical distribution of credit exposures relevant for the calculation of the countercyclical buffer (UK CCyB1) – Solo consolidation
- 127 112. Amount of institution-specific countercyclical capital buffer (UK CCyB2) – Solo consolidation
- 127 113. LRSum: Summary reconciliation of accounting assets and leverage ratio exposures (UK LR1) – Solo consolidation
- 128 114. LRCom: Leverage ratio common disclosure (UK LR2) – Solo consolidation
- 129 115. LRSpl: Split-up of on balance sheet exposures (excluding derivatives, SFTs and exempted exposures) (UK LR3) – Solo consolidation
-
130 1116. Performing and non-performing exposures and related provisions (UK CR1) – Standard Chartered – Solo Consolidation
-
132 117. Maturity of exposures (UK CR1-A) Solo Consolidation
- 132 118. Changes in the stock of non-performing loans and advances (UK CR2) – Solo Consolidation
- 132 119. Credit quality of forborne exposures (UK CQ1) Solo Consolidation
- 133 120. Credit quality of performing and non-performing exposures by past due days (UK CQ3) – Solo Consolidation
- 135 121. Quality of non-performing exposures by geography (UK CQ4) – Solo Consolidation
- 136 122. Credit quality of loans and advances to nonfinancial corporations by industry (UK CQ5) – Solo Consolidation
- 137 123. CRM techniques overview: Disclosure of the use of credit risk mitigation techniques (UK CR3) – Solo Consolidation
- 137 124. Standardised approach Credit risk exposure and CRM effects (UK CR4) – Solo consolidation
- 138 125. Liquidity Coverage Ratio (LCR) (UK LIQ1) Solo consolidation
- 140 126. Net Stable Funding Ratio (UK LIQ2) Solo consolidation
- 142 127. Remuneration awarded for the financial year (UK REM1) – Solo Consolidation
- 143 128. Special payments to staff whose professional activities have a material impact on institutions' risk profile (identified staff) – Solo Consolidation (UK REM2)
- 144 129. Deferred remuneration (UK REM3) Solo Consolidation
- 146 130. Remuneration of 1 million EUR or more per year (UK REM4) – Solo Consolidation
- 146 131. Information on remuneration of staff whose professional activities have a material impact on institutions' risk profile (identified staff) (UK REM5) – Solo Consolidation
- 147 132. Overview of RWA Significant Subsidiaries
- 149 133. Leverage ratio common disclosure Significant Subsidiaries
- 149 134. Market risk regulatory capital requirements for significant subsidiaries
Standard Chartered Bank is headquartered in London where it is authorised by the UK's Prudential Regulation Authority (PRA), and Standard Chartered PLC Group and Standard Chartered Bank are regulated by the Financial Conduct Authority (FCA) and the PRA. Within this document 'the Group' refers to Standard Chartered PLC together with its subsidiary undertakings. Unless the context requires, within this document, 'China' refers to the People's Republic of China and, for the purposes of this document only, excludes Hong Kong Special Administrative Region (Hong Kong), Macau Special Administrative Region (Macau) and Taiwan. 'Korea' or 'South Korea' refers to the Republic of Korea. Greater China & North Asia (GCNA) includes China, Hong Kong, Japan, Korea, Macau and Taiwan; ASEAN & South Asia (ASA) includes Australia, Bangladesh, Brunei, Cambodia, India, Indonesia, Laos, Malaysia, Myanmar, Nepal, Philippines, Singapore, Sri Lanka, Thailand and Vietnam; and Africa & Middle East (AME) includes Bahrain, Egypt, Iraq, Jordan, Lebanon, Oman, Pakistan, Qatar, Saudi Arabia and the United Arab Emirates (UAE). Throughout this document unless specified the disclosures are at Group level. Throughout this document, unless another currency is specified, the word 'dollar' or symbol \$ means United States dollar. Throughout this document IRB refers to internal ratings based models. The Group does not use the Foundation IRB approach.
Standard Chartered | Pillar 3 Disclosures Report B
1. Introduction
1.1 Purpose and basis of preparation
The Pillar 3 disclosures comprise information on the underlying drivers of risk-weighted assets (RWA), capital, leverage and liquidity ratios as at 31 December 2025 in accordance with the United Kingdom's (UK) onshored Capital Requirements Regulation (CRR) and the Prudential Regulation Authority's (PRA) Rulebook.
The disclosures have been prepared in line with the disclosure templates introduced by the PRA Policy Statement PS22/21 'Implementation of Basel standards: Final rules published in October 2021.
This report presents the annual Pillar 3 disclosures of Standard Chartered PLC ('the Group') as at 31 December 2025 and should be read in conjunction with the Group's Annual Report and Accounts.
The information presented in this Pillar 3 report is not required to be, and has not been, subjected to external audit.
1.2 Highlights
- The Group's capital and leverage position is managed within the Board-approved risk appetite. The Group is well capitalised with low leverage and high levels of lossabsorbing capacity
- The Group is well capitalised with a Common Equity Tier 1 (CET1) ratio of 14.1 per cent, well ahead of the current requirement of 10.3 per cent
- The Group is not highly leveraged and its leverage ratio of 4.7 per cent is well ahead of the current leverage requirement of 3.7 per cent
- The Group continues to manage its balance sheet proactively, with a particular focus on the efficient management of RWA


RWA by risk type 2025 \$million RWA by risk type 2024 \$million

1.3 Key prudential metrics Table 1: Key metrics template (UK KM1)
| 31.12.25 \$million |
30.09.25 \$million |
30.06.25 \$million |
31.03.25 \$million |
31.12.24 \$million |
||
|---|---|---|---|---|---|---|
| Available own funds | ||||||
| 1 | Common Equity Tier 1 (CET1) capital | 36,440 | 36,594 | 37,260 | 35,122 | 35,190 |
| 2 | Tier 1 capital | 43,949 | 43,109 | 43,777 | 42,629 | 41,672 |
| 3 | Total capital | 53,227 | 52,531 | 53,281 | 53,111 | 53,091 |
| Risk-weighted exposure amounts | ||||||
| 4 | Total risk-weighted exposure amount | 258,031 | 258,378 | 259,684 | 253,596 | 247,065 |
| Risk-based capital ratios as a percentage of RWA |
||||||
| 5 | Common Equity Tier 1 ratio | 14.1% | 14.2% | 14.3% | 13.8% | 14.2% |
| 6 | Tier 1 ratio | 17.0% | 16.7% | 16.9% | 16.8% | 16.9% |
| 7 | Total capital ratio | 20.6% | 20.3% | 20.5% | 20.9% | 21.5% |
| Additional CET1 buffer requirements as a percentage of RWA |
||||||
| 8 | Capital conservation buffer | 2.50% | 2.50% | 2.50% | 2.50% | 2.50% |
| 9 | Institution specific countercyclical capital buffer | 0.38% | 0.37% | 0.38% | 0.37% | 0.37% |
| 10 | Global Systemically Important Institution buffer | 1.00% | 1.00% | 1.00% | 1.00% | 1.00% |
| 11 | Combined buffer requirement | 3.88% | 3.87% | 3.88% | 3.87% | 3.87% |
| UK 11a | Overall capital requirements | 10.26% | 10.25% | 10.48% | 10.48% | 10.48% |
| 12 | CET1 available after meeting the total SREP own funds requirements |
7.74% | 7.78% | 7.75% | 7.25% | 7.64% |
| UK leverage ratio | ||||||
| 13 | Leverage ratio total exposure measure | 938,190 | 936,824 | 933,234 | 909,072 | 868,344 |
| 14 | Leverage ratio | 4.7% | 4.6% | 4.7% | 4.7% | 4.8% |
| Additional leverage ratio disclosure requirements |
||||||
| 14a | Fully loaded ECL accounting model leverage ratio excluding claims on central banks (%) |
4.7% | 4.6% | 4.7% | 4.7% | 4.8% |
| 14b | Leverage ratio including claims on central banks (%) |
4.3% | 4.2% | 4.2% | 4.3% | 4.4% |
| 14c | Average leverage ratio excluding claims on central banks (%) |
4.6% | 4.6% | 4.6% | 4.6% | 4.7% |
| 14d | Average leverage ratio including claims on central banks (%) |
4.2% | 4.1% | 4.2% | 4.2% | 4.2% |
| 14e | Countercyclical leverage ratio buffer (%) | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% |
| Liquidity Coverage Ratio | ||||||
| 15 | Total high-quality liquid assets (HQLA) (Weighted value – average) |
185,262 | 182,646 | 180,147 | 177,586 | 178,676 |
| UK 16a | Cash outflows – Total weighted value | 193,861 | 191,877 | 190,919 | 187,301 | 185,890 |
| UK 16b | Cash inflows – Total weighted value | 74,049 | 71,495 | 69,800 | 68,352 | 66,896 |
| 16 | Total net cash outflows (adjusted value) | 119,812 | 120,381 | 121,119 | 118,948 | 118,995 |
| 17 | Liquidity coverage ratio | 154.8% | 151.9% | 148.8% | 149.4% | 150.3% |
| Net Stable Funding Ratio | ||||||
| 18 | Total available stable funding | 464,406 | 450,956 | 439,809 | 426,699 | 417,658 |
| 19 | Total required stable funding | 335,158 | 324,273 | 319,956 | 314,036 | 308,948 |
| 20 | NSFR ratio (%) | 138.6% | 139.0% | 137.5% | 135.9% | 135.2% |
1.3 Key prudential metrics continued
Table 2 shows information about the Group's total loss-absorbing capacity (TLAC) available, and TLAC requirements, applied at the resolution group level under a Single Point of Entry resolution strategy.
Table 2: Key metrics – TLAC requirements (KM2)
| 31.12.25 \$million |
30.09.25 \$million |
30.06.25 \$million |
31.03.25 \$million |
31.12.24 \$million |
|
|---|---|---|---|---|---|
| Resolution group | |||||
| Total loss-absorbing capacity (TLAC) available | 86,461 | 88,130 | 86,574 | 85,180 | 84,563 |
| Total RWA at the level of the resolution group | 258,031 | 258,378 | 259,684 | 253,596 | 247,065 |
| TLAC as a percentage of RWA | 33.5% | 34.1% | 33.3% | 33.6% | 34.2% |
| UK Leverage ratio exposure measure at the level of the resolution group |
938,190 | 936,824 | 933,234 | 909,072 | 868,344 |
| TLAC as a percentage of UK Leverage exposure measure | 9.2% | 9.4% | 9.3% | 9.4% | 9.7% |
| Does the subordination exemption in the antepenultimate paragraph of Section 11 of the FSB TLAC Term Sheet apply? |
Yes | Yes | Yes | Yes | Yes |
| Does the subordination exemption in the penultimate paragraph of Section 11 of the FSB TLAC Term Sheet apply? |
No | No | No | No | No |
| If the capped subordination exemption applies, the amount of funding issued that ranks pari passu with Excluded Liabilities and that is recognised as external TLAC, divided by funding issued that ranks pari passu with Excluded Liabilities and that would be recognised as external TLAC if no cap was applied (%) |
N/A | N/A | N/A | N/A | N/A |
1.4 Regulatory disclosure framework
The Group complies with the Basel III framework as implemented in the United Kingdom. The Basel III framework is built on the three pillars of the Basel II framework.
Pillar 1: Sets the minimum capital requirements for credit risk, market risk and operational risk
Pillar 2: Considers through the Supervisory Review and Evaluation Process whether further capital is required in addition to Pillar 1 calculations
Pillar 3: Aims to provide a consistent and comprehensive disclosure framework that enhances comparability between banks and further promotes improvements in risk management. Pillar 3 requires all material risks to be disclosed, enabling a comprehensive view of the bank's risk profile
The Pillar 3 Disclosures 2025 comprise all information required to be included in the UK and are prepared at the Group consolidated level. Where disclosure has been withheld as proprietary or non-material, as permitted by the rules, appropriate comment has been included. It is the Group's intention that the Pillar 3 Disclosures be viewed as an integral, albeit separately reported, element of the Annual Report and Accounts. The Group considers a number of factors in determining where disclosure is made between the Annual Report and Accounts and Pillar 3, including International Financial Reporting Standards (IFRS), regulatory requirements and industry best practice. Pages 176 to 177 of this document provide a summary of differences and cross references between the Annual Report and Accounts and the Pillar 3 Disclosures.
Remuneration
The qualitative Pillar 3 remuneration disclosures for the 2025 performance year are set out on pages 182 to 208 of the Directors' remuneration report in the 2025 Annual Report and Accounts. Information is provided on the key components of our remuneration approach and how we develop our approach. The disclosures follow the requirements set out in Part 8 of the CRR and the Basel Committee on Banking Supervision (BCBS) standards issued in March 2017.
G-SIB
The Group has been identified as a Global Systemically Important Bank (G-SIB) by the Financial Stability Board (FSB) since November 2012. The Group's score from the BCBS's methodology for assessing and identifying G-SIBs has resulted in an additional loss-absorbency requirement of 1 per cent of CET1. The EU's Capital Requirements Directive (CRD) mandates the Group to publicly disclose the value of its Global Systemically Important Institution (G-SII) indicators on an annual basis. The terms 'G-SIB' and 'G-SII' are interchangeable – 'G-SIB' is used by the FSB and Basel Committee, whereas CRD refers to 'G-SII'. The Standard Chartered PLC 2025 G-SII disclosure is published on: https://www.sc.com/en/investors/financial-results/.
1.4 Regulatory disclosure framework continued
Frequency
In accordance with Group policy the Pillar 3 Disclosures are made quarterly as at 31 March, 30 June, 30 September and 31 December in line with Article 432 of the CRR. Disclosures are published on the Standard Chartered PLC website aligning with the publication date of the Group's Interim, Half Year and Annual Report and Accounts.
Verification
Whilst the Pillar 3 Disclosures 2025 are not required to be externally audited, the document has been verified internally in accordance with the Group's policies on disclosure and its financial reporting and governance processes. Controls comparable to those for the 2025 Annual Report and Accounts have been applied to confirm compliance with PRA regulations.
- Items excluded on the grounds of materiality:
- Quantitative disclosures of non-deducted participations in insurance undertakings and Collateral obtained by taking possession and execution processes
- Qualitative and quantitative disclosures on exposures to equities not included in the trading book
1.5 Risk management
Effective risk management is essential in delivering consistent and sustainable performance for all our stakeholders and is a central part of the financial and operational management of the Group. The Group adds value to clients and the communities in which they operate by balancing risk and reward to generate returns for shareholders.
The Enterprise Risk Management Framework (ERMF) enables the Group to manage enterprise-wide risks, with the objective of maximising risk-adjusted returns while remaining within our Risk Appetite (RA). RA is defined by the Group and approved by the Board. It is the boundary for the risk that the Group is willing to undertake to achieve its strategic objectives and corporate plan. We set RA to enable us to grow sustainably while managing our risks, giving confidence to our stakeholders. The Group RA is supplemented by risk control tools such as granular level limits, policies, and standards to maintain the Group's risk profile within approved RA.
The ERMF is complemented by frameworks, policies and standards which are mainly aligned to the Principal Risk Types (PRTs), and is embedded across the Group, including its branches and subsidiaries. PRTs are those risks that are inherent in our strategy and business model and have been formally defined in the Group's ERMF.
In the Risk Management Approach section of the 2025 Annual Report and Accounts, we outline our approach and strategy for managing risks. We discuss our risk management practices, monitoring and mitigation, and governance in relation to our main activities and significant risks.
The Group defines nine PRTs in its ERMF:
- Credit Risk (refer to section Credit Risk in pages 226 to 226 of the 2025 Annual Report and Accounts)
- Traded Risk (refer to section Traded Risk on pages 227 to 229 of the 2025 Annual Report and Accounts)
- Treasury Risk (refer to section Treasury Risk on pages 228 to 229 of the 2025 Annual Report and Accounts)
- Operational and Technology Risk (refer to section Operational and Technology Risk on page 286 of the 2025 Annual Report and Accounts)
- Information and Cyber Security Risk (refer to section Information and Cyber Security Risk on page 230 of the 2025 Annual Report and Accounts)
- Financial Crime Risk (refer to section Financial Crime Risk on page 230 of the 2025 Annual Report and Accounts)
- Compliance Risk (refer to section Compliance Risk on page 231 of the 2025 Annual Report and Accounts)
- Environmental, Social and Governance and Reputational (ESGR) Risk (refer to section ESGR Risk on page 231 of the 2025 Annual Report and Accounts)
- Model Risk (refer to section Model Risk on page 232 of the 2025 Annual Report and Accounts)
Credit Risk
Credit risk is the potential for loss due to the failure of a counterparty to meet its obligations to pay the Group. Credit exposures arise from both the banking and trading books.
Credit risk is managed through a framework that sets out policies and procedures covering the measurement and management of credit risk. The Credit Risk Function, as a second line control function, performs independent challenge, monitoring and oversight of the credit risk management practices of the Business and Functions engaged in or supporting revenue generating activities which constitute the First Line of defence. Credit exposure limits are approved within a defined credit approval authority framework.
The Group manages its credit exposures following the principle of diversification across products, geographies, client segments and industry sectors.
The Group uses the Advanced Internal Ratings Based (IRB) approach to calculate credit risk capital requirements with the approval of our relevant regulators. This approach builds on the Group's risk management practices and is the result of a continuing investment in data warehouses and risk models.
1.5 Risk management continued
For portfolios where the Group does not have IRB approval, or where the exposures are permanently exempt from the IRB approach, the Standardised Approach (SA) is used.
Refer to Credit Risk (pages 226 to 227) in the 2025 Annual Report and Accounts where we describe the main components of credit risk management, including our credit risk profile, credit risk measurement and policies set in line with risk appetite. For the scope and main content of reporting to senior management, refer to page 226 in the 2025 Annual Report and Accounts.
Traded Risk
Market Risk is the potential for fair value loss due to adverse moves in financial markets. The Group's exposure to Market Risk arises predominantly from the following sources:
Trading book:
• The Group provides clients access to markets, facilitation of which entails the Group taking moderate Market Risk positions. All trading teams support client activity. There are no proprietary trading teams. Hence, income earned from Market risk-related activities is primarily driven by the volume of client activity
Non-trading book:
- Treasury is required to hold a liquid assets buffer, much of which is held in high-quality marketable debt securities
- The Group underwrites and sells down loans, and invests in select investment grade debt securities with no trading intent
1.6 Accounting and regulatory consolidation
The Pillar 3 Disclosures are prepared at the Group consolidated level. The accounting policy for financial consolidation is provided in the notes to the financial statements in the 2025 Annual Report and Accounts. All banking subsidiaries are fully consolidated for both regulatory and accounting purposes. For associates and joint ventures, the regulatory treatment may differ from the accounting policy, which applies the equity accounting method.
The regulatory consolidation approaches used by the Group are shown in the following table, which identifies the principal undertakings, including investments, associates and joint ventures, which are all principally engaged in the business of banking and provision of other financial services.
| Type | Description | Regulatory consolidation | Principal undertakings within each category |
|---|---|---|---|
| Investment (non significant) |
The Group holds no more than 10 per cent of the issued share capital |
The Group risk-weights the investment subject to the CRD threshold calculation |
– |
| Associate | The Group holds more than 10 per cent and less than 20 per cent of the issued share capital |
The Group risk-weights the investment subject to the CRD threshold calculation |
China Bohai Bank |
| Joint Venture |
The Group enters into a contractual arrangement to exercise joint control over an undertaking |
Where the Group's liability to the joint venture is greater than the capital held, full consolidation is undertaken. Otherwise joint ventures are proportionately consolidated |
Olea Global Pte. Ltd CurrencyFair Limited Exchange Ireland |
| Subsidiary | The Group holds more than 50 per cent of the issued share capital of a financial entity |
The Group fully consolidates the undertaking |
Standard Chartered Bank Standard Chartered Bank Korea Limited Standard Chartered Bank Malaysia Berhad Standard Chartered Bank (Pakistan) Limited Standard Chartered Bank (Taiwan) Limited Standard Chartered Bank (Hong Kong) Limited Standard Chartered Bank (China) Limited Standard Chartered Bank (Singapore) Limited Standard Chartered Bank (Thai) Public Company Limited Standard Chartered Bank Nigeria Limited Standard Chartered Bank Kenya Limited Standard Chartered Private Equity Managers (Hong Kong) Limited |
| Excluded entities |
Insurance or corporate entities excluded from the scope of banking prudential consolidation |
The Group risk-weights the investment subject to the CRD threshold calculation |
Standard Chartered Assurance Ltd Standard Chartered Insurance Ltd |
Table 3: Regulatory consolidation
1.6 Accounting and regulatory consolidation continued Table 4: Outline of the differences in the scopes of consolidation (UK LI3)
| 2025 | ||||||||
|---|---|---|---|---|---|---|---|---|
| Method of regulatory consolidation | ||||||||
| Name of the entity | Description of the entity |
Method of accounting consolidation |
Full consolidation |
Proportional consolidation |
Neither consolidated nor deducted |
Deducted | ||
| Standard Chartered Assurance Ltd Insurance entity | Full consolidation | |||||||
| Standard Chartered Insurance Ltd | Insurance entity | Full consolidation |
1.7 Significant subsidiaries
Under Part 2, rule 2.3 of the CRR requires the application of disclosure requirements of Large subsidiaries of UK parent institutions, UK parent financial holding companies.
These subsidiaries are Standard Chartered – solo consolidated, a UK regulated banking entity, Standard Chartered Bank (Hong Kong) Limited (regulated by the Hong Kong Monetary Authority), Standard Chartered Bank Korea Limited (regulated by the Financial Supervisory Service (FSS) in Korea), and Standard Chartered Bank (Singapore) Limited (regulated by the Monetary Authority of Singapore).
The capital resources of these subsidiaries are calculated in accordance with the regulatory requirements applicable in the countries in which they are incorporated, and therefore cannot be aggregated, but are presented to align with the Group format.
Annex 1 provides a summary of the disclosure for the significant subsidiaries.
1.8 Comparison of accounting balance sheet and exposure at default
The differences between the financial and prudential consolidated balance sheets arise primarily from differences in the basis of consolidation and the requirement to not consolidate for prudential purposes insurance entities which are subject to full consolidation for financial purposes.
Table 5 splits the regulatory balance sheet measured under IFRS into each regulatory risk category. The regulatory risk category drives the approach applied in the calculation of regulatory exposures and RWA.
1.8 Comparison of accounting balance sheet and exposure at default continued
Table 5: Differences between accounting and regulatory scopes of consolidation and the mapping of financial statement categories with regulatory risk categories (UK LI1)
| 2025 | |||||||
|---|---|---|---|---|---|---|---|
| Carrying values as reported in published financial statements \$million |
Carrying values under the scope of regulatory consoli dation \$million |
Subject to the credit risk framework \$million |
Subject to the CCR framework \$million |
Subject to the securitisation framework \$million |
Subject to the market risk framework \$million |
Not subject to own funds requirements or subject to deduction from own funds \$million |
|
| Assets | |||||||
| Cash and balances at central banks | 77,746 | 77,816 | 77,816 | – | – | – | – |
| Financial assets held at fair value through profit | |||||||
| or loss | 195,257 | 195,253 | 15,339 | 170,834 | 1,424 | 179,918 | – |
| Derivative financial instruments | 65,782 | 65,782 | – | 65,782 | – | 65,782 | – |
| Loans and advances to banks | 43,901 | 43,901 | 43,901 | – | – | 730 | – |
| Loans and advances to customers | 286,788 | 286,788 | 258,885 | 9,548 | 18,182 | 9,548 | – |
| Investment securities | 166,956 | 168,743 | 107,671 | 47,128 | 13,944 | 67,054 | – |
| Other assets | 67,931 | 68,172 | 40,422 | 27,750 | – | 30,766 | – |
| Current tax assets | 574 | 573 | 573 | – | – | – | – |
| Prepayments and accrued income | 3,058 | 3,064 | 3,064 | – | – | – | – |
| Interests in associates and joint ventures | 1,426 | 1,486 | 1,486 | – | – | – | – |
| Goodwill and intangible assets | 6,231 | 6,263 | – | – | – | – | 6,263 |
| Property, plant and equipment | 2,559 | 2,558 | 2,558 | – | – | – | – |
| Deferred tax assets | 493 | 493 | 473 | – | – | – | 20 |
| Retirement benefit schemes in surplus | 154 | 154 | 154 | – | – | – | – |
| Asset classified as held for sale | 1,099 | 1,099 | 1,099 | – | – | – | – |
| Total assets | 919,955 | 922,145 | 553,441 | 321,041 | 33,551 | 353,797 | 6,283 |
| Liabilities | |||||||
| Deposits by banks | 30,846 | 30,846 | – | – | – | – | 30,846 |
| Customer accounts | 530,161 | 530,161 | – | – | – | – | 530,161 |
| Repurchase agreements and other similar secured | |||||||
| borrowing | 7,757 | 7,757 | – | 7,757 | – | – | – |
| Financial liabilities held at fair value through profit | |||||||
| or loss | 89,597 | 89,597 | – | 68,965 | – | – | 20,632 |
| Derivative financial instruments | 68,204 | 68,204 | – | 68,204 | – | 68,204 | – |
| Debt securities in issue | 72,858 | 72,858 | – | – | – | – | 72,858 |
| Other liabilities | 46,655 | 48,911 | 6,448 | 15,539 | – | 15,539 | 33,372 |
| Current tax liabilities | 709 | 705 | – | – | – | – | 705 |
| Accruals and deferred income | 7,358 | 7,237 | – | – | – | – | 7,237 |
| Subordinated liabilities and other borrowed funds | 8,834 | 8,834 | – | – | – | – | 8,834 |
| Of which: considered as Additional Tier 1 capital | – | – | – | – | – | – | – |
| Of which: considered as Tier 2 capital | 8,834 | 8,834 | – | – | – | – | 8,834 |
| Deferred tax liabilities | 752 | 752 | – | – | – | – | 752 |
| Provisions for liabilities and charges | 401 | 401 | – | – | – | – | 401 |
| Retirement benefit obligation | 323 | 323 | – | – | – | – | – |
| Liabilities included in disposal groups held for sale | 914 | 914 | – | – | – | – | – |
| Total liabilities | 865,369 | 867,500 | 6,448 | 160,465 | – | 83,743 | 705,798 |
| Equity | |||||||
| Share capital and share premium account | 6,614 | 6,614 | – | – | – | – | – |
| Other reserves & retained earnings | 39,979 | 40,034 | – | – | – | – | – |
| Total parent company shareholders' equity | 46,593 | 46,648 | – | – | – | – | – |
| Other equity instruments | 7,528 | 7,529 | – | – | – | – | – |
| Total equity excluding non-controlling interests | 54,121 | 54,177 | – | – | – | – | – |
| Non-controlling interest | 465 | 468 | – | – | – | – | – |
| Total equity | 54,586 | 54,645 | – | – | – | – | – |
| Total equity and liabilities | 919,955 | 922,145 | 6,448 | 160,465 | – | 83,743 | 705,798 |
1.8 Comparison of accounting balance sheet and exposure at default continued Table 5: Differences between accounting and regulatory scopes of consolidation and the mapping of financial statement categories with regulatory risk categories (UK LI1) continued
| 2024 | |||||||
|---|---|---|---|---|---|---|---|
| Carrying values as reported in published financial statements \$million |
Carrying values under the scope of regulatory consoli dation \$million |
Subject to the credit risk framework \$million |
Subject to the CCR framework \$million |
Subject to the securitisation framework \$million |
Subject to the market risk framework \$million |
Not subject to own funds requirements or subject to deduction from own funds \$million |
|
| Assets | |||||||
| Cash and balances at central banks | 63,447 | 63,500 | 63,500 | – | – | – | – |
| Financial assets held at fair value through profit | |||||||
| or loss | 177,517 | 177,515 | 9,297 | 162,734 | 824 | 168,220 | – |
| Derivative financial instruments | 81,472 | 81,472 | – | 81,472 | – | 81,472 | – |
| Loans and advances to banks | 43,593 | 43,593 | 43,593 | – | – | 4,852 | – |
| Loans and advances to customers | 281,032 | 281,032 | 255,773 | 5,247 | 18,335 | 5,247 | – |
| Investment securities | 144,556 | 145,568 | 111,267 | 20,634 | 13,668 | 44,502 | – |
| Other assets | 43,468 | 43,794 | 34,446 | 9,348 | – | 8,479 | – |
| Current tax assets | 663 | 663 | 663 | – | – | – | – |
| Prepayments and accrued income | 3,207 | 3,209 | 3,209 | – | – | – | – |
| Interests in associates and joint ventures | 1,020 | 996 | 996 | – | – | – | – |
| Goodwill and intangible assets | 5,791 | 5,814 | – | – | – | – | 5,814 |
| Property, plant and equipment | 2,425 | 2,424 | 2,424 | – | – | – | – |
| Deferred tax assets | 414 | 414 | 315 | – | – | – | 99 |
| Retirement benefit schemes in surplus | 151 | 151 | 151 | – | – | – | – |
| Asset classified as held for sale | 932 | 932 | 932 | – | – | – | – |
| Total assets | 849,688 | 851,077 | 526,566 | 279,434 | 32,827 | 312,773 | 5,913 |
| Liabilities | |||||||
| Deposits by banks | 25,400 | 25,400 | – | – | – | – | 25,400 |
| Customer accounts | 464,489 | 464,489 | – | – | – | – | 464,489 |
| Repurchase agreements and other similar secured | |||||||
| borrowing | 12,132 | 12,132 | – | 12,132 | – | – | – |
| Financial liabilities held at fair value through profit | |||||||
| or loss | 85,462 | 85,462 | – | 66,307 | – | – | 19,155 |
| Derivative financial instruments | 82,064 | 82,064 | – | 82,064 | – | 82,064 | – |
| Debt securities in issue | 64,609 | 64,609 | – | – | – | – | 64,609 |
| Other liabilities | 44,681 | 46,148 | 6,550 | 14,527 | – | 14,527 | 31,621 |
| Current tax liabilities | 726 | 727 | – | – | – | – | 727 |
| Accruals and deferred income | 6,896 | 6,768 | – | – | – | – | 6,768 |
| Subordinated liabilities and other borrowed funds | 10,382 | 10,382 | – | – | – | – | 10,382 |
| Of which: considered as Additional Tier 1 capital | – | – | – | – | – | – | – |
| Of which: considered as Tier 2 capital | 10,382 | 10,382 | – | – | – | – | 10,382 |
| Deferred tax liabilities | 567 | 567 | – | – | – | – | 567 |
| Provisions for liabilities and charges | 349 | 349 | – | – | – | – | 349 |
| Retirement benefit obligation | 266 | 266 | – | – | – | – | – |
| Liabilities included in disposal groups held for sale | 381 | 381 | – | – | – | – | – |
| Total liabilities | 798,404 | 799,744 | 6,550 | 175,030 | – | 96,591 | 624,067 |
| Equity | – | – | – | – | – | – | – |
| Share capital and share premium account | 6,695 | 6,695 | – | – | – | – | – |
| Other reserves & retained earnings | 37,693 | 37,745 | – | – | – | – | – |
| Total parent company shareholders' equity | 44,388 | 44,440 | – | – | – | – | – |
| Other equity instruments | 6,502 | 6,502 | – | – | – | – | – |
| Total equity excluding non-controlling interests | 50,890 | 50,942 | – | – | – | – | – |
| Non-controlling interest | 394 | 391 | – | – | – | – | – |
| Total equity | 51,284 | 51,333 | – | – | – | – | – |
| Total equity and liabilities | 849,688 | 851,077 | 6,550 | 175,030 | – | 96,591 | 624,067 |
1.8 Comparison of accounting balance sheet and exposure at default continued
Table 6 shows the effect of regulatory adjustments required to derive the Group's exposure at default (EAD) for the purposes of calculating its credit risk capital requirements. The differences between the carrying values under regulatory scope of consolidation and amounts considered for regulatory purposes shown in Table 6 are mainly due to derivatives netting benefits, provisions, collateral and off-balance sheet exposures. The standardised credit risk before and after the effect of CRM is presented in Table 68; standardised credit and counterparty credit risk by risk weight is presented in Tables 71 and 88 and IRB credit and counterparty credit risk before and after the effect of Credit Risk Mitigation (CRM) is presented in Table 51. Information on the standardised and IRB counterparty credit risk exposures can be found in section 4.2. Further detail on the EAD under the securitisation framework can be found in Tables 72 and 73.
Table 6: Main sources of differences between regulatory exposure amounts and carrying values in financial statements (UK LI2)
| 2025 | |||||
|---|---|---|---|---|---|
| Subject to the credit risk framework \$million |
Subject to the CCR framework \$million |
Subject to Securitisation framework \$million |
Subject to Market risk framework \$million |
||
| 1 | Assets carrying value amount under the scope of regulatory consolidation (as per template LI1) |
553,441 | 321,041 | 33,551 | 353,797 |
| 2 | Liabilities carrying value amount under the regulatory scope of consolidation (as per template LI1) |
6,448 | 160,465 | – | 83,743 |
| 3 | Total net amount under the regulatory scope of consolidation | 546,993 | 160,577 | 33,551 | 270,054 |
| 4 | Off-balance-sheet amounts | 108,243 | – | – | – |
| 5 | Differences in valuations | – | 81,336 | – | – |
| 6 | Differences due to different netting rules, other than those already included in row 2 |
– | – | – | – |
| 7 | Differences due to consideration of provisions | 4,153 | – | – | – |
| 8 | Differences due to the use of credit risk mitigation techniques (CRMs) |
1,012 | 126,701 | 1,565 | – |
| 9 | Differences due to credit conversion factors | – | – | – | – |
| 10 | Differences due to Securitisation with risk transfer | – | 10,114 | – | – |
| 11 | Other differences | 443 | (836) | (1) | – |
| 12 | Regulatory exposure at default pre credit risk mitigation | 660,844 | 377,892 | 35,115 | 270,054 |
| 2024 | ||||||
|---|---|---|---|---|---|---|
| Subject to the credit risk framework \$million |
Subject to the CCR framework \$million |
Subject to Securitisation framework \$million |
Subject to Market risk framework \$million |
|||
| 1 | Assets carrying value amount under the scope of regulatory consolidation (as per template LI1) |
526,566 | 279,434 | 32,827 | 312,773 | |
| 2 | Liabilities carrying value amount under the regulatory scope of consolidation (as per template LI1) |
6,550 | 175,030 | – | 96,591 | |
| 3 | Total net amount under the regulatory scope of consolidation | 520,016 | 104,404 | 32,827 | 216,182 | |
| 4 | Off-balance-sheet amounts | 101,055 | – | – | ||
| 5 | Differences in valuations | – | 79,094 | – | ||
| 6 | Differences due to different netting rules, other than those already included in row 2 |
– | – | – | ||
| 7 | Differences due to consideration of provisions | 4,579 | – | – | ||
| 8 | Differences due to the use of credit risk mitigation techniques (CRMs) |
883 | 106,339 | 1,498 | ||
| 9 | Differences due to credit conversion factors | – | – | – | ||
| 10 | Differences due to Securitisation with risk transfer | – | 31,479 | – | ||
| 11 | Other differences | (657) | 133 | (1) | ||
| 12 | Regulatory exposure at default pre credit risk mitigation | 625,877 | 321,449 | 34,324 | 216,182 |
1.8 Comparison of accounting balance sheet and exposure at default continued
The CRR provisions on prudential valuation require banks to quantify several valuation uncertainties pertaining to the valuation of assets and liabilities recorded at fair value for accounting purposes. The amounts by which the resulting Prudent Valuation Adjustments (PVA) exceed any associated Fair Value Adjustments are referred to as the Additional Valuation Adjustments (AVAs) and their aggregate is deducted from CET1 capital. AVAs arise from uncertainties related to market prices, close-out costs, model risk, concentrated positions, future administrative costs, early terminations and operational risks.
Table 7: Prudent valuation adjustments (PVA) (UK PV1)
| 2025 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Risk category | Category level AVA – Valuation uncertainty |
|||||||||||
| Equity \$millions |
Interest rates \$millions |
FX \$millions |
Credit \$millions |
Commodities \$millions |
Unearned credit spreads AVA \$millions |
Investment and funding costs AVA \$millions |
Total category level \$millions |
Of which: Total core approach in the trading book \$millions |
Of which: Total core approach in the banking book \$millions |
|||
| 1 | Market price uncertainty | 35.7 | 101.8 | 16.0 | 47.9 | 18.2 | 23.3 | 0.7 | 243.6 | 152.9 | 90.7 | |
| 3 | Close-out cost | 1.5 | 111.4 | 7.1 | 6.6 | 6.7 | 1.3 | 0.7 | 135.4 | 102.9 | 32.5 | |
| 4 | Concentrated positions | 111.7 | 41.9 | 4.8 | 60.2 | 2.7 | – | – | 221.3 | 14.0 | 207.3 | |
| 5 | Early termination | – | – | – | – | – | – | – | – | – | – | |
| 6 | Model risk | 0.0 | 12.7 | 0.0 | 0.6 | 0.6 | 0.6 | – | 14.5 | 14.5 | – | |
| 7 | Operational risk | 3.7 | 25.3 | 2.3 | 5.7 | 1.9 | 2.5 | 0.1 | 41.6 | 26.6 | 15.0 | |
| 10 | Future administrative costs | 3.7 | 3.1 | 0.7 | 29.0 | 0.2 | – | – | 36.7 | 32.8 | 4.0 | |
| 12 | Total Additional Valuation Adjustments (AVAs) |
693.2 | 343.8 | 349.4 |
| 2024 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Risk category | Category level AVA – Valuation uncertainty |
|||||||||||
| Equity \$millions |
Interest rates \$millions |
FX \$millions |
Credit \$millions |
Commodities \$millions |
Unearned credit spreads AVA \$millions |
Investment and funding costs AVA \$millions |
Total category level \$millions |
Of which: Total core approach in the trading book \$millions |
Of which: Total core approach in the banking book \$millions |
|||
| 1 | Market price uncertainty | 35.9 | 115.2 | 20.1 | 53.4 | 11.3 | 30.3 | 2.3 | 268.5 | 168.3 | 100.2 | |
| 3 | Close-out cost | 2.3 | 87.4 | 3.6 | 4.0 | 6.0 | 1.2 | 0.7 | 105.3 | 77.9 | 27.4 | |
| 4 | Concentrated positions | 63.8 | 74.9 | 3.8 | 32.4 | 2.9 | – | – | 177.9 | 58.2 | 119.7 | |
| 5 | Early termination | – | – | – | – | – | – | – | – | – | – | |
| 6 | Model risk | 0.0 | 9.4 | 0.1 | 0.5 | 0.1 | 1.0 | – | 11.1 | 11.1 | – | |
| 7 | Operational risk | 3.8 | 20.6 | 4.0 | 4.7 | 1.7 | 3.1 | 0.3 | 38.3 | 26.2 | 12.1 | |
| 10 | Future administrative costs | 0.8 | 2.6 | 0.3 | 18.7 | 0.1 | – | – | 22.4 | 21.7 | 0.7 | |
| 12 | Total Additional Valuation Adjustments (AVAs) |
623.5 | 363.4 | 260.1 |
2. Capital
2.1 Capital management
The Group's capital, leverage and Minimum Requirements for own funds and Eligible Liabilities (MREL) positions are managed within the Board-approved risk appetite. The Group is well capitalised with low leverage and high levels of lossabsorbing capacity.
The Risk management approach section of the 2025 Annual Report and Accounts sets out our approach to capital management (pages 222 to 234).
2.2 Capital resources
All capital instruments included in the capital base meet the requirements set out in the CRR for their respective tier of capital.
For regulatory purposes, capital is categorised into two tiers, depending on the degree of permanence and loss-absorbency exhibited. These are Tier 1 and Tier 2 capital which are described below.
Tier 1 capital
- Tier 1 capital is going concern capital and is available for use to cover risks and losses whilst enabling the organisation to continue trading
- Tier 1 capital comprises permanent share capital, profit and loss account and other eligible reserves, equity non-controlling interests and Additional Tier 1 instruments, after the deduction of certain regulatory adjustments
- Permanent share capital is an item of capital issued by an organisation to an investor, which is fully paid-up and where the proceeds of issue are immediately and fully available. It can only be redeemed on the winding-up of the organisation. Profit and loss account and other eligible reserves are accumulated resources included in shareholders' funds in an organisation's balance sheet, with certain regulatory adjustments applied
- Equity non-controlling interests represent the equity stakes held by non-controlling shareholders in the Group's undertakings
- Additional Tier 1 securities are deeply subordinated instruments which have loss-absorbing qualities such as discretionary coupons, principal write-down or conversion to equity and can therefore be included as Tier 1 capital
Tier 2 capital
Tier 2 capital is gone concern capital to help ensure senior creditors and depositors can be repaid if the organisation fails. Tier 2 capital consists of capital instruments which are normally of medium to long-term maturity with an original maturity of at least five years. For regulatory purposes, it is a requirement that these instruments be amortised on a straight-line basis in their final five years of maturity.
Details of the Group's capital instruments (both Tier 1 and 2 capital) are set out in the Standard Chartered PLC Main Features of Capital Instruments document available on the Group's website at https://www.sc.com/en/investors/credit-ratings-fixedincome/#capitalsecurities.
Table 8 summarises the consolidated capital position of the Group.
Table 8: Reconciliation between financial total equity and regulatory CET1 before regulatory adjustments
| 2025 \$million |
2024 \$million |
|
|---|---|---|
| Total equity per balance sheet (financial view) | 54,586 | 51,284 |
| Consolidation and regulatory adjustments | 56 | 53 |
| Total equity per balance sheet (regulatory view) | 54,642 | 51,337 |
| Foreseeable dividend | (1,377) | (923) |
| Other equity instruments (included in AT1) | (9,024) | (7,996) |
| Non-controlling interests | (202) | (159) |
| Common Equity Tier 1 capital before regulatory adjustments | 44,039 | 42,259 |
2.2 Capital resources continued Table 9: Composition of regulatory own funds (UK CC1)
| 2025 \$million |
2024 \$million |
||
|---|---|---|---|
| Common Equity Tier 1 (CET1) capital: instruments and reserves | |||
| 1 | Capital instruments and the related share premium accounts | 5,120 | 5,201 |
| Of which: Share premium accounts | 3,989 | 3,989 | |
| 2 | Retained earnings1 | 24,528 | 24,950 |
| 3 | Accumulated other comprehensive income (and other reserves) | 10,406 | 8,724 |
| 5 | Minority interests (amount allowed in consolidated CET1) | 262 | 235 |
| 5a | Independently reviewed interim and year-end profits/(loss)2 | 5,100 | 4,072 |
| Foreseeable dividends3 | (1,377) | (923) | |
| 6 | Common Equity Tier 1 (CET1) capital before regulatory adjustments | 44,039 | 42,259 |
| Common Equity Tier 1 capital: regulatory adjustments | |||
| 7 | Additional value adjustments | (693) | (624) |
| 8 | Intangible assets (net of related tax liability) | (6,145) | (5,696) |
| 10 | Deferred tax assets that rely on future profitability excluding those arising from | ||
| temporary differences (net of related tax liability where the conditions in Article 38 (3) | |||
| CRR are met) | (15) | (31) | |
| 11 | Fair value reserves related to gains or losses on cash flow hedges of financial instruments | ||
| that are not valued at fair value | (315) | (4) | |
| 12 | Negative amounts resulting from the calculation of expected loss amounts | (599) | (702) |
| 14 | Gains or losses on liabilities valued at fair value resulting from changes in own | ||
| credit standing | 412 | 278 | |
| 15 | Defined-benefit pension fund assets | (149) | (149) |
| Fair value gains and losses from own credit risk related to derivative liabilities | (70) | (97) | |
| UK-20a | Exposure amount of the following items which qualify for a RW of 1250%, where the | ||
| institution opts for the deduction alternative | (25) | (44) | |
| UK-20c | Of which: securitisation positions | (11) | (8) |
| UK-20d | Of which: free deliveries | (14) | (36) |
| 27a | Other regulatory adjustments to CET1 capital (including IFRS 9 transitional adjustments when relevant) |
– | – |
| 28 | Total regulatory adjustments to Common Equity Tier 1 (CET1) | (7,599) | (7,069) |
| 29 | Common Equity Tier 1 (CET1) capital | 36,440 | 35,190 |
| Additional Tier 1 (AT1) capital: instruments | |||
| 30 | Capital instruments and the related share premium accounts | 7,529 | 6,502 |
| 31 | Of which: classified as equity under applicable accounting standards | 7,529 | 6,502 |
| 32 | Of which: classified as liabilities under applicable accounting standards | – | – |
| 36 | Additional Tier 1 (AT1) capital before regulatory adjustments | 7,529 | 6,502 |
| Additional Tier 1 capital: regulatory adjustments | – | – | |
| 37 | Direct, indirect and synthetic holdings by an institution of own AT1 instruments | ||
| (negative amount) | (20) | (20) | |
| 43 | Total regulatory adjustments to Additional Tier 1 (AT1) capital | (20) | (20) |
| 44 | Additional Tier 1 (AT1) capital | 7,509 | 6,482 |
| 45 | Tier 1 capital (T1 = CET1 + AT1) | 43,949 | 41,672 |
| Tier 2 (T2) capital: instruments and provisions | |||
| 46 | Capital instruments and the related share premium accounts | 9,041 | 11,231 |
| 47 | Amount of qualifying items referred to in Article 484 (5) CRR and the related share | ||
| premium accounts subject to phase out from T2 as described in Article 486(4) CRR | – | – | |
| 48 | Qualifying own funds instruments included in consolidated T2 capital (including minority | ||
| interests and AT1 instruments not included in rows 5 or 34) issued by subsidiaries and | |||
| held by third parties | 267 | 218 | |
| 51 | Tier 2 (T2) capital before regulatory adjustments | 9,308 | 11,449 |
| Tier 2 capital: regulatory adjustments | |||
| 52 | Direct, indirect and synthetic holdings by an institution of own T2 instruments and | ||
| subordinated loans | (30) | (30) | |
| 57 | Total regulatory adjustments to Tier 2 (T2) capital | (30) | (30) |
| 58 | Tier 2 (T2) capital | 9,278 | 11,419 |
| 59 | Total capital (TC = T1 + T2) | 53,227 | 53,091 |
2.2 Capital resources continued
| 2025 \$million |
2024 \$million |
||
|---|---|---|---|
| 60 | Total Risk exposure amount | 258,031 | 247,065 |
| Capital ratios and buffers | |||
| 61 | Common Equity Tier 1 (as a percentage of total risk exposure amount) | 14.1% | 14.2% |
| 62 | Tier 1 (as a percentage of total risk exposure amount) | 17.0% | 16.9% |
| 63 | Total capital (as a percentage of total risk exposure amount) | 20.6% | 21.5% |
| 64 | Institution CET1 overall capital requirement (CET1 requirement in accordance with Article 92 (1) CRR, plus additional CET1 requirement which the institution is required to hold in accordance with point (a) of Article 104(1) CRD, plus combined buffer requirement in accordance with Article 128(6) CRD) expressed as a percentage of risk exposure amount) |
10.26% | 10.48% |
| 65 | Of which: capital conservation buffer requirement | 2.50% | 2.50% |
| 66 | Of which: countercyclical buffer requirement | 0.38% | 0.37% |
| 67 | Of which: systemic risk buffer requirement | – | – |
| UK-67a | Of which: Global Systemically Important Institution (G-SII) or Other Systemically Important Institution (O-SII) buffer |
1.0% | 1.0% |
| 68 | Common Equity Tier 1 available to meet buffers (as a percentage of risk exposure amount) | 7.74% | 7.64% |
| Amounts below the thresholds for deduction (before risk weighting) | |||
| 72 | Direct and indirect holdings of own funds and eligible liabilities of financial sector entities where the institution does not have a significant investment in those entities (amount below 10% threshold and net of eligible short positions) |
2,270 | 2,560 |
| 73 | Direct and indirect holdings by the institution of the CET1 instruments of financial sector entities where the institution has a significant investment in those entities (amount below 17.65% thresholds and net of eligible short positions) |
1,186 | 868 |
| 75 | Deferred tax assets arising from temporary differences (amount below 17,65% threshold, net of related tax liability where the conditions in Article 38 (3) CRR are met) |
572 | 480 |
| Applicable caps on the inclusion of provisions in Tier 2 | |||
| 76 | Credit risk adjustments included in T2 in respect of exposures subject to standardised approach (prior to the application of the cap) |
– | – |
| 77 | Cap on inclusion of credit risk adjustments in T2 under standardised approach | 575 | 500 |
| 78 | Credit risk adjustments included in T2 in respect of exposures subject to internal ratings-based approach (prior to the application of the cap) |
– | – |
| 79 | Cap for inclusion of credit risk adjustments in T2 under internal ratings-based approach | 826 | 845 |
1 Retained earnings under CRD IV include the effect of regulatory consolidation adjustments.
2 Independently reviewed year-end profits are in accordance with regulatory consolidation rules.
3 Foreseeable dividends as at FY 2025 represent ordinary, preference and AT1 securities dividends.
The main movements in capital in the period were:
- CET1 capital increased by \$1.2 billion as retained profits of \$5.1 billion, movement in other comprehensive income of \$0.5 billion, foreign currency translation impact of \$0.9 billion were partly offset by share buyback of \$2.8 billion, distributions paid and foreseeable of \$1.9 billion, and an increase in regulatory deductions and other movements of \$0.5 billion.
- AT1 capital increased by \$1.0 billion following the issuance of \$1.0 billion of 7.63 per cent securities and \$1.0 billion of 7.00 per cent securities partly offset by the redemption of \$1.0 billion of 6.00 per cent securities.
- Tier 2 capital decreased by \$2.1 billion due to the redemption of \$2.2 billion of Tier 2 during the year partly offset by the reversal of regulatory amortisation and foreign currency translation impact.
The Group's current CET1 requirement is 10.3 per cent, comprising:
- A minimum Pillar 1 CET1 requirement of 4.5 per cent
- A Pillar 2A CET1 requirement of 1.9 per cent being 56 per cent of the total Pillar 2A requirement of 3.3 per cent
- A capital conservation buffer of 2.5 per cent
- A G-SII buffer of 1.0 per cent
- A countercyclical capital buffer of 0.4 per cent
2.2 Capital resources continued
Table 10: Reconciliation of regulatory own funds to balance sheet in the audited financial statements (UK CC2)
| 2025 | 2024 | |||
|---|---|---|---|---|
| Balance sheet as in published financial statements |
Under regulatory scope of consolidation |
Balance sheet as in published financial statements |
Under regulatory scope of consolidation |
|
| Assets | \$million | \$million | \$million | \$million |
| Cash and balances at central banks | 77,746 | 77,816 | 63,447 | 63,500 |
| Financial assets held at fair value through profit or loss | 195,257 | 195,253 | 177,517 | 177,515 |
| Derivative financial instruments | 65,782 | 65,782 | 81,472 | 81,472 |
| Loans and advances to banks | 43,901 | 43,901 | 43,593 | 43,593 |
| Loans and advances to customers | 286,788 | 286,788 | 281,032 | 281,032 |
| Investment securities | 166,956 | 168,743 | 144,556 | 145,568 |
| Other assets | 67,931 | 68,172 | 43,468 | 43,794 |
| Current tax assets | 574 | 573 | 663 | 663 |
| Prepayments and accrued income | 3,058 | 3,064 | 3,207 | 3,209 |
| Interests in associates and joint ventures | 1,426 | 1,486 | 1,020 | 996 |
| Goodwill and intangible assets | 6,231 | 6,263 | 5,791 | 5,814 |
| Of which: goodwill | 6,224 | 6,258 | 5,791 | 5,810 |
| Of which: other intangibles (excluding MSRs) | 7 | 5 | – | 4 |
| Of which: MSRs | – | – | – | – |
| Property, plant and equipment | 2,559 | 2,558 | 2,425 | 2,424 |
| Deferred tax assets | 493 | 493 | 414 | 414 |
| Retirement benefit schemes in surplus | 154 | 154 | 151 | 151 |
| Assets classified as held for sale | 1,099 | 1,099 | 932 | 932 |
| Total assets | 919,955 | 922,145 | 849,688 | 851,077 |
| Liabilities | ||||
| Deposits by banks | 30,846 | 30,846 | 25,400 | 25,400 |
| Customer accounts | 530,161 | 530,161 | 464,489 | 464,489 |
| Repurchase agreements and other similar secured borrowing | 7,757 | 7,757 | 12,132 | 12,132 |
| Financial liabilities held at fair value through profit or loss | 89,597 | 89,597 | 85,462 | 85,462 |
| Derivative financial instruments | 68,204 | 68,204 | 82,064 | 82,064 |
| Debt securities in issue | 72,858 | 72,858 | 64,609 | 64,609 |
| Other liabilities | 46,655 | 48,911 | 44,681 | 46,148 |
| Current tax liabilities | 709 | 705 | 726 | 727 |
| Accruals and deferred income | 7,358 | 7,237 | 6,896 | 6,768 |
| Subordinated liabilities and other borrowed funds | 8,834 | 8,834 | 10,382 | 10,382 |
| Of which: considered as Additional Tier 1 capital | – | – | – | – |
| Of which: considered as Tier 2 capital | 8,834 | 8,834 | 10,382 | 10,382 |
| Deferred tax liabilities | 752 | 752 | 567 | 567 |
| Provisions for liabilities and charges | 401 | 401 | 349 | 349 |
| Retirement benefit obligations | 323 | 323 | 266 | 266 |
| Liabilities included in disposal groups held for sale | 914 | 914 | 381 | 381 |
| Total liabilities | 865,369 | 867,500 | 798,404 | 799,744 |
| Shareholders' Equity | ||||
| Share capital and share premium account Other reserves & retained earnings |
6,614 39,979 |
6,614 40,034 |
6,695 37,693 |
6,695 37,745 |
| Total parent company shareholders' equity | 46,593 | 46,648 | 44,388 | 44,440 |
| Other equity instruments | 7,528 | 7,529 | 6,502 | 6,502 |
| Total equity excluding non-controlling interests | 54,121 | 54,177 | 50,890 | 50,942 |
| Non-controlling interest | 465 54,586 |
468 54,645 |
394 | 391 |
| Total equity Total equity and liabilities |
919,955 | 922,145 | 51,284 849,688 |
51,333 851,077 |
2.3 Minimum requirement for own funds and eligible liabilities
From 1 January 2019, a requirement for total loss-absorbing capacity (TLAC) was introduced, as defined in the final standards adopted by the Financial Stability Board (FSB). In the EU, TLAC requirements were implemented by the Capital Requirements Regulation II (CRR II) which was published in the Official Journal of the European Union on the 7 June 2019 and came into effect on 27 June 2019 and included a new framework on MREL.
MREL is intended to ensure that there is sufficient equity and specific types of liabilities to facilitate an orderly resolution that minimises any impact on financial stability and ensures the continuity of critical functions and avoids exposing taxpayers to loss. The new framework is complemented with new disclosure requirements. As the specific EU format for disclosure is yet to be agreed, the disclosures are based on the formats provided in the Basel Committee Standards for Pillar 3 Phase 2 disclosures requirements.
The Group's MREL leverage requirement as at 31 December 2025 was 28.4 per cent of RWA. This is composed of a minimum requirement of 24.5 per cent of RWA and the Group's combined buffer (comprising the capital conservation buffer, the G-SII buffer and the countercyclical buffer). The Group's MREL ratio was 33.5 per cent of RWA and 9.2 per cent of leverage exposure at 31 December 2025.
During 2025, the Group successfully raised \$9.9 billion of MREL eligible securities from its holding company, Standard Chartered PLC. Issuance include \$2.0 billion of Additional Tier 1 and \$7.9 billion of callable senior debt.
The Group raised an additional \$0.6 billion of Additional Tier 1 and \$3.7 billion in senior securities post the balance sheet date, i.e. not included in the FY 2025 MREL position.
Details of the Group's MREL eligible instruments are set out in the Standard Chartered PLC Main Features of Capital Instruments document available on the Group's website at https://www.sc.com/en/investors/credit-ratings-fixedincome/#capitalsecurities.
2.3 Minimum requirement for own funds and eligible liabilities continued
Table 11 shows details of the composition of the Groups MREL.
Table 11: TLAC composition for G-SIBs (TLAC1)
| 2025 \$million |
2024 \$million |
|
|---|---|---|
| Regulatory capital elements of TLAC and adjustments | ||
| Common Equity Tier 1 capital (CET1) | 36,440 | 35,189 |
| Additional Tier 1 capital (AT1) before TLAC adjustments | 7,509 | 6,482 |
| AT1 ineligible as TLAC as issued out of subsidiaries to third parties | – | – |
| Other adjustments | – | – |
| AT1 instruments eligible under the TLAC framework | 7,509 | 6,482 |
| Tier 2 capital (T2) before TLAC adjustments | 9,278 | 11,419 |
| Amortised portion of T2 instruments where remaining maturity > 1 year | 941 | 714 |
| T2 capital ineligible as TLAC as issued out of subsidiaries to third parties | (267) | (218) |
| Other adjustments | – | – |
| T2 instruments eligible under the TLAC framework | 9,952 | 11,915 |
| TLAC arising from regulatory capital | 53,901 | 53,587 |
| Non-regulatory capital elements of TLAC | ||
| External TLAC instruments issued directly by the bank and subordinated to excluded liabilities | – | – |
| External TLAC instruments issued directly by the bank which are not subordinated to excluded liabilities | ||
| but meet all other TLAC term sheet requirements | 32,599 | 30,987 |
| Of which: amount eligible as TLAC after application of the caps | 32,599 | 30,987 |
| External TLAC instruments issued by funding vehicles prior to 1 January 2022 | – | – |
| Eligible ex ante commitments to recapitalise a G-SIB in resolution | – | – |
| TLAC arising from non-regulatory capital instruments before adjustments | 32,599 | 30,987 |
| Non-regulatory capital elements of TLAC: adjustments | ||
| TLAC before deductions | 86,461 | 84,573 |
| Deductions of exposures between MPE resolution groups that correspond to items eligible for TLAC (not | ||
| applicable to SPE G-SIBs) | – | – |
| Deduction of investments in own other TLAC liabilities | (39) | (11) |
| Other adjustments to TLAC | – | – |
| TLAC after deductions | 86,561 | 84,562 |
| Risk-weighted assets and leverage exposure measure for TLAC purposes | ||
| Total risk-weighted assets adjusted as permitted under the TLAC regime | 258,031 | 247,065 |
| UK Leverage exposure measure | 938,190 | 868,344 |
| TLAC ratios and buffers | ||
| TLAC (as a percentage of risk-weighted assets adjusted as permitted under the TLAC regime) | 33.5% | 34.2% |
| TLAC (as a percentage of leverage exposure) | 9.2% | 9.7% |
| CET1 (as a percentage of risk-weighted assets) available after meeting the resolution group's minimum | ||
| capital and TLAC requirements | 7.7% | 7.7% |
| Institution-specific buffer requirement (capital conservation buffer plus countercyclical buffer | ||
| requirements plus higher loss absorbency requirement, expressed as a percentage of risk-weighted assets) |
3.9% | 3.9% |
| Of which: capital conservation buffer requirement | 2.5% | 2.5% |
| Of which: bank specific countercyclical buffer requirement | 0.4% | 0.4% |
| Of which: higher loss absorbency requirement | 1.0% | 1.0% |
2.3 Minimum requirement for own funds and eligible liabilities continued
Table 12 shows information regarding the ranking of the Group's liabilities at the resolution group level.
Table 12: Resolution entity – creditor ranking at legal entity level (TLAC3)
| 2025 | ||||
|---|---|---|---|---|
| Creditor ranking | ||||
| 1 \$million |
2 \$million |
3 \$million |
Total \$million |
|
| Description of creditor ranking | Tertiary | Tertiary | Ordinary | |
| non | non | non | ||
| preferential | preferential | preferential | ||
| debt2 | debt – Tier 2 | debt3 | ||
| securities | ||||
| Total capital and liabilities net of credit risk mitigation1 | 7,580 | 10,147 | 36,890 | 54,617 |
| Of which: are excluded liabilities | – | – | (1,278) | (1,278) |
| Total capital and liabilities less excluded liabilities | 7,580 | 10,147 | 35,612 | 53,339 |
| Of which: are potentially eligible as TLAC | 7,580 | 10,147 | 35,612 | 53,339 |
| Of which: with 1 year ≤ residual maturity < 2 years | – | 1,250 | 5,316 | 6,566 |
| Of which: with 2 years ≤ residual maturity < 5 years | – | – | 13,474 | 13,474 |
| Of which: with 5 years ≤ residual maturity < 10 years | – | 3,134 | 12,721 | 15,855 |
| Of which: with residual maturity ≥ 10 years, but excluding | ||||
| perpetual securities | – | 4,000 | 4,101 | 8,101 |
| Of which: perpetual securities | 7,580 | 1,763 | – | 9,343 |
| 2024 | ||||||
|---|---|---|---|---|---|---|
| Creditor ranking | ||||||
| 1 \$million |
2 \$million |
3 \$million |
Total \$million |
|||
| Description of creditor ranking | Tertiary | Tertiary | Ordinary | |||
| non | non | non | ||||
| preferential | preferential | preferential | ||||
| debt2 | debt – Tier 2 | debt3 | ||||
| securities | ||||||
| Total capital and liabilities net of credit risk mitigation1 | 6,580 | 11,975 | 32,646 | 51,202 | ||
| Of which: are excluded liabilities | – | – | (650) | (650) | ||
| Total capital and liabilities less excluded liabilities | 6,580 | 11,975 | 31,996 | 50,552 | ||
| Of which: are potentially eligible as TLAC | 6,580 | 11,975 | 31,996 | 50,552 | ||
| Of which: with 1 year ≤ residual maturity < 2 years | – | – | 5,032 | 5,032 | ||
| Of which: with 2 years ≤ residual maturity < 5 years | – | 1,250 | 12,934 | 14,184 | ||
| Of which: with 5 years ≤ residual maturity < 10 years | – | 4,980 | 10,004 | 14,984 | ||
| Of which: with residual maturity ≥ 10 years, but excluding | ||||||
| perpetual securities | – | 4,000 | 4,027 | 8,027 | ||
| Of which: perpetual securities | 6,580 | 1,745 | – | 8,325 |
1 Excludes CET1 and is based on accounting values.
2 AT1 Preference shares and Contingent Convertible Capital Instruments.
3 Senior bonds, derivative liabilities, tax claims etc.
TLAC 2 is a G-SII disclosure requirement to provide the ranking of the liability structure of all of the Group's material sub-groups in as defined by the FSB TLAC Term Sheet. The group has 5 material sub-groups; Standard Chartered Bank, Standard Chartered Bank (Hong Kong) Limited, Standard Chartered Bank Korea Limited, Standard Chartered Bank (China) Limited, and Standard Chartered Bank (Singapore) Limited for which disclosure would be required.
2.3 Minimum requirement for own funds and eligible liabilities continued Table 13: Standard Chartered Bank – creditor ranking (TLAC2)
| 2025 | ||||||
|---|---|---|---|---|---|---|
| Creditor ranking | ||||||
| 1 | 2 | 3 | 4 | 5 | Total | |
| \$million | \$million | \$million | \$million | \$million | \$million | |
| Is the resolution entity the creditor/ investor? |
No1 | Yes | No | Yes | Yes | |
| Description of creditor ranking | Tertiary | Tertiary | Tertiary | Tertiary | Secondary | |
| non | non | non | non | non | ||
| preferential | preferential | preferential | preferential | preferential | ||
| debt – | debt – | debt – | debt – | debt | ||
| common | AT1 cocos | Tier 2 | Tier 2 | |||
| shares | securities | securities | ||||
| Total capital and liabilities net of credit | ||||||
| risk mitigation2 | 20,597 | 5,722 | 291 | 8,888 | 8,248 | 43,746 |
| Of which: are excluded liabilities | – | – | – | – | – | – |
| Total capital and liabilities less | ||||||
| excluded liabilities | 20,597 | 5,722 | 291 | 8,888 | 8,248 | 43,746 |
| Of which: are potentially eligible | ||||||
| as TLAC | 20,597 | 5,722 | 291 | 8,888 | 8,248 | 43,746 |
| Of which: with 1 year ≤ residual maturity | ||||||
| < 2 years | – | – | – | – | – | – |
| Of which: with 2 years ≤ residual | ||||||
| maturity < 5 years | – | – | – | – | 6,550 | 6,550 |
| Of which: with 5 years ≤ residual | ||||||
| maturity < 10 years | – | – | 291 | 4,000 | 1,698 | 5,990 |
| Of which: with residual maturity ≥ 10 | ||||||
| years, but excluding perpetual securities | – | – | – | 4,138 | – | 4,138 |
| Of which: is perpetual securities | 20,597 | 5,722 | – | 750 | – | 27,069 |
| 2024 | ||||||
|---|---|---|---|---|---|---|
| Creditor ranking | ||||||
| 1 \$million |
2 \$million |
3 \$million |
4 \$million |
5 \$million |
Total \$million |
|
| Is the resolution entity the creditor/ investor? |
No1 | Yes | No | Yes | Yes | |
| Description of creditor ranking | Tertiary | Tertiary | Tertiary | Tertiary | Secondary | |
| non | non | non | non | non | ||
| preferential | preferential | preferential | preferential | preferential | ||
| debt – | debt – | debt – | debt – | debt | ||
| common | AT1 cocos | Tier 2 | Tier 2 | |||
| shares | securities | securities | ||||
| Total capital and liabilities net of credit risk mitigation2 |
20,597 | 5,722 | 291 | 10,826 | 8,165 | 45,601 |
| Of which: are excluded liabilities | – | – | – | – | – | – |
| Total capital and liabilities less excluded liabilities |
20,597 | 5,722 | 291 | 10,826 | 8,165 | 45,601 |
| Of which: are potentially eligible as TLAC |
20,597 | 5,722 | 291 | 10,826 | 8,165 | 45,601 |
| Of which: with 1 year ≤ residual maturity < 2 years |
– | – | – | – | 280 | 280 |
| Of which: with 2 years ≤ residual maturity < 5 years |
– | – | – | – | 5,544 | 5,544 |
| Of which: with 5 years ≤ residual maturity < 10 years |
– | – | 291 | 4,035 | 841 | 5,167 |
| Of which: with residual maturity ≥ 10 years, but excluding perpetual securities |
– | – | – | 6,041 | 1,500 | 7,541 |
| Of which: is perpetual securities | 20,597 | 5,722 | – | 750 | – | 27,069 |
1 Held by Standard Chartered Holdings Limited.
2.3 Minimum requirement for own funds and eligible liabilities continued Table 14: Standard Chartered Bank (Hong Kong) Limited – creditor ranking (TLAC2)
| 2025 | ||||||
|---|---|---|---|---|---|---|
| Creditor ranking | ||||||
| 1 \$million |
2 \$million |
3 \$million |
4 \$million |
Total \$million |
||
| Is the resolution entity the creditor/investor? | Yes | Yes | Yes | Yes | ||
| Description of creditor ranking | Common Shares |
Securities and preference shares qualifying as AT1 |
Dated subordinated notes qualifying as Tier 2 |
Loss absorbing non preferred notes |
||
| Total capital and liabilities net of credit risk mitigation1 | 8,354 | 4,800 | 1,873 | 3,923 | 18,949 | |
| Of which: are excluded liabilities | – | – | – | – | – | |
| Total capital and liabilities less excluded liabilities | 8,354 | 4,800 | 1,873 | 3,923 | 18,949 | |
| Of which: are potentially eligible as TLAC | 8,354 | 4,800 | 1,873 | 3,923 | 18,949 | |
| Of which: with 1 year ≤ residual maturity < 2 years | – | – | – | 1,500 | 1,500 | |
| Of which: with 2 years ≤ residual maturity < 5 years | – | – | – | 1,250 | 1,250 | |
| Of which: with 5 years ≤ residual maturity < 10 years | – | – | 1,173 | 1,173 | 2,345 | |
| Of which: with residual maturity ≥ 10 years, but excluding perpetual securities |
– | – | 700 | – | 700 | |
| Of which: is perpetual securities | 8,354 | 4,800 | – | – | 13,154 |
| 2024 | |||||||
|---|---|---|---|---|---|---|---|
| Creditor ranking | |||||||
| 1 \$million |
2 \$million |
3 \$million |
4 \$million |
Total \$million |
|||
| Is the resolution entity the creditor/investor? | Yes | Yes | Yes | Yes | |||
| Description of creditor ranking | Common Shares |
Securities and preference shares qualifying as AT1 |
Dated subordinated notes qualifying as Tier 2 |
Loss absorbing non-preferred notes |
|||
| Total capital and liabilities net of credit risk mitigation1 | 8,374 | 3,000 | 1,290 | 3,790 | 16,454 | ||
| Of which: are excluded liabilities | – | – | – | – | – | ||
| Total capital and liabilities less excluded liabilities | 8,374 | 3,000 | 1,290 | 3,790 | 16,454 | ||
| Of which: are potentially eligible as TLAC | 8,374 | 3,000 | 1,290 | 3,790 | 16,454 | ||
| Of which: with 1 year ≤ residual maturity < 2 years | – | – | – | – | – | ||
| Of which: with 2 years ≤ residual maturity < 5 years | – | – | – | 2,750 | 2,750 | ||
| Of which: with 5 years ≤ residual maturity < 10 years | – | – | 1,290 | 1,040 | 2,330 | ||
| Of which: with residual maturity ≥ 10 years, but excluding perpetual securities |
– | – | – | – | – | ||
| Of which: is perpetual securities | 8,374 | 3,000 | – | – | 11,374 |
2.3 Minimum requirement for own funds and eligible liabilities continued Table 15: Standard Chartered Bank Korea Limited – creditor ranking (TLAC2)
| 2025 | ||||
|---|---|---|---|---|
| Creditor ranking | ||||
| 1 \$million |
2 \$million |
3 \$million |
Total \$million |
|
| Is the resolution entity the creditor/investor? | No1 | No2 | No3 | |
| Description of creditor ranking | Common | Additional | Tier 2 | |
| Shares | Tier 1 securities |
securities | ||
| Total capital and liabilities net of credit risk mitigation4 | 1,302 | 266 | 695 | 2,263 |
| Of which: are excluded liabilities | – | – | – | – |
| Total capital and liabilities less excluded liabilities | 1,302 | 266 | 695 | 2,263 |
| Of which: are potentially eligible as TLAC | 1,302 | 266 | 695 | 2,263 |
| Of which: with 1 year ≤ residual maturity < 2 years | – | – | – | – |
| Of which: with 2 years ≤ residual maturity < 5 years | – | – | 695 | 695 |
| Of which: with 5 years ≤ residual maturity < 10 years | – | – | – | – |
| Of which: with residual maturity ≥ 10 years, but excluding | ||||
| perpetual securities | – | – | – | – |
| Of which: is perpetual securities | 1,302 | 266 | – | 1,568 |
| 2024 | |||||
|---|---|---|---|---|---|
| Creditor ranking | |||||
| 1 \$million |
2 \$million |
3 \$million |
Total \$million |
||
| Is the resolution entity the creditor/investor? | No1 | No2 | No3 | ||
| Description of creditor ranking | Common Shares |
Additional Tier 1 securities |
Tier 2 securities |
||
| Total capital and liabilities net of credit risk mitigation4 | 1,302 | 266 | 679 | 2,247 | |
| Of which: are excluded liabilities | – | – | – | – | |
| Total capital and liabilities less excluded liabilities | 1,302 | 266 | 679 | 2,247 | |
| Of which: are potentially eligible as TLAC | 1,302 | 266 | 679 | 2,247 | |
| Of which: with 1 year ≤ residual maturity < 2 years | – | – | – | – | |
| Of which: with 2 years ≤ residual maturity < 5 years | – | – | 679 | 679 | |
| Of which: with 5 years ≤ residual maturity < 10 years | – | – | – | – | |
| Of which: with residual maturity ≥ 10 years, but excluding perpetual securities |
– | – | – | – | |
| Of which: is perpetual securities | 1,302 | 266 | – | 1,568 |
1 Held by Standard Chartered NEA Limited.
2 Held by Standard Chartered Bank (Hong Kong) Limited.
3 Held by Standard Chartered Bank.
2.3 Minimum requirement for own funds and eligible liabilities continued Table 16: Standard Chartered Bank (Singapore) Limited – creditor ranking (TLAC2)
| 2025 | |||||||
|---|---|---|---|---|---|---|---|
| Creditor ranking | |||||||
| 1 \$million |
1 \$million |
2 \$million |
2 \$million |
3 \$million |
3 \$million |
Total \$million |
|
| Is the resolution entity the creditor/investor? |
No1 | Yes | No2 | No2 | Yes | No2 | |
| Description of creditor ranking | Common Shares | AT1 Non cumulative Preference Shares |
AT1 Non cumulative Preference Shares |
AT1 Non cumulative Capital Securities |
Tier 2 Subordinated Notes |
Tier 2 Subordinated Notes |
|
| Total capital and liabilities net of credit risk mitigation3 |
5,770 | 500 | 298 | 580 | – | 2,650 | 9,799 |
| Of which: are excluded liabilities |
– | – | – | – | – | – | – |
| Total capital and liabilities less excluded liabilities |
5,770 | 500 | 298 | 580 | – | 2,650 | 9,799 |
| Of which: are potentially eligible as TLAC |
5,770 | 500 | 298 | 580 | – | 2,650 | 9,799 |
| Of which: with 1 year ≤ residual maturity < 2 years |
– | – | – | – | – | – | – |
| Of which: with 2 years ≤ residual maturity < 5 years |
– | – | – | – | – | – | – |
| Of which: with 5 years ≤ residual maturity < 10 years |
– | – | – | – | – | 2,650 | 2,650 |
| Of which: with residual maturity ≥ 10 years, but excluding perpetual securities |
– | – | – | – | – | – | – |
| Of which: is perpetual securities | 5,770 | 500 | 298 | 580 | – | – | 7,149 |
| 2024 | |||||||
|---|---|---|---|---|---|---|---|
| Creditor ranking | |||||||
| 1 \$million |
1 \$million |
2 \$million |
3 \$million |
3 \$million |
3 \$million |
Total \$million |
|
| Is the resolution entity the creditor/investor? |
No1 | Yes | No2 | No2 | Yes | No2 | |
| Description of creditor ranking | Common Shares | AT1 Non cumulative Preference |
AT1 Non cumulative Preference |
AT1 Non cumulative Capital Securities |
Tier 2 Subordinated Notes |
Tier 2 Subordinated Notes |
|
| Total capital and liabilities net of credit risk mitigation2 |
5,770 | Shares 500 |
Shares 298 |
580 | 540 | 2,096 | 9,785 |
| Of which: are excluded liabilities |
– | – | – | – | – | – | – |
| Total capital and liabilities less excluded liabilities |
5,770 | 500 | 298 | 580 | 540 | 2,096 | 9,785 |
| Of which: are potentially eligible as TLAC |
5,770 | 500 | 298 | 580 | 540 | 2,096 | 9,785 |
| Of which: with 1 year ≤ residual maturity < 2 years |
– | – | – | – | – | – | – |
| Of which: with 2 years ≤ residual maturity < 5 years |
– | – | – | – | – | – | – |
| Of which: with 5 years ≤ residual maturity < 10 years |
– | – | – | – | 540 | 2,096 | 2,636 |
| Of which: with residual maturity ≥ 10 years, but excluding perpetual securities |
– | – | – | – | – | – | – |
| Of which: is perpetual securities | 5,770 | 500 | 298 | 580 | – | – | 7,149 |
1 Held by Standard Chartered Holdings (Singapore) Private Limited (\$3,963 million), Standard Chartered Bank Malaysia Berhad (\$1,273 million), Standard Chartered Bank Vietnam Limited (\$333 million), and Standard Chartered Bank (Thai) PCL (\$203 million).
2 Held by Standard Chartered Bank.
2.3 Minimum requirement for own funds and eligible liabilities continued Table 17: Standard Chartered Bank (China) Limited – creditor ranking (TLAC2)
| 2025 | |||
|---|---|---|---|
| Creditor ranking | |||
| 1 \$million |
2 \$million |
Total \$million |
|
| Is the resolution entity the creditor/investor? | No1 | Yes | |
| Description of creditor ranking | Common Shares |
Tier-2 capital |
|
| Total capital and liabilities net of credit risk mitigation2 | 1,446 | 858 | 2,304 |
| Of which: are excluded liabilities | – | – | – |
| Total capital and liabilities less excluded liabilities | 1,446 | 858 | 2,304 |
| Of which: are potentially eligible as TLAC | 1,446 | 858 | 2,304 |
| Of which: with 1 year ≤ residual maturity < 2 years | – | – | – |
| Of which: with 2 years ≤ residual maturity < 5 years | – | – | – |
| Of which: with 5 years ≤ residual maturity < 10 years | – | – | – |
| Of which: with residual maturity ≥ 10 years, but excluding perpetual securities | – | 858 | 858 |
| Of which: is perpetual securities | 1,446 | – | 1,446 |
| 2024 | |||
|---|---|---|---|
| Creditor ranking | |||
| 1 \$million |
2 \$million |
Total \$million |
|
| Is the resolution entity the creditor/investor? | No1 | Yes | |
| Description of creditor ranking | Common Shares |
Tier-2 capital |
|
| Total capital and liabilities net of credit risk mitigation2 | 1,446 | 557 | 2,003 |
| Of which: are excluded liabilities | – | – | – |
| Total capital and liabilities less excluded liabilities | 1,446 | 557 | 2,003 |
| Of which: are potentially eligible as TLAC | 1,446 | 557 | 2,003 |
| Of which: with 1 year ≤ residual maturity < 2 years | – | – | – |
| Of which: with 2 years ≤ residual maturity < 5 years | – | – | – |
| Of which: with 5 years ≤ residual maturity < 10 years | – | 557 | 557 |
| Of which: with residual maturity ≥ 10 years, but excluding perpetual securities | – | – | – |
| Of which: is perpetual securities | 1,446 | – | 1,446 |
1 Held by Standard Chartered Bank (Hong Kong) Limited.
2 Excludes CET1 (except common shares) and is based on accounting carrying values.
2.4 Countercyclical capital buffer
The Group's countercyclical capital buffer (CCyB) is determined by applying various country-specific CCyB rates to the Group's qualifying credit exposures in the relevant country (based on the jurisdiction of the obligor) on a weighted average basis.
The Group's CCyB requirement is 38 basis points, representing an increase of 1 basis point compared to 31 December 2024.
Countries are included in the table if the relevant own funds requirements of that country are greater than 1 per cent of the Group's total relevant own funds requirements for CCyB calculation.
2.4 Countercyclical capital buffer continued
Table 18: Geographical distribution of credit exposures relevant for the calculation of the countercyclical buffer (UK CCyB1)
| 2025 | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| General credit exposures | Relevant credit exposures – Market risk |
Own funds requirements | |||||||||||
| Breakdown by country |
Exposure value under the standardised approach \$million |
Exposure value under the IRB approach \$million |
Sum of long and short positions of trading book exposures for SA \$million |
Value of trading book exposures for internal models \$million |
Securiti sation exposures Exposure value for non-trading book \$million |
Total exposure value \$million |
Relevant credit risk exposures – Credit risk \$million |
Relevant credit exposures – Market risk \$million |
Relevant credit exposures – Securiti sation positions in the non-trading book \$million |
Total \$million |
Risk weighted exposure amounts \$million |
Own fund require ments weights % |
Countercy clical buffer rate % |
| Armenia | – | – | – | – | – | – | – | – | – | – | – | 0.0% | 1.5% |
| Australia | 251 | 3,212 | 468 | – | 289 | 4,220 | 96 | 36 | 4 | 136 | 1,701 | 1.1% | 1.0% |
| Belgium | – | 564 | 2 | – | 20 | 586 | 8 | – | – | 9 | 114 | 0.1% | 1.0% |
| Bulgaria | – | – | – | – | – | – | – | – | – | – | – | 0.0% | 2.0% |
| Chile | – | 206 | 106 | – | 7 | 319 | 6 | 4 | – | 10 | 120 | 0.1% | 0.5% |
| Croatia | – | 5 | – | – | – | 5 | – | – | – | – | 3 | 0.0% | 1.5% |
| Cyprus | 2 | 157 | – | – | – | 159 | 9 | – | – | 9 | 109 | 0.1% | 1.0% |
| Czech Republic | – | – | 6 | – | – | 6 | – | 1 | – | 1 | 18 | 0.0% | 1.3% |
| Denmark | 12 | 771 | 3 | – | 177 | 963 | 12 | – | 3 | 14 | 179 | 0.1% | 2.5% |
| Estonia | – | – | 4 | – | – | 4 | – | – | – | – | – | 0.0% | 1.5% |
| France | 51 | 3,302 | 378 | – | 1,035 | 4,766 | 75 | 21 | 16 | 112 | 1,403 | 0.9% | 1.0% |
| Germany | 69 | 5,549 | 390 | – | 1,475 | 7,483 | 102 | 26 | 22 | 150 | 1,871 | 1.2% | 0.8% |
| Greece | 1 | 471 | 7 | – | – | 479 | 6 | 1 | – | 6 | 80 | 0.0% | 0.3% |
| Hong Kong | 6,272 | 71,804 | 468 | – | 230 | 78,774 | 1,698 | 16 | 3 | 1,718 | 21,472 | 13.3% | 0.5% |
| Hungary | – | 238 | 201 | – | – | 439 | 12 | 1 | – | 12 | 153 | 0.1% | 1.0% |
| Iceland | – | – | – | – | – | – | – | – | – | – | – | 0.0% | 2.5% |
| Ireland | 30 | 3,628 | 1,023 | – | 176 | 4,857 | 54 | 82 | 3 | 139 | 1,739 | 1.1% | 1.5% |
| Korea | 868 | 34,843 | 1,302 | – | 178 | 37,191 | 736 | 11 | 3 | 749 | 9,367 | 5.8% | 1.0% |
| Latvia | – | – | – | – | – | – | – | – | – | – | – | 0.0% | 1.0% |
| Lithuania | – | – | – | – | – | – | – | – | – | – | – | 0.0% | 1.0% |
| Luxembourg | 267 | 7,241 | 101 | – | 379 | 7,988 | 144 | 7 | 6 | 157 | 1,959 | 1.2% | 0.5% |
| Netherlands | 2 | 2,039 | 66 | – | 769 | 2,876 | 109 | 4 | 12 | 125 | 1,560 | 1.0% | 2.0% |
| Norway | – | 386 | 7 | – | 305 | 698 | 13 | – | 5 | 18 | 227 | 0.1% | 2.5% |
| Poland | 30 | 173 | 10 | – | – | 213 | 9 | – | – | 9 | 110 | 0.1% | 1.0% |
| Romania | 1 | – | – | – | – | 1 | – | – | – | – | – | 0.0% | 1.0% |
| Slovakia | 1 | 5 | – | – | – | 6 | – | – | – | – | 2 | 0.0% | 1.5% |
| Slovenia | – | – | 7 | – | – | 7 | – | 1 | – | 1 | 10 | 0.0% | 1.0% |
| Spain | 9 | 251 | 59 | – | 60 | 379 | 12 | 4 | 1 | 17 | 217 | 0.1% | 0.5% |
| Sweden | – | 975 | 52 | – | 245 | 1,272 | 26 | 5 | 4 | 35 | 437 | 0.3% | 2.0% |
| United Kingdom | 4,366 | 46,594 | 1,444 | – | 16,522 | 68,926 | 820 | 42 | 240 | 1,102 | 13,773 | 8.5% | 2.0% |
| Other countries | 39,271 | 235,970 | 24,528 | – | 10,039 | 309,808 | 7,619 | 615 | 147 | 8,384 | 104,785 | 73.7% | 0.0% |
2.4 Countercyclical capital buffer continued
Table 18: Geographical distribution of credit exposures relevant for the calculation of the countercyclical buffer (UK CCyB1) continued
| 2024 | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| General credit exposures | Relevant credit exposures – Market risk |
Own funds requirements | |||||||||||
| Breakdown by country |
Exposure value under the standardised approach \$million |
Exposure value under the IRB approach \$million |
Sum of long and short positions of trading book exposures for SA \$million |
Value of trading book exposures for internal models \$million |
Securiti sation exposures Exposure value for non-trading book \$million |
Total exposure value \$million |
Relevant credit risk exposures – Credit risk \$million |
Relevant credit exposures – Market risk \$million |
Relevant credit exposures – Securiti sation positions in the non-trading book \$million |
Total \$million |
Risk weighted exposure amounts \$million |
Own fund require ments weights % |
Countercy clical buffer rate % |
| Armenia | – | – | – | – | – | – | – | – | – | – | – | 0.0% | 1.5% |
| Australia | 156 | 2,333 | 144 | – | 34 | 2,667 | 82 | 11 | – | 94 | 1,170 | 0.7% | 1.0% |
| Belgium | – | 757 | 4 | – | – | 761 | 4 | – | – | 5 | 59 | 0.0% | 1.0% |
| Bulgaria | – | – | – | – | – | – | – | – | – | – | – | 0.0% | 2.0% |
| Chile | – | 129 | 25 | – | – | 154 | 3 | 3 | – | 6 | 78 | 0.0% | 0.5% |
| Croatia | – | 7 | – | – | – | 7 | – | – | – | – | 4 | 0.0% | 1.5% |
| Cyprus | 2 | 134 | – | – | – | 136 | 4 | – | – | 4 | 55 | 0.0% | 1.0% |
| Czech Republic | – | – | 3 | – | – | 3 | – | – | – | – | 4 | 0.0% | 1.3% |
| Denmark | 6 | 665 | 1 | – | – | 672 | 20 | – | – | 20 | 248 | 0.2% | 2.5% |
| Estonia | – | – | – | – | – | – | – | – | – | – | – | 0.0% | 1.5% |
| France | 14 | 4,117 | 221 | – | – | 4,352 | 66 | 10 | – | 76 | 946 | 0.6% | 1.0% |
| Germany | 31 | 6,709 | 329 | – | 3,152 | 10,220 | 85 | 8 | 47 | 140 | 1,747 | 1.1% | 0.8% |
| Hong Kong | 5,692 | 72,370 | 620 | – | 3,902 | 82,583 | 1,776 | 8 | 60 | 1,844 | 23,048 | 14.6% | 0.5% |
| Hungary | – | 553 | 196 | – | – | 749 | 15 | – | – | 15 | 190 | 0.1% | 0.5% |
| Ireland | – | – | – | – | – | – | – | – | – | – | – | 0.0% | 2.5% |
| Ireland | 53 | 2,113 | 33 | – | 78 | 2,278 | 32 | 50 | 1 | 83 | 1,041 | 0.7% | 1.5% |
| Korea | 910 | 34,811 | 292 | – | – | 36,014 | 789 | 3 | – | 792 | 9,895 | 6.3% | 1.0% |
| Lithuania | – | – | – | – | – | – | – | – | – | – | – | 0.0% | 1.0% |
| Luxembourg | 134 | 6,519 | 12 | – | 332 | 6,997 | 110 | 2 | 4 | 116 | 1,450 | 0.9% | 0.5% |
| Netherlands | 20 | 2,261 | 31 | – | – | 2,312 | 86 | 2 | – | 88 | 1,099 | 0.7% | 2.0% |
| Norway | 1 | 239 | 4 | – | – | 244 | 10 | – | – | 11 | 131 | 0.1% | 2.5% |
| Romania | 1 | – | – | – | – | 1 | – | – | – | – | – | 0.0% | 1.0% |
| Slovakia | – | – | – | – | – | – | – | – | – | – | – | 0.0% | 1.5% |
| Slovenia | – | – | – | – | – | – | – | – | – | – | – | 0.0% | 0.5% |
| Sweden | – | 1,229 | 8 | – | – | 1,238 | 28 | 1 | – | 30 | 374 | 0.2% | 2.0% |
| United Kingdom | 3,780 | 41,306 | 1,054 | – | 18,348 | 64,487 | 822 | 27 | 265 | 1,114 | 13,926 | 8.8% | 2.0% |
| Other Countries | 36,254 | 229,587 | 16,766 | – | 5,482 | 288,090 | 7,533 | 572 | 79 | 8,184 | 102,302 | 64.8% | 0.0% |
Table 19: Amount of institution-specific countercyclical capital buffer (UK CCyB2)
| 2025 \$million |
2024 \$million |
||
|---|---|---|---|
| 1 | Total risk exposure amount (see Table 20: Overview of RWA (OV1)) | 258,031 | 247,065 |
| 2 | Institution specific countercyclical capital buffer rate | 0.38% | 0.37% |
| 3 | Institution specific countercyclical capital buffer requirement | 982 | 926 |
2.5 Capital Requirements
The Group's Pillar 1 and Pillar 2A requirements, together with the Combined Buffer, define the threshold at which Maximum Distributable Amount (MDA) restrictions take effect. If the Group's capital falls below this level, restrictions on discretionary distributions would apply. The Group expects to continue to maintain a prudent management buffer above this threshold.
The PRA may also set an additional buffer of CET1 capital, known as the PRA buffer. The purpose of the PRA buffer is to cover losses that may arise in a period of stress, with its calibration informed by supervisory assessments and stress testing outcomes. The PRA buffer is not disclosed.
The Group's Pillar 1 capital requirements, together with the corresponding RWAs, are set out in the table below. Additional detail on credit RWAs is provided in Table 51 for IRB credit risk (including counterparty credit risk); Table 22 for the IRB RWA flow statements (excluding securitisation balances below); Table 68 for exposures under the Standardised Approach (including amounts below the threshold for deduction); and section 4.2 for exposures subject to counterparty credit risk.
2.5 Capital Requirements continued Table 20: Overview of risk weighted exposure amounts (UK OV1)
| 31.12.25 | 30.09.25 | 31.12.24 | ||||||
|---|---|---|---|---|---|---|---|---|
| Risk weighted assets \$million |
Regulatory capital requirement1 \$million |
Risk weighted assets \$million |
Regulatory capital requirement1 \$million |
Risk weighted assets \$million |
Regulatory capital requirement1 \$million |
|||
| 1 | Credit risk (excluding CCR)2 | 159,477 | 12,758 | 160,229 | 12,818 | 158,107 | 12,649 | |
| 2 | Of which the standardised approach (Table 68) | 37,456 | 2,996 | 38,201 | 3,056 | 34,063 | 2,725 | |
| 4 | Of which slotting approach | 5,857 | 469 | 5,812 | 465 | 5,868 | 469 | |
| 5 | Of which the advanced IRB (AIRB) approach (Table 53) |
116,164 | 9,293 | 116,216 | 9,297 | 118,175 | 9,454 | |
| 6 | Counterparty credit risk – CCR3 | 22,406 | 1,792 | 20,941 | 1,675 | 22,128 | 1,770 | |
| 7 | Of which the standardised approach | 4,197 | 336 | 4,165 | 333 | 3,583 | 287 | |
| 8 | Of which internal model method (IMM) | 10,667 | 853 | 9,786 | 783 | 11,322 | 906 | |
| UK 8a | Of which exposures to a CCP | 1,322 | 106 | 1,221 | 98 | 1,051 | 84 | |
| UK 8b | Of which credit valuation adjustment – CVA (Table 91) |
2,413 | 193 | 2,095 | 168 | 2,706 | 216 | |
| 9 | Of which other CCR | 3,806 | 304 | 3,675 | 294 | 3,467 | 277 | |
| 15 | Settlement risk | – | – | – | – | – | – | |
| 16 | Securitisation exposures in the non-trading book | 5,867 | 469 | 5,667 | 453 | 5,697 | 456 | |
| 17 | Of which SEC-IRBA approach | 2,779 | 222 | 2,937 | 235 | 2,843 | 227 | |
| 18 | Of which SEC-ERBA (including IAA) | 2,059 | 165 | 2,018 | 161 | 2,188 | 175 | |
| 19 | Of which SEC-SA approach | 1,029 | 82 | 711 | 57 | 666 | 53 | |
| UK 19a | Of which 1250%/deduction | – | – | – | – | – | – | |
| 20 | Position, foreign exchange and commodities risks (Market risk) (Table 81) |
30,663 | 2,453 | 34,726 | 2,778 | 28,283 | 2,263 | |
| 21 | Of which the standardised approach | 17,156 | 1,372 | 18,588 | 1,487 | 13,810 | 1,105 | |
| 22 | Of which IMA | 13,507 | 1,081 | 16,138 | 1,291 | 14,474 | 1,158 | |
| UK 22a | Large exposures | – | – | – | – | – | – | |
| 23 | Operational risk4 | 35,223 | 2,818 | 32,578 | 2,606 | 29,479 | 2,358 | |
| 25 | Of which standardised approach | 35,223 | 2,818 | 32,578 | 2,606 | 29,479 | 2,358 | |
| 27 | Amounts below the thresholds for deduction (subject to 250% risk weight) (Table 68) |
4,395 | 352 | 4,237 | 339 | 3,371 | 270 | |
| 28 | Floor Adjustment | – | – | – | – | – | – | |
| 29 | Total | 258,031 | 20,642 | 258,378 | 20,670 | 247,065 | 19,765 |
1 The regulatory capital requirement is calculated as 8 per cent of the RWA, and represents the minimum total capital ratio in accordance with CRR Article 92 (1).
2 Credit risk (excluding counterparty credit risk) includes non-credit obligation assets.
3 Counterparty credit risk includes assets which are assessed under IRB and SA.
4 To calculate operational risk standardised risk-weighted assets, a regulatory defined beta co-efficient is applied to average gross income for the previous three years, across each of the eight business lines prescribed in the CRR.
RWA increased by \$11.0 billion, or 4 per cent from 31 December 2024 to \$258.0 billion.
- Credit risk RWA increased by \$2.8 billion to \$192.1 billion. This was driven by an increase of \$6.4 billion in asset growth, quality and mix, a \$1.0 billion increase in derivatives and a \$3.9 billion increases from foreign currency translation. The increase was partly offset by a decrease of \$7.4 billion from optimisation actions and \$1.1 billion reduction from model changes.
- Total Market Risk RWA increased by \$2.4 billion, or 8.4 per cent from 31 December 2024 to \$30.7 billion, mainly due to \$2.1 billion increase in Standardised Approach (SA) Specific Interest Rate Risk RWA mainly due to increases in the Credit Trading portfolio.
- Operational risk RWA increased by \$5.7 billion, or 19.5 per cent, from 31 December 2024 to \$35.2 billion primarily driven by an increase in average income measured over a rolling three-year time horizon. The Group has brought forward the annual refresh of Operational Risk RWA with RWA increase recognised in Q4'25 rather than Q1'26, as earlier guided, resulting in two operational risk RWA increases in 2025.
2.5 Capital Requirements continued
Table 21 shows the significant drivers of credit risk, market risk and operational risk RWA movements from 31 December 2024.
Table 21: Movement analysis for RWA
| Total Credit & | ||||||||
|---|---|---|---|---|---|---|---|---|
| Credit risk IRB |
Credit risk SA |
Credit risk Total |
Counterparty Credit risk |
Counterparty Credit risk |
Operational risk |
Market risk |
Total | |
| \$million | \$million | \$million | \$million | \$million | \$million | \$million | \$million | |
| As at 31 December 2024 | 129,074 | 38,101 | 167,175 | 22,128 | 189,303 | 29,479 | 28,283 | 247,065 |
| Asset size | (7,193) | 4,293 | (2,899) | (432) | (3,332) | – | – | (3,332) |
| Asset quality | 2,248 | 1 | 2,249 | 75 | 2,324 | – | – | 2,324 |
| Model updates | 419 | – | 419 | (1,300) | (881) | – | 51 | (830) |
| Methodology and policy | – | – | – | – | – | – | – | – |
| Acquisitions and disposals | (114) | (3) | (117) | – | (117) | – | – | (117) |
| Foreign exchange movements | 2,550 | 756 | 3,306 | 468 | 3,774 | – | – | 3,774 |
| Other, including non-credit risk | ||||||||
| movements1 | – | – | – | – | – | 3,099 | 6,392 | 9,491 |
| As at 30 September 2025 | 126,984 | 43,149 | 170,133 | 20,941 | 191,074 | 32,578 | 34,726 | 258,378 |
| Asset size | 849 | (194) | 655 | 1,629 | 2,284 | – | – | 2,284 |
| Asset quality | (735) | (1) | (736) | (161) | (897) | – | – | (897) |
| Model updates | (186) | – | (186) | – | (186) | – | 12 | (174) |
| Methodology and policy | – | – | – | – | – | – | – | – |
| Acquisitions and disposals | (287) | (1) | (288) | 1 | (287) | – | – | (287) |
| Foreign exchange movements | 234 | (73) | 161 | (4) | 157 | – | – | 157 |
| Other, including non-credit risk | ||||||||
| movements1 | – | – | – | – | – | 2,645 | (4,075) | (1,430) |
| As at 31 December 2025 | 126,859 | 42,880 | 169,739 | 22,406 | 192,145 | 35,223 | 30,663 | 258,031 |
1 RWA efficiencies are disclosed against 'Other, including non-credit risk movements'.
2 See Table 20: Overview of risk weighted exposure amounts (UK OV1). To note that 'Securitisation exposures in the non-trading book', 'Settlement risk' and 'Amounts below the threshold for deduction (subject to 250% risk-weight)' are included in credit risk.
Table 22 shows the significant drivers of credit risk, IRB RWA movements (excluding counterparty credit risk and standardised credit risk) from 31 December 2024.
Table 22: RWEA flow statements of credit risk exposures under the IRB approach (UK CR8)
| Risk-weighted assets1 \$million |
Regulatory capital requirement1 \$million |
||
|---|---|---|---|
| As at 31 December 2024 | 124,043 | 9,923 | |
| Asset size | (6,940) | (555) | |
| Asset quality | 2,248 | 180 | |
| Model updates | 419 | 34 | |
| Methodology and policy | – | – | |
| Acquisitions and disposals | (114) | (9) | |
| Foreign exchange movements | 2,372 | 190 | |
| Other | – | – | |
| 1 | As at 30 September 2025 | 122,028 | 9,762 |
| 2 | Asset size | 972 | 78 |
| 3 | Asset quality | (735) | (59) |
| 4 | Model updates | (186) | (15) |
| 5 | Methodology and policy | – | – |
| 6 | Acquisitions and disposals | (287) | (23) |
| 7 | Foreign exchange movements | 228 | 18 |
| 8 | Other | – | – |
| 9 | As at 31 December 2025 | 122,021 | 9,762 |
1 The total in this table has been represented to show credit risk under the AIRB approach excluding securitisation and non-credit obligation assets and hence will not directly reconcile to the credit risk AIRB RWAs in table 21.
IRB credit RWA decreased by \$2.0 billion from 31 December 2024 driven by:
• \$6.0 billion net decrease in asset size.
• \$2.6 billion increase from foreign currency translation.
• \$1.5 billion increase due to a deterioration in asset quality.
2.5 Capital Requirements continued
Table 23 shows the significant drivers of credit counterparty risk under IMM RWA movements from 31 December 2024.
Table 23: RWEA flow statements of CCR exposures under the IMM (UK CCR7)
| Risk-weighted assets1 \$million |
Regulatory capital requirement1 \$million |
||
|---|---|---|---|
| As at 31 December 2024 | 11,322 | 906 | |
| Asset size | 51 | 4 | |
| Credit quality of counterparties | 17 | 1 | |
| Model updates (IMM only) | (1,300) | (104) | |
| Methodology and policy (IMM only) | – | – | |
| Acquisitions and disposals | – | – | |
| Foreign exchange movements | (304) | (24) | |
| Other1 | – | – | |
| 1 | As at 30 September 2025 | 9,786 | 783 |
| 2 | Asset size | 997 | 80 |
| 3 | Credit quality of counterparties | (111) | (9) |
| 4 | Model updates (IMM only) | – | – |
| 5 | Methodology and policy (IMM only) | – | – |
| 6 | Acquisitions and disposals | – | – |
| 7 | Foreign exchange movements | (5) | – |
| 8 | Other1 | – | – |
| 9 | As at 31 December 2025 | 10,667 | 854 |
1 RWA efficiencies are disclosed against 'Other'.
Table 24 shows the RWA flow statements of market risk RWA exposures under the Internal Model Approach (IMA) from 31 December 2024.
Table 24: RWA flow statements of market risk exposures under the IMA (UK MR2-B)
| Comprehensive | Total own funds | |||||||
|---|---|---|---|---|---|---|---|---|
| VaR | SVaR | IRC | risk measure | Other1 | Total RWAs | requirements | ||
| \$million | \$million | \$million | \$million | \$million | \$million | \$million | ||
| At 31 December 2024 | 3,984 | 5,529 | – | – | 4,960 | 14,474 | 1,158 | |
| Regulatory adjustment | – | – | – | – | – | – | – | |
| RWAs post adjustment at | ||||||||
| 31 December 2024 | 3,984 | 5,529 | – | – | 4,960 | 14,474 | 1,158 | |
| Movement in risk levels | (770) | 2,355 | – | – | 29 | 1,614 | 129 | |
| Model updates/changes | – | – | – | – | 51 | 51 | 4 | |
| Methodology and policy | – | – | – | – | – | – | – | |
| Acquisitions and disposals | – | – | – | – | – | – | – | |
| Foreign exchange movements | – | – | – | – | – | – | – | |
| Other | – | – | – | – | – | – | – | |
| 1 | At 30 September 2025 | 3,214 | 7,884 | – | – | 5,040 | 16,139 | 1,291 |
| 1a | Regulatory adjustment | – | – | – | – | – | – | – |
| 1b | RWAs post adjustment at | |||||||
| 30 September 2025 | 3,214 | 7,884 | – | – | 5,040 | 16,138 | 1,291 | |
| 2 | Movement in risk levels | (642) | (1,485) | – | – | (517) | (2,644) | (212) |
| 3 | Model updates/changes | – | – | – | – | 12 | 12 | 1 |
| 4 | Methodology and policy | – | – | – | – | – | – | – |
| 5 | Acquisitions and disposals | – | – | – | – | – | – | – |
| 6 | Foreign exchange movements | – | – | – | – | – | – | – |
| 7 | Other | – | – | – | – | – | – | – |
| 8a | At 31 December 2025 | 2,572 | 6,399 | – | – | 4,536 | 13,507 | 1,081 |
| 8b | Regulatory adjustment | – | – | – | – | – | – | – |
| 8 | RWAs post adjustment at | |||||||
| 31 December 2025 | 2,572 | 6,399 | – | – | 4,536 | 13,507 | 1,081 |
1 Other IMA capital add-ons for market risks not fully captured in either VaR or SVar. More details on Risks not in VaR can be found in the Group's Year End Report 2025 on page 278.
Market risk RWA under an IMA approach decreased by \$1.0 billion from 31 December 2024 driven by a \$1.4 billion decrease in VaR from positions in the Rates business.
2.6 Leverage ratio
UK banks are currently subject to a minimum leverage ratio of 3.25 per cent. In addition, a supplementary leverage ratio buffer is applicable, set at 35 per cent of the corresponding G-SII capital buffer and the countercyclical capital buffer. Following the FPC's recommendation to the PRA to exclude qualifying claims on central bank exposures from the leverage exposure measure in the UK leverage ratio framework, and the corresponding waiver granted by the PRA, the Group has been reporting the leverage ratio on a UK basis (excluding qualifying claims on central banks exposures) from March 2017.
In October 2021, the PRA published a policy statement outlining changes to the leverage ratio framework. The UK's minimum leverage ratio requirement is maintained at 3.25 per cent and must be met by at least 75 per cent of CET1. Additional buffers based on the countercyclical and global systemically important bank (G'SIB') buffers are set at 35 per cent of their risk-weighted equivalent and must be met with 100 per cent of CET1. Firms who breach their leverage ratio buffers will not face any capital distribution restrictions. The exposure value of derivative contracts will be based on the standardised approach to counterparty credit risk, whilst central bank reserves continue to be excluded from the leverage ratio exposure measure. The rules came into force on 1 January 2022.
At 31 December 2025, the Group's current minimum requirement inclusive of leverage buffers was 3.7 per cent:
- i The minimum 3.25 per cent
- ii A 0.35 per cent G-SII leverage ratio buffer and
- iii A 0.1 per cent countercyclical capital leverage ratio buffer, based on FY 2025 countercyclical capital buffer rates
The Group's leverage ratio, which excludes qualifying claims on central banks, was 4.7 per cent at FY 2025, which was above the current minimum requirement of 3.7 per cent. The leverage ratio was 11 basis points lower than FY 2024. Leverage exposure increased by \$69.8 billion from increase in Loans and advances and other assets of \$85.2 billion, an increase in Derivatives of \$3.7 billion partly offset by decrease in claims on central banks of \$16.9 billion, decrease in Off-balance sheet items of \$1.3 billion, and decrease in asset amounts deducted in determining Tier 1 capital (Leverage) of \$0.8 billion. Tier 1 capital increased by \$2.3 billion as CET1 capital increased by \$1.2 billion and AT1 capital increased by \$1.0 billion following the issuance of \$2.0 billion partly offset by the redemption of \$1.0 billion AT1 securities.
Table 25: Leverage ratio
| 31.12.25 \$million |
30.09.25 \$million |
31.12.24 \$million |
|
|---|---|---|---|
| Tier 1 capital (end point) | 43,949 | 43,109 | 41,672 |
| Leverage exposure | 938,190 | 936,824 | 868,344 |
| Leverage ratio | 4.7% | 4.6% | 4.8% |
| Leverage exposure quarterly average | 949,214 | 933,449 | 894,296 |
| Leverage ratio quarterly average | 4.6% | 4.6% | 4.7% |
| Countercyclical leverage ratio buffer | 0.1% | 0.1% | 0.1% |
| G-SII additional leverage ratio buffer | 0.4% | 0.4% | 0.4% |
2.6 Leverage ratio continued
CRR leverage ratio
Table 26, 27 and 28 present the leverage ratio based on CRR basis requirements.
Table 26: LRSum: Summary reconciliation of accounting assets and leverage ratio exposures (UK LR1)
| 2025 \$million |
2024 \$million |
||
|---|---|---|---|
| 1 | Total assets as per published financial statements | 919,955 | 849,688 |
| 2 | Adjustment for entities which are consolidated for accounting purposes but are outside the scope of prudential consolidation |
2,192 | 1,390 |
| 3 | (Adjustment for securitised exposures that meet the operational requirements for the recognition of risk transference) |
– | – |
| 4 | (Adjustment for exemption of exposures to central banks) | (94,673) | (77,730) |
| 5 | (Adjustment for fiduciary assets recognised on the balance sheet pursuant to the applicable accounting framework but excluded from the total exposure measure in accordance with point (i) of Article 429a(1) of the CRR) |
– | – |
| 6 | Adjustment for regular-way purchases and sales of financial assets subject to trade date accounting |
(4,254) | (84) |
| 7 | Adjustment for eligible cash pooling transactions | – | – |
| 8 | Adjustment for derivative financial instruments | 8,839 | (10,536) |
| 9 | Adjustment for securities financing transactions (SFTs) | 6,715 | 4,198 |
| 10 | Adjustment for off-balance sheet items (i.e. conversion to credit equivalent amounts of off-balance sheet exposures) |
117,341 | 118,607 |
| 11 | (Adjustment for prudent valuation adjustments and specific and general provisions which have reduced tier 1 capital (leverage)) |
(1,291) | (1,326) |
| UK-11a | (Adjustment for exposures excluded from the total exposure measure in accordance with point (c) of Article 429a(1) of the CRR) |
– | – |
| UK-11b | (Adjustment for exposures excluded from the total exposure measure in accordance with point (j) of Article 429a(1) of the CRR) |
– | – |
| 12 | Other adjustments1 | (16,634) | (15,863) |
| 13 | Total exposure measure | 938,190 | 868,344 |
1 Other Adjustments include Cash Collateral posted \$(10,011) million, Tier-1 Capital deduction other than disclosed in above row 11 \$(6,793) million, DTL \$170 million.
2.6 Leverage ratio continued Table 27: LRCom: Leverage ratio common disclosure (UK LR2)
| 2025 \$million |
2024 \$million |
||
|---|---|---|---|
| On-balance sheet exposures (excluding derivatives and SFTs) | |||
| 1 | On-balance sheet items (excluding derivatives, SFTs, but including collateral) | 756,185 | 670,948 |
| 2 | Gross-up for derivatives collateral provided, where deducted from the balance sheet assets pursuant to the applicable accounting framework |
– | – |
| 3 | (Deductions of receivables assets for cash variation margin provided in derivatives transactions) |
(10,011) | (10,169) |
| 4 | (Adjustment for securities received under securities financing transactions that are recognised as an asset) |
– | – |
| 5 | (General credit risk adjustments to on-balance sheet items) | – | – |
| 6 | (Asset amounts deducted in determining tier 1 capital (leverage)) | (8,084) | (7,247) |
| 7 | Total on-balance sheet exposures (excluding derivatives and SFTs) | 738,090 | 653,532 |
| Derivative exposures | |||
| 8 | Replacement cost associated with SA-CCR derivatives transactions (i.e. net of eligible cash variation margin) |
17,685 | 22,550 |
| UK-8a | Derogation for derivatives: replacement costs contribution under the simplified standardised approach |
– | – |
| 9 | Add-on amounts for potential future exposure associated with SA-CCR derivatives transactions |
59,656 | 52,346 |
| UK-9a | Derogation for derivatives: potential future exposure contribution under the simplified standardised approach |
– | – |
| UK-9b | Exposure determined under the original exposure method | – | – |
| 10 | (Exempted CCP leg of client-cleared trade exposures) (SA-CCR) | (5,324) | (6,035) |
| UK-10a | (Exempted CCP leg of client-cleared trade exposures) (simplified standardised approach) | – | – |
| UK-10b | (Exempted CCP leg of client-cleared trade exposures) (original exposure method) | – | – |
| 11 | Adjusted effective notional amount of written credit derivatives | 24,572 | 97,504 |
| 12 | (Adjusted effective notional offsets and add-on deductions for written credit derivatives) | (21,968) | (95,429) |
| 13 | Total derivatives exposures | 74,621 | 70,936 |
| Securities financing transaction exposures | |||
| 14 | Gross SFT assets (with no recognition of netting), after adjustment for sales accounting transactions |
160,963 | 137,115 |
| 15 | (Netted amounts of cash payables and cash receivables of gross SFT assets) | (64,868) | (38,314) |
| 16 | Counterparty credit risk exposure for SFT assets | 6,715 | 4,198 |
| UK-16a | Derogation for SFTs: counterparty credit risk exposure in accordance with Articles 429e(5) and 222 of the CRR |
– | – |
| 17 | Agent transaction exposures | – | – |
| UK-17a | (Exempted CCP leg of client-cleared SFT exposures) | – | – |
| 18 | Total securities financing transaction exposures | 102,811 | 102,999 |
| Other off-balance sheet exposures | |||
| 19 | Off-balance sheet exposures at gross notional amount | 447,113 | 468,134 |
| 20 | (Adjustments for conversion to credit equivalent amounts) | (329,772) | (349,527) |
| 21 | (General provisions deducted in determining tier 1 capital (leverage) and specific provisions associated with off-balance sheet exposures) |
– | – |
| 22 | Off-balance sheet exposures | 117,341 | 118,607 |
| Excluded exposures | |||
| UK-22a | (Exposures excluded from the total exposure measure in accordance with point (c) of Article 429a(1) of the CRR) |
– | – |
| UK-22b | (Exposures exempted in accordance with point (j) of Article 429a(1) of the CRR (on- and off- balance sheet)) |
– | – |
| UK-22g | (Excluded excess collateral deposited at triparty agents) | – | – |
| UK-22k | (Total exempted exposures) | – | – |
| Capital and total exposures | |||
| 23 | Tier 1 capital (leverage) | 43,949 | 41,672 |
| 24 | Total exposure measure including claims on central banks | 1,032,863 | 946,074 |
| UK-24a | (-) Claims on central banks excluded | (94,673) | (77,730) |
2.6 Leverage ratio continued
| 2025 \$million |
2024 \$million |
||
|---|---|---|---|
| UK-24b | Total exposure measure excluding claims on central banks | 938,190 | 868,344 |
| Leverage ratio | |||
| 25 | Leverage ratio excluding claims on central banks (%) | 4.7% | 4.8% |
| UK-25a | Fully loaded ECL accounting model leverage ratio excluding claims on central banks (%) | 4.7% | 4.8% |
| UK-25b | Leverage ratio excluding central bank reserves as if the temporary treatment of unrealised gains and losses measured at fair value through other comprehensive income had not been |
4.7% | |
| UK-25c | applied (%) Leverage ratio including claims on central banks (%) |
4.3% | 4.8% 4.4% |
| 26 | Regulatory minimum leverage ratio requirement (%) | 3.3% | 3.3% |
| Additional leverage ratio disclosure requirements – leverage ratio buffers | |||
| 27 | Leverage ratio buffer (%) | 0.5% | 0.5% |
| UK-27a | Of which: G-SII or O-SII additional leverage ratio buffer (%) | 0.4% | 0.4% |
| UK-27b | Of which: countercyclical leverage ratio buffer (%) | 0.1% | 0.1% |
| Additional leverage ratio disclosure requirements – disclosure of mean values | |||
| 28 | Mean of daily values of gross SFT assets, after adjustment for sale accounting transactions and netted of amounts of associated cash payables and cash receivable |
100,155 | 101,902 |
| 29 | Quarter-end value of gross SFT assets, after adjustment for sale accounting transactions and netted of amounts of associated cash payables and cash receivables |
96,096 | 98,801 |
| UK-31 | Average total exposure measure including claims on central banks | 1,042,790 | 982,761 |
| UK-32 | Average total exposure measure excluding claims on central banks | 949,214 | 894,296 |
| UK-33 | Average leverage ratio including claims on central banks | 4.2% | 4.2% |
| UK-34 | Average leverage ratio excluding claims on central banks | 4.6% | 4.7% |
Table 28: LRSpl: Split-up of on balance sheet exposures (excluding derivatives, SFTs and exempted exposures) (UK LR3)
| 2025 \$million |
2024 \$million |
||
|---|---|---|---|
| UK-1 | Total on-balance sheet exposures (excluding derivatives, SFTs, and exempted exposures), | ||
| of which: | 746,174 | 660,779 | |
| UK-2 | Trading book exposures | 125,923 | 88,194 |
| UK-3 | Banking book exposures, of which: | 620,251 | 572,585 |
| UK-4 | Covered bonds | 3,056 | 3,901 |
| UK-5 | Exposures treated as sovereigns | 228,715 | 204,143 |
| UK-6 | Exposures to regional governments, MDB, international organisations and PSE not treated | ||
| as sovereigns | 17,098 | 15,595 | |
| UK-7 | Institutions | 48,577 | 49,414 |
| UK-8 | Secured by mortgages of immovable properties | 88,624 | 83,859 |
| UK-9 | Retail exposures | 28,307 | 28,845 |
| UK-10 | Corporates | 146,503 | 129,903 |
| UK-11 | Exposures in default | 6,658 | 5,761 |
| UK-12 | Other exposures (e.g. equity, securitisations, and other non-credit obligation assets) | 52,713 | 51,164 |
3. Credit risk
Our approach to credit risk can be found in the Risk management approach section in the 2025 Annual Report and Accounts on page 233 to 234.
3.1. Internal Ratings Based Approach (IRB) to credit risk
The Group uses the Advanced IRB approach to measure credit risk for the majority of its portfolios. This allows the Group to use its own internal estimates of Probability of Default (PD), Loss Given Default (LGD), and Exposure at Default (EAD) to determine an asset risk-weighting. The IRB models cover 82 per cent of the Group's credit RWA (2024: 78 per cent).
PD is the likelihood that an obligor will default on an obligation within the next 12 months. Banks utilising the IRB approach must assign an internal PD to all borrowers. EAD is the expected amount of exposure to a particular facility at the point of default; it is modelled based on historical experience to determine the amount that is expected to be further drawn down from the undrawn portion of a facility. LGD is the percentage of EAD that a lender expects to lose in the event of obligor default. EAD and LGD are measured based on historical experience in economic downturn periods, if these were more conservative than the long-run average, else the long-run average is used.
All assets under the Advanced IRB approach have internal PD, LGD and EAD models developed to support the credit decision making process as well as RWA and capital estimate. RWA under the Advanced IRB approach is determined by regulatory specified formulae dependent on the Group's estimates of PD, LGD, EAD, and residual maturity. The development, use and governance of Corporate and Investment Banking (CIB) and Wealth and Retail Banking (WRB) models under the Advanced IRB approach are covered in more detail in Section 3.3 Internal Ratings Based models.
3.2. Standardised Approach to credit risk
The Standardised Approach is applied to portfolios that are classified as permanently exempted from the IRB approach, and those portfolios for which an IRB approach has yet to be developed, for instance due to insufficient data availability.
CRR Article 150 allows IRB banks to elect to permanently exclude certain exposures from the IRB approach and use the Standardised Approach. These are known as permanent exemptions.
The permanent exemptions apply to:
- Africa all retail portfolios
- Private Banking
- Private Equity
- Development organisations
- Jordan
- Purchased receivables
- Hedge funds
- Exposures to, or guaranteed by, central governments and central banks of EEA States, provided they are eligible for a zero per cent risk weighting under the Standardised Approach
The Standardised Approach measures credit risk pursuant to fixed risk-weights and is the least sophisticated of the capital requirement calculation methodologies under Basel III. The risk-weight applied under the Standardised Approach is prescribed within the CRR and is based on the asset class to which the exposure is assigned.
3.3 Internal Ratings Based models
Model Governance
All IRB models are developed by independent model analytics teams aligned to the CIB and WRB business functions. Both new models and changes to the existing models, are subject to independent validation by Group Model Validation (GMV), which is part of the Model Risk Management function, a separate department within Group Risk, and are reviewed and approved by the Credit Model Assessment Committee (CMAC) and the Model Risk Committee (MRC) based on materiality. The Model Risk Policy and Governance team (MRPG) was established to provide independent oversight of model risk governance activities including model issue reporting, inventory management and model risk appetite reporting.
The performance of existing IRB models, including metrics on actual against predicted, is monitored regularly by the Model Monitoring teams and reported to CMAC on a quarterly basis. GMV independently reviews model performance monitoring results based on applicable standards. In addition, existing models are subject to annual independent validation by GMV. The Group Model Risk Policy and associated standards set out internal requirements and operating guidelines for model development, validation, and performance monitoring. The Board Risk Committee is updated on the status of IRB (and other) models on a semi-annual basis. Any concerns on IRB model performance or material model issues impacting IRB models are also captured as part of Risk Appetite monitoring, reported to the Board Risk Committee monthly. Rating overrides are tracked, and threshold breaches are escalated to the relevant risk management committees, and model issues are tracked and reported at CMAC. An annual self-assessment on IRB models' regulatory compliance is carried out as part of the Senior Management Function attestation.
The Group has a strong monitoring and governance framework in place to identify and mitigate model performance issues. While most models are conservative and over predict PD, LGD and EAD, in cases where the models under predict, a post model adjustment may be taken to ensure adequate capitalisation, in addition to having a remediation plan in place.
Group Internal Audit is responsible for carrying out independent reviews on the effectiveness of the controls supporting IRB models' development, validation, approval and monitoring.
Probability of Default
PDs are estimated based on one of the three industry standard approaches, namely the good-bad approach where a sufficient number of internal defaults is available, the shadow-bond approach where there are no sufficient internal defaults but there are external ratings for a large number of obligors, or the constrained expert judgement approach where neither internal defaults nor external ratings are available.
In CIB, the largest portfolios are rated based on the shadow bond approach (Sovereigns, Large Corporates) or the good-bad approach (Banks, Mid Corporates). Central governments and central banks are rated using the Sovereign model. Non-bank financial institutions are rated using one of six constrained expert judgement models depending on their line of business, with the largest being Funds, Finance & Leasing, and Broker Dealers. Corporate clients are differentiated by their annual sales turnover and rated using one of the corporate models unless they are commodity buyers and traders (for which a separate model has been developed) or are classified under Specialised Lending or Supply Chain Finance. Excluding the Sovereign model, all other CIB IRB PD models are subject to the 0.03 per cent regulatory PD floor.
Within CIB, each client is assigned a credit grade, regardless of whether the client is under standardised or IRB capital estimate method, and exposures to each client or client group are aggregated consistently with the regulatory Large Exposures requirements.
The CIB PD models are calibrated following a hybrid through-the-cycle rating philosophy based on historical data that includes a full economic cycle.
Estimates of PD are computed as of 1 January 2025 (including additional exposures that are valid January through March) and are compared with default observations through 31 December 2025.
PD models for retail clients under each asset class are developed based on a combination of product and geography following the good-bad approach.
The same PD modelling approach is taken across the four key retail client product types: Residential Mortgages, Credit Cards (Qualifying Revolving Retail), Personal Instalment Loans (Other Retail) and Retail SME (Other Retail). The approach is based on using the country and product specific application scores for new to bank clients and behaviour scores for existing clients. The scorecards are built using demographic information, credit bureau data, and observed client performance data (for behaviour scores). Statistical techniques are used to develop a relationship between this information and the probability of default. The scorecards are used to make credit decisions. All retail client PD models are built and validated using internal default data.
3.3 Internal Ratings Based models continued Loss Given Default
The CIB LGD model is a component-based model reflecting the Bank's recovery and workout process, which takes into account risk drivers such as portfolio segment, jurisdiction, product, and collateral attached to the exposure. The model is calibrated based on downturn experience if that is more conservative than the long-run experience. Regulatory floors are applied to both unsecured and secured facilities (except for those secured by cash) if the LGD parameters are based on fewer than 20 defaults or by regulatory mandate (Sovereign, Financial Institutions, and Covered Bonds). This is in accordance with the PRA's lowdefault framework which states that where there are insufficient defaults to estimate a parameter at granular level an LGD floor must be applied.
The calculation of realised versus predicted LGD is affected by the fact that it may take a number of years for the workout process to be completed. As such, an observed recovery value cannot be assigned to the majority of the 2025 defaults, making it meaningless to compare realised versus predicted outcomes in a manner similar to that for PD and EAD.
To address this for corporates and institutions we have adopted an approach based on a four-year rolling period of predicted and realised LGD, which for the current reporting year includes 2022 to 2025 defaults that have completed their workout process as at the end of 2025. This approach compares the four-year rolling predicted LGD, providing the predicted outcome of these resolved defaults one year prior to default, against the realised LGD for the same set of defaults. These two figures are fully comparable, thereby providing a meaningful assessment of the LGD model's performance.
Under this approach, realised LGD values for Corporates are lower than the predicted. This is explained by the regulatory guidance to calibrate LGD models to downturn conditions. There were no defaults that had resolved in the previous four years for Central Governments, Central Banks and Institutions.
LGDs for retail portfolios follow two approaches:
- i LGDs for unsecured products are based on historical loss experience of defaults during a downturn; these are portfoliospecific LGD estimates segmented by default status (including restructuring)
- ii LGDs for secured products are parameter-based estimates mainly driven by how the default is resolved (e.g., cure, sale, charge-off). Key LGD parameters are differentiated by segments such as loan-to-value, property type and default status. These parameters are calibrated based on the portfolio's downturn experience
Retail LGD model monitoring considers defaults from a cohort and the actual recoveries up to the end of the workout window.
Under this approach, realised LGD values for all retail asset classes are lower than predicted, primarily due to the regulatory guidance to calibrate LGD models to downturn conditions. This is most evident in the mortgage portfolios, where predicted LGD values include a significant assumed reduction in property values.
Exposure at Default
EAD takes into consideration the potential drawdown of a commitment as an obligor moves towards default by estimating the Credit Conversion Factor (CCF) of undrawn commitments.
EAD for sovereign, corporate and institutional clients is determined by product but on a global basis, while the commercial and retail EAD is dependent on the combination of country and product.
The sovereign, corporate and institutional EAD model has adopted the momentum approach to estimate the CCF, with the type of facility and the level of utilisation being key drivers of CCF. The model is calibrated based on the Bank's internal downturn experience and CCF is floored at 0 percent.
EAD for retail products differs between revolving products and term products. For revolving products, EAD is computed by estimating the CCF of undrawn commitments, with a floor at 0 percent. For term products, EAD is set at the outstanding balance plus any undrawn portion. All the retail client EAD models are developed and validated using internal default data.
The comparison of realised versus predicted EAD is summarised in the ratio of EAD of assets that defaulted in a particular year to the outstanding amount at the time of default. The ratios for all models are larger than one, indicating that the predicted EAD is higher than the realised outstanding amount at default. This is explained by the regulatory guidance to assign conservatism to the CCF and to calibrate the models to downturn conditions, as well as by the impact of management action leading to a reduction in actual exposure prior to default.
The estimates provided in the table are before the application of any conservative adjustment.
Table 29: IRB approach – Back-testing of PD per exposure class for central governments or central banks (fixed PD scale) (UK CR9)
| 2025 | ||||||||
|---|---|---|---|---|---|---|---|---|
| Number of obligors at the end of previous year |
||||||||
| PD Range % | Of which number of obligors which defaulted in the year |
Observed average default rate % |
Exposures weighted average PD % |
Average PD % |
Average historical annual default rate % |
|||
| 0.00 to <0.15 | 84 | – | – | 0.03 | 0.05 | – | ||
| 0.00 to <0.10 | 73 | – | – | 0.02 | 0.03 | – | ||
| 0.10 to <0.15 | 11 | – | – | 0.13 | 0.13 | – | ||
| 0.15 to <0.25 | 6 | – | – | 0.22 | 0.22 | – | ||
| 0.25 to <0.50 | 3 | – | – | 0.39 | 0.39 | – | ||
| 0.50 to <0.75 | 4 | – | – | – | 0.59 | – | ||
| 0.75 to <2.50 | 24 | 1 | 4.17 | 1.62 | 1.24 | – | ||
| 0.75 to <1.75 | 21 | 1 | 4.76 | 1.00 | 1.12 | – | ||
| 1.75 to <2.50 | 3 | – | – | 2.03 | 2.03 | – | ||
| 2.50 to <10.00 | 26 | – | – | 4.83 | 4.02 | 1.38 | ||
| 2.50 to <5.00 | 24 | – | – | 3.58 | 3.76 | 2.11 | ||
| 5.00 to <10.00 | 2 | – | – | 8.01 | 7.05 | – | ||
| 10.00 to <100.00 | 12 | – | – | 10.54 | 20.70 | 10.66 | ||
| 10.00 to <20.00 | 8 | – | – | 10.54 | 15.61 | 5.00 | ||
| 20.00 to <30.00 | 1 | – | – | – | 24.55 | 10.00 | ||
| 30.00 to <100.00 | 3 | – | – | – | 33.00 | 25.00 | ||
| 100.00 (Default) | – | – | – | 100.00 | 100.00 | – |
| 2024 | ||||||||
|---|---|---|---|---|---|---|---|---|
| Number of obligors at the end of previous year |
||||||||
| PD Range % | Of which number of obligors which defaulted in the year |
Exposures weighted average PD % |
Average PD % |
Average historical annual default rate % |
||||
| 0.00 to <0.15 | 77 | – | – | 0.03 | 0.05 | – | ||
| 0.00 to <0.10 | 68 | – | – | 0.02 | 0.04 | – | ||
| 0.10 to <0.15 | 9 | – | – | 0.15 | 0.13 | – | ||
| 0.15 to <0.25 | 6 | – | – | 0.22 | 0.22 | – | ||
| 0.25 to <0.50 | 1 | – | – | 0.39 | 0.39 | – | ||
| 0.50 to <0.75 | 9 | – | – | – | 0.56 | – | ||
| 0.75 to <2.50 | 21 | – | – | 1.28 | 1.22 | – | ||
| 0.75 to <1.75 | 17 | – | – | 1.24 | 1.02 | – | ||
| 1.75 to <2.50 | 4 | – | – | 2.03 | 2.03 | – | ||
| 2.50 to <10.00 | 25 | – | – | 3.98 | 4.25 | 1.38 | ||
| 2.50 to <5.00 | 22 | – | – | 3.98 | 3.82 | 2.11 | ||
| 5.00 to <10.00 | 4 | – | – | – | 7.04 | – | ||
| 10.00 to <100.00 | 13 | – | – | 21.86 | 22.81 | 10.66 | ||
| 10.00 to <20.00 | 6 | – | – | 17.09 | 12.32 | 5.00 | ||
| 20.00 to <30.00 | 1 | – | – | – | 24.55 | 10.00 | ||
| 30.00 to <100.00 | 6 | – | – | 33.00 | 33.00 | 25.00 | ||
| 100.00 (Default) | – | – | – | 100.00 | 100.00 | – |
Table 30: IRB approach – Back-testing of PD per exposure class for institutions (fixed PD scale) (UK CR9)
| 2025 | |||||||
|---|---|---|---|---|---|---|---|
| Number of obligors at the end of previous year |
|||||||
| PD Range % | Of which number of obligors which defaulted in the year |
Observed average default rate % |
Exposures weighted average PD % |
Average PD % |
Average historical annual default rate % |
||
| 0.00 to <0.15 | 632 | – | – | 0.05 | 0.07 | 0.03 | |
| 0.00 to <0.10 | 524 | – | – | 0.04 | 0.05 | – | |
| 0.10 to <0.15 | 108 | – | – | 0.13 | 0.13 | 0.22 | |
| 0.15 to <0.25 | 115 | – | – | 0.22 | 0.22 | – | |
| 0.25 to <0.50 | 71 | – | – | 0.39 | 0.39 | – | |
| 0.50 to <0.75 | 112 | – | – | 0.52 | 0.55 | – | |
| 0.75 to <2.50 | 196 | 1 | 0.51 | 1.38 | 1.28 | – | |
| 0.75 to <1.75 | 161 | 1 | 0.62 | 1.18 | 1.12 | – | |
| 1.75 to <2.50 | 35 | – | – | 2.03 | 2.03 | – | |
| 2.50 to <10.00 | 119 | – | – | 4.06 | 4.33 | 3.10 | |
| 2.50 to <5.00 | 102 | – | – | 3.45 | 3.83 | 0.61 | |
| 5.00 to <10.00 | 17 | – | – | 7.69 | 7.50 | 7.06 | |
| 10.00 to <100.00 | 52 | 2 | 3.95 | 13.78 | 21.88 | 8.35 | |
| 10.00 to <20.00 | 32 | – | – | 13.76 | 15.47 | 9.63 | |
| 20.00 to <30.00 | 1 | – | – | – | 24.55 | 10.00 | |
| 30.00 to <100.00 | 19 | 2 | 10.53 | 33.00 | 33.00 | 6.96 | |
| 100.00 (Default) | – | – | – | 100.00 | 100.00 | – |
| Number of obligors at the end of previous year |
||||||
|---|---|---|---|---|---|---|
| PD Range % | Of which number of obligors which defaulted in the year |
Observed average default rate % |
Exposures weighted average PD % |
Average PD % |
Average historical annual default rate % |
|
| 0.00 to <0.15 | 618 | – | – | 0.05 | 0.06 | 0.06 |
| 0.00 to <0.10 | 525 | – | – | 0.04 | 0.05 | 0.03 |
| 0.10 to <0.15 | 93 | – | – | 0.13 | 0.13 | 0.22 |
| 0.15 to <0.25 | 114 | – | – | 0.22 | 0.22 | – |
| 0.25 to <0.50 | 71 | – | – | 0.39 | 0.39 | – |
| 0.50 to <0.75 | 124 | – | – | 0.52 | 0.56 | – |
| 0.75 to <2.50 | 160 | – | – | 1.30 | 1.32 | 0.06 |
| 0.75 to <1.75 | 126 | – | – | 1.19 | 1.13 | 0.09 |
| 1.75 to <2.50 | 34 | – | – | 2.03 | 2.03 | – |
| 2.50 to <10.00 | 144 | – | – | 4.66 | 4.98 | 3.10 |
| 2.50 to <5.00 | 89 | – | – | 4.02 | 3.70 | 0.61 |
| 5.00 to <10.00 | 55 | – | – | 6.73 | 7.06 | 7.06 |
| 10.00 to <100.00 | 61 | 8 | 13.11 | 19.48 | 26.96 | 5.73 |
| 10.00 to <20.00 | 18 | – | – | 17.88 | 12.98 | 9.63 |
| 20.00 to <30.00 | 1 | – | – | – | 24.55 | 10.00 |
| 30.00 to <100.00 | 42 | 8 | 19.05 | 33.00 | 33.00 | 3.15 |
| 100.00 (Default) | – | – | – | 100.00 | 100.00 | – |
2024
Table 31: IRB approach – Back-testing of PD per exposure class for corporates – other (fixed PD scale) (UK CR9)
| 2025 | ||||||||
|---|---|---|---|---|---|---|---|---|
| Number of obligors at the end of previous year |
||||||||
| PD Range % | Of which number of obligors which defaulted in the year |
Observed average default rate % |
Exposures weighted average PD % |
Average PD % |
Average historical annual default rate % |
|||
| 0.00 to <0.15 | 4,096 | 1 | 0.02 | 0.07 | 0.09 | 0.04 | ||
| 0.00 to <0.10 | 2,753 | 1 | 0.04 | 0.05 | 0.07 | 0.05 | ||
| 0.10 to <0.15 | 1,343 | – | – | 0.13 | 0.13 | 0.02 | ||
| 0.15 to <0.25 | 1,711 | 1 | 0.06 | 0.22 | 0.22 | 0.11 | ||
| 0.25 to <0.50 | 1,208 | – | – | 0.39 | 0.39 | 0.20 | ||
| 0.50 to <0.75 | 2,121 | – | – | 0.57 | 0.57 | 0.29 | ||
| 0.75 to <2.50 | 3,142 | 9 | 0.29 | 1.36 | 1.42 | 0.65 | ||
| 0.75 to <1.75 | 2,333 | 7 | 0.30 | 1.15 | 1.22 | 0.64 | ||
| 1.75 to <2.50 | 809 | 2 | 0.25 | 2.03 | 2.00 | 0.69 | ||
| 2.50 to <10.00 | 1,438 | 13 | 0.90 | 4.31 | 4.30 | 1.75 | ||
| 2.50 to <5.00 | 1,062 | 9 | 0.85 | 3.73 | 3.52 | 1.59 | ||
| 5.00 to <10.00 | 376 | 4 | 1.06 | 7.33 | 6.52 | 2.38 | ||
| 10.00 to <100.00 | 1,382 | 22 | 1.59 | 20.19 | 16.71 | 4.13 | ||
| 10.00 to <20.00 | 1,251 | 11 | 0.88 | 13.88 | 13.89 | 2.71 | ||
| 20.00 to <30.00 | 51 | 1 | 1.96 | 24.56 | 24.45 | 13.40 | ||
| 30.00 to <100.00 | 80 | 10 | 12.50 | 33.03 | 56.29 | 17.05 | ||
| 100.00 (Default) | – | – | – | 100.00 | 100.00 | – |
| 2024 | |||||||
|---|---|---|---|---|---|---|---|
| Number of obligors at the end of previous year |
|||||||
| PD Range % | Of which number of obligors which defaulted in the year |
Exposures weighted average PD % |
Average PD % |
Average historical annual default rate % |
|||
| 0.00 to <0.15 | 3,609 | 1 | 0.03 | 0.07 | 0.09 | 0.03 | |
| 0.00 to <0.10 | 2,482 | – | – | 0.06 | 0.07 | 0.05 | |
| 0.10 to <0.15 | 1,128 | 1 | 0.09 | 0.13 | 0.13 | – | |
| 0.15 to <0.25 | 1,856 | 2 | 0.11 | 0.22 | 0.22 | 0.10 | |
| 0.25 to <0.50 | 1,303 | 1 | 0.08 | 0.39 | 0.39 | 0.20 | |
| 0.50 to <0.75 | 2,047 | 1 | 0.05 | 0.56 | 0.58 | 0.29 | |
| 0.75 to <2.50 | 2,928 | 9 | 0.31 | 1.29 | 1.40 | 0.69 | |
| 0.75 to <1.75 | 2,207 | 5 | 0.23 | 1.14 | 1.20 | 0.69 | |
| 1.75 to <2.50 | 723 | 4 | 0.55 | 2.03 | 2.01 | 0.68 | |
| 2.50 to <10.00 | 1,367 | 20 | 1.46 | 4.29 | 4.44 | 1.85 | |
| 2.50 to <5.00 | 1,050 | 13 | 1.24 | 3.66 | 3.60 | 1.68 | |
| 5.00 to <10.00 | 317 | 7 | 2.21 | 6.83 | 7.21 | 2.54 | |
| 10.00 to <100.00 | 1,656 | 20 | 1.21 | 17.52 | 17.40 | 4.92 | |
| 10.00 to <20.00 | 1,378 | 6 | 0.44 | 14.98 | 13.41 | 2.99 | |
| 20.00 to <30.00 | 58 | – | – | 24.55 | 24.48 | 18.49 | |
| 30.00 to <100.00 | 222 | 14 | 6.31 | 33.26 | 40.38 | 20.67 | |
| 100.00 (Default) | – | – | – | 100.00 | 100.00 | – |
Table 32: IRB approach – Back-testing of PD per exposure class for corporates – specialised lending (fixed PD scale) (UK CR9)
| 2025 | ||||||||
|---|---|---|---|---|---|---|---|---|
| Number of obligors at the end of previous year |
||||||||
| PD Range % | Of which number of obligors which defaulted in the year |
Observed average default rate % |
Exposures weighted average PD % |
Average PD % |
Average historical annual default rate % |
|||
| 0.00 to <0.15 | 201 | – | – | 0.09 | 0.09 | 0.14 | ||
| 0.00 to <0.10 | 134 | – | – | 0.07 | 0.07 | 0.11 | ||
| 0.10 to <0.15 | 67 | – | – | 0.13 | 0.13 | 0.13 | ||
| 0.15 to <0.25 | 190 | – | – | 0.22 | 0.22 | 0.82 | ||
| 0.25 to <0.50 | 83 | – | – | 0.39 | 0.39 | 0.69 | ||
| 0.50 to <0.75 | 129 | 4 | 3.10 | 0.57 | 0.57 | 0.86 | ||
| 0.75 to <2.50 | 120 | – | – | 1.24 | 1.28 | 1.51 | ||
| 0.75 to <1.75 | 99 | – | – | 1.13 | 1.13 | 2.04 | ||
| 1.75 to <2.50 | 21 | – | – | 2.03 | 2.03 | - | ||
| 2.50 to <10.00 | 36 | 1 | 2.78 | 4.11 | 4.59 | 3.97 | ||
| 2.50 to <5.00 | 25 | – | – | 3.62 | 3.47 | 3.96 | ||
| 5.00 to <10.00 | 11 | 1 | 9.09 | 6.19 | 7.13 | 5.78 | ||
| 10.00 to <100.00 | 15 | 1 | 6.67 | 13.45 | 14.97 | 16.10 | ||
| 10.00 to <20.00 | 12 | – | – | 10.54 | 11.16 | 7.24 | ||
| 20.00 to <30.00 | 1 | – | – | 24.55 | 24.55 | 46.29 | ||
| 30.00 to <100.00 | 2 | 1 | 50.00 | – | 33.00 | 30.38 | ||
| 100.00 (Default) | – | – | – | 100.00 | 100.00 | – |
| 2024 | |||||||
|---|---|---|---|---|---|---|---|
| Number of obligors at the end of previous year Of which number of obligors which defaulted in the year |
Average historical annual default rate % |
||||||
| PD Range % | Exposures weighted average PD % |
Average PD % |
|||||
| 0.00 to <0.15 | 188 | 1 | 0.01 | 0.10 | – | – | |
| 0.00 to <0.10 | 110 | – | – | 0.07 | – | – | |
| 0.10 to <0.15 | 78 | 1 | 0.01 | 0.13 | – | – | |
| 0.15 to <0.25 | 133 | – | – | 0.22 | – | 0.01 | |
| 0.25 to <0.50 | 71 | – | – | 0.39 | – | 0.01 | |
| 0.50 to <0.75 | 118 | 1 | 0.01 | 0.58 | 0.01 | 0.01 | |
| 0.75 to <2.50 | 115 | – | – | 1.25 | 0.01 | 0.02 | |
| 0.75 to <1.75 | 87 | – | – | 1.12 | 0.01 | 0.02 | |
| 1.75 to <2.50 | 28 | – | – | 2.03 | 0.02 | – | |
| 2.50 to <10.00 | 38 | – | – | 3.77 | 0.04 | 0.04 | |
| 2.50 to <5.00 | 28 | – | – | 3.38 | 0.03 | 0.04 | |
| 5.00 to <10.00 | 10 | – | – | 6.63 | 0.07 | 0.07 | |
| 10.00 to <100.00 | 19 | 2 | 0.11 | 25.25 | 0.15 | 0.16 | |
| 10.00 to <20.00 | 16 | – | - | 11.35 | 0.12 | 0.07 | |
| 20.00 to <30.00 | 1 | 1 | 1.00 | 24.55 | 0.25 | 0.35 | |
| 30.00 to <100.00 | 2 | 1 | 0.50 | 33.00 | 0.33 | 0.32 | |
| 100.00 (Default) | – | – | – | 100.00 | 100.00 | – |
Table 33: IRB approach – Back-testing of PD per exposure class for corporates – SME (fixed PD scale) (UK CR9)
| 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Number of obligors at the end of previous year |
|||||||||
| PD Range % | Of which number of obligors which defaulted in the year |
Observed average default rate % |
Exposures weighted average PD % |
Average PD % |
Average historical annual default rate % |
||||
| 0.00 to <0.15 | 14 | – | – | 0.08 | 0.09 | – | |||
| 0.00 to <0.10 | 9 | – | – | 0.04 | 0.07 | – | |||
| 0.10 to <0.15 | 5 | – | – | 0.13 | 0.13 | – | |||
| 0.15 to <0.25 | 188 | – | – | 0.23 | 0.23 | 0.15 | |||
| 0.25 to <0.50 | 102 | – | – | 0.40 | 0.41 | 0.49 | |||
| 0.50 to <0.75 | 467 | 3 | 0.64 | 0.64 | 0.62 | 0.59 | |||
| 0.75 to <2.50 | 801 | 12 | 1.50 | 1.47 | 1.52 | 1.13 | |||
| 0.75 to <1.75 | 560 | 7 | 1.25 | 1.29 | 1.27 | 0.95 | |||
| 1.75 to <2.50 | 241 | 5 | 2.07 | 2.08 | 2.11 | 1.57 | |||
| 2.50 to <10.00 | 1,394 | 38 | 2.73 | 4.62 | 5.10 | 1.99 | |||
| 2.50 to <5.00 | 864 | 18 | 2.08 | 3.62 | 3.81 | 1.54 | |||
| 5.00 to <10.00 | 530 | 20 | 3.77 | 6.24 | 7.20 | 2.77 | |||
| 10.00 to <100.00 | 868 | 89 | 10.25 | 15.98 | 13.69 | 6.66 | |||
| 10.00 to <20.00 | 856 | 88 | 10.28 | 14.06 | 13.41 | 6.30 | |||
| 20.00 to <30.00 | 3 | – | – | 24.48 | 24.55 | 9.24 | |||
| 30.00 to <100.00 | 9 | 1 | 11.11 | 33.00 | 36.93 | 23.51 | |||
| 100.00 (Default) | – | – | – | 100.00 | 100.00 | – |
| 2024 | |||||||
|---|---|---|---|---|---|---|---|
| Number of obligors at the end of previous year |
|||||||
| PD Range % | Of which number of obligors which defaulted in the year |
Observed average default rate % |
Exposures weighted average PD % |
Average PD % |
Average historical annual default rate % |
||
| 0.00 to <0.15 | 7 | – | – | 0.07 | 0.12 | – | |
| 0.00 to <0.10 | 2 | – | – | 0.06 | 0.09 | – | |
| 0.10 to <0.15 | 5 | – | – | 0.13 | 0.13 | – | |
| 0.15 to <0.25 | 236 | – | – | 0.23 | 0.23 | 0.19 | |
| 0.25 to <0.50 | 127 | 1 | 0.79 | 0.41 | 0.41 | 0.46 | |
| 0.50 to <0.75 | 551 | 5 | 0.91 | 0.62 | 0.61 | 0.41 | |
| 0.75 to <2.50 | 886 | 20 | 2.26 | 1.35 | 1.52 | 0.77 | |
| 0.75 to <1.75 | 620 | 15 | 2.42 | 1.17 | 1.26 | 0.52 | |
| 1.75 to <2.50 | 266 | 5 | 1.88 | 2.09 | 2.12 | 1.37 | |
| 2.50 to <10.00 | 1,519 | 45 | 2.96 | 4.73 | 5.07 | 1.83 | |
| 2.50 to <5.00 | 947 | 19 | 2.01 | 3.71 | 3.79 | 1.51 | |
| 5.00 to <10.00 | 572 | 26 | 4.55 | 6.93 | 7.19 | 2.40 | |
| 10.00 to <100.00 | 713 | 55 | 7.71 | 14.64 | 13.79 | 6.25 | |
| 10.00 to <20.00 | 695 | 52 | 7.48 | 13.63 | 13.42 | 5.82 | |
| 20.00 to <30.00 | 10 | 2 | 20.00 | 24.55 | 24.35 | 7.74 | |
| 30.00 to <100.00 | 8 | 1 | 12.50 | 36.76 | 33.00 | 28.07 | |
| 100.00 (Default) | – | – | – | 100.00 | 100.00 | – |
Table 34: IRB approach – Back-testing of PD per exposure class for retail other – non SME (fixed PD scale) (UK CR9)
| 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Number of obligors at the end of previous year |
|||||||||
| PD Range % | Of which number of obligors which defaulted in the year |
Observed average default rate % |
Exposures weighted average PD % |
Average PD % |
Average historical annual default rate % |
||||
| 0.00 to <0.15 | 50,515 | 22 | 0.04 | 0.07 | 0.05 | 0.03 | |||
| 0.00 to <0.10 | 43,722 | 18 | 0.04 | 0.06 | 0.04 | 0.02 | |||
| 0.10 to <0.15 | 6,793 | 4 | 0.06 | 0.11 | 0.11 | 0.06 | |||
| 0.15 to <0.25 | 24,328 | 22 | 0.09 | 0.20 | 0.17 | 0.13 | |||
| 0.25 to <0.50 | 28,749 | 71 | 0.25 | 0.37 | 0.33 | 0.16 | |||
| 0.50 to <0.75 | 35,245 | 95 | 0.27 | 0.65 | 0.68 | 0.27 | |||
| 0.75 to <2.50 | 139,303 | 881 | 0.63 | 1.45 | 1.67 | 0.77 | |||
| 0.75 to <1.75 | 82,099 | 519 | 0.63 | 1.25 | 1.32 | 0.58 | |||
| 1.75 to <2.50 | 57,204 | 362 | 0.63 | 2.08 | 2.17 | 1.11 | |||
| 2.50 to <10.00 | 207,098 | 5,174 | 2.50 | 4.40 | 5.11 | 1.51 | |||
| 2.50 to <5.00 | 122,978 | 1,858 | 1.51 | 3.31 | 3.62 | 1.15 | |||
| 5.00 to <10.00 | 84,120 | 3,316 | 3.94 | 7.16 | 7.31 | 2.49 | |||
| 10.00 to <100.00 | 77,632 | 12,037 | 15.51 | 24.36 | 24.45 | 12.38 | |||
| 10.00 to <20.00 | 52,499 | 3,549 | 6.76 | 15.65 | 13.52 | 5.30 | |||
| 20.00 to <30.00 | 10,108 | 1,633 | 16.16 | 25.01 | 24.07 | 11.92 | |||
| 30.00 to <100.00 | 15,025 | 6,855 | 45.62 | 59.99 | 63.13 | 29.64 | |||
| 100.00 (Default) | – | – | – | 100.00 | 100.00 | – |
| 2024 | |||||||
|---|---|---|---|---|---|---|---|
| Number of obligors at the end of previous year |
|||||||
| PD Range % | Of which number of obligors which defaulted in the year |
Observed average default rate % |
Exposures weighted average PD % |
Average PD % |
Average historical annual default rate % |
||
| 0.00 to <0.15 | 61,308 | 37 | 0.06 | 0.06 | 0.05 | 0.03 | |
| 0.00 to <0.10 | 53,656 | 30 | 0.06 | 0.05 | 0.04 | 0.02 | |
| 0.10 to <0.15 | 7,652 | 7 | 0.09 | 0.11 | 0.11 | 0.05 | |
| 0.15 to <0.25 | 39,597 | 42 | 0.11 | 0.18 | 0.17 | 0.11 | |
| 0.25 to <0.50 | 70,334 | 115 | 0.16 | 0.34 | 0.34 | 0.16 | |
| 0.50 to <0.75 | 52,520 | 208 | 0.40 | 0.68 | 0.66 | 0.25 | |
| 0.75 to <2.50 | 227,713 | 2,806 | 1.23 | 1.52 | 1.61 | 0.61 | |
| 0.75 to <1.75 | 141,654 | 1,285 | 0.91 | 1.31 | 1.27 | 0.46 | |
| 1.75 to <2.50 | 86,059 | 1,521 | 1.77 | 2.16 | 2.17 | 0.89 | |
| 2.50 to <10.00 | 276,402 | 6,072 | 2.20 | 4.76 | 4.59 | 1.31 | |
| 2.50 to <5.00 | 205,317 | 3,345 | 1.63 | 3.45 | 3.66 | 1.00 | |
| 5.00 to <10.00 | 71,085 | 2,727 | 3.84 | 7.32 | 7.25 | 2.15 | |
| 10.00 to <100.00 | 73,455 | 12,799 | 17.42 | 26.63 | 28.87 | 10.83 | |
| 10.00 to <20.00 | 41,501 | 3,113 | 7.50 | 13.46 | 13.70 | 4.72 | |
| 20.00 to <30.00 | 11,390 | 1,638 | 14.38 | 23.83 | 24.16 | 11.07 | |
| 30.00 to <100.00 | 20,564 | 8,048 | 39.14 | 61.85 | 62.09 | 26.06 | |
| 100.00 (Default) | – | – | – | 100.00 | 100.00 | – |
Table 35: IRB approach – Back-testing of PD per exposure class for retail other – SME (fixed PD scale) (UK CR9)
| 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| the end of previous year | Number of obligors at | ||||||||
| PD Range % | Of which number of obligors which defaulted in the year |
Observed average default rate % |
Exposures weighted average PD % |
Average PD % |
Average historical annual default rate % |
||||
| 0.00 to <0.15 | 917 | 2 | 0.22 | 0.10 | 0.09 | 0.15 | |||
| 0.00 to <0.10 | 566 | 2 | 0.35 | 0.07 | 0.06 | 0.07 | |||
| 0.10 to <0.15 | 351 | – | – | 0.13 | 0.13 | 0.28 | |||
| 0.15 to <0.25 | 938 | 2 | 0.21 | 0.20 | 0.19 | 0.40 | |||
| 0.25 to <0.50 | 1,527 | 6 | 0.39 | 0.38 | 0.38 | 0.50 | |||
| 0.50 to <0.75 | 1,785 | 19 | 1.06 | 0.63 | 0.62 | 0.73 | |||
| 0.75 to <2.50 | 9,210 | 225 | 2.44 | 1.61 | 1.49 | 1.32 | |||
| 0.75 to <1.75 | 6,632 | 134 | 2.02 | 1.35 | 1.28 | 1.13 | |||
| 1.75 to <2.50 | 2,578 | 91 | 3.53 | 2.03 | 2.04 | 1.88 | |||
| 2.50 to <10.00 | 6,879 | 250 | 3.63 | 4.27 | 4.79 | 2.54 | |||
| 2.50 to <5.00 | 4,396 | 150 | 3.41 | 3.47 | 3.54 | 2.15 | |||
| 5.00 to <10.00 | 2,483 | 100 | 4.03 | 6.87 | 6.99 | 3.17 | |||
| 10.00 to <100.00 | 2,253 | 365 | 16.20 | 21.63 | 23.63 | 11.26 | |||
| 10.00 to <20.00 | 1,695 | 99 | 5.84 | 13.15 | 13.08 | 4.45 | |||
| 20.00 to <30.00 | 147 | 25 | 17.01 | 26.17 | 24.40 | 17.04 | |||
| 30.00 to <100.00 | 411 | 241 | 58.64 | 67.53 | 66.87 | 41.68 | |||
| 100.00 (Default) | – | – | – | 100.00 | 100.00 | – |
| 2024 | |||||||
|---|---|---|---|---|---|---|---|
| Number of obligors at the end of previous year |
|||||||
| PD Range % | Of which number of obligors which defaulted in the year |
Exposures weighted average PD % |
Average PD % |
Average historical annual default rate % |
|||
| 0.00 to <0.15 | 834 | 1 | 0.12 | 0.09 | 0.08 | 0.14 | |
| 0.00 to <0.10 | 516 | – | – | 0.07 | 0.06 | 0.10 | |
| 0.10 to <0.15 | 318 | 1 | 0.31 | 0.12 | 0.13 | 0.22 | |
| 0.15 to <0.25 | 1,245 | 8 | 0.64 | 0.19 | 0.19 | 0.31 | |
| 0.25 to <0.50 | 2,007 | 27 | 1.35 | 0.38 | 0.38 | 0.25 | |
| 0.50 to <0.75 | 2,322 | 31 | 1.34 | 0.62 | 0.62 | 0.52 | |
| 0.75 to <2.50 | 9,201 | 238 | 2.59 | 1.57 | 1.45 | 0.96 | |
| 0.75 to <1.75 | 6,872 | 149 | 2.17 | 1.36 | 1.25 | 0.82 | |
| 1.75 to <2.50 | 2,329 | 89 | 3.82 | 2.00 | 2.06 | 1.37 | |
| 2.50 to <10.00 | 6,721 | 269 | 4.00 | 4.49 | 4.97 | 2.11 | |
| 2.50 to <5.00 | 4,069 | 137 | 3.37 | 3.52 | 3.63 | 1.80 | |
| 5.00 to <10.00 | 2,652 | 132 | 4.98 | 6.83 | 7.02 | 2.64 | |
| 10.00 to <100.00 | 2,476 | 352 | 14.22 | 25.27 | 22.73 | 10.56 | |
| 10.00 to <20.00 | 1,914 | 105 | 5.49 | 12.94 | 13.17 | 4.31 | |
| 20.00 to <30.00 | 148 | 27 | 18.24 | 25.28 | 24.52 | 15.54 | |
| 30.00 to <100.00 | 414 | 220 | 53.14 | 67.83 | 66.27 | 36.42 | |
| 100.00 (Default) | – | – | – | 100.00 | 100.00 | – |
Table 36: IRB approach – Back-testing of PD per exposure class for retail – secured by real estate property – Non SME (fixed PD scale) (UK CR9)
| 2025 | ||||||||
|---|---|---|---|---|---|---|---|---|
| Number of obligors at the end of previous year |
Average historical annual default rate % |
|||||||
| PD Range % | Of which number of obligors which defaulted in the year |
Observed average default rate % |
Exposures weighted average PD % |
Average PD % |
||||
| 0.00 to <0.15 | 208,995 | 309 | 0.15 | 0.07 | 0.06 | 0.06 | ||
| 0.00 to <0.10 | 188,341 | 251 | 0.13 | 0.06 | 0.05 | 0.03 | ||
| 0.10 to <0.15 | 20,654 | 58 | 0.28 | 0.12 | 0.12 | 0.17 | ||
| 0.15 to <0.25 | 21,163 | 49 | 0.23 | 0.19 | 0.20 | 0.30 | ||
| 0.25 to <0.50 | 15,268 | 77 | 0.50 | 0.37 | 0.37 | 0.42 | ||
| 0.50 to <0.75 | 24,975 | 106 | 0.42 | 0.63 | 0.60 | 0.81 | ||
| 0.75 to <2.50 | 13,874 | 137 | 0.99 | 1.34 | 1.29 | 0.68 | ||
| 0.75 to <1.75 | 10,888 | 83 | 0.76 | 1.11 | 1.08 | 0.55 | ||
| 1.75 to <2.50 | 2,986 | 54 | 1.81 | 2.06 | 2.06 | 1.24 | ||
| 2.50 to <10.00 | 3,771 | 206 | 5.46 | 4.63 | 5.00 | 1.84 | ||
| 2.50 to <5.00 | 2,251 | 92 | 4.09 | 3.44 | 3.58 | 1.59 | ||
| 5.00 to <10.00 | 1,520 | 114 | 7.50 | 6.97 | 7.10 | 2.30 | ||
| 10.00 to <100.00 | 2,344 | 549 | 23.42 | 37.28 | 32.85 | 17.36 | ||
| 10.00 to <20.00 | 1,001 | 62 | 6.19 | 13.46 | 13.39 | 3.78 | ||
| 20.00 to <30.00 | 252 | 39 | 15.48 | 24.23 | 24.68 | 16.99 | ||
| 30.00 to <100.00 | 1,091 | 448 | 41.06 | 52.40 | 52.50 | 35.86 | ||
| 100.00 (Default) | – | – | – | 100.00 | 100.00 | – |
| Number of obligors at the end of previous year |
Exposures weighted average PD % |
Average historical annual default rate % |
||||
|---|---|---|---|---|---|---|
| PD Range % | Of which number of obligors which defaulted in the year |
Observed average default rate % |
Average PD % |
|||
| 0.00 to <0.15 | 245,186 | 425 | 0.17 | 0.07 | 0.06 | 0.04 |
| 0.00 to <0.10 | 221,151 | 310 | 0.14 | 0.06 | 0.05 | 0.03 |
| 0.10 to <0.15 | 24,035 | 115 | 0.48 | 0.12 | 0.12 | 0.07 |
| 0.15 to <0.25 | 22,831 | 73 | 0.32 | 0.19 | 0.20 | 0.34 |
| 0.25 to <0.50 | 16,091 | 262 | 1.63 | 0.35 | 0.36 | 0.10 |
| 0.50 to <0.75 | 25,991 | 752 | 2.89 | 0.61 | 0.61 | 0.24 |
| 0.75 to <2.50 | 14,919 | 200 | 1.34 | 1.34 | 1.30 | 0.55 |
| 0.75 to <1.75 | 11,721 | 146 | 1.25 | 1.11 | 1.09 | 0.39 |
| 1.75 to <2.50 | 3,198 | 54 | 1.69 | 2.08 | 2.08 | 1.27 |
| 2.50 to <10.00 | 4,024 | 185 | 4.60 | 4.75 | 4.92 | 1.06 |
| 2.50 to <5.00 | 2,500 | 97 | 3.88 | 3.48 | 3.59 | 0.82 |
| 5.00 to <10.00 | 1,524 | 88 | 5.77 | 7.02 | 7.10 | 1.76 |
| 10.00 to <100.00 | 2,467 | 573 | 23.23 | 37.32 | 32.21 | 15.24 |
| 10.00 to <20.00 | 1,099 | 100 | 9.10 | 13.72 | 13.41 | 2.94 |
| 20.00 to <30.00 | 250 | 44 | 17.60 | 24.41 | 24.79 | 14.94 |
| 30.00 to <100.00 | 1,118 | 429 | 38.37 | 53.28 | 52.34 | 38.96 |
| 100.00 (Default) | – | – | – | 100.00 | 100.00 | – |
2024
Table 37: IRB approach – Back-testing of PD per exposure class for retail – secured by real estate property – SME (fixed PD scale) (UK CR9)
| 2025 | ||||||||
|---|---|---|---|---|---|---|---|---|
| Number of obligors at the end of previous year |
||||||||
| PD Range % | Of which number of obligors which defaulted in the year |
Observed average default rate % |
Exposures weighted average PD % |
Average PD % |
Average historical annual default rate % |
|||
| 0.00 to <0.15 | 538 | – | – | 0.10 | 0.09 | 0.04 | ||
| 0.00 to <0.10 | 308 | – | – | 0.08 | 0.07 | 0.04 | ||
| 0.10 to <0.15 | 230 | – | – | 0.13 | 0.13 | 0.04 | ||
| 0.15 to <0.25 | 270 | 2 | 0.74 | 0.18 | 0.18 | 0.25 | ||
| 0.25 to <0.50 | 275 | 1 | 0.36 | 0.39 | 0.38 | 0.33 | ||
| 0.50 to <0.75 | 289 | 1 | 0.35 | 0.62 | 0.61 | 0.23 | ||
| 0.75 to <2.50 | 500 | 1 | 0.20 | 1.49 | 1.29 | 0.54 | ||
| 0.75 to <1.75 | 413 | – | – | 1.15 | 1.12 | 0.43 | ||
| 1.75 to <2.50 | 87 | 1 | 1.15 | 2.20 | 2.10 | 1.02 | ||
| 2.50 to <10.00 | 166 | 2 | 1.20 | 5.44 | 4.74 | 1.92 | ||
| 2.50 to <5.00 | 75 | 2 | 2.67 | 3.77 | 3.15 | 1.38 | ||
| 5.00 to <10.00 | 91 | – | – | 6.90 | 6.06 | 3.42 | ||
| 10.00 to <100.00 | 55 | 8 | 14.55 | 16.80 | 26.10 | 13.35 | ||
| 10.00 to <20.00 | 22 | – | – | 13.95 | 14.74 | 2.78 | ||
| 20.00 to <30.00 | 26 | 4 | 15.38 | 26.50 | 26.62 | 14.51 | ||
| 30.00 to <100.00 | 7 | 4 | 57.14 | 49.48 | 59.87 | 30.69 | ||
| 100.00 (Default) | – | – | – | 100.00 | 100.00 | – |
| 2024 | ||||||||
|---|---|---|---|---|---|---|---|---|
| Number of obligors at the end of previous year |
||||||||
| PD Range % | Of which number of obligors which defaulted in the year |
Exposures weighted average PD % |
Average PD % |
Average historical annual default rate % |
||||
| 0.00 to <0.15 | 495 | – | – | 0.10 | 0.09 | 0.06 | ||
| 0.00 to <0.10 | 298 | – | – | 0.07 | 0.06 | 0.06 | ||
| 0.10 to <0.15 | 197 | – | – | 0.13 | 0.13 | 0.08 | ||
| 0.15 to <0.25 | 259 | 2 | 0.77 | 0.18 | 0.18 | 0.13 | ||
| 0.25 to <0.50 | 299 | 2 | 0.67 | 0.38 | 0.38 | 0.25 | ||
| 0.50 to <0.75 | 319 | – | – | 0.60 | 0.61 | 0.31 | ||
| 0.75 to <2.50 | 676 | 2 | 0.30 | 1.39 | 1.33 | 0.66 | ||
| 0.75 to <1.75 | 577 | 2 | 0.35 | 1.17 | 1.21 | 0.53 | ||
| 1.75 to <2.50 | 99 | – | – | 2.16 | 2.06 | 1.25 | ||
| 2.50 to <10.00 | 211 | 3 | 1.42 | 4.84 | 4.74 | 2.30 | ||
| 2.50 to <5.00 | 160 | 1 | 0.63 | 3.13 | 3.84 | 1.84 | ||
| 5.00 to <10.00 | 51 | 2 | 3.92 | 5.93 | 7.54 | 3.44 | ||
| 10.00 to <100.00 | 71 | 6 | 8.45 | 20.38 | 25.24 | 14.64 | ||
| 10.00 to <20.00 | 33 | – | – | 15.01 | 13.12 | 3.80 | ||
| 20.00 to <30.00 | 28 | 2 | 7.14 | 26.56 | 26.50 | 14.78 | ||
| 30.00 to <100.00 | 10 | 4 | 40.00 | 64.21 | 61.67 | 27.55 | ||
| 100.00 (Default) | – | – | – | 100.00 | 100.00 | – |
Table 38: IRB approach – Back-testing of PD per exposure class for retail – qualifying revolving (fixed PD scale) (UK CR9)
| 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Number of obligors at the end of previous year |
|||||||||
| PD Range % | Of which number of obligors which defaulted in the year |
Observed average default rate % |
Exposures weighted average PD % |
Average PD % |
Average historical annual default rate % |
||||
| 0.00 to <0.15 | 912,958 | 587 | 0.06 | 0.08 | 0.07 | 0.08 | |||
| 0.00 to <0.10 | 716,953 | 403 | 0.06 | 0.07 | 0.06 | 0.08 | |||
| 0.10 to <0.15 | 196,005 | 184 | 0.09 | 0.11 | 0.12 | 0.11 | |||
| 0.15 to <0.25 | 163,867 | 440 | 0.27 | 0.18 | 0.21 | 0.25 | |||
| 0.25 to <0.50 | 168,857 | 787 | 0.47 | 0.34 | 0.33 | 0.50 | |||
| 0.50 to <0.75 | 195,245 | 708 | 0.36 | 0.67 | 0.66 | 0.36 | |||
| 0.75 to <2.50 | 579,569 | 11,467 | 1.98 | 1.39 | 1.53 | 1.00 | |||
| 0.75 to <1.75 | 436,486 | 7,452 | 1.71 | 1.29 | 1.34 | 0.88 | |||
| 1.75 to <2.50 | 143,083 | 4,015 | 2.81 | 2.12 | 2.11 | 1.35 | |||
| 2.50 to <10.00 | 540,560 | 24,884 | 4.60 | 4.10 | 4.77 | 1.89 | |||
| 2.50 to <5.00 | 341,873 | 12,699 | 3.71 | 2.98 | 3.50 | 1.36 | |||
| 5.00 to <10.00 | 198,687 | 12,185 | 6.13 | 7.07 | 6.95 | 3.17 | |||
| 10.00 to <100.00 | 134,559 | 32,726 | 24.32 | 22.61 | 28.04 | 13.16 | |||
| 10.00 to <20.00 | 81,278 | 8,393 | 10.33 | 13.93 | 13.59 | 5.76 | |||
| 20.00 to <30.00 | 21,167 | 4,512 | 21.32 | 23.72 | 23.92 | 14.92 | |||
| 30.00 to <100.00 | 32,114 | 19,821 | 61.72 | 56.12 | 67.31 | 27.98 | |||
| 100.00 (Default) | – | – | – | 100.00 | 100.00 | – |
| 2024 | ||||||
|---|---|---|---|---|---|---|
| Number of obligors at the end of previous year |
||||||
| PD Range % | Of which number of obligors which defaulted in the year |
Observed average default rate % |
Exposures weighted average PD % |
Average PD % |
Average historical annual default rate % |
|
| 0.00 to <0.15 | 933,556 | 2,242 | 0.24 | 0.08 | 0.07 | 0.04 |
| 0.00 to <0.10 | 750,239 | 1,620 | 0.22 | 0.06 | 0.06 | 0.04 |
| 0.10 to <0.15 | 183,317 | 622 | 0.34 | 0.11 | 0.12 | 0.05 |
| 0.15 to <0.25 | 240,896 | 1,485 | 0.62 | 0.21 | 0.20 | 0.15 |
| 0.25 to <0.50 | 500,192 | 2,301 | 0.46 | 0.33 | 0.34 | 0.44 |
| 0.50 to <0.75 | 326,854 | 1,562 | 0.48 | 0.67 | 0.65 | 0.30 |
| 0.75 to <2.50 | 455,644 | 5,590 | 1.23 | 1.42 | 1.40 | 0.85 |
| 0.75 to <1.75 | 357,870 | 3,804 | 1.06 | 1.29 | 1.22 | 0.76 |
| 1.75 to <2.50 | 97,774 | 1,786 | 1.83 | 2.12 | 2.09 | 1.09 |
| 2.50 to <10.00 | 432,512 | 10,025 | 2.32 | 4.12 | 4.66 | 1.66 |
| 2.50 to <5.00 | 310,451 | 5,554 | 1.79 | 2.97 | 3.71 | 1.17 |
| 5.00 to <10.00 | 122,061 | 4,471 | 3.66 | 7.08 | 7.07 | 2.78 |
| 10.00 to <100.00 | 95,723 | 17,724 | 18.52 | 23.08 | 31.96 | 10.26 |
| 10.00 to <20.00 | 48,398 | 3,569 | 7.37 | 13.94 | 13.61 | 4.67 |
| 20.00 to <30.00 | 15,208 | 2,052 | 13.49 | 23.43 | 24.02 | 14.27 |
| 30.00 to <100.00 | 32,117 | 12,103 | 37.68 | 62.07 | 63.37 | 23.11 |
| 100.00 (Default) | – | – | – | 100.00 | 100.00 | – |
Table 39: IRB – Backtesting of probability of default (PD) for central governments or central banks (UK CR9.1)
| 2025 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Number of obligors at the end of previous year |
||||||||||||
| PD Range % | External Rating equivalent (S&P) |
Of which number of obligors which defaulted in the year |
Observed average default rate % |
Average PD % |
Average historical annual default rate % |
|||||||
| 0.000 to <0.015 | AAA | 13 | – | – | 0.01 | – | ||||||
| 0.015 to <0.025 | AA+ | 18 | – | – | 0.02 | – | ||||||
| 0.025 to <0.035 | AA/AA– | 4 | – | – | 0.03 | – | ||||||
| 0.035 to <0.045 | A+ | 14 | – | – | 0.04 | – | ||||||
| 0.045 to <0.060 | A | 1 | – | – | 0.05 | – | ||||||
| 0.060 to <0.083 | A– | 9 | – | – | 0.07 | – | ||||||
| 0.083 to <0.110 | BBB+/BBB | 5 | – | – | 0.09 | – | ||||||
| 0.110 to <0.170 | BBB/BBB– | 9 | – | – | 0.13 | – | ||||||
| 0.170 to <0.300 | BBB– | 5 | – | – | 0.22 | 0.01 | ||||||
| 0.300 to <0.425 | BB+ | 2 | – | – | 0.39 | 0.03 | ||||||
| 0.425 to <0.585 | BB+/BB | 1 | – | – | 0.51 | 0.02 | ||||||
| 0.585 to <0.770 | BB | 1 | – | – | 0.67 | – | ||||||
| 0.770 to <1.020 | BB/BB– | 9 | – | – | 0.89 | 0.06 | ||||||
| 1.020 to <1.350 | BB– | 6 | – | – | 1.17 | – | ||||||
| 1.350 to <1.750 | BB–/B+ | 4 | 1 | 25.00 | 1.54 | 0.33 | ||||||
| 1.750 to <2.350 | B+ | 2 | – | – | 2.03 | 0.20 | ||||||
| 2.350 to <3.050 | B | 4 | – | – | 2.67 | 3.75 | ||||||
| 3.050 to <4.000 | B | 6 | – | – | 3.51 | 6.86 | ||||||
| 4.000 to <5.300 | B/B– | 10 | – | – | 4.62 | 1.09 | ||||||
| 5.300 to <7.000 | B– | – | – | – | – | 2.00 | ||||||
| 7.000 to <9.200 | B– | – | – | – | – | – | ||||||
| 9.200 to <12.000 | B– | 1 | – | – | 10.54 | – | ||||||
| 12.000 to <15.750 | B–/CCC+ | – | – | – | – | 0.25 | ||||||
| 15.750 to <21.000 | CCC+ | 4 | – | – | 18.00 | 25.00 | ||||||
| 21.000 to <28.500 | CCC+ | – | – | – | – | 21.45 | ||||||
| 28.500 to <99.999 | CCC to C | 2 | – | – | 33.00 | 44.00 | ||||||
| 100 | N/A | – | – | – | – | – | ||||||
| 100 | N/A | 4 | – | – | 18.00 | – | ||||||
| Unrated | N/A | – | – | – | – | – |
3.3 Internal Ratings Based models continued Table 39: IRB – Backtesting of probability of default (PD) for central governments or central banks (UK CR9.1) continued
| 2024 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Number of obligors at the end of previous year |
||||||||||||
| PD Range % | External Rating equivalent (S&P) |
Of which number of obligors which defaulted in the year |
Observed average default rate % |
Average PD % |
Average historical annual default rate % |
|||||||
| 0.000 to <0.015 | AAA | 10 | – | – | 0.01 | – | ||||||
| 0.015 to <0.025 | AA+/AA | 19 | – | – | 0.02 | – | ||||||
| 0.025 to <0.035 | AA– | 4 | – | – | 0.03 | – | ||||||
| 0.035 to <0.045 | A+ | 12 | – | – | 0.04 | – | ||||||
| 0.045 to <0.060 | A | 5 | – | – | 0.05 | – | ||||||
| 0.060 to <0.083 | A– | 10 | – | – | 0.07 | – | ||||||
| 0.083 to <0.110 | BBB+ | 4 | – | – | 0.09 | – | ||||||
| 0.110 to <0.170 | BBB | 8 | – | – | 0.13 | – | ||||||
| 0.170 to <0.300 | BBB– | 5 | – | – | 0.22 | 0.05 | ||||||
| 0.300 to <0.425 | BB+ | – | – | – | – | 0.14 | ||||||
| 0.425 to <0.585 | BB+/BB | 5 | – | – | 0.51 | 0.09 | ||||||
| 0.585 to <0.770 | BB | 2 | – | – | 0.67 | – | ||||||
| 0.770 to <1.020 | BB– | 8 | – | – | 0.89 | 0.32 | ||||||
| 1.020 to <1.350 | BB–/B+ | 5 | – | – | 1.17 | – | ||||||
| 1.350 to <1.750 | B+ | – | – | – | – | 1.63 | ||||||
| 1.750 to <2.350 | B+/B | 2 | – | – | 2.03 | 0.98 | ||||||
| 2.350 to <3.050 | B | 2 | – | – | 2.67 | 4.46 | ||||||
| 3.050 to <4.000 | B/B– | 9 | – | – | 3.51 | 9.29 | ||||||
| 4.000 to <5.300 | B– | 9 | – | – | 4.62 | 5.45 | ||||||
| 5.300 to <7.000 | B– | 1 | – | – | 6.08 | 10.00 | ||||||
| 7.000 to <15.750 | B–/CCC+ | 1 | – | – | 8.01 | – | ||||||
| 15.750 to <99.999 | CCC+/C | 3 | – | – | 10.54 | – | ||||||
| 100 | N/A | – | – | – | – | 1.25 | ||||||
| 100 | N/A | – | – | – | – | 25.00 | ||||||
| Unrated | N/A | – | – | – | – | 7.27 |
| 2025 | ||||||
|---|---|---|---|---|---|---|
| the end of previous year | Number of obligors at | |||||
| PD Range % | External Rating equivalent (S&P) |
Of which number of obligors which defaulted in the year |
Observed average default rate % |
Average PD % |
Average historical annual default rate % |
|
| 0.000 to <0.015 | AAA/AA+ | – | – | – | – | – |
| 0.015 to <0.025 | AA/AA– | – | – | – | – | – |
| 0.025 to <0.035 | A+ | 23 | – | – | 0.03 | – |
| 0.035 to <0.045 | A | 5 | – | – | 0.04 | – |
| 0.045 to <0.060 | A– | 1 | – | – | 0.05 | – |
| 0.060 to <0.083 | BBB+/BBB | 1 | – | – | 0.07 | – |
| 0.083 to <0.110 | BBB/BBB– | 1 | – | – | 0.09 | – |
| 0.110 to <0.170 | BBB– | 5 | – | – | 0.13 | – |
| 0.170 to <0.300 | BB+ | 2 | – | – | 0.22 | – |
| 0.300 to <0.425 | BB+/BB | – | – | – | – | – |
| 0.425 to <0.585 | BB | – | – | – | – | – |
| 0.585 to <0.770 | BB/BB– | – | – | – | – | – |
| 0.770 to <1.020 | BB– | 1 | – | – | 0.89 | – |
| 1.020 to <1.350 | B+ | – | – | – | – | – |
| 1.350 to <1.750 | B+/B | – | – | – | – | – |
| 1.750 to <2.350 | B | 1 | – | – | 2.03 | – |
| 2.350 to <3.050 | B | – | – | – | – | – |
| 3.050 to <4.000 | B/B– | – | – | – | – | – |
| 4.000 to <5.300 | B– | – | – | – | – | – |
| 5.300 to <7.000 | B–/CCC+ to C | – | – | – | – | – |
| 7.000 to <9.200 | CCC+ to C | 1 | – | – | 8.01 | – |
| 9.200 to <12.000 | CCC+ to C | – | – | – | – | – |
| 12.000 to <15.750 | CCC+ to C | – | – | – | – | – |
| 15.750 to <21.000 | CCC+ to C | – | – | – | – | – |
| 21.000 to <28.500 | CCC+ to C | – | – | – | – | – |
| 28.500 to <99.999 | CCC+ to C | – | – | – | – | – |
| 100 | N/A | – | – | – | – | – |
100 N/A – – – – – Unrated N/A – – – – –
3.3 Internal Ratings Based models continued Table 40: IRB – Backtesting of probability of default (PD) for institutions (CR9.1)
| 2024 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Number of obligors at the end of previous year |
||||||||||||
| PD Range % | External Rating equivalent (S&P) |
Of which number of obligors which defaulted in the year |
Observed average default rate % |
Average PD % |
Average historical annual default rate % |
|||||||
| 0.000 to <0.015 | AAA/AA+ | – | – | – | – | – | ||||||
| 0.015 to <0.025 | AA | – | – | – | – | – | ||||||
| 0.025 to <0.035 | AA–/A+ | 17 | – | – | 0.03 | – | ||||||
| 0.035 to <0.045 | A | 6 | – | – | 0.04 | – | ||||||
| 0.045 to <0.060 | A– | 2 | – | – | 0.05 | – | ||||||
| 0.060 to <0.083 | BBB+ | – | – | – | – | – | ||||||
| 0.083 to <0.110 | BBB | 1 | – | – | 0.09 | – | ||||||
| 0.110 to <0.170 | BBB/BBB– | 3 | – | – | 0.13 | – | ||||||
| 0.170 to <0.300 | BBB– | 6 | – | – | 0.22 | – | ||||||
| 0.300 to <0.425 | BB+ | – | – | – | – | – | ||||||
| 0.425 to <0.585 | BB | – | – | – | – | – | ||||||
| 0.585 to <0.770 | BB/BB– | 1 | – | – | 0.67 | – | ||||||
| 0.770 to <1.020 | BB– | – | – | – | – | – | ||||||
| 1.020 to <1.350 | BB–/B+ | 1 | – | – | 1.17 | – | ||||||
| 1.350 to <1.750 | B+ | – | – | – | – | – | ||||||
| 1.750 to <2.350 | B+/B | – | – | – | – | – | ||||||
| 2.350 to <3.050 | B | – | – | – | – | – | ||||||
| 3.050 to <4.000 | B/B– | – | – | – | – | – | ||||||
| 4.000 to <5.300 | B– | – | – | – | – | – | ||||||
| 5.300 to <7.000 | B–/CCC | – | – | – | – | – | ||||||
| 7.000 to <15.750 | CCC/C | – | – | – | – | – | ||||||
| 15.750 to <99.999 | CCC/C | – | – | – | – | – | ||||||
| 100 | N/A | – | – | – | – | – | ||||||
| 100 | N/A | – | – | – | – | – | ||||||
| Unrated | N/A | – | – | – | – | – |
3.3 Internal Ratings Based models continued Table 40: IRB – Backtesting of probability of default (PD) for institutions (CR9.1) continued
| 2025 | |||||||
|---|---|---|---|---|---|---|---|
| the end of previous year | Number of obligors at | ||||||
| PD Range % | External Rating equivalent (S&P) |
Of which number of obligors which defaulted in the year |
Observed average default rate % |
Average PD % |
Average historical annual default rate % |
||
| 0.000 to <0.015 | AAA/AA+ | – | – | – | – | – | |
| 0.015 to <0.025 | AA | – | – | – | – | – | |
| 0.025 to <0.035 | AA– | 57 | – | – | 0.03 | – | |
| 0.035 to <0.045 | A+ | 51 | – | – | 0.04 | – | |
| 0.045 to <0.060 | A/A– | 108 | – | – | 0.05 | – | |
| 0.060 to <0.083 | BBB+ | 210 | – | – | 0.07 | 0.13 | |
| 0.083 to <0.110 | BBB+/BBB | 235 | – | – | 0.09 | – | |
| 0.110 to <0.170 | BBB | 368 | – | – | 0.13 | – | |
| 0.170 to <0.300 | BBB– | 432 | – | – | 0.22 | 1.43 | |
| 0.300 to <0.425 | BBB–/BB+ | 282 | – | – | 0.39 | 0.32 | |
| 0.425 to <0.585 | BB | 281 | – | – | 0.51 | 0.32 | |
| 0.585 to <0.770 | BB/BB– | 217 | – | – | 0.67 | 0.36 | |
| 0.770 to <1.020 | BB– | 144 | – | – | 0.89 | 0.99 | |
| 1.020 to <1.350 | BB–/B+ | 101 | 1 | 0.99 | 1.17 | 0.75 | |
| 1.350 to <1.750 | B+ | 64 | – | – | 1.54 | 1.63 | |
| 1.750 to <2.350 | B+ | 42 | 1 | 2.38 | 2.03 | 1.52 | |
| 2.350 to <3.050 | B | 25 | – | – | 2.67 | 5.75 | |
| 3.050 to <4.000 | B/B– | 24 | – | – | 3.51 | 8.79 | |
| 4.000 to <5.300 | B– | 41 | – | – | 4.62 | 5.82 | |
| 5.300 to <7.000 | B– | 2 | – | – | 6.08 | 10.67 | |
| 7.000 to <9.200 | B– | 3 | 1 | 33.33 | 8.01 | – | |
| 9.200 to <12.000 | B–/CCC+ | 1 | – | – | 10.54 | – | |
| 12.000 to <15.750 | CCC+ | 14 | – | – | 13.77 | 2.96 | |
| 15.750 to <21.000 | CCC+ | 17 | 1 | 5.88 | 18.00 | 10.53 | |
| 21.000 to <28.500 | CCC+/CCC to C | 3 | – | – | 24.55 | 21.85 | |
| 28.500 to <99.999 | CCC to C | 2 | 1 | 50.00 | 33.00 | 35.33 | |
| 100 | N/A | – | – | – | – | – | |
| 100 | N/A | – | 1 | 5.88 | – | – | |
| Unrated | N/A | – | – | – | – | – |
3.3 Internal Ratings Based models continued Table 41: IRB – Backtesting of probability of default (PD) for corporates (CR9.1)
| 2024 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Number of obligors at the end of previous year |
||||||||||||
| PD Range % | External Rating equivalent (S&P) |
Of which number of obligors which defaulted in the year |
Observed average default rate % |
Average PD % |
Average historical annual default rate % |
|||||||
| 0.000 to <0.015 | AAA/AA+ | – | – | – | – | – | ||||||
| 0.015 to <0.025 | AA | – | – | – | – | – | ||||||
| 0.025 to <0.035 | AA– | 57 | – | – | 0.03 | – | ||||||
| 0.035 to <0.045 | A+ | 51 | – | – | 0.04 | – | ||||||
| 0.045 to <0.060 | A/A– | 99 | – | – | 0.05 | – | ||||||
| 0.060 to <0.083 | BBB+ | 208 | – | – | 0.07 | 0.11 | ||||||
| 0.083 to <0.110 | BBB+/BBB | 261 | – | – | 0.09 | – | ||||||
| 0.110 to <0.170 | BBB | 299 | 1 | 0.33 | 0.13 | – | ||||||
| 0.170 to <0.300 | BBB– | 494 | – | – | 0.22 | 6.71 | ||||||
| 0.300 to <0.425 | BBB–/BB+ | 261 | – | – | 0.39 | 0.23 | ||||||
| 0.425 to <0.585 | BB+/BB | 277 | – | – | 0.51 | 0.27 | ||||||
| 0.585 to <0.770 | BB | 188 | 1 | 0.53 | 0.67 | 0.30 | ||||||
| 0.770 to <1.020 | BB– | 122 | – | – | 0.89 | 0.71 | ||||||
| 1.020 to <1.350 | BB– | 86 | – | – | 1.17 | 0.95 | ||||||
| 1.350 to <1.750 | BB–/B+ | 50 | – | – | 1.54 | – | ||||||
| 1.750 to <2.350 | B+ | 40 | 1 | 2.50 | 2.03 | 0.85 | ||||||
| 2.350 to <3.050 | B | 26 | – | – | 2.67 | 5.73 | ||||||
| 3.050 to <4.000 | B | 23 | – | – | 3.51 | 3.76 | ||||||
| 4.000 to <5.300 | B/B– | 22 | – | – | 4.62 | 1.82 | ||||||
| 5.300 to <7.000 | B– | 5 | – | – | 6.08 | 3.33 | ||||||
| 7.000 to <15.750 | B–/CCC+ | 13 | – | – | 8.01 | – | ||||||
| 15.750 to <99.999 | CCC+/C | 2 | – | – | 10.54 | – | ||||||
| 100 | N/A | 10 | – | – | 13.77 | 1.43 | ||||||
| 100 | N/A | 2 | – | – | 18.00 | 5.72 | ||||||
| Unrated | N/A | 6 | – | – | 24.55 | 21.80 |
3.3 Internal Ratings Based models continued Table 41: IRB – Backtesting of probability of default (PD) for corporates (CR9.1) continued
Table 42: IRB – Backtesting of probability of default (PD) for corporates – specialised lending (CR9.1)
| 2025 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Number of obligors at the end of previous year |
||||||||||||
| PD Range % | External Rating equivalent (S&P) |
Of which number of obligors which defaulted in the year |
Observed average default rate % |
Average PD % |
Average historical annual default rate % |
|||||||
| 0.000 to <0.015 | AAA/AA+ | – | – | – | – | – | ||||||
| 0.015 to <0.025 | AA | – | – | – | – | – | ||||||
| 0.025 to <0.035 | AA– | – | – | – | – | – | ||||||
| 0.035 to <0.045 | A+ | – | – | – | – | – | ||||||
| 0.045 to <0.060 | A/A– | 1 | – | – | 0.05 | – | ||||||
| 0.060 to <0.083 | BBB+ | – | – | – | – | – | ||||||
| 0.083 to <0.110 | BBB+/BBB | – | – | – | – | – | ||||||
| 0.110 to <0.170 | BBB | – | – | – | – | – | ||||||
| 0.170 to <0.300 | BBB– | 10 | – | – | 0.22 | 6.67 | ||||||
| 0.300 to <0.425 | BBB–/BB+ | 3 | – | – | 0.39 | – | ||||||
| 0.425 to <0.585 | BB | 1 | – | – | 0.51 | – | ||||||
| 0.585 to <0.770 | BB/BB– | – | – | – | – | – | ||||||
| 0.770 to <1.020 | BB– | – | – | – | – | – | ||||||
| 1.020 to <1.350 | BB–/B+ | 1 | – | – | 1.17 | – | ||||||
| 1.350 to <1.750 | B+ | – | – | – | – | – | ||||||
| 1.750 to <2.350 | B+ | – | – | – | – | – | ||||||
| 2.350 to <3.050 | B | – | – | – | – | – | ||||||
| 3.050 to <4.000 | B/B– | – | – | – | – | – | ||||||
| 4.000 to <5.300 | B– | – | – | – | – | – | ||||||
| 5.300 to <7.000 | B– | – | – | – | – | – | ||||||
| 7.000 to <9.200 | B– | – | – | – | – | 4.00 | ||||||
| 9.200 to <12.000 | B–/CCC+ | – | – | – | – | – | ||||||
| 12.000 to <15.750 | CCC+ | – | – | – | – | 4.00 | ||||||
| 15.750 to <21.000 | CCC+ | – | – | – | – | – | ||||||
| 21.000 to <28.500 | CCC+/CCC to C | – | – | – | – | – | ||||||
| 28.500 to <99.999 | CCC to C | – | – | – | – | – | ||||||
| 100 | N/A | – | – | – | – | – | ||||||
| 100 | N/A | – | – | – | – | – | ||||||
| Unrated | N/A | – | – | – | – | – |
3.3 Internal Ratings Based models continued Table 42: IRB – Backtesting of probability of default (PD) for corporates – specialised lending (CR9.1) continued
| 2024 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Number of obligors at the end of previous year |
||||||||||||
| PD Range % | External Rating equivalent (S&P) |
Of which number of obligors which defaulted in the year |
Observed average default rate % |
Average PD % |
Average historical annual default rate % |
|||||||
| 0.000 to <0.015 | AAA/AA+ | – | – | – | – | – | ||||||
| 0.015 to <0.025 | AA | – | – | – | – | – | ||||||
| 0.025 to <0.035 | AA– | – | – | – | – | – | ||||||
| 0.035 to <0.045 | A+ | – | – | – | – | – | ||||||
| 0.045 to <0.060 | A/A– | 1 | – | – | 0.05 | – | ||||||
| 0.060 to <0.083 | BBB+ | – | – | – | – | – | ||||||
| 0.083 to <0.110 | BBB+/BBB | – | – | – | – | – | ||||||
| 0.110 to <0.170 | BBB | 1 | – | – | 0.13 | – | ||||||
| 0.170 to <0.300 | BBB– | 5 | – | – | 0.22 | – | ||||||
| 0.300 to <0.425 | BBB–/BB+ | 4 | – | – | 0.39 | – | ||||||
| 0.425 to <0.585 | BB+/BB | – | – | – | – | – | ||||||
| 0.585 to <0.770 | BB | – | – | – | – | – | ||||||
| 0.770 to <1.020 | BB– | – | – | – | – | – | ||||||
| 1.020 to <1.350 | BB– | 1 | – | – | 1.17 | – | ||||||
| 1.350 to <1.750 | BB–/B+ | – | – | – | – | – | ||||||
| 1.750 to <2.350 | B+ | – | – | – | – | – | ||||||
| 2.350 to <3.050 | B | – | – | – | – | – | ||||||
| 3.050 to <4.000 | B | – | – | – | – | – | ||||||
| 4.000 to <5.300 | B/B– | – | – | – | – | – | ||||||
| 5.300 to <7.000 | B– | – | – | – | – | – | ||||||
| 7.000 to <15.750 | B–/CCC+ | – | – | – | – | 20.00 | ||||||
| 15.750 to <99.999 | CCC+/C | – | – | – | – | – | ||||||
| 100 | N/A | – | – | – | – | 20.00 | ||||||
| 100 | N/A | – | – | – | – | – | ||||||
| Unrated | N/A | – | – | – | – | – |
| 3.3 Internal Ratings Based models continued |
|---|
| Table 43: IRB – Backtesting of probability of default (PD) for corporates – SME (CR9.1) |
| 2025 |
| the end of previous year | Number of obligors at | |||||
|---|---|---|---|---|---|---|
| PD Range % | External Rating equivalent (S&P) |
Of which number of obligors which defaulted in the year |
Observed average default rate % |
Average historical annual default rate % |
||
| 0.000 to <0.015 | AAA/AA+ | – | – | – | % – |
– |
| 0.015 to <0.025 | AA | – | – | – | – | – |
| 0.025 to <0.035 | AA– | – | – | – | – | – |
| 0.035 to <0.045 | A+ | – | – | – | – | – |
| 0.045 to <0.060 | A/A– | 1 | – | – | 0.05 | – |
| 0.060 to <0.083 | BBB+ | – | – | – | – | – |
| 0.083 to <0.110 | BBB+/BBB | 1 | – | – | 0.09 | – |
| 0.110 to <0.170 | BBB | 2 | – | – | 0.13 | – |
| 0.170 to <0.300 | BBB– | 6 | – | – | 0.22 | – |
| 0.300 to <0.425 | BBB–/BB+ | 1 | – | – | 0.39 | – |
| 0.425 to <0.585 | BB | 3 | – | – | 0.51 | – |
| 0.585 to <0.770 | BB/BB– | 1 | – | – | 0.67 | – |
| 0.770 to <1.020 | BB– | 2 | – | – | 0.89 | – |
| 1.020 to <1.350 | BB–/B+ | 1 | – | – | 1.17 | – |
| 1.350 to <1.750 | B+ | 1 | – | – | 1.54 | – |
| 1.750 to <2.350 | B+ | – | – | – | – | – |
| 2.350 to <3.050 | B | 2 | – | – | 2.67 | – |
| 3.050 to <4.000 | B/B– | – | – | – | – | – |
| 4.000 to <5.300 | B– | – | – | – | – | – |
| 5.300 to <7.000 | B– | – | – | – | – | – |
| 7.000 to <9.200 | B– | – | – | – | – | 20.00 |
| 9.200 to <12.000 | B–/CCC+ | – | – | – | – | – |
| 12.000 to <15.750 | CCC+ | – | – | – | – | 20.00 |
| 15.750 to <21.000 | CCC+ | – | – | – | – | – |
| 21.000 to <28.500 | CCC+/CCC to C | – | – | – | – | – |
| 28.500 to <99.999 | CCC to C | – | – | – | – | – |
| 100 | N/A | – | – | – | – | – |
| 100 | N/A | – | – | – | – | – |
| Unrated | N/A | – | – | – | – | – |
3.3 Internal Ratings Based models continued Table 43: IRB – Backtesting of probability of default (PD) for corporates – SME (CR9.1) continued
| 2024 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| the end of previous year | Number of obligors at | |||||||||||
| PD Range % | External Rating equivalent (S&P) |
Of which number of obligors which defaulted in the year |
Observed average default rate % |
Average PD % |
Average historical annual default rate % |
|||||||
| 0.000 to <0.015 | AAA/AA+ | – | – | – | – | – | ||||||
| 0.016 to <0.025 | AA | – | – | – | – | – | ||||||
| 0.026 to <0.035 | AA– | – | – | – | – | – | ||||||
| 0.036 to <0.045 | A+ | – | – | – | – | – | ||||||
| 0.046 to <0.060 | A/A– | – | – | – | – | – | ||||||
| 0.061 to <0.083 | BBB+ | – | – | – | – | – | ||||||
| 0.084 to <0.110 | BBB+/BBB | 1 | – | – | 0.09 | – | ||||||
| 0.111 to <0.170 | BBB | 2 | – | – | 0.13 | – | ||||||
| 0.171 to <0.300 | BBB– | 1 | – | – | 0.22 | – | ||||||
| 0.301 to <0.425 | BBB–/BB+ | 1 | – | – | 0.39 | – | ||||||
| 0.426 to <0.585 | BB+/BB | 5 | – | – | 0.51 | – | ||||||
| 0.586 to <0.770 | BB | – | – | – | – | – | ||||||
| 0.771 to <1.020 | BB– | 2 | – | – | 0.89 | – | ||||||
| 1.021 to <1.350 | BB– | 2 | – | – | 1.17 | – | ||||||
| 1.351 to <1.750 | BB–/B+ | 4 | – | – | 1.54 | – | ||||||
| 1.751 to <2.350 | B+ | – | – | – | – | – | ||||||
| 2.351 to <3.050 | B | 1 | – | – | 2.67 | – | ||||||
| 3.051 to <4.000 | B | – | – | – | – | – | ||||||
| 4.001 to <5.300 | B/B– | 1 | – | – | 4.62 | – | ||||||
| 5.301 to <7.000 | B– | – | – | – | – | – | ||||||
| 7.001 to <15.750 | B–/CCC+ | – | – | – | – | – | ||||||
| 15.751 to <99.999 | CCC+/C | – | – | – | – | – | ||||||
| 100 | N/A | – | – | – | – | – | ||||||
| 100 | N/A | – | – | – | – | – | ||||||
| Unrated | N/A | – | – | – | – | – |
3.4 Credit risk quality
The following tables detail the Group's Credit quality of exposures. The amounts shown are based on IFRS accounting values according to the regulatory scope of consolidation.
Table 44 shows the credit quality of on and off-balance sheet non-performing exposures and related impairments, provisions and valuation adjustments by portfolio and exposure class.
Table 45 shows the on and off-balance sheet net credit risk exposures by residual contractual maturity, split by either loans and advances or debt securities.
Table 46 shows information on changes in the institutions stock of on balance sheet non-performing loans and advances.
Table 47 shows the quality of on and off-balance sheet forborne exposures.
Table 48 shows the credit quality of performing and non-performing exposures by past due days.
Table 49 shows the credit quality of on balance sheet and off-balance sheet exposure for loans and advances, debt securities derivatives and equity instruments by geography.
Table 50 shows the credit quality of loans and advances on balance sheet exposure to non-financial corporation by industry types.
The scope and definitions of 'past-due' and 'impaired' exposures used for accounting purposes, the extent of past-due exposures (more than 90 days) that are not considered to be impaired and the reasons for this, and methods used for determining general and specific credit risk adjustments are shown in the 2025 Annual Report and Accounts on page 343 to 345.
Table 44: Performing and non-performing exposures and related provisions (UK CR1)
| 2025 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross carrying amount/nominal amount | Accumulated impairment, accumulated negative changes in fair value due to credit risk and provisions |
Collateral and financial guarantees received |
||||||||||||||
| Performing exposures | Non-performing exposures | Performing exposures – accumulated impairment and provisions |
Non-performing exposures – accumulated impairment, accumulated negative changes in fair value due to credit risk and provisions |
|||||||||||||
| \$million | Of which stage 1 \$million |
Of which stage 2 \$million |
\$million | Of which stage 2 \$million |
Of which stage 3 \$million |
\$million | Of which stage 1 \$million |
Of which stage 2 \$million |
\$million | Of which stage 2 \$million |
Of which stage 3 \$million |
Accumu lated partial write-off \$million |
On performing exposures \$million |
On non performing exposures \$million |
||
| 005 Cash balances at central banks and other demand deposits |
79,728 | 79,256 | 472 | 773 | – | 773 | (1) | – | (1) | (9) | – | (9) | – | – | – | |
| 010 | Loans and advances |
410,810 400,732 | 10,078 | 6,053 | – | 6,053 | (981) | (534) | (447) (3,094) | – | (3,094) (4,883) 138,866 | 995 | ||||
| 020 Central banks | 14,895 | 14,895 | – | – | – | - | – | – | – | – | – | – | – | 535 | – | |
| 030 General | ||||||||||||||||
| governments | 5,555 | 5,435 | 120 | 855 | – | 855 | (3) | (3) | – | (37) | – | (37) | (6) | 1,505 | – | |
| 040 Credit institutions | 82,376 | 82,190 | 186 | 76 | – | 76 | (3) | (3) | – | (10) | – | (10) | (27) | 4,313 | – | |
| 050 Other financial corporations |
80,141 | 79,208 | 933 | 204 | – | 204 | (26) | (10) | (16) | (68) | – | (68) | (328) | 10,912 | – | |
| 060 Non-financial corporations |
106,236 | 99,084 | 7,152 | 3,673 | – | 3,673 | (511) | (193) | (318) | (2,622) | – | (2,622) (4,520) 23,524 | 340 | |||
| 070 | Of which SMEs | 9,548 | 9,170 | 378 | 660 | – | 660 | (93) | (84) | (9) | (414) | – | (414) | – | 2,230 | 6 |
| 080 Households | 121,608 119,920 | 1,688 | 1,245 | – | 1,245 | (438) | (325) | (113) | (357) | – | (356) | (3) 98,078 | 655 | |||
| 090 Debt securities | 168,552 167,350 | 1,202 | 301 | – | 301 | (60) | (55) | (5) | (5) | – | (5) | – | 730 | – | ||
| 100 | Central banks | 23,762 | 23,760 | 2 | 283 | – | 283 | (15) | (15) | – | (5) | – | (5) | – | 5 | – |
| 110 | General governments |
92,761 | 91,919 | 842 | – | – | - | (23) | (22) | (1) | – | – | – | – | 423 | – |
| 120 | Credit institutions | 30,782 | 30,678 | 104 | – | – | 0 | (8) | (7) | (1) | – | – | – | – | 220 | – |
| 130 | Other financial corporations |
20,010 | 19,815 | 195 | – | – | - | (12) | (10) | (2) | – | – | – | – | 5 | – |
| 140 | Non-financial corporations |
1,237 | 1,178 | 59 | 18 | – | 18 | (1) | (1) | – | – | – | – | – | 77 | – |
| 150 | Off-balance sheet exposures |
312,840 | 307,121 | 5,719 | 596 | – | 596 | (124) | (75) | (49) | (100) | – | (100) | 6,672 | 56 | |
| 160 | Central banks | 580 | 580 | – | – | – | - | – | – | – | – | – | – | – | – | |
| 170 | General | |||||||||||||||
| governments | 5,197 | 5,165 | 32 | – | – | - | (4) | (2) | (2) | – | – | – | 568 | – | ||
| 180 | Credit institutions | 14,774 | 14,548 | 226 | 9 | – | 9 | (2) | (2) | – | - | – | – | 185 | – | |
| 190 | Other financial | |||||||||||||||
| corporations | 82,367 | 81,250 | 1,117 | 1 | – | 1 | (7) | (5) | (1) | – | – | – | 437 | – | ||
| 200 Non-financial | ||||||||||||||||
| corporations | 139,345 | 135,121 | 4,224 | 582 | – | 582 | (98) | (56) | (43) | (100) | – | (100) | 5,350 | 57 | ||
| 210 | Households | 70,577 | 70,457 | 120 | 4 | – | 4 | (13) | (9) | (3) | – | – | – | 132 | – | |
| 220 Total | 971,930 954,458 | 17,472 | 7,723 | – | 7,723 | (1,166) | (664) | (502) (3,208) | – | (3,208) (4,883) 146,267 | 1,052 |
3.4 Credit risk quality continued Table 44: Performing and non-performing exposures and related provisions (UK CR1)
| Collateral and Accumulated impairment, accumulated negative changes financial guarantees Gross carrying amount/nominal amount in fair value due to credit risk and provisions received Non-performing exposures – accumulated impairment, Performing exposures – accumulated negative accumulated impairment changes in fair value due to Performing exposures Non-performing exposures and provisions credit risk and provisions Accumu lated On Of which Of which Of which Of which Of which Of which Of which Of which partial performing stage 1 stage 2 stage 2 stage 3 stage 1 stage 2 stage 2 stage 3 write-off exposures \$million \$million \$million \$million \$million \$million \$million \$million \$million \$million \$million \$million \$million \$million 005 Cash balances at central banks and other demand deposits 65,592 65,160 432 427 – 427 (4) – (4) (4) – (4) – – 010 Loans and advances 407,490 396,481 11,009 6,286 – 6,286 (967) (493) (474) (3,953) – (3,953) (4,818) 122,859 020 Central banks 24,738 24,729 9 – – – (1) (1) – – – – – 177 030 General governments 13,952 13,549 403 107 – 107 (4) (3) (1) (42) – (42) (6) 1,123 040 Credit institutions 74,043 73,898 145 54 – 54 (4) (4) – (12) – (12) (27) 3,441 050 Other financial corporations 81,571 80,342 1,229 101 – 101 (154) (12) (142) (55) – (55) (328) 11,855 060 Non-financial corporations 100,301 92,574 7,727 5,063 – 5,063 (353) (143) (210) (3,561) – (3,561) (4,454) 22,961 070 Of which SMEs 10,534 9,967 567 669 – 669 (112) (91) (21) (389) – (389) – 1,343 080 Households 112,885 111,389 1,496 961 – 961 (451) (330) (121) (283) – (283) (3) 83,302 090 Debt securities 145,725 144,108 1,617 105 – 105 (27) (23) (4) (2) – (2) – 201 100 Central banks 19,675 19,563 112 86 – 86 (4) (2) (2) (2) – (2) – 9 110 General governments 68,968 67,608 1,360 – – – (8) (6) (2) – – – – 105 120 Credit institutions 28,838 28,783 55 – – – (9) (9) – – – – – 15 130 Other financial corporations 26,257 26,167 90 – – – (5) (5) – – – – – 24 140 Non-financial corporations 1,987 1,987 – 19 – 19 (1) (1) – – – – – 48 150 Off-balance sheet exposures 272,674 266,630 6,044 609 – 609 (125) (66) (59) (130) – (130) 4,251 160 Central banks 386 386 – – – – – – – – – – – 170 General governments 5,061 5,042 19 – – – – – – – – – 297 180 Credit institutions 14,445 14,013 432 23 – 23 (4) (3) (1) (6) – (6) 104 190 Other financial corporations 62,826 62,001 825 1 – 1 (19) (6) (13) – – – 875 200 Non-financial corporations 118,977 114,332 4,645 578 – 578 (83) (39) (44) (124) – (124) 2,642 210 Households 70,979 70,856 123 7 – 7 (19) (18) (1) – – – 333 220 Total 891,481 872,379 19,102 7,427 – 7,427 (1,123) (582) (541) (4,089) – (4,089) (4,818) 127,311 |
2024 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| On non performing exposures \$million |
|||||||||
| – | |||||||||
| 881 | |||||||||
| – | |||||||||
| 5 | |||||||||
| – – |
|||||||||
| 321 | |||||||||
| 11 | |||||||||
| 555 | |||||||||
| – | |||||||||
| – | |||||||||
| – | |||||||||
| – | |||||||||
| – | |||||||||
| – | |||||||||
| 46 | |||||||||
| – | |||||||||
| – | |||||||||
| – | |||||||||
| – | |||||||||
| 46 | |||||||||
| – | |||||||||
| 927 |
Table 45: Maturity of exposures (UK CR1-A)
| 2025 | |||||||
|---|---|---|---|---|---|---|---|
| Net exposure value | |||||||
| On demand \$million |
<= 1 year \$million |
> 1 year <= 5 years \$million |
> 5 years \$million |
No stated maturity \$million |
Total \$million |
||
| 1 | Loans and advances | 13,653 | 224,952 | 86,751 | 104,802 | – | 430,158 |
| 2 | Debt securities | 111 | 108,429 | 83,109 | 60,808 | – | 252,457 |
| 3 | Total | 13,764 | 333,381 | 169,860 | 165,610 | – | 682,615 |
| 2024 | |||||||
| Net exposure value | |||||||
| On demand \$million |
<= 1 year \$million |
> 1 year <= 5 years \$million |
> 5 years \$million |
No stated maturity \$million |
Total \$million |
||
| 1 | Loans and advances | 12,269 | 236,043 | 75,128 | 96,677 | – | 420,117 |
| 2 | Debt securities | 159 | 89,766 | 74,237 | 55,939 | – | 220,101 |
| 3 | Total | 12,428 | 325,809 | 149,365 | 152,616 | – | 640,218 |
Table 46: Changes in the stock of non-performing loans and advances (UK CR2)
| 2025 | 2024 | ||
|---|---|---|---|
| Gross carrying amount \$million |
Gross carrying amount \$million |
||
| 010 | Initial stock of non-performing loans and advances | 6,286 | 7,304 |
| 020 | Inflows to non-performing portfolios | 3,509 | 2,440 |
| 030 | Outflows from non-performing portfolios | (3,742) | (3,458) |
| 040 | Outflows due to write-offs | (1,718) | (1,464) |
| 050 | Outflow due to other situations | (2,023) | (1,994) |
| 060 | Final stock of non-performing loans and advances | 6,053 | 6,286 |
Table 47: Credit quality of forborne exposures (UK CQ1)
| 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| of exposures with forbearance measures | Gross carrying amount/nominal amount | Accumulated impairment, accumulated negative changes in fair value due to credit risk and provisions |
Collateral received and financial guarantees received on forborne exposures |
||||||
| Non-performing forborne | |||||||||
| Performing forborne \$million |
\$million | Of which defaulted \$million |
Of which impaired \$million |
On performing forborne exposures \$million |
On non performing forborne exposures \$million |
\$million | Of which collateral and financial guarantees received on non-performing exposures with forbearance measures |
||
| 005 | Cash balances at central banks and other demand deposits |
– | – | – | – | – | – | – | – |
| 010 | Loans and advances | 356 | 1,606 | 1,606 | 1,606 | (68) | (873) | 244 | 203 |
| 020 | Central banks | – | – | – | – | – | – | – | – |
| 030 | General governments | – | 27 | 27 | 27 | – | (1) | – | – |
| 040 | Credit institutions | – | – | – | – | – | – | – | – |
| 050 | Other financial corporations | 48 | 35 | 35 | 35 | – | (30) | – | – |
| 060 | Non-financial corporations | 264 | 1,284 | 1,284 | 1,284 | (67) | (744) | 194 | 182 |
| 070 | Households | 44 | 259 | 259 | 259 | – | (98) | 49 | 21 |
| 080 | Debt Securities | – | – | – | – | – | – | – | – |
| 090 | Loan commitments given | – | – | – | – | – | – | – | – |
| 100 | Total | 356 | 1,606 | 1,606 | 1,606 | (68) | (873) | 244 | 203 |
| 2024 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross carrying amount/nominal amount of exposures with forbearance measures |
LRCom: Leverage ratio common disclosure |
Collateral received and financial guarantees received on forborne exposures |
||||||||||||
| Non-performing forborne | ||||||||||||||
| Performing forborne \$million |
\$million | Of which defaulted \$million |
Of which impaired \$million |
On performing forborne exposures \$million |
On non performing forborne exposures \$million |
\$million | Of which collateral and financial guarantees received on non-performing exposures with forbearance measures |
|||||||
| 005 | Cash balances at central banks and other | |||||||||||||
| demand deposits | – | – | – | – | – | – | – | – | ||||||
| 010 | Loans and advances | 53 | 2,323 | 2,323 | 2,320 | (1) | (1,591) | 274 | 247 | |||||
| 020 | Central banks | – | – | – | – | – | – | – | – | |||||
| 030 | General governments | – | – | – | – | – | – | – | – | |||||
| 040 | Credit institutions | – | – | – | – | – | – | – | – | |||||
| 050 | Other financial corporations | 16 | 43 | 43 | 43 | – | (28) | – | – | |||||
| 060 | Non-financial corporations | 20 | 2,069 | 2,069 | 2,066 | – | (1,475) | 227 | 210 | |||||
| 070 | Households | 17 | 211 | 211 | 211 | (1) | (88) | 47 | 37 | |||||
| 080 | Debt Securities | – | – | – | – | – | – | – | – | |||||
| 090 | Loan commitments given | – | – | – | – | – | – | – | – | |||||
| 100 | Total | 53 | 2,323 | 2,323 | 2,320 | (1) | (1,591) | 274 | 247 |
Table 48: Credit quality of performing and non-performing exposures by past due days (UK CQ3)
| 2025 | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross carrying amount/nominal amount | |||||||||||||
| Performing exposures | Non-performing exposures | ||||||||||||
| \$million | Not past due or past due ≤ 30 days \$million |
Past due > 30 days ≤ 90 days \$million |
\$million | Unlikely to pay that are not past due or are past due ≤ 90 days \$million |
Past due > 90 days ≤ 180 days \$million |
Past due > 180 days ≤ 1 year \$million |
Past due > 1 year ≤ 2 years \$million |
Past due > 2 years ≤ 5 years \$million |
Past due > 5 years ≤ 7 years \$million |
Past due > 7 years \$million |
Of which defaulted \$million |
||
| 005 | Cash balances at central banks and other | ||||||||||||
| demand deposits | 79,728 | 79,728 | – | 773 | 773 | – | – | – | – | – | – | 773 | |
| 010 | Loans and advances | 410,810 | 410,168 | 641 | 6,053 | 3,017 | 689 | 132 | 470 | 520 | 488 | 738 | 6,053 |
| 020 | Central banks | 14,895 | 14,895 | – | – | – | – | – | – | – | – | – | – |
| 030 | General governments | 5,555 | 5,555 | – | 855 | 794 | – | – | 1 | 23 | 37 | – | 855 |
| 040 | Credit institutions | 82,376 | 82,372 | 4 | 76 | 34 | 42 | – | – | – | – | – | 76 |
| 050 | Other financial corporations | 80,141 | 80,042 | 99 | 204 | 139 | – | – | – | 50 | – | 15 | 204 |
| 060 | Non-financial corporations | 106,236 105,992 | 244 | 3,673 | 1,623 | – | 83 | 402 | 400 | 446 | 719 | 3,673 | |
| 070 | Of which SMEs | 9,548 | 9,511 | 37 | 660 | 227 | – | 83 | 80 | 75 | 35 | 161 | 660 |
| 080 | Households | 121,608 | 121,314 | 294 | 1,245 | 427 | 647 | 49 | 66 | 46 | 6 | 4 | 1,245 |
| 090 | Debt securities | 168,552 168,552 | – | 301 | 301 | – | – | – | – | – | – | 18 | |
| 100 | Central banks | 23,762 | 23,762 | – | 283 | 283 | – | – | – | – | – | – | – |
| 110 | General governments | 92,761 | 92,761 | – | – | – | – | – | – | – | – | – | – |
| 120 | Credit institutions | 30,783 | 30,783 | – | – | – | – | – | – | – | – | – | – |
| 130 | Other financial corporations | 20,010 | 20,010 | – | – | – | – | – | – | – | – | – | – |
| 140 | Non-financial corporations | 1,237 | 1,237 | – | 18 | 18 | – | – | – | – | – | – | 18 |
| 150 | Off-balance-sheet exposures | 312,840 | 596 | 596 | |||||||||
| 160 | Central banks | 580 | – | – | |||||||||
| 170 | General governments | 5,197 | – | – | |||||||||
| 180 | Credit institutions | 14,774 | 9 | 9 | |||||||||
| 190 | Other financial corporations | 82,367 | 1 | 1 | |||||||||
| 200 | Non-financial corporations | 139,345 | 582 | 582 | |||||||||
| 210 | Households | 70,577 | 4 | 4 | |||||||||
| 220 | Total | 971,930 658,448 | 641 | 7,723 | 4,090 | 689 | 132 | 470 | 520 | 488 | 738 | 7,440 |
| 2024 | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross carrying amount/nominal amount | |||||||||||||
| Performing exposures | Non-performing exposures | ||||||||||||
| \$million | Not past due or past due ≤ 30 days \$million |
Past due > 30 days ≤ 90 days \$million |
\$million | Unlikely to pay that are not past due or are past due ≤ 90 days \$million |
Past due > 90 days ≤ 180 days \$million |
Past due > 180 days ≤ 1 year \$million |
Past due > 1 year ≤ 2 years \$million |
Past due > 2 years ≤ 5 years \$million |
Past due > 5 years ≤ 7 years \$million |
Past due > 7 years \$million |
Of which defaulted \$million |
||
| 005 | Cash balances at central banks and other demand deposits |
65,592 | 65,592 | – | 427 | 427 | – | – | – | – | – | – | 427 |
| 010 | Loans and advances | 407,490 | 407,133 | 357 | 6,286 | 2,143 | 780 | 409 | 657 | 1,420 | 230 | 647 | 6,286 |
| 020 | Central banks | 24,738 | 24,738 | – | – | – | – | – | – | – | – | – | – |
| 030 | General governments | 13,952 | 13,952 | – | 107 | 51 | 1 | – | – | 55 | – | – | 107 |
| 040 | Credit institutions | 74,043 | 74,041 | 2 | 54 | – | 51 | – | – | 3 | – | – | 54 |
| 050 | Other financial corporations | 81,571 | 81,571 | – | 101 | – | 16 | – | 28 | 42 | – | 15 | 101 |
| 060 | Non-financial corporations | 100,301 100,224 | 77 | 5,063 | 1,908 | 95 | 358 | 567 | 1,281 | 225 | 629 | 5,063 | |
| 070 | Of which SMEs | 10,534 | 10,487 | 47 | 669 | 252 | 47 | 49 | 39 | 72 | 94 | 116 | 669 |
| 080 | Households | 112,885 | 112,607 | 278 | 961 | 184 | 617 | 51 | 62 | 39 | 5 | 3 | 961 |
| 090 | Debt securities | 145,725 | 145,725 | – | 105 | 105 | – | – | – | – | – | – | 105 |
| 100 | Central banks | 19,675 | 19,675 | – | 86 | 86 | – | – | – | – | – | – | 86 |
| 110 | General governments | 68,968 | 68,968 | – | – | – | – | – | – | – | – | – | – |
| 120 | Credit institutions | 28,838 | 28,838 | – | – | – | – | – | – | – | – | – | – |
| 130 | Other financial corporations | 26,257 | 26,257 | – | – | – | – | – | – | – | – | – | – |
| 140 | Non-financial corporations | 1,987 | 1,987 | – | 19 | 19 | – | – | – | – | – | – | 19 |
| 150 | Off-balance-sheet exposures | 272,674 | 609 | 609 | |||||||||
| 160 | Central banks | 386 | – | – | |||||||||
| 170 | General governments | 5,061 | – | – | |||||||||
| 180 | Credit institutions | 14,445 | 23 | 23 | |||||||||
| 190 | Other financial corporations | 62,826 | 1 | 1 | |||||||||
| 200 | Non-financial corporations | 118,977 | 578 | 578 | |||||||||
| 210 | Households | 70,979 | 7 | 7 | |||||||||
| 220 | Total | 891,481 | 618,450 | 357 | 7,427 | 2,675 | 780 | 409 | 657 | 1,420 | 230 | 647 | 7,427 |
Tables 49 and 50 break down defaulted and non-defaulted exposures by exposure class, as defined in the CRR, and by geography and industry.
Table 49: Quality of non-performing exposures by geography (UK CQ4)
| 2025 | ||||||||
|---|---|---|---|---|---|---|---|---|
| Gross carrying amount | Accumulated | |||||||
| Of which non-performing | Of which loans | Provisions on off-balance-sheet |
negative changes in fair value due to |
|||||
| \$million | \$million | Of which defaulted \$million |
and advances subject to impairment \$million |
Accumulated impairment \$million |
commitments and financial guarantees given \$million |
credit risk on non performing exposures \$million |
||
| 010 | On-balance-sheet | |||||||
| exposures | 666,218 | 6,844 | (4,151) | – | ||||
| 020 | Hong Kong | 79,750 | 418 | (573) | – | |||
| 030 | Korea | 47,152 | 314 | (248) | – | |||
| 040 | Singapore | 77,747 | 492 | (545) | – | |||
| 050 | United States | 99,654 | 107 | (71) | – | |||
| 060 | Other countries | 361,915 | 5,512 | (2,715) | – | |||
| 070 | Off-balance-sheet exposures |
313,436 | 596 | (224) | ||||
| 080 | United Kingdom | 33,056 | 2 | (9) | ||||
| 090 | Hong Kong | 44,243 | – | (25) | ||||
| 100 | Singapore | 45,310 | 2 | (8) | ||||
| 110 | United States | 72,037 | 11 | (18) | ||||
| 120 | Other countries | 118,790 | 581 | (164) | ||||
| 130 | Total | 979,654 | 7,440 | (4,151) | (224) | – |
| 2024 | ||||||||
|---|---|---|---|---|---|---|---|---|
| Gross carrying amount | Accumulated | |||||||
| Of which non-performing | Of which loans | Provisions on off-balance-sheet |
negative changes in fair value due to |
|||||
| \$million | \$million | Of which defaulted \$million |
and advances subject to impairment \$million |
Accumulated impairment \$million |
commitments and financial guarantees given \$million |
credit risk on non performing exposures \$million |
||
| 010 | On-balance-sheet exposures |
625,625 | 6,818 | (4,957) | – | |||
| 020 | Hong Kong | 71,357 | 383 | (580) | – | |||
| 030 | Korea | 42,772 | 213 | (197) | – | |||
| 040 | Singapore | 73,968 | 473 | (612) | – | |||
| 050 | United States | 91,052 | 2 | (9) | – | |||
| 060 | Other countries | 346,476 | 5,747 | (3,559) | – | |||
| 070 | Off-balance-sheet | |||||||
| exposures | 273,283 | 609 | (254) | |||||
| 080 | United Kingdom | 22,065 | 5 | (9) | ||||
| 090 | Hong Kong | 49,161 | – | (37) | ||||
| 100 | Singapore | 44,146 | 31 | (9) | ||||
| 110 | United States | 50,659 | – | (11) | ||||
| 120 | Other countries | 107,252 | 573 | (188) | ||||
| 130 | Total | 898,908 | 7,427 | (4,957) | (254) | – |
Table 50: Credit quality of loans and advances to non-financial corporations by industry (UK CQ5)
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross carrying amount | Accumulated | ||||||||||
| Of which non-performing | Of which loans | negative changes in fair value due to |
|||||||||
| \$million | \$million | Of which defaulted \$million |
and advances subject to impairment \$million |
Accumulated impairment \$million |
credit risk on non-performing exposures \$million |
||||||
| 005 | Cash balances at central banks and other demand deposits |
80,501 | 773 | (10) | – | ||||||
| 010 | Agriculture, forestry and fishing | 804 | 28 | (29) | – | ||||||
| 020 | Mining and quarrying | 4,175 | 32 | (25) | – | ||||||
| 030 | Manufacturing | 32,175 | 1,149 | (1,188) | – | ||||||
| 040 | Electricity, gas, steam and air conditioning supply |
9,714 | 269 | (87) | – | ||||||
| 050 | Water supply | 296 | – | (2) | – | ||||||
| 060 | Construction | 1,550 | 66 | (76) | – | ||||||
| 070 | Wholesale and retail trade | 22,754 | 786 | (602) | – | ||||||
| 080 | Transport and storage | 7,000 | 107 | (46) | – | ||||||
| 090 | Accommodation and food service activities |
1,882 | 111 | (67) | – | ||||||
| 100 | Information and communication | 4,374 | 53 | (90) | – | ||||||
| 110 | Financial and insurance activities | 284 | 36 | (1) | – | ||||||
| 120 | Real estate activities | 15,540 | 691 | (636) | – | ||||||
| 130 | Professional, scientific and technical activities |
697 | 7 | (8) | – | ||||||
| 140 | Administrative and support service activities |
778 | 5 | (7) | – | ||||||
| 150 | Public administration and defence, compulsory social security |
– | – | – | – | ||||||
| 160 | Education | 151 | 11 | – | – | ||||||
| 170 | Human health services and social work activities |
508 | – | – | – | ||||||
| 180 | Arts, entertainment and recreation | 241 | 1 | – | – | ||||||
| 190 | Other services | 6,986 | 319 | (271) | – | ||||||
| 200 | Total | 109,909 | 3,673 | (3,133) | – | ||||||
| 210 | Households | 122,853 | 1,245 | (795) | – | ||||||
| 220 | Total | 313,263 | 5,691 | (3,938) | – |
| 2024 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross carrying amount | Accumulated | |||||||||||
| Of which non-performing | Of which loans | negative changes in fair value due to |
||||||||||
| \$million | \$million | Of which defaulted \$million |
and advances subject to impairment \$million |
Accumulated impairment \$million |
credit risk on non-performing exposures \$million |
|||||||
| 005 | Cash balances at central banks and other demand deposits |
66,019 | 427 | (8) | – | |||||||
| 010 | Agriculture, forestry and fishing | 1,240 | 39 | (36) | – | |||||||
| 020 | Mining and quarrying | 4,740 | 236 | (214) | – | |||||||
| 030 | Manufacturing | 36,216 | 1,821 | (1,192) | – | |||||||
| 040 | Electricity, gas, steam and air conditioning supply |
8,497 | 217 | (74) | – | |||||||
| 050 | Water supply | 285 | – | (5) | – | |||||||
| 060 | Construction | 1,685 | 105 | (114) | – | |||||||
| 070 | Wholesale and retail trade | 22,836 | 828 | (531) | – | |||||||
| 080 | Transport and storage | 6,933 | 97 | (43) | – | |||||||
| 090 | Accommodation and food service activities |
1,456 | 113 | (29) | – | |||||||
| 100 | Information and communication | 3,234 | 57 | (110) | – | |||||||
| 110 | Financial and insurance activities | 23 | – | – | – | |||||||
| 120 | Real estate activities | 15,719 | 1,503 | (1,305) | – | |||||||
| 130 | Professional, scientific and technical activities |
969 | 10 | (8) | – | |||||||
| 140 | Administrative and support service activities |
688 | 24 | (18) | – | |||||||
| 150 | Public administration and defence, compulsory social security |
– | – | – | – | |||||||
| 160 | Education | 148 | 11 | – | – | |||||||
| 170 | Human health services and social work activities |
268 | – | – | – | |||||||
| 180 | Arts, entertainment and recreation | 186 | 1 | – | – | |||||||
| 190 | Other services | 241 | – | (234) | – | |||||||
| 200 | Total | 105,364 | 5,063 | (3,914) | – | |||||||
| 210 | Households | 113,846 | 961 | (734) | – | |||||||
| 220 | Total | 285,229 | 6,451 | (4,656) | – |
3.5 Risk grade profile
Exposures by internal credit grading
For CIB IRB portfolios, an alphanumeric credit risk-grading system is used. The grading is based on the Group's internal estimate of probability of default over a one-year horizon, with customers or portfolios assessed against a range of quantitative and qualitative factors from credit risk models. The numeric grades run from 1 to 14 and some of the grades are further sub-classified. Numerically lower credit grades are indicative of a lower likelihood of default. Credit grades 1 to 12 are assigned to performing customers and credit grades 13 and 14 are assigned to non-performing or defaulted customers. The Group's credit grades in CIB and CB are not intended to replicate external credit grades, and ratings assigned by external credit assessment institutions (ECAI) are not used in determining internal credit grades. Nonetheless, as the assessment factors used to grade a borrower may be similar, a borrower rated poorly by an ECAI is typically expected to be assigned a weak internal credit grade.
For Retail exposures, application and behaviour credit scores are calibrated to generate a PD used for RWA and capital estimate purposes for IRB portfolios.
IRB models cover a substantial majority of the Group's exposures and are used extensively in assessing risks at customer and portfolio level, setting strategy and optimising the Group's risk-return decisions. The Group makes use of internal risk estimates of PD, LGD and EAD in the areas of:
- Credit Approval and Decision In CIB, the level of authority required for the sanctioning of credit requests and the decision made is based on a combination of PD, LGD and EAD of the obligor with reference to the nominal exposure. In Retail, credit scores are relied upon as one of the primary drivers for credit decisioning.
- Pricing In CIB, a pre-deal pricing calculator, which takes into consideration PD, LGD and EAD in the calculation of expected loss and risk-weighted assets, is used for the proposed transactions to ensure appropriate returns. In Retail unsecured lending, a risk-return approach based on PD estimates is used as guidance for pricing strategy.
- Limit Setting In CIB, single name concentration limits are determined by PD, LGD and EAD. The limits operate on a sliding scale to ensure that the Group does not have an excessive concentration of low credit quality assets. In Retail unsecured lending, limit assignment / loan amounts are risk-based and segregated by credit score bands.
3.5 Risk grade profile continued
Table 51 sets out credit and counterparty risk EAD within the IRB portfolios by regulatory exposure classes. EAD has been calculated after taking into account the impact of credit risk mitigation. Where an exposure is guaranteed or covered by credit derivatives, it is shown against the exposure class of the guarantor or derivative issuer. A further split of the major exposure classes by credit grade can be seen in Tables 53 to 64.
IRB credit risk excluding counterparty credit risk EAD increased by \$27.4 billion and RWA decreased by \$2 billion (Tables 53 to 64):
- Central governments and central banks EAD increased \$8.2 billion and RWA decreased \$0.6 billion
- Institutions EAD increased \$1.6 billion and RWA decreased by \$0.8 billion
- Corporates EAD increased \$15.0 billion and RWA by \$1.0 billion
- Retail EAD increased \$2.7 billion and RWA decreased by \$1.6 billion
Table 51: IRB – Credit risk exposure by exposure class
| 2025 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Original on balance sheet gross exposure \$million |
Off balance sheet exposure pre CCF \$million |
Average CCF \$million |
EAD post CRM and post CCF \$million |
Average PD1 \$million |
Number of obligors2 \$million |
Average LGD1 \$million |
Average maturity1 \$million |
RWA \$million |
RWA density1 \$million |
Expected loss \$million |
Value adjustments and provisions \$million |
|
| IRB Exposure Class | ||||||||||||
| Central governments or central banks |
179,125 | 5,238 | 22 | 174,443 | 0.43 | 0.2 | 45 | 1.21 | 21,328 | 12 | 144 | (96) |
| Institutions | 57,686 | 21,704 | 65 | 69,637 | 0.34 | 1.2 | 32 | 0.91 | 12,143 | 17 | 47 | (9) |
| Corporates | 109,300 | 289,087 | 25 | 203,590 | 2.05 | 19.9 | 39 | 1.45 | 64,608 | 32 | 2,721 | (2,783) |
| Other | 89,096 | 270,291 | 25 | 183,197 | 1.64 | 15.7 | 40 | 1.36 | 58,559 | 32 | 1,754 | (1,850) |
| Of which Specialised lending |
17,767 | 16,624 | 29 | 17,576 | 4.46 | 0.8 | 24 | 2.51 | 4,811 | 27 | 508 | (540) |
| Of which SME | 2,437 | 2,172 | 22 | 2,817 | 13.83 | 3.4 | 29 | 1.28 | 1,238 | 44 | 259 | (246) |
| Retail | 87,983 | 32,274 | 47 | 102,148 | 1.47 | 3,027.6 | 31 | 18,080 | 18 | 745 | (401) | |
| Of which secured by real estate |
74,370 | 2,299 | 99 | 76,647 | 0.66 | 295.3 | 15 | 5,800 | 8 | 103 | (46) | |
| - SME | 341 | 49 | 51 | 366 | 4.39 | 2.0 | 6 | 17 | 5 | 2 | (2) | |
| - Non SME | 74,029 | 2,250 | 100 | 76,281 | 0.64 | 293.3 | 15 | 5,783 | 8 | 101 | (44) | |
| Of which qualifying revolving retail |
4,494 | 23,446 | 45 | 15,023 | 2.35 | 2,320.5 | 84 | 4,691 | 31 | 242 | (129) | |
| Of which other retail | 9,119 | 6,529 | 34 | 10,478 | 6.47 | 411.8 | 69 | 7,589 | 72 | 400 | (226) | |
| - SME | 2,178 | 1,991 | 5 | 2,119 | 10.48 | 22.2 | 47 | 1,197 | 56 | 120 | (68) | |
| - Non SME | 6,941 | 4,538 | 47 | 8,359 | 5.01 | 389.6 | 77 | 6,392 | 76 | 280 | (158) | |
| Non-credit obligation assets | 43 | - | - | 43 | - | 43 | 100 | - | ||||
| Total IRB4 | 434,137 | 348,303 | 38 | 549,861 | 2.06 | 3,048.9 | 46 | 1.46 | 116,202 | 21 | 3,657 | (3,289) |
| 2024 | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Original on balance sheet exposure \$million |
Off balance sheet exposure pre CCF \$million |
Average CCF \$million |
EAD post CRM and post CCF \$million |
Average PD1 \$million |
Number of obligors2 \$million |
Average LGD1 \$million |
Average maturity1 \$million |
RWA \$million |
RWA density1 \$million |
Expected loss \$million |
Value adjustments and provisions \$million |
||
| IRB Exposure Class | |||||||||||||
| Central governments or | |||||||||||||
| central banks | 163,054 | 6,639 | 9 | 166,287 | 0.43 | 0.2 | 44 | 1.47 | 21,960 | 13 | 159 | (46) | |
| Institutions | 59,165 | 27,260 | 47 | 68,036 | 0.55 | 1.3 | 32 | 0.95 | 12,903 | 19 | 62 | (15) | |
| Corporates | 113,853 | 307,312 | 39 | 188,625 | 2.46 | 20.6 | 39 | 1.37 | 63,622 | 34 | 3,305 | (3,186) | |
| Other | 96,642 | 283,883 | 22 | 171,223 | 2.11 | 15.8 | 41 | 1.29 | 58,270 | 34 | 2,759 | (2,583) | |
| Of which Specialised lending |
14,617 | 21,273 | 20 | 14,354 | 4.69 | 0.7 | 23 | 2.37 | 3,997 | 28 | 340 | (414) | |
| Of which SME | 2,594 | 2,156 | 26 | 3,048 | 11.72 | 4.1 | 30 | 1.29 | 1,355 | 44 | 206 | (189) | |
| Retail | 83,616 | 35,697 | 45 | 99,468 | 1.52 | 3,626.0 | 34 | 19,690 | 20 | 756 | (405) | ||
| Of which secured by real estate |
69,046 | 1,682 | 99 | 70,707 | 0.66 | 295.3 | 16 | 4,968 | 7 | 67 | (42) | ||
| - SME | 314 | 53 | 53 | 343 | 3.15 | 2.2 | 7 | 18 | 5 | 1 | (2) | ||
| - Non SME | 68,732 | 1,629 | 100 | 70,364 | 0.65 | 293.1 | 16 | 4,950 | 7 | 66 | (40) | ||
| Of which qualifying revolving retail |
4,413 | 26,398 | 44 | 16,010 | 2.07 | 2,723.6 | 85 | 4,908 | 31 | 243 | (127) | ||
| Of which other retail | 10,157 | 7,617 | 36 | 12,751 | 6.06 | 607.1 | 68 | 9,814 | 77 | 446 | (236) | ||
| - SME | 2,080 | 2,134 | 4 | 1,988 | 10.33 | 25.1 | 50 | 1,181 | 59 | 109 | (61) | ||
| - Non SME | 8,077 | 5,483 | 49 | 10,763 | 4.73 | 582.0 | 74 | 8,633 | 80 | 337 | (175) | ||
| Non-credit obligation assets | 43 | - | - | 43 | - | 43 | 100 | - | |||||
| Total IRB4 | 419,731 | 376,908 | 43 | 522,459 | 2.59 | 3,648.1 | 49 | 1.44 | 118,218 | 23 | 4,282 | (3,652) |
1 Weighted averages are based on EAD.
2 Number of obligors is based on number of counterparties for central governments or central banks, institutions and corporates and on individual pools of clients for retail.
3 Corporates of which specialised lending includes exposures for specialised lending subject to supervisory slotting criteria.
4 Refer to Table 20 (OV1) for RWA.
3.5 Risk grade profile continued
The table below demonstrates Standard Chartered's internal ratings and its approximate relation to external credit ratings.
Tables 53 to 64 and tables 90 to 94 provide further detail on the exposure classes subject to credit and counterparty credit risk, in particular for central governments or central banks, institutions, corporates and retail. These have been split by internal credit grade which relate to the PD ranges presented. These exposure classes represent 82 per cent (2024: 85 per cent) of the Group's total credit risk exposure before collateral.
Table 52: Internal default grade probabilities and mapping to external ratings
| SCB internal ratings |
PD range (%) | Standard & Poor's external rating equivalent for corporates |
Standard & Poor's external rating equivalent for banks |
Standard & Poor's external rating equivalent for sovereigns |
|---|---|---|---|---|
| 1A | 0.000 - 0.015 | AAA/AA+ | AAA/AA+ | AAA |
| 1B | 0.016 - 0.025 | AA | AA/AA- | AA+ |
| 2A | 0.026 - 0.035 | AA- | A+ | AA/AA |
| 2B | 0.036 - 0.045 | A+ | A | A+ |
| 3A | 0.046 - 0.060 | A/A- | A- | A |
| 3B | 0.061 - 0.083 | BBB+ | BBB+/BBB | A |
| 4A | 0.084 - 0.110 | BBB+/BBB | BBB/BBB- | BBB+/BBB |
| 4B | 0.111 - 0.170 | BBB | BBB- | BBB/BBB |
| 5A | 0.171 - 0.300 | BBB- | BB+ | BBB |
| 5B | 0.301 - 0.425 | BBB-/BB+ | BB+/BB | BB+ |
| 6A | 0.426 - 0.585 | BB | BB | BB+/BB |
| 6B | 0.586 - 0.770 | BB/BB- | BB/BB- | BB |
| 7A | 0.771 - 1.020 | BB- | BB- | BB/BB |
| 7B | 1.021 - 1.350 | BB-/B+ | B+ | BB |
| 8A | 1.351 - 1.750 | B+ | B+/B | BB-/B+ |
| 8B | 1.751 - 2.350 | B+ | B | B+ |
| 9A | 2.351 - 3.050 | B | B | B |
| 9B | 3.051 - 4.000 | B/B- | B/B- | B |
| 10A | 4.001 - 5.300 | B- | B- | B/B |
| 10B | 5.301 - 7.000 | B- | B-/CCC+ to C | B |
| 11A/B/C | 7.001 - 15.750 | B-/CCC+ | CCC/C | B-/CCC+ |
| 12A/B/C | 15.751 - 99.999 | CCC+/C | CCC+/C | CCC+/C |
| 13 | 100 | N/A | N/A | N/A |
| 14 | 100 | N/A | N/A | N/A |
| Unrated | N/A | N/A | N/A |
3.5 Risk grade profile continued Table 53: IRB approach – Credit risk exposures by exposure class and PD range for central governments or central banks (UK CR6)
| 2025 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PD range % | Original on-balance sheet exposure \$million |
Off-balance sheet exposure pre CCF \$million |
Average CCF % |
EAD post CRM and post CCF \$million |
Average PD1 % |
Number of obligors2 thousands |
Average LGD1 % |
Average maturity1 years |
RWA \$million |
RWA density1 % |
Expected loss \$million |
Value adjustments and provisions \$million |
| 0.00 to <0.15 | 166,224 | 2,582 | 13 | 169,733 | 0.03 | 0.1 | 45 | 1.22 | 14,696 | 9 | 22 | (16) |
| 0.00 to <0.10 | 156,781 | 1,980 | 8 | 160,482 | 0.02 | 0.1 | 45 | 1.17 | 11,522 | 7 | 16 | (12) |
| 0.10 to <0.15 | 9,442 | 602 | 28 | 9,251 | 0.13 | 0.0 | 43 | 2.01 | 3,174 | 34 | 5 | (4) |
| 0.15 to <0.25 | 612 | 4 | 100 | 282 | 0.22 | 0.0 | 45 | 1.02 | 95 | 34 | – | – |
| 0.25 to <0.50 | 215 | 54 | 17.00 | 124 | 0.39 | 0.0 | 44 | 1.00 | 62 | 50 | – | – |
| 0.50 to <0.75 | – | – | – | – | – | – | – | – | – | – | – | – |
| 0.75 to <2.50 | 5,494 | 333 | 21 | 2,434 | 1.62 | 0.0 | 44 | 0.88 | 2,130 | 88 | 17 | (8) |
| 0.75 to <1.75 | 2,598 | 318 | 21 | 980 | 1.00 | 0.0 | 43 | 1.31 | 734 | 75 | 4 | (2) |
| 1.75 to <2.5 | 2,897 | 15 | 32 | 1,453 | 2.03 | 0.0 | 45 | 0.59 | 1,395 | 96 | 13 | (6) |
| 2.50 to <10.00 | 4,463 | 2,190 | 33 | 1,143 | 4.83 | 0.0 | 43 | 1.10 | 1,515 | 133 | 23 | (9) |
| 2.5 to <5 | 3,187 | 1,535 | 43 | 821 | 3.58 | 0.0 | 45 | 1.31 | 1,050 | 128 | 13 | (7) |
| 5 to <10 | 1,276 | 655 | 9.00 | 322 | 8.01 | 0.0 | 36.09 | 0.56 | 465 | 144 | 10 | (2) |
| 10.00 to <100.00 | 414 | – | – | 161 | 10.54 | 0.0 | 45 | 0.11 | 289 | 180 | 8 | (1) |
| 10 to <20 | 414 | – | – | 161 | 10.54 | 0.0 | 45 | 0.11 | 289 | 180 | 8 | (1) |
| 20 to <30 | – | – | – | – | – | – | – | – | – | – | – | – |
| 30.00 to <100.00 | – | – | – | – | – | – | – | – | – | – | – | – |
| 100.00 (Default) | 1,703 | 75 | – | 566 | 100.00 | 0.1 | 43 | 1.00 | 2,541 | 449 | 74 | (62) |
| Total | 179,125 | 5,238 | 21.5 | 174,443 | 0.42 | 0.2 | 45 | 1.21 | 21,328 | 12 | 144 | (96) |
| PD range % | Original on balance sheet exposure \$million |
Off balance sheet exposure pre CCF \$million |
Average CCF % |
EAD post CRM and post CCF \$million |
Average PD1 % |
Number of obligors2 thousands |
Average LGD1 % |
Average maturity1 years |
RWA \$million |
RWA density1 % |
Expected loss \$million |
Value adjustments and provisions \$million |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 to <0.15 | 150,625 | 3,032 | 6 | 160,490 | 0.03 | 0.1 | 44 | 1.49 | 13,592 | 8 | 20 | (7) |
| 0.00 to <0.10 | 139,054 | 2,618 | 6 | 149,316 | 0.02 | 0.1 | 44 | 1.47 | 9,954 | 7 | 13 | (4) |
| 0.10 to <0.15 | 11,571 | 414 | – | 11,173 | 0.15 | – | 43 | 1.70 | 3,638 | 33 | 8 | (3) |
| 0.15 to <0.25 | 497 | 79 | 31 | 220 | 0.22 | – | 45 | 0.42 | 62 | 28 | – | – |
| 0.25 to <0.50 | 25 | – | – | 24 | 0.39 | – | 30 | 1.66 | 8 | 33 | – | – |
| 0.50 to <0.75 | – | – | – | – | – | – | – | – | – | – | – | – |
| 0.75 to <2.50 | 5,940 | 818 | 21 | 2,762 | 1.28 | – | 45 | 0.87 | 2,307 | 84 | 16 | (6) |
| 0.75 to <1.75 | 5,647 | 805 | 22 | 2,622 | 1.24 | – | 45 | 0.87 | 2,166 | 83 | 15 | (6) |
| 1.75 to <2.5 | 293 | 13 | 3 | 138 | 2.03 | – | 46 | 0.84 | 141 | 102 | 1 | – |
| 2.50 to <10.00 | 3,739 | 2,302 | 23 | 1,662 | 3.98 | – | 45 | 1.04 | 2,144 | 129 | 30 | (8) |
| 2.5 to <5 | 3,739 | 2,302 | 23 | 1,662 | 3.98 | – | 45 | 1.04 | 2,144 | 129 | 30 | (8) |
| 5 to <10 | – | – | – | – | – | – | – | – | – | – | – | – |
| 10.00 to <100.00 | 1,593 | 300 | – | 723 | 21.86 | – | 44 | 0.44 | 1,685 | 233 | 72 | (9) |
| 10 to <20 | 1,215 | 300 | – | 506 | 17.09 | – | 43 | 0.58 | 1,141 | 225 | 39 | (4) |
| 20 to <30 | – | – | – | – | – | – | – | – | – | – | – | – |
| 30.00 to <100.00 | 378 | – | – | 217 | 33.00 | – | 47 | 0.11 | 544 | 251 | 33 | (5) |
| 100.00 (Default) | 635 | 108 | – | 406 | 100.00 | 0.1 | 44 | 1.49 | 2,162 | 533 | 21 | (16) |
| Total | 163,054 | 6,639 | 9 | 166,287 | 0.42 | 0.2 | 44 | 1.47 | 21,960 | 13 | 159 | (46) |
2024
1 Weighted averages are based on EAD.
3.5 Risk grade profile continued
Table 54: IRB approach – Credit risk exposures by exposure class and PD range for institutions (UK CR6)
| 2025 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PD range % | Original on-balance sheet exposure \$million |
Off-balance sheet exposure pre CCF \$million |
Average CCF % |
EAD post CRM and post CCF \$million |
Average PD1 % |
Number of obligors2 thousands |
Average LGD1 % |
Average maturity1 years |
RWA \$million |
RWA density1 % |
Expected loss \$million |
Value adjustments and provisions \$million |
| 0.00 to <0.15 | 41,309 | 15,881 | 60 | 55,724 | 0.05 | 0.6 | 35 | 0.97 | 5,879 | 11 | 9 | (6) |
| 0.00 to <0.10 | 37,176 | 14,712 | 60 | 50,743 | 0.04 | 0.5 | 35 | 1.01 | 4,904 | 10 | 7 | (5) |
| 0.10 to <0.15 | 4,132 | 1,170 | 67 | 4,981 | 0.13 | 0.1 | 32 | 0.64 | 975 | 20 | 2 | – |
| 0.15 to <0.25 | 988 | 910 | 66 | 1,483 | 0.22 | 0.1 | 26 | 0.49 | 350 | 24 | 1 | – |
| 0.25 to <0.50 | 374 | 379 | 66 | 523 | 0.39 | 0.1 | 25 | 0.38 | 187 | 36 | 1 | – |
| 0.50 to <0.75 | 7,089 | 1,344 | 81 | 5,803 | 0.52 | 0.1 | 13 | 0.81 | 1,200 | 21 | 4 | (1) |
| 0.75 to <2.50 | 5,772 | 1,643 | 81 | 4,111 | 1.38 | 0.2 | 31 | 0.75 | 3,173 | 77 | 17 | (1) |
| 0.75 to <1.75 | 4,699 | 1,247 | 76 | 3,135 | 1.18 | 0.1 | 34 | 0.82 | 2,279 | 73 | 13 | – |
| 1.75 to <2.5 | 1,073 | 396 | 97 | 976 | 2.03 | – | 23 | 0.53 | 894 | 92 | 5 | (1) |
| 2.50 to <10.00 | 1,794 | 1,058 | 100 | 1,772 | 4.06 | 0.1 | 13 | 0.25 | 959 | 54 | 8 | – |
| 2.5 to <5 | 1,650 | 763 | 99 | 1,519 | 3.45 | 0.1 | 14 | 0.27 | 771 | 51 | 8 | – |
| 5 to <10 | 144 | 295 | 100 | 254 | 7.69 | – | 4 | 0.16 | 187 | 74 | 1 | – |
| 10.00 to <100.00 | 299 | 484 | 27 | 204 | 13.78 | – | 21 | 0.28 | 332 | 163 | 6 | – |
| 10 to <20 | 299 | 484 | 27 | 204 | 13.76 | – | 21 | 0.28 | 331 | 162 | 6 | – |
| 20 to <30 | – | – | – | – | – | – | – | – | – | – | – | – |
| 30.00 to <100.00 | – | – | – | – | 33.00 | – | 45 | 1.00 | 1 | – | – | – |
| 100.00 (Default) | 61 | 5 | 53 | 17 | 100.00 | – | 35 | 1.44 | 63 | 371 | 1 | (1) |
| Total | 57,686 | 21,704 | 65 | 69,637 | 0.34 | 1.2 | 32 | 0.91 | 12,143 | 17 | 47 | (9) |
| PD range % | Original on balance sheet exposure \$million |
Off balance sheet exposure pre CCF \$million |
Average CCF % |
EAD post CRM and post CCF \$million |
Average PD1 % |
Number of obligors2 thousands |
Average LGD1 % |
Average maturity1 years |
RWA \$million |
RWA density1 % |
Expected loss \$million |
Value adjustments and provisions \$million |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 to <0.15 | 42,348 | 21,469 | 42 | 53,997 | 0.05 | 0.6 | 35 | 1.03 | 5,805 | 11 | 9 | (4) |
| 0.00 to <0.10 | 38,091 | 19,546 | 43 | 49,340 | 0.04 | 0.5 | 35 | 1.07 | 4,915 | 10 | 7 | (3) |
| 0.10 to <0.15 | 4,257 | 1,924 | 36 | 4,658 | 0.13 | 0.1 | 31 | 0.54 | 890 | 19 | 2 | (1) |
| 0.15 to <0.25 | 1,649 | 1,319 | 56 | 2,048 | 0.22 | 0.1 | 27 | 0.55 | 533 | 26 | 1 | – |
| 0.25 to <0.50 | 491 | 554 | 74 | 893 | 0.39 | 0.1 | 29 | 0.91 | 414 | 46 | 1 | – |
| 0.50 to <0.75 | 5,894 | 965 | 50 | 4,596 | 0.52 | 0.1 | 19 | 0.83 | 1,456 | 32 | 5 | (1) |
| 0.75 to <2.50 | 6,047 | 1,581 | 72 | 4,109 | 1.30 | 0.2 | 28 | 0.59 | 2,674 | 65 | 14 | (1) |
| 0.75 to <1.75 | 5,431 | 1,270 | 71 | 3,541 | 1.19 | 0.2 | 29 | 0.62 | 2,343 | 66 | 12 | (1) |
| 1.75 to <2.5 | 616 | 312 | 80 | 568 | 2.03 | – | 20 | 0.43 | 332 | 58 | 2 | – |
| 2.50 to <10.00 | 2,500 | 716 | 100 | 2,033 | 4.66 | 0.1 | 23 | 0.50 | 1,704 | 84 | 21 | – |
| 2.5 to <5 | 2,188 | 547 | 99 | 1,558 | 4.02 | 0.1 | 20 | 0.37 | 1,134 | 73 | 12 | – |
| 5 to <10 | 312 | 168 | 100 | 474 | 6.73 | – | 30 | 0.95 | 569 | 120 | 9 | – |
| 10.00 to <100.00 | 169 | 580 | 39 | 240 | 19.48 | 0.1 | 4 | 0.10 | 74 | 31 | 2 | – |
| 10 to <20 | 121 | 553 | 37 | 214 | 17.88 | – | 4 | 0.10 | 62 | 29 | 1 | – |
| 20 to <30 | – | – | – | – | – | – | – | – | – | – | – | – |
| 30.00 to <100.00 | 48 | 27 | 80 | 25 | 33.00 | – | 7 | 0.16 | 12 | 48 | 1 | – |
| 100.00 (Default) | 67 | 76 | 95 | 120 | 100.00 | – | 25 | 0.36 | 243 | 203 | 9 | (9) |
| Total | 59,165 | 27,260 | 47 | 68,036 | 0.55 | 1.3 | 32 | 0.95 | 12,903 | 19 | 62 | (15) |
2024
1 Weighted averages are based on EAD.
3.5 Risk grade profile continued
Table 55: IRB approach – Credit risk exposures by exposure class and PD range for Corporates (UK CR6)
| 2025 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PD range % | Original on-balance sheet exposure \$million |
Off-balance sheet exposure pre CCF \$million |
Average CCF % |
EAD post CRM and post CCF \$million |
Average PD1 % |
Number of obligors2 thousands |
Average LGD1 % |
Average maturity1 years |
RWA \$million |
RWA density1 % |
Expected loss \$million |
Value adjustments and provisions \$million |
| 0.00 to <0.15 | 46,628 | 139,433 | 26 | 117,942 | 0.07 | 4.4 | 41 | 1.50 | 18,906 | 16 | 33 | (26) |
| 0.00 to <0.10 | 34,146 | 98,877 | 26 | 94,290 | 0.05 | 2.8 | 42 | 1.50 | 13,640 | 14 | 22 | (20) |
| 0.10 to <0.15 | 12,482 | 40,555 | 27 | 23,652 | 0.13 | 1.5 | 37 | 1.47 | 5,267 | 22 | 12 | (6) |
| 0.15 to <0.25 | 15,128 | 40,226 | 23 | 22,716 | 0.22 | 2.1 | 38 | 1.39 | 7,162 | 32 | 19 | (6) |
| 0.25 to <0.50 | 9,635 | 32,445 | 28 | 17,747 | 0.39 | 1.7 | 33 | 1.32 | 6,660 | 38 | 22 | (7) |
| 0.50 to <0.75 | 14,088 | 36,919 | 22 | 19,757 | 0.57 | 2.5 | 36 | 1.33 | 10,118 | 51 | 41 | (13) |
| 0.75 to <2.50 | 10,407 | 26,347 | 23 | 13,986 | 1.35 | 3.9 | 34 | 1.54 | 10,866 | 78 | 73 | (25) |
| 0.75 to <1.75 | 7,659 | 21,361 | 23 | 10,821 | 1.15 | 2.8 | 32 | 1.52 | 6,737 | 62 | 44 | (14) |
| 1.75 to <2.5 | 2,748 | 4,986 | 20 | 3,164 | 2.03 | 1.1 | 39 | 1.72 | 4,130 | 131 | 29 | (10) |
| 2.50 to <10.00 | 7,032 | 9,847 | 24 | 6,797 | 4.31 | 2.5 | 33 | 1.28 | 7,291 | 107 | 97 | (40) |
| 2.5 to <5 | 5,674 | 7,920 | 25 | 5,516 | 3.72 | 1.8 | 33 | 1.30 | 5,547 | 101 | 68 | (29) |
| 5 to <10 | 1,357 | 1,928 | 19 | 1,282 | 7.11 | 0.8 | 33 | 1.20 | 1,743 | 136 | 28 | (10) |
| 10.00 to <100.00 | 3,261 | 1,966 | 27 | 1,556 | 18.85 | 2.1 | 32 | 1.93 | 2,650 | 170 | 92 | (96) |
| 10 to <20 | 2,190 | 1,707 | 25 | 943 | 13.74 | 2.0 | 33 | 1.24 | 1,447 | 153 | 41 | (35) |
| 20 to <30 | 861 | 142 | 40 | 445 | 24.55 | – | 25 | 3.64 | 987 | 222 | 38 | (51) |
| 30.00 to <100.00 | 210 | 117 | 28 | 168 | 33.03 | 0.1 | 24 | 1.04 | 215 | 128 | 13 | (9) |
| 100.00 (Default) | 3,121 | 1,904 | 33 | 3,089 | 100 | 0.7 | 56 | 1.23 | 955 | 31 | 2,344 | (2,570) |
| Total | 109,300 | 289,087 | 25 | 203,590 | 2.05 | 19.9 | 39 | 1.45 | 64,608 | 32 | 2,721 | (2,783) |
| PD range % | Original on balance sheet exposure \$million |
Off balance sheet exposure pre CCF \$million |
Average CCF % |
EAD post CRM and post CCF \$million |
Average PD1 % |
Number of obligors2 thousands |
Average LGD1 % |
Average maturity1 years |
RWA \$million |
RWA density1 % |
Expected loss \$million |
Value adjustments and provisions \$million |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 to <0.15 | 51,328 | 148,578 | 22 | 103,107 | 0.07 | 4.3 | 41 | 1.41 | 16,866 | 16 | 29 | (10) |
| 0.00 to <0.10 | 41,576 | 114,418 | 22 | 86,025 | 0.06 | 2.9 | 42 | 1.37 | 12,221 | 14 | 19 | (7) |
| 0.10 to <0.15 | 9,752 | 34,160 | 21 | 17,084 | 0.13 | 1.4 | 41 | 1.63 | 4,645 | 27 | 9 | (4) |
| 0.15 to <0.25 | 15,327 | 42,674 | 22 | 22,590 | 0.22 | 2.1 | 35 | 1.43 | 7,017 | 31 | 17 | (10) |
| 0.25 to <0.50 | 7,733 | 29,042 | 27 | 14,463 | 0.39 | 1.4 | 37 | 1.27 | 6,442 | 45 | 20 | (9) |
| 0.50 to <0.75 | 14,573 | 42,143 | 23 | 22,552 | 0.56 | 2.7 | 37 | 1.31 | 12,000 | 53 | 48 | (33) |
| 0.75 to <2.50 | 11,815 | 26,309 | 23 | 14,327 | 1.29 | 4.0 | 34 | 1.39 | 9,973 | 70 | 62 | (33) |
| 0.75 to <1.75 | 9,101 | 21,832 | 24 | 11,914 | 1.14 | 3.0 | 34 | 1.37 | 7,908 | 66 | 44 | (21) |
| 1.75 to <2.5 | 2,713 | 4,476 | 22 | 2,413 | 2.03 | 1.0 | 33 | 1.47 | 2,066 | 86 | 16 | (12) |
| 2.50 to <10.00 | 7,170 | 9,330 | 22 | 6,480 | 4.26 | 2.8 | 34 | 1.25 | 6,492 | 100 | 92 | (41) |
| 2.5 to <5 | 5,913 | 7,641 | 22 | 5,155 | 3.63 | 2.0 | 35 | 1.26 | 5,123 | 99 | 65 | (28) |
| 5 to <10 | 1,257 | 1,689 | 20 | 1,325 | 6.82 | 0.9 | 30 | 1.22 | 1,370 | 103 | 27 | (13) |
| 10.00 to <100.00 | 2,153 | 7,571 | 7 | 1,493 | 17.90 | 2.3 | 37 | 1.04 | 2,634 | 176 | 96 | (39) |
| 10 to <20 | 1,814 | 7,273 | 7 | 1,208 | 14.71 | 2.2 | 36 | 1.14 | 2,002 | 166 | 63 | (21) |
| 20 to <30 | 85 | 191 | 18 | 119 | 24.55 | 0.1 | 45 | 0.71 | 295 | 248 | 13 | (12) |
| 30.00 to <100.00 | 255 | 106 | 40 | 165 | 33.40 | 0.1 | 35 | 1.45 | 338 | 205 | 19 | (7) |
| 100.00 (Default) | 3,754 | 1,665 | 30 | 3,613 | 100.00 | 1.0 | 55 | 1.16 | 2,198 | 61 | 2,941 | (3,011) |
| Total | 113,853 | 307,312 | 39 | 188,625 | 2.46 | 20.6 | 39 | 1.37 | 63,622 | 34 | 3,305 | (3,186) |
2024
1 Weighted averages are based on EAD.
3.5 Risk grade profile continued Table 56: IRB approach – Credit risk exposures by exposure class and PD range for Corporates – Other (UK CR6)
| 2025 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PD range % | Original on-balance sheet exposure \$million |
Off-balance sheet exposure pre CCF \$million |
Average CCF % |
EAD post CRM and post CCF \$million |
Average PD1 % |
Number of obligors2 thousands |
Average LGD1 % |
Average maturity1 years |
RWA \$million |
RWA density1 % |
Expected loss \$million |
Value adjustments and provisions \$million |
| 0.00 to <0.15 | 41,741 | 133,829 | 26 | 112,194 | 0.07 | 4.1 | 42 | 1.42 | 18,104 | 16 | 32 | (25) |
| 0.00 to <0.10 | 31,165 | 95,184 | 26 | 90,383 | 0.05 | 2.6 | 43 | 1.43 | 13,133 | 15 | 21 | (20) |
| 0.10 to <0.15 | 10,576 | 38,644 | 27 | 21,811 | 0.13 | 1.4 | 38 | 1.35 | 4,971 | 23 | 11 | (5) |
| 0.15 to <0.25 | 11,648 | 37,502 | 22 | 19,135 | 0.22 | 1.8 | 39 | 1.17 | 6,225 | 33 | 17 | (5) |
| 0.25 to <0.50 | 6,391 | 29,597 | 28 | 14,323 | 0.39 | 1.5 | 34 | 1.31 | 5,725 | 40 | 19 | (6) |
| 0.50 to <0.75 | 11,967 | 33,089 | 22 | 17,301 | 0.57 | 2.0 | 38 | 1.24 | 9,326 | 54 | 38 | (12) |
| 0.75 to <2.50 | 7,748 | 23,591 | 23 | 11,602 | 1.36 | 3.1 | 36 | 1.39 | 9,770 | 84 | 66 | (17) |
| 0.75 to <1.75 | 5,486 | 19,464 | 23 | 8,817 | 1.15 | 2.2 | 34 | 1.39 | 5,862 | 66 | 39 | (11) |
| 1.75 to <2.5 | 2,262 | 4,127 | 21 | 2,785 | 2.03 | 0.9 | 43 | 1.41 | 3,908 | 140 | 27 | (6) |
| 2.50 to <10.00 | 5,378 | 9,148 | 23 | 5,404 | 4.31 | 1.4 | 34 | 1.15 | 6,387 | 118 | 82 | (22) |
| 2.5 to <5 | 4,476 | 7,426 | 24 | 4,534 | 3.73 | 1.1 | 34 | 1.19 | 4,938 | 109 | 59 | (18) |
| 5 to <10 | 901 | 1,721 | 18 | 870 | 7.33 | 0.4 | 34 | 0.96 | 1,449 | 167 | 22 | (4) |
| 10.00 to <100.00 | 2,272 | 1,737 | 28 | 1,124 | 20.19 | 1.3 | 34 | 1.59 | 2,217 | 197 | 77 | (72) |
| 10 to <20 | 1,735 | 1,575 | 26 | 588 | 13.88 | 1.2 | 34 | 1.04 | 1,082 | 184 | 29 | (17) |
| 20 to <30 | 332 | 56 | 75 | 374 | 24.56 | – | 40 | 2.74 | 931 | 249 | 36 | (46) |
| 30.00 to <100.00 | 206 | 106 | 28 | 161 | 33.03 | 0.1 | 23 | 0.94 | 204 | 127 | 12 | (9) |
| 100.00 (Default) | 1,951 | 1,798 | 34 | 2,114 | 100 | 0.5 | 60 | 1.30 | 805 | 38 | 1,623 | (1,838) |
| Total | 89,096 | 270,291 | 25 | 183,197 | 1.64 | 15.7 | 40 | 1.36 | 58,559 | 32 | 1,954 | (1,997) |
| PD range % | Original on balance sheet exposure \$million |
Off balance sheet exposure pre CCF \$million |
Average CCF % |
EAD post CRM and post CCF \$million |
Average PD1 % |
Number of obligors2 thousands |
Average LGD1 % |
Average maturity1 years |
RWA \$million |
RWA density1 % |
Expected loss \$million |
Value adjustments and provisions \$million |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 to <0.15 | 47,218 | 140,433 | 22 | 98,631 | 0.07 | 4.1 | 43 | 1.33 | 16,357 | 17 | 28 | (9) |
| 0.00 to <0.10 | 38,752 | 108,508 | 23 | 83,328 | 0.06 | 2.8 | 43 | 1.30 | 11,969 | 14 | 19 | (6) |
| 0.10 to <0.15 | 8,466 | 31,925 | 20 | 15,303 | 0.13 | 1.3 | 43 | 1.54 | 4,388 | 29 | 9 | (3) |
| 0.15 to <0.25 | 11,452 | 37,445 | 22 | 18,450 | 0.22 | 1.7 | 37 | 1.21 | 6,001 | 33 | 15 | (6) |
| 0.25 to <0.50 | 6,694 | 26,592 | 26 | 12,807 | 0.39 | 1.2 | 38 | 1.23 | 6,015 | 47 | 19 | (8) |
| 0.50 to <0.75 | 12,136 | 38,615 | 23 | 20,160 | 0.56 | 2.1 | 39 | 1.20 | 11,123 | 55 | 44 | (27) |
| 0.75 to <2.50 | 9,396 | 23,730 | 23 | 12,124 | 1.29 | 3.1 | 35 | 1.33 | 9,041 | 75 | 55 | (22) |
| 0.75 to <1.75 | 7,075 | 19,823 | 24 | 10,061 | 1.14 | 2.3 | 35 | 1.29 | 7,162 | 71 | 40 | (15) |
| 1.75 to <2.5 | 2,320 | 3,907 | 20 | 2,063 | 2.03 | 0.8 | 35 | 1.51 | 1,879 | 91 | 14 | (7) |
| 2.50 to <10.00 | 5,273 | 8,625 | 21 | 5,150 | 4.29 | 1.4 | 36 | 1.05 | 5,673 | 110 | 78 | (24) |
| 2.5 to <5 | 4,346 | 7,123 | 21 | 4,125 | 3.66 | 1.1 | 37 | 1.07 | 4,505 | 109 | 56 | (15) |
| 5 to <10 | 927 | 1,502 | 22 | 1,025 | 6.83 | 0.4 | 31 | 0.98 | 1,168 | 114 | 22 | (9) |
| 10.00 to <100.00 | 1,744 | 7,018 | 7 | 1,138 | 17.52 | 1.4 | 37 | 0.96 | 2,202 | 193 | 76 | (33) |
| 10 to <20 | 1,469 | 6,738 | 7 | 924 | 14.98 | 1.3 | 37 | 0.93 | 1,692 | 183 | 51 | (16) |
| 20 to <30 | 82 | 188 | 18 | 116 | 24.55 | 0.1 | 46 | 0.70 | 294 | 253 | 13 | (12) |
| 30.00 to <100.00 | 193 | 92 | 40 | 98 | 33.26 | 0.1 | 34 | 1.57 | 217 | 221 | 11 | (6) |
| 100.00 (Default) | 2,729 | 1,425 | 32 | 2,763 | 100.00 | 0.8 | 59 | 1.28 | 1,858 | 67 | 2,444 | (2,454) |
| Total | 96,642 | 283,883 | 22 | 171,223 | 2.11 | 15.8 | 41 | 1.29 | 58,270 | 34 | 2,759 | (2,583) |
2024
1 Weighted averages are based on EAD.
3.5 Risk grade profile continued Table 57: IRB approach – Credit risk exposures by exposure class and PD range for corporates – specialised lending (UK CR6)
| Original Off-balance on-balance sheet EAD post sheet exposure pre Average CRM and Average Number of Average Average PD1 obligors2 LGD1 maturity1 exposure CCF CCF post CCF |
RWA \$million 780 |
RWA density1 % |
Expected loss |
Value adjustments and |
|---|---|---|---|---|
| PD range % \$million \$million % \$million % thousands % years |
\$million | provisions \$million |
||
| 0.00 to <0.15 4,831 5,225 30 5,582 0.09 0.3 23 2.91 |
14 | 1 | (1) | |
| 0.00 to <0.10 2,980 3,449 33 3,808 0.07 0.2 23 2.84 |
503 | 13 | 1 | – |
| 0.10 to <0.15 1,851 1,776 23 1,774 0.13 0.1 22 3.06 |
277 | 16 | 1 | (1) |
| 0.15 to <0.25 3,350 2,512 36 3,397 0.22 0.2 25 3.20 |
912 | 27 | 2 | (1) |
| 0.25 to <0.50 3,137 2,675 33 3,279 0.39 0.1 25 1.42 |
913 | 28 | 3 | (1) |
| 0.50 to <0.75 1,969 3,510 25 2,197 0.57 0.1 25 2.14 |
738 | 34 | 3 | (1) |
| 0.75 to <2.50 2,058 2,161 19 1,647 1.24 0.1 21 2.78 |
746 | 45 | 4 | (7) |
| 0.75 to <1.75 1,724 1,407 23 1,442 1.13 0.1 21 2.65 |
645 | 45 | 3 | (3) |
| 1.75 to <2.5 334 754 11 204 2.03 – 16 3.74 |
101 | 50 | 1 | (4) |
| 2.50 to <10.00 878 402 45 634 4.11 – 25 2.90 |
520 | 82 | 7 | (13) |
| 2.5 to <5 725 282 44 514 3.62 – 21 2.71 |
330 | 64 | 4 | (7) |
| 5 to <10 153 121 46 121 6.19 – 40 3.71 |
190 | 157 | 3 | (6) |
| 10.00 to <100.00 666 81 17 163 13.45 – 21 3.92 |
180 | 110 | 4 | (22) |
| 10 to <20 172 14 5 130 10.54 – 23 3.77 |
144 | 111 | 3 | (17) |
| 20 to <30 494 67 20 34 24.55 – 17 4.50 |
35 | 103 | 1 | (5) |
| 30.00 to <100.00 – – – – – – – – |
– | – | – | – |
| 100.00 (Default) 878 58 32 677 100 – 38 0.93 |
22 | 3 | 484 | (494) |
| Total 17,767 16,624 29 17,576 4.46 0.8 24 2.51 |
4,811 | 27 | 508 | (540) |
| PD range % | Original on balance sheet exposure \$million |
Off balance sheet exposure pre CCF \$million |
Average CCF % |
EAD post CRM and post CCF \$million |
Average PD1 % |
Number of obligors2 thousands |
Average LGD1 % |
Average maturity1 years |
RWA \$million |
RWA density1 % |
Expected loss \$million |
Value adjustments and provisions \$million |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 to <0.15 | 4,086 | 7,879 | 18 | 4,331 | 0.10 | 0.2 | 19 | 2.62 | 490 | 11 | 1 | (1) |
| 0.00 to <0.10 | 2,821 | 5,680 | 11 | 2,583 | 0.07 | 0.1 | 18 | 2.57 | 244 | 9 | – | (1) |
| 0.10 to <0.15 | 1,265 | 2,199 | 36 | 1,749 | 0.13 | 0.1 | 20 | 2.69 | 246 | 14 | – | (1) |
| 0.15 to <0.25 | 3,610 | 4,713 | 22 | 3,781 | 0.22 | 0.2 | 24 | 2.68 | 913 | 24 | 2 | (4) |
| 0.25 to <0.50 | 989 | 2,388 | 36 | 1,603 | 0.39 | 0.1 | 23 | 1.69 | 421 | 26 | 1 | (1) |
| 0.50 to <0.75 | 2,124 | 3,240 | 22 | 1,996 | 0.58 | 0.1 | 24 | 2.33 | 738 | 37 | 3 | (6) |
| 0.75 to <2.50 | 1,717 | 1,956 | 26 | 1,351 | 1.25 | 0.1 | 26 | 2.01 | 685 | 51 | 4 | (11) |
| 0.75 to <1.75 | 1,480 | 1,464 | 22 | 1,168 | 1.12 | 0.1 | 27 | 2.12 | 588 | 50 | 3 | (6) |
| 1.75 to <2.5 | 237 | 491 | 38 | 183 | 2.03 | – | 22 | 1.30 | 97 | 53 | 1 | (5) |
| 2.50 to <10.00 | 1,169 | 477 | 35 | 623 | 3.77 | – | 21 | 3.02 | 422 | 68 | 5 | (15) |
| 2.5 to <5 | 1,075 | 347 | 47 | 548 | 3.38 | – | 20 | 2.93 | 350 | 64 | 4 | (12) |
| 5 to <10 | 94 | 130 | 1 | 75 | 6.63 | – | 24 | 3.68 | 72 | 96 | 1 | (3) |
| 10.00 to <100.00 | 135 | 472 | 1 | 89 | 25.25 | – | 33 | 2.14 | 159 | 179 | 7 | (3) |
| 10 to <20 | 78 | 471 | 1 | 32 | 11.35 | – | 36 | 4.19 | 59 | 184 | 1 | (3) |
| 20 to <30 | – | – | 100 | – | 24.55 | – | 15 | 3.12 | – | – | – | – |
| 30.00 to <100.00 | 57 | – | – | 57 | 33.00 | – | 31 | 1.00 | 100 | 175 | 6 | – |
| 100.00 (Default) | 787 | 148 | 6 | 580 | 100.00 | – | 37 | 0.74 | 169 | 29 | 317 | (373) |
| Total | 14,617 | 21,273 | 20 | 14,354 | 4.69 | 0.7 | 23 | 2.37 | 3,997 | 28 | 340 | (414) |
2024
1 Weighted averages are based on EAD.
3.5 Risk grade profile continued Table 58: IRB approach – Credit risk exposures by exposure class and PD range for corporates – SME (UK CR6)
| 2025 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PD range % | Original on-balance sheet exposure \$million |
Off-balance sheet exposure pre CCF \$million |
Average CCF % |
EAD post CRM and post CCF \$million |
Average PD1 % |
Number of obligors2 thousands |
Average LGD1 % |
Average maturity1 years |
RWA \$million |
RWA density1 % |
Expected loss \$million |
Value adjustments and provisions \$million |
| 0.00 to <0.15 | 56 | 379 | 5 | 166 | 0.08 | – | 33 | 2.17 | 22 | 13 | – | – |
| 0.00 to <0.10 | 1 | 244 | 4 | 99 | 0.04 | – | 16 | 2.32 | 4 | 4 | – | – |
| 0.10 to <0.15 | 55 | 135 | 8 | 67 | 0.13 | – | 58 | 1.93 | 19 | 28 | – | – |
| 0.15 to <0.25 | 130 | 212 | 26 | 184 | 0.23 | 0.1 | 19 | 1.55 | 25 | 14 | – | – |
| 0.25 to <0.50 | 107 | 173 | 23 | 145 | 0.40 | 0.1 | 18 | 1.20 | 22 | 15 | – | – |
| 0.50 to <0.75 | 152 | 320 | 37 | 259 | 0.64 | 0.4 | 20 | 0.97 | 54 | 21 | – | – |
| 0.75 to <2.50 | 601 | 595 | 27 | 737 | 1.47 | 0.7 | 31 | 1.10 | 350 | 47 | 3 | (1) |
| 0.75 to <1.75 | 449 | 490 | 27 | 562 | 1.29 | 0.5 | 29 | 1.15 | 230 | 41 | 2 | – |
| 1.75 to <2.5 | 152 | 105 | 28 | 175 | 2.08 | 0.2 | 37 | 0.95 | 121 | 69 | 1 | – |
| 2.50 to <10.00 | 776 | 297 | 15 | 759 | 4.62 | 1.1 | 25 | 1.15 | 384 | 51 | 8 | (5) |
| 2.5 to <5 | 473 | 212 | 17 | 468 | 3.62 | 0.7 | 31 | 1.22 | 279 | 60 | 5 | (4) |
| 5 to <10 | 303 | 86 | 10 | 291 | 6.24 | 0.4 | 15 | 1.04 | 104 | 36 | 3 | – |
| 10.00 to <100.00 | 323 | 148 | 18 | 269 | 15.98 | 0.8 | 27 | 1.65 | 253 | 94 | 11 | (2) |
| 10 to <20 | 283 | 118 | 19 | 225 | 14.06 | 0.8 | 30 | 1.69 | 221 | 98 | 9 | (1) |
| 20 to <30 | 35 | 19 | 9 | 37 | 24.48 | – | 12 | 1.16 | 21 | 57 | 1 | – |
| 30.00 to <100.00 | 4 | 11 | 25 | 7 | 33.00 | – | 38 | 3.07 | 11 | 157 | 1 | – |
| 100.00 (Default) | 292 | 48 | 15 | 298 | 100 | 0.2 | 58 | 1.34 | 128 | 43 | 237 | (238) |
| Total | 2,437 | 2,172 | 22 | 2,817 | 13.83 | 3.4 | 29 | 1.28 | 1,238 | 44 | 259 | (246) |
| PD range % | Original on balance sheet exposure \$million |
Off balance sheet exposure pre CCF \$million |
Average CCF % |
EAD post CRM and post CCF \$million |
Average PD1 % |
Number of obligors2 thousands |
Average LGD1 % |
Average maturity1 years |
RWA \$million |
RWA density1 % |
Expected loss \$million |
Value adjustments and provisions \$million |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 to <0.15 | 24 | 266 | 52 | 145 | 0.07 | – | 33 | 1.06 | 19 | 13 | – | – |
| 0.00 to <0.10 | 3 | 230 | 56 | 114 | 0.06 | – | 27 | 0.54 | 8 | 7 | – | – |
| 0.10 to <0.15 | 21 | 36 | 25 | 32 | 0.13 | – | 53 | 2.90 | 11 | 34 | – | – |
| 0.15 to <0.25 | 265 | 516 | 18 | 359 | 0.23 | 0.2 | 35 | 2.20 | 103 | 29 | – | – |
| 0.25 to <0.50 | 50 | 62 | 8 | 53 | 0.41 | 0.1 | 14 | 1.28 | 6 | 11 | – | – |
| 0.50 to <0.75 | 313 | 288 | 32 | 396 | 0.62 | 0.5 | 32 | 1.50 | 139 | 35 | 1 | – |
| 0.75 to <2.50 | 702 | 623 | 27 | 852 | 1.35 | 0.8 | 21 | 1.17 | 247 | 29 | 3 | – |
| 0.75 to <1.75 | 546 | 545 | 28 | 685 | 1.17 | 0.6 | 18 | 1.20 | 158 | 23 | 1 | – |
| 1.75 to <2.5 | 156 | 78 | 23 | 167 | 2.09 | 0.2 | 34 | 1.04 | 90 | 54 | 1 | – |
| 2.50 to <10.00 | 728 | 228 | 16 | 707 | 4.73 | 1.4 | 28 | 1.11 | 397 | 56 | 9 | (2) |
| 2.5 to <5 | 492 | 171 | 17 | 482 | 3.71 | 0.9 | 30 | 1.03 | 268 | 56 | 5 | (1) |
| 5 to <10 | 236 | 57 | 13 | 225 | 6.93 | 0.5 | 24 | 1.29 | 130 | 58 | 4 | (1) |
| 10.00 to <100.00 | 274 | 81 | 19 | 266 | 14.64 | 0.9 | 34 | 1.19 | 273 | 103 | 13 | (3) |
| 10 to <20 | 267 | 64 | 16 | 252 | 13.63 | 0.9 | 33 | 1.20 | 251 | 100 | 11 | (2) |
| 20 to <30 | 3 | 3 | 2 | 3 | 24.55 | – | 4 | 1.00 | 1 | 33 | – | – |
| 30.00 to <100.00 | 5 | 14 | 38 | 10 | 36.76 | – | 56 | 1.00 | 21 | 210 | 2 | (1) |
| 100.00 (Default) | 238 | 92 | 37 | 270 | 100.00 | 0.2 | 48 | 0.86 | 171 | 63 | 180 | (184) |
| Total | 2,594 | 2,156 | 26 | 3,048 | 11.72 | 4.1 | 30 | 1.29 | 1,355 | 44 | 206 | (189) |
2024
1 Weighted averages are based on EAD.
3.5 Risk grade profile continued
Table 59: IRB approach – Credit risk exposures by exposure class and PD range for retail (UK CR6)
| 2025 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PD range % | Original on-balance sheet exposure \$million |
Off-balance sheet exposure pre CCF \$million |
Average CCF % |
EAD post CRM and post CCF \$million |
Average PD1 % |
Number of obligors2 thousands |
Average LGD1 % |
Average maturity1 years |
RWA \$million |
RWA density1 % |
Expected loss \$million |
Value adjustments and provisions \$million |
| 0.00 to <0.15 | 61,964 | 15,878 | 51 | 69,401 | 0.07 | 1,097.0 | 29 | 3,097 | 4 | 27 | (10) | |
| 0.00 to <0.10 | 53,479 | 10,602 | 52 | 58,240 | 0.06 | 815.3 | 27 | 2,430 | 4 | 21 | (7) | |
| 0.10 to <0.15 | 8,484 | 5,275 | 51 | 11,162 | 0.12 | 281.7 | 41 | 669 | 6 | 5 | (3) | |
| 0.15 to <0.25 | 6,054 | 2,203 | 49 | 7,122 | 0.19 | 125.8 | 28 | 640 | 9 | 6 | (2) | |
| 0.25 to <0.50 | 5,240 | 3,671 | 48 | 6,976 | 0.36 | 271.1 | 54 | 1,470 | 21 | 13 | (6) | |
| 0.50 to <0.75 | 3,965 | 3,759 | 46 | 5,695 | 0.65 | 247.9 | 62 | 1,986 | 35 | 26 | (10) | |
| 0.75 to <2.50 | 4,967 | 4,066 | 33 | 6,228 | 1.39 | 628.0 | 58 | 3,164 | 51 | 54 | (32) | |
| 0.75 to <1.75 | 3,683 | 3,327 | 35 | 4,800 | 1.24 | 501.1 | 61 | 2,296 | 48 | 37 | (24) | |
| 1.75 to <2.5 | 1,284 | 739 | 22 | 1,426 | 2.10 | 126.8 | 51 | 870 | 61 | 17 | (7) | |
| 2.50 to <10.00 | 3,798 | 2,194 | 40 | 4,631 | 4.24 | 485.5 | 70 | 4,406 | 95 | 143 | (63) | |
| 2.5 to <5 | 2,642 | 1,740 | 41 | 3,333 | 3.11 | 305.1 | 72 | 2,915 | 87 | 79 | (31) | |
| 5 to <10 | 1,156 | 456 | 36 | 1,299 | 7.09 | 180.6 | 67 | 1,490 | 115 | 64 | (30) | |
| 10.00 to <100.00 | 1,256 | 350 | 30 | 1,350 | 25.25 | 130.1 | 63 | 2,086 | 155 | 209 | (75) | |
| 10 to <20 | 821 | 279 | 29 | 893 | 14.59 | 84.0 | 66 | 1,394 | 156 | 93 | (34) | |
| 20 to <30 | 120 | 35 | 36 | 132 | 24.37 | 18.5 | 65 | 247 | 187 | 21 | (8) | |
| 30.00 to <100.00 | 313 | 38 | 31 | 324 | 55.87 | 27.5 | 50 | 444 | 137 | 95 | (31) | |
| 100.00 (Default) | 739 | 153 | 4 | 745 | 100.00 | 42.2 | 50 | 1,231 | 165 | 267 | (203) | |
| Total | 87,983 | 32,274 | 47 | 102,148 | 1.47 | 3,028 | 31 | 18,080 | 18 | 745 | (401) |
| PD range % | Original on balance sheet exposure \$million |
Off balance sheet exposure pre CCF \$million |
Average CCF % |
EAD post CRM and post CCF \$million |
Average PD1 % |
Number of obligors2 thousands |
Average LGD1 % |
Average maturity1 years |
RWA \$million |
RWA density1 % |
Expected loss \$million |
Value adjustments and provisions \$million |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 to <0.15 | 57,468 | 17,084 | 49 | 65,921 | 0.07 | 1,173.9 | 31 | 2,582 | 4 | 12 | (9) | |
| 0.00 to <0.10 | 50,792 | 13,261 | 49 | 57,210 | 0.06 | 949.9 | 30 | 2,056 | 4 | 8 | (7) | |
| 0.10 to <0.15 | 6,675 | 3,823 | 53 | 8,710 | 0.12 | 224.1 | 41 | 526 | 6 | 3 | (2) | |
| 0.15 to <0.25 | 5,192 | 3,169 | 43 | 6,560 | 0.19 | 210.6 | 36 | 655 | 10 | 3 | (3) | |
| 0.25 to <0.50 | 3,915 | 2,818 | 51 | 5,326 | 0.34 | 214.7 | 55 | 1,084 | 20 | 9 | (6) | |
| 0.50 to <0.75 | 4,165 | 4,246 | 49 | 6,214 | 0.65 | 257.5 | 62 | 2,107 | 34 | 21 | (9) | |
| 0.75 to <2.50 | 5,866 | 4,815 | 29 | 7,224 | 1.44 | 742.5 | 62 | 4,256 | 59 | 61 | (39) | |
| 0.75 to <1.75 | 4,402 | 3,791 | 32 | 5,556 | 1.26 | 536.5 | 63 | 3,027 | 54 | 42 | (26) | |
| 1.75 to <2.5 | 1,463 | 1,024 | 21 | 1,670 | 2.13 | 206.0 | 60 | 1,230 | 74 | 21 | (12) | |
| 2.50 to <10.00 | 5,124 | 2,932 | 38 | 6,218 | 4.42 | 758.6 | 70 | 5,860 | 94 | 186 | (84) | |
| 2.5 to <5 | 3,358 | 2,262 | 41 | 4,248 | 3.18 | 471.7 | 72 | 3,783 | 89 | 96 | (43) | |
| 5 to <10 | 1,766 | 671 | 33 | 1,970 | 7.17 | 286.9 | 64 | 2,078 | 105 | 89 | (40) | |
| 10.00 to <100.00 | 1,248 | 444 | 28 | 1,360 | 26.21 | 216.9 | 65 | 2,064 | 152 | 223 | (84) | |
| 10 to <20 | 758 | 348 | 29 | 851 | 13.76 | 136.5 | 69 | 1,324 | 156 | 83 | (32) | |
| 20 to <30 | 132 | 36 | 35 | 143 | 23.80 | 31.7 | 66 | 263 | 184 | 22 | (10) | |
| 30.00 to <100.00 | 357 | 61 | 21 | 367 | 59.45 | 48.6 | 54 | 476 | 130 | 119 | (43) | |
| 100.00 (Default) | 638 | 189 | 4 | 645 | 100.00 | 51.3 | 52 | 1,082 | 168 | 241 | (171) | |
| Total | 83,616 | 35,697 | 45 | 99,468 | 1.52 | 3,626.0 | 34 | 19,690 | 20 | 756 | (405) |
2024
1 Weighted averages are based on EAD.
real estate property – SME (UK CR6)
3.5 Risk grade profile continued Table 60: IRB approach – Credit risk exposures by exposure class and PD range for retail – secured by
| 2025 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PD range % | Original on-balance sheet exposure \$million |
Off-balance sheet exposure pre CCF \$million |
Average CCF % |
EAD post CRM and post CCF \$million |
Average PD1 % |
Number of obligors2 thousands |
Average LGD1 % |
Average maturity1 years |
RWA \$million |
RWA density1 % |
Expected loss \$million |
Value adjustments and provisions \$million |
| 0.00 to <0.15 | 63 | – | 100 | 63 | 0.10 | 0.5 | 15 | 2 | 3 | – | – | |
| 0.00 to <0.10 | 35 | – | 100 | 35 | 0.08 | 0.3 | 15 | 1 | 3 | – | – | |
| 0.10 to <0.15 | 27 | – | – | 27 | 0.13 | 0.2 | 15 | 1 | 4 | – | – | |
| 0.15 to <0.25 | 40 | 11 | 61 | 47 | 0.18 | 0.2 | 12 | 2 | 4 | – | – | |
| 0.25 to <0.50 | 21 | – | 87 | 21 | 0.39 | 0.2 | 5 | 1 | 5 | – | – | |
| 0.50 to <0.75 | 27 | 2 | 49 | 28 | 0.62 | 0.3 | 3 | 1 | 4 | – | – | |
| 0.75 to <2.50 | 117 | 23 | 36 | 125 | 1.49 | 0.6 | 2 | 3 | 2 | – | (1) | |
| 0.75 to <1.75 | 77 | 21 | 32 | 84 | 1.15 | 0.5 | 2 | 2 | 2 | – | (1) | |
| 1.75 to <2.5 | 40 | 2 | 82 | 41 | 2.20 | 0.1 | 3 | 2 | 5 | – | – | |
| 2.50 to <10.00 | 44 | 9 | 64 | 49 | 5.44 | 0.1 | 5 | 4 | 8 | – | – | |
| 2.5 to <5 | 20 | 6 | 50 | 23 | 3.77 | 0.1 | 7 | 2 | 9 | – | – | |
| 5 to <10 | 24 | 3 | 96 | 26 | 6.90 | – | 3 | 1 | 4 | – | – | |
| 10.00 to <100.00 | 23 | 3 | 75 | 26 | 16.80 | 0.1 | 4 | 2 | 8 | – | – | |
| 10 to <20 | 19 | 3 | 76 | 21 | 13.95 | – | 2 | 1 | 5 | – | – | |
| 20 to <30 | 3 | – | 100 | 3 | 26.50 | – | 14 | 1 | 33 | – | – | |
| 30.00 to <100.00 | 1 | – | 25 | 1 | 49.48 | – | 10 | – | – | – | – | |
| 100.00 (Default) | 6 | 1 | 100 | 7 | 100.00 | – | 5 | 2 | 29 | 2 | (1) | |
| Total | 341 | 49 | 51 | 366 | 4.39 | 2.0 | 6 | 17 | 5 | 2 | (2) |
| 2024 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PD range % | Original on balance sheet exposure \$million |
Off balance sheet exposure pre CCF \$million |
Average CCF % |
EAD post CRM and post CCF \$million |
Average PD1 % |
Number of obligors2 thousands |
Average LGD1 % |
Average maturity1 years |
RWA \$million |
RWA density1 % |
Expected loss \$million |
Value adjustments and provisions \$million |
| 0.00 to <0.15 | 74 | 1 | 92 | 75 | 0.10 | 0.5 | 14 | 3 | 4 | – | – | |
| 0.00 to <0.10 | 38 | 1 | 88 | 39 | 0.07 | 0.3 | 15 | 1 | 3 | – | – | |
| 0.10 to <0.15 | 36 | – | – | 36 | 0.13 | 0.2 | 14 | 2 | 6 | – | – | |
| 0.15 to <0.25 | 49 | 12 | 58 | 56 | 0.18 | 0.3 | 11 | 2 | 4 | – | – | |
| 0.25 to <0.50 | 29 | 1 | 63 | 30 | 0.38 | 0.3 | 3 | 1 | 3 | – | – | |
| 0.50 to <0.75 | 30 | 5 | 58 | 33 | 0.60 | 0.3 | 2 | 1 | 3 | – | – | |
| 0.75 to <2.50 | 70 | 21 | 51 | 81 | 1.39 | 0.5 | 2 | 2 | 2 | – | – | |
| 0.75 to <1.75 | 56 | 15 | 47 | 63 | 1.17 | 0.4 | 2 | 1 | 2 | – | – | |
| 1.75 to <2.5 | 14 | 6 | 61 | 18 | 2.16 | 0.1 | 3 | 1 | 6 | – | – | |
| 2.50 to <10.00 | 46 | 11 | 42 | 51 | 4.84 | 0.2 | 7 | 5 | 10 | – | – | |
| 2.5 to <5 | 17 | 4 | 76 | 20 | 3.13 | 0.1 | 5 | 2 | 10 | – | – | |
| 5 to <10 | 29 | 8 | 26 | 31 | 5.93 | 0.1 | 7 | 4 | 13 | – | – | |
| 10.00 to <100.00 | 12 | 2 | 72 | 13 | 20.38 | 0.1 | 5 | 2 | 15 | – | – | |
| 10 to <20 | 8 | 2 | 72 | 9 | 15.01 | – | 2 | – | – | – | – | |
| 20 to <30 | 3 | – | 100 | 3 | 26.56 | – | 13 | 1 | 33 | – | – | |
| 30.00 to <100.00 | 1 | – | 100 | 1 | 64.21 | – | 10 | – | – | – | – | |
| 100.00 (Default) | 4 | – | 76 | 4 | 100.00 | – | 5 | 2 | 50 | 1 | (2) | |
| Total | 314 | 53 | 53 | 343 | 3.15 | 2.2 | 7 | 18 | 5 | 1 | (2) |
1 Weighted averages are based on EAD.
3.5 Risk grade profile continued
Table 61: IRB approach – Credit risk exposures by exposure class and PD range for retail – secured by real estate property Non SME (UK CR6)
| 2025 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PD range % | Original on-balance sheet exposure \$million |
Off-balance sheet exposure pre CCF \$million |
Average CCF % |
EAD post CRM and post CCF \$million |
Average PD1 % |
Number of obligors2 thousands |
Average LGD1 % |
Average maturity1 years |
RWA \$million |
RWA density1 % |
Expected loss \$million |
Value adjustments and provisions \$million |
| 0.00 to <0.15 | 59,661 | 1,448 | 100 | 61,109 | 0.07 | 207.4 | 15 | 2,547 | 4 | 21 | (1) | |
| 0.00 to <0.10 | 51,728 | 848 | 100 | 52,577 | 0.06 | 185.4 | 14 | 2,073 | 4 | 18 | (1) | |
| 0.10 to <0.15 | 7,933 | 600 | 100 | 8,533 | 0.12 | 22.0 | 16 | 474 | 6 | 3 | – | |
| 0.15 to <0.25 | 5,726 | 515 | 100 | 6,242 | 0.19 | 23.1 | 15 | 519 | 8 | 4 | – | |
| 0.25 to <0.50 | 3,461 | 132 | 100 | 3,594 | 0.37 | 20.6 | 17 | 492 | 14 | 4 | – | |
| 0.50 to <0.75 | 2,388 | 70 | 100 | 2,458 | 0.63 | 19.8 | 21 | 669 | 27 | 8 | (1) | |
| 0.75 to <2.50 | 1,883 | 78 | 100 | 1,961 | 1.34 | 13.7 | 16 | 639 | 33 | 10 | (1) | |
| 0.75 to <1.75 | 1,459 | 35 | 100 | 1,493 | 1.11 | 10.8 | 16 | 429 | 29 | 6 | (1) | |
| 1.75 to <2.5 | 424 | 43 | 100 | 467 | 2.06 | 2.8 | 16 | 211 | 45 | 4 | – | |
| 2.50 to <10.00 | 407 | 5 | 100 | 412 | 4.63 | 3.7 | 16 | 289 | 70 | 6 | (1) | |
| 2.5 to <5 | 268 | 5 | 100 | 273 | 3.44 | 2.3 | 16 | 176 | 64 | 3 | – | |
| 5 to <10 | 139 | 1 | 100 | 139 | 6.97 | 1.5 | 15 | 112 | 81 | 2 | – | |
| 10.00 to <100.00 | 224 | 2 | 100 | 226 | 37.28 | 2.4 | 15 | 223 | 99 | 15 | (4) | |
| 10 to <20 | 71 | 1 | 100 | 72 | 13.46 | 0.9 | 16 | 76 | 106 | 2 | (1) | |
| 20 to <30 | 22 | – | 100 | 22 | 24.23 | 0.3 | 15 | 26 | 118 | 1 | – | |
| 30.00 to <100.00 | 131 | 1 | 100 | 132 | 52.40 | 1.2 | 15 | 121 | 92 | 12 | (2) | |
| 100.00 (Default) | 279 | – | 100 | 279 | 100.00 | 2.6 | 22 | 405 | 145 | 33 | (36) | |
| Total | 74,029 | 2,250 | 100 | 76,281 | 0.64 | 293.3 | 15 | 5,783 | 8 | 101 | (44) |
| PD range % | Original on balance sheet exposure \$million |
Off balance sheet exposure pre CCF \$million |
Average CCF % |
EAD post CRM and post CCF \$million |
Average PD1 % |
Number of obligors2 thousands |
Average LGD1 % |
Average maturity1 years |
RWA \$million |
RWA density1 % |
Expected loss \$million |
Value adjustments and provisions \$million |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 to <0.15 | 56,138 | 978 | 100 | 57,117 | 0.07 | 209.0 | 15 | 2,060 | 4 | 6 | (1) | |
| 0.00 to <0.10 | 49,955 | 614 | 100 | 50,570 | 0.06 | 188.3 | 16 | 1,715 | 3 | 5 | (1) | |
| 0.10 to <0.15 | 6,182 | 364 | 100 | 6,547 | 0.12 | 20.7 | 15 | 345 | 5 | 1 | – | |
| 0.15 to <0.25 | 4,744 | 352 | 100 | 5,096 | 0.19 | 21.2 | 14 | 404 | 8 | 1 | – | |
| 0.25 to <0.50 | 2,531 | 110 | 100 | 2,642 | 0.35 | 15.3 | 18 | 379 | 14 | 2 | – | |
| 0.50 to <0.75 | 2,672 | 99 | 100 | 2,771 | 0.61 | 25.0 | 20 | 683 | 25 | 3 | – | |
| 0.75 to <2.50 | 1,808 | 84 | 100 | 1,892 | 1.34 | 13.9 | 16 | 606 | 32 | 4 | – | |
| 0.75 to <1.75 | 1,408 | 37 | 100 | 1,445 | 1.11 | 10.9 | 16 | 413 | 29 | 3 | – | |
| 1.75 to <2.5 | 400 | 47 | 100 | 447 | 2.08 | 3.0 | 17 | 194 | 43 | 2 | – | |
| 2.50 to <10.00 | 368 | 4 | 100 | 372 | 4.75 | 3.8 | 15 | 238 | 64 | 3 | – | |
| 2.5 to <5 | 236 | 3 | 100 | 239 | 3.48 | 2.3 | 16 | 141 | 59 | 1 | – | |
| 5 to <10 | 133 | 1 | 100 | 133 | 7.02 | 1.5 | 14 | 97 | 73 | 1 | – | |
| 10.00 to <100.00 | 210 | 2 | 100 | 213 | 37.32 | 2.3 | 16 | 213 | 100 | 12 | (4) | |
| 10 to <20 | 69 | 1 | 100 | 71 | 13.72 | 1.0 | 18 | 80 | 113 | 2 | (1) | |
| 20 to <30 | 20 | – | 100 | 21 | 24.41 | 0.3 | 19 | 28 | 133 | 1 | – | |
| 30.00 to <100.00 | 120 | 1 | 100 | 121 | 53.28 | 1.1 | 14 | 106 | 88 | 9 | (3) | |
| 100.00 (Default) | 261 | – | 100 | 261 | 100.00 | 2.6 | 24 | 367 | 141 | 35 | (35) | |
| Total | 68,732 | 1,629 | 100 | 70,364 | 0.65 | 293.1 | 16 | 4,950 | 7 | 66 | (40) |
2024
1 Weighted averages are based on EAD.
3.5 Risk grade profile continued Table 62: IRB approach – Credit risk exposures by exposure class and PD range for retail – qualifying revolving (UK CR6)
| 2025 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PD range % | Original on-balance sheet exposure \$million |
Off-balance sheet exposure pre CCF \$million |
Average CCF % |
EAD post CRM and post CCF \$million |
Average PD1 % |
Number of obligors2 thousands |
Average LGD1 % |
Average maturity1 years |
RWA \$million |
RWA density1 % |
Expected loss \$million |
Value adjustments and provisions \$million |
| 0.00 to <0.15 | 961 | 12,291 | 45 | 6,532 | 0.08 | 828.1 | 86 | 300 | 5 | 5 | (7) | |
| 0.00 to <0.10 | 500 | 8,125 | 46 | 4,199 | 0.07 | 573.2 | 87 | 164 | 4 | 2 | (4) | |
| 0.10 to <0.15 | 461 | 4,165 | 45 | 2,334 | 0.11 | 254.9 | 84 | 136 | 6 | 2 | (3) | |
| 0.15 to <0.25 | 93 | 1,196 | 37 | 534 | 0.18 | 95.8 | 71 | 40 | 7 | 1 | (1) | |
| 0.25 to <0.50 | 562 | 2,812 | 45 | 1,822 | 0.34 | 198.1 | 82 | 258 | 14 | 5 | (4) | |
| 0.50 to <0.75 | 477 | 3,047 | 47 | 1,910 | 0.67 | 185.4 | 87 | 493 | 26 | 11 | (6) | |
| 0.75 to <2.50 | 720 | 2,699 | 39 | 1,778 | 1.39 | 549.4 | 82 | 758 | 43 | 21 | (18) | |
| 0.75 to <1.75 | 597 | 2,354 | 41 | 1,559 | 1.29 | 447.2 | 83 | 641 | 41 | 17 | (14) | |
| 1.75 to <2.5 | 123 | 345 | 28 | 218 | 2.12 | 102.2 | 74 | 117 | 54 | 4 | (3) | |
| 2.50 to <10.00 | 1,224 | 1,287 | 53 | 1,913 | 4.10 | 363.2 | 84 | 1,758 | 92 | 67 | (33) | |
| 2.5 to <5 | 835 | 1,056 | 53 | 1,391 | 2.98 | 235.4 | 85 | 1,063 | 76 | 36 | (17) | |
| 5 to <10 | 389 | 231 | 58 | 522 | 7.07 | 127.8 | 83 | 696 | 133 | 31 | (16) | |
| 10.00 to <100.00 | 322 | 114 | 68 | 399 | 22.61 | 77.3 | 81 | 808 | 203 | 73 | (24) | |
| 10 to <20 | 223 | 78 | 76 | 282 | 13.93 | 47.9 | 82 | 554 | 196 | 33 | (11) | |
| 20 to <30 | 35 | 20 | 50 | 45 | 23.72 | 11.3 | 77 | 104 | 231 | 8 | (3) | |
| 30.00 to <100.00 | 63 | 17 | 51 | 72 | 56.12 | 18.1 | 78 | 150 | 208 | 32 | (10) | |
| 100.00 (Default) | 135 | – | – | 135 | 100.00 | 23.2 | 60 | 276 | 204 | 59 | (36) | |
| Total | 4,494 | 23,446 | 45 | 15,023 | 2.35 | 2,320.5 | 84 | 4,691 | 31 | 242 | (129) |
| PD range % | Original on balance sheet exposure \$million |
Off balance sheet exposure pre CCF \$million |
Average CCF % |
EAD post CRM and post CCF \$million |
Average PD1 % |
Number of obligors2 thousands |
Average LGD1 % |
Average maturity1 years |
RWA \$million |
RWA density1 % |
Expected loss \$million |
Value adjustments and provisions \$million |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 to <0.15 | 962 | 13,893 | 45 | 7,271 | 0.08 | 913.0 | 86 | 312 | 4 | 5 | (7) | |
| 0.00 to <0.10 | 583 | 10,859 | 45 | 5,435 | 0.06 | 717.0 | 85 | 199 | 4 | 3 | (5) | |
| 0.10 to <0.15 | 379 | 3,034 | 48 | 1,835 | 0.11 | 196.0 | 87 | 113 | 6 | 2 | (2) | |
| 0.15 to <0.25 | 119 | 1,930 | 34 | 776 | 0.21 | 163.9 | 72 | 65 | 8 | 1 | (2) | |
| 0.25 to <0.50 | 485 | 2,132 | 48 | 1,510 | 0.33 | 168.9 | 85 | 214 | 14 | 4 | (4) | |
| 0.50 to <0.75 | 447 | 3,384 | 48 | 2,078 | 0.67 | 195.2 | 88 | 546 | 26 | 12 | (6) | |
| 0.75 to <2.50 | 674 | 3,045 | 34 | 1,722 | 1.42 | 579.6 | 82 | 743 | 43 | 20 | (18) | |
| 0.75 to <1.75 | 544 | 2,503 | 37 | 1,465 | 1.29 | 436.5 | 83 | 604 | 41 | 16 | (13) | |
| 1.75 to <2.5 | 130 | 542 | 23 | 257 | 2.12 | 143.1 | 76 | 139 | 54 | 4 | (4) | |
| 2.50 to <10.00 | 1,318 | 1,851 | 45 | 2,159 | 4.12 | 540.6 | 85 | 2,011 | 93 | 75 | (38) | |
| 2.5 to <5 | 891 | 1,454 | 46 | 1,555 | 2.97 | 341.9 | 85 | 1,190 | 77 | 39 | (20) | |
| 5 to <10 | 426 | 397 | 45 | 604 | 7.08 | 198.7 | 84 | 821 | 136 | 36 | (18) | |
| 10.00 to <100.00 | 307 | 162 | 53 | 393 | 23.08 | 134.6 | 84 | 804 | 205 | 75 | (25) | |
| 10 to <20 | 219 | 114 | 59 | 287 | 13.94 | 81.3 | 85 | 581 | 202 | 34 | (12) | |
| 20 to <30 | 30 | 24 | 40 | 39 | 23.43 | 21.2 | 81 | 95 | 244 | 7 | (3) | |
| 30.00 to <100.00 | 58 | 25 | 36 | 67 | 62.07 | 32.1 | 81 | 128 | 191 | 34 | (10) | |
| 100.00 (Default) | 101 | 1 | – | 101 | 100.00 | 27.8 | 67 | 213 | 211 | 51 | (27) | |
| Total | 4,413 | 26,398 | 44 | 16,010 | 2.07 | 2,723.6 | 85 | 4,908 | 31 | 243 | (127) |
2024
1 Weighted averages are based on EAD.
3.5 Risk grade profile continued Table 63: IRB approach – Credit risk exposures by exposure class and PD range for retail – SME (UK CR6)
| 2025 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PD range % | Original on-balance sheet exposure \$million |
Off-balance sheet exposure pre CCF \$million |
Average CCF % |
EAD post CRM and post CCF \$million |
Average PD1 % |
Number of obligors2 thousands |
Average LGD1 % |
Average maturity1 years |
RWA \$million |
RWA density1 % |
Expected loss \$million |
Value adjustments and provisions \$million |
| 0.00 to <0.15 | 23 | 18 | 1 | 20 | 0.10 | 0.7 | 61 | 2 | 10 | – | – | |
| 0.00 to <0.10 | 10 | 7 | 2 | 9 | 0.07 | 0.4 | 60 | 1 | 11 | – | – | |
| 0.10 to <0.15 | 13 | 11 | – | 11 | 0.13 | 0.3 | 61 | 2 | 18 | – | – | |
| 0.15 to <0.25 | 71 | 156 | 6 | 77 | 0.20 | 0.7 | 43 | 10 | 13 | – | – | |
| 0.25 to <0.50 | 65 | 84 | 20 | 72 | 0.38 | 0.9 | 36 | 12 | 17 | – | – | |
| 0.50 to <0.75 | 112 | 99 | 3 | 99 | 0.63 | 1.4 | 45 | 29 | 29 | – | – | |
| 0.75 to <2.50 | 988 | 745 | 3 | 930 | 1.61 | 8.5 | 45 | 407 | 44 | 7 | (2) | |
| 0.75 to <1.75 | 614 | 467 | 3 | 571 | 1.35 | 5.8 | 44 | 230 | 40 | 3 | (1) | |
| 1.75 to <2.5 | 374 | 278 | 2 | 359 | 2.03 | 2.8 | 47 | 177 | 49 | 3 | (1) | |
| 2.50 to <10.00 | 643 | 559 | 8 | 644 | 4.27 | 6.6 | 48 | 359 | 56 | 13 | (2) | |
| 2.5 to <5 | 482 | 394 | 9 | 492 | 3.47 | 4.5 | 48 | 268 | 54 | 8 | (1) | |
| 5 to <10 | 161 | 165 | 5 | 153 | 6.87 | 2.2 | 48 | 91 | 59 | 5 | – | |
| 10.00 to <100.00 | 129 | 178 | 5 | 126 | 21.63 | 1.9 | 47 | 91 | 72 | 13 | (2) | |
| 10 to <20 | 103 | 160 | 6 | 103 | 13.15 | 1.5 | 46 | 72 | 70 | 6 | (1) | |
| 20 to <30 | 5 | 7 | – | 4 | 26.17 | 0.1 | 64 | 5 | 125 | 1 | – | |
| 30.00 to <100.00 | 20 | 12 | – | 19 | 67.53 | 0.3 | 48 | 14 | 74 | 6 | – | |
| 100.00 (Default) | 147 | 152 | 3 | 151 | 100.00 | 1.5 | 64 | 287 | 190 | 87 | (62) | |
| Total | 2,178 | 1,991 | 5 | 2,119 | 10.48 | 22.2 | 47 | 1,197 | 56 | 120 | (68) |
| PD range % | Original on balance sheet exposure \$million |
Off balance sheet exposure pre CCF \$million |
Average CCF % |
EAD post CRM and post CCF \$million |
Average PD1 % |
Number of obligors2 thousands |
Average LGD1 % |
Average maturity1 years |
RWA \$million |
RWA density1 % |
Expected loss \$million |
Value adjustments and provisions \$million |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 to <0.15 | 28 | 15 | 2 | 24 | 0.09 | 0.9 | 63 | 3 | 13 | – | – | |
| 0.00 to <0.10 | 15 | 8 | 3 | 14 | 0.07 | 0.6 | 63 | 1 | 7 | – | – | |
| 0.10 to <0.15 | 13 | 7 | 2 | 10 | 0.12 | 0.4 | 63 | 2 | 20 | – | – | |
| 0.15 to <0.25 | 75 | 149 | 7 | 81 | 0.19 | 0.9 | 46 | 12 | 15 | – | – | |
| 0.25 to <0.50 | 74 | 68 | 3 | 55 | 0.38 | 1.5 | 46 | 13 | 24 | – | – | |
| 0.50 to <0.75 | 106 | 98 | 9 | 92 | 0.62 | 1.8 | 50 | 30 | 33 | – | – | |
| 0.75 to <2.50 | 909 | 874 | 2 | 857 | 1.57 | 9.2 | 48 | 396 | 46 | 6 | (3) | |
| 0.75 to <1.75 | 622 | 582 | 2 | 582 | 1.36 | 6.6 | 48 | 255 | 44 | 4 | (2) | |
| 1.75 to <2.5 | 286 | 292 | 2 | 276 | 2.00 | 2.6 | 49 | 141 | 51 | 3 | (1) | |
| 2.50 to <10.00 | 629 | 533 | 5 | 615 | 4.49 | 6.9 | 50 | 362 | 59 | 14 | (2) | |
| 2.5 to <5 | 442 | 359 | 5 | 436 | 3.52 | 4.4 | 50 | 250 | 57 | 8 | (1) | |
| 5 to <10 | 187 | 174 | 5 | 179 | 6.83 | 2.5 | 51 | 112 | 63 | 6 | – | |
| 10.00 to <100.00 | 136 | 209 | 6 | 135 | 25.27 | 2.3 | 51 | 105 | 78 | 17 | (2) | |
| 10 to <20 | 98 | 182 | 7 | 102 | 12.94 | 1.7 | 52 | 78 | 76 | 7 | (1) | |
| 20 to <30 | 6 | 4 | – | 4 | 25.28 | 0.1 | 65 | 5 | 125 | 1 | – | |
| 30.00 to <100.00 | 32 | 23 | – | 29 | 67.83 | 0.4 | 47 | 21 | 72 | 9 | (2) | |
| 100.00 (Default) | 123 | 188 | 4 | 129 | 100.00 | 1.6 | 63 | 260 | 202 | 72 | (54) | |
| Total | 2,080 | 2,134 | 4 | 1,988 | 10.33 | 25.1 | 50 | 1,181 | 59 | 109 | (61) |
2024
1 Weighted averages are based on EAD.
3.5 Risk grade profile continued Table 64: IRB approach – Credit risk exposures by exposure class and PD range for retail – Non SME (UK CR6)
| 2025 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PD range % | Original on-balance sheet exposure \$million |
Off-balance sheet exposure pre CCF \$million |
Average CCF % |
EAD post CRM and post CCF \$million |
Average PD1 % |
Number of obligors2 thousands |
Average LGD1 % |
Average maturity1 years |
RWA \$million |
RWA density1 % |
Expected loss \$million |
Value adjustments and provisions \$million |
| 0.00 to <0.15 | 1,256 | 2,121 | 54 | 1,677 | 0.07 | 60.3 | 75 | 246 | 15 | 1 | (2) | |
| 0.00 to <0.10 | 1,206 | 1,622 | 57 | 1,420 | 0.06 | 56.0 | 75 | 191 | 13 | 1 | (2) | |
| 0.10 to <0.15 | 50 | 499 | 41 | 257 | 0.11 | 4.3 | 76 | 56 | 22 | – | – | |
| 0.15 to <0.25 | 124 | 325 | 30 | 222 | 0.20 | 6.0 | 73 | 69 | 31 | 1 | (1) | |
| 0.25 to <0.50 | 1,131 | 643 | 52 | 1,467 | 0.37 | 51.3 | 77 | 707 | 48 | 4 | (2) | |
| 0.50 to <0.75 | 961 | 541 | 44 | 1,200 | 0.65 | 41.0 | 75 | 794 | 66 | 7 | (3) | |
| 0.75 to <2.50 | 1,259 | 521 | 34 | 1,434 | 1.45 | 55.8 | 78 | 1,357 | 95 | 16 | (10) | |
| 0.75 to <1.75 | 936 | 450 | 35 | 1,093 | 1.25 | 36.8 | 78 | 994 | 91 | 11 | (7) | |
| 1.75 to <2.5 | 323 | 71 | 25 | 341 | 2.08 | 18.9 | 77 | 363 | 106 | 6 | (3) | |
| 2.50 to <10.00 | 1,480 | 334 | 40 | 1,613 | 4.40 | 111.9 | 81 | 1,996 | 124 | 57 | (27) | |
| 2.5 to <5 | 1,037 | 279 | 42 | 1,154 | 3.31 | 62.8 | 82 | 1,406 | 122 | 32 | (13) | |
| 5 to <10 | 443 | 56 | 29 | 459 | 7.16 | 49.1 | 78 | 590 | 129 | 26 | (14) | |
| 10.00 to <100.00 | 558 | 53 | 28 | 573 | 24.36 | 48.4 | 78 | 962 | 168 | 108 | (45) | |
| 10 to <20 | 405 | 37 | 27 | 415 | 15.65 | 33.7 | 79 | 691 | 167 | 52 | (21) | |
| 20 to <30 | 55 | 8 | 33 | 58 | 25.01 | 6.8 | 75 | 111 | 191 | 11 | (5) | |
| 30.00 to <100.00 | 98 | 8 | 26 | 100 | 59.99 | 7.9 | 75 | 159 | 159 | 45 | (19) | |
| 100.00 (Default) | 172 | – | 86 | 173 | 100.00 | 14.9 | 62 | 261 | 151 | 86 | (68) | |
| Total | 6,941 | 4,538 | 47 | 8,359 | 5.01 | 389.6 | 77 | 6,392 | 76 | 280 | (158) |
| PD range % | Original on balance sheet exposure \$million |
Off balance sheet exposure pre CCF \$million |
Average CCF % |
EAD post CRM and post CCF \$million |
Average PD1 % |
Number of obligors2 thousands |
Average LGD1 % |
Average maturity1 years |
RWA \$million |
RWA density1 % |
Expected loss \$million |
Value adjustments and provisions \$million |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 to <0.15 | 266 | 2,197 | 53 | 1,434 | 0.06 | 50.5 | 76 | 204 | 14 | 1 | (1) | |
| 0.00 to <0.10 | 201 | 1,779 | 53 | 1,152 | 0.05 | 43.7 | 76 | 140 | 12 | – | (1) | |
| 0.10 to <0.15 | 65 | 418 | 52 | 282 | 0.11 | 6.8 | 79 | 64 | 23 | – | – | |
| 0.15 to <0.25 | 205 | 726 | 48 | 551 | 0.18 | 24.3 | 78 | 172 | 31 | 1 | (1) | |
| 0.25 to <0.50 | 796 | 507 | 58 | 1,089 | 0.34 | 28.7 | 73 | 477 | 44 | 3 | (2) | |
| 0.50 to <0.75 | 910 | 660 | 50 | 1,240 | 0.68 | 35.2 | 76 | 847 | 68 | 6 | (3) | |
| 0.75 to <2.50 | 2,405 | 791 | 34 | 2,672 | 1.52 | 139.3 | 75 | 2,509 | 94 | 31 | (18) | |
| 0.75 to <1.75 | 1,772 | 654 | 35 | 2,001 | 1.31 | 82.1 | 74 | 1,754 | 88 | 19 | (11) | |
| 1.75 to <2.5 | 633 | 137 | 28 | 672 | 2.16 | 57.2 | 81 | 755 | 112 | 12 | (7) | |
| 2.50 to <10.00 | 2,763 | 533 | 48 | 3,021 | 4.76 | 207.1 | 69 | 3,244 | 107 | 94 | (44) | |
| 2.5 to <5 | 1,772 | 442 | 51 | 1,998 | 3.45 | 123.0 | 73 | 2,200 | 110 | 48 | (22) | |
| 5 to <10 | 991 | 91 | 35 | 1,023 | 7.32 | 84.1 | 62 | 1,044 | 102 | 46 | (22) | |
| 10.00 to <100.00 | 583 | 69 | 34 | 606 | 26.63 | 77.6 | 75 | 940 | 155 | 119 | (53) | |
| 10 to <20 | 364 | 49 | 36 | 382 | 13.46 | 52.5 | 77 | 585 | 153 | 40 | (18) | |
| 20 to <30 | 73 | 8 | 37 | 76 | 23.83 | 10.1 | 70 | 134 | 176 | 13 | (7) | |
| 30.00 to <100.00 | 146 | 12 | 23 | 149 | 61.85 | 15.0 | 73 | 221 | 148 | 67 | (28) | |
| 100.00 (Default) | 149 | – | 93 | 150 | 100.00 | 19.3 | 67 | 240 | 160 | 82 | (53) | |
| Total | 8,077 | 5,483 | 49 | 10,763 | 4.73 | 582.0 | 74 | 8,633 | 80 | 337 | (175) |
2024
1 Weighted averages are based on EAD.
3.5 Risk grade profile continued
Table 65 sets out the allocation of exposures subject to the Standardised Approach laid down in Chapter 2 of Title II of Part Three and IRB Approach laid down in Chapter 3 of Title II of Part Three to the exposure classes as defined under the IRB Approach. This template excludes counterparty credit risk (CCR) exposures (Chapter 6 of Title II of Part Three CRR), and securitisation exposures.
Table 65: Scope of the use of IRB and SA approaches (UK CR6-A)
| 2025 | ||||||
|---|---|---|---|---|---|---|
| Exposure value as defined in Article 166 CRR for exposures subject to IRB approach \$million |
Total exposure value for exposures subject to the Standardised approach and to the IRB approach \$million |
Percentage of total exposure value subject to the permanent partial use of the SA % |
Percentage of total exposure value subject to IRB Approach % |
Percentage of total exposure value subject to a roll-out plan % |
||
| 1 | Central governments or central banks | 180,278 | 231,658 | 21.61 | 77.82 | – |
| 1.1 | Of which Regional governments or local authorities |
– | – | – | – | |
| 1.2 | Of which Public sector entities | 92 | – | 78.12 | – | |
| 2 | Institutions | 71,707 | 82,827 | 2.82 | 86.57 | – |
| 3 | Corporates | 191,701 | 249,323 | 11.65 | 76.89 | 2.08 |
| 3.1 | Of which Corporates – Specialised lending, excluding slotting approach |
22,910 | 0.40 | 98.71 | – | |
| 3.2 | Of which Corporates – Specialised lending under slotting approach |
9,717 | – | 100.00 | – | |
| 3.3 | Of which Corporates – SMEs | 25,037 | 74.60 | 11.62 | 13.40 | |
| 4 | Retail | 103,031 | 124,276 | 6.52 | 82.91 | 8.39 |
| 4.1 | Of which Retail – Secured by real estate SMEs | 626 | 1.12 | 58.44 | – | |
| 4.2 | Of which Retail – Secured by real estate non-SMEs |
80,934 | 0.15 | 94.25 | 3.97 | |
| 4.3 | Of which Retail – Qualifying revolving | 15,482 | – | 97.04 | – | |
| 4.4 | Of which Retail – Other SMEs | 5,712 | 0.66 | 40.03 | 34.28 | |
| 4.5 | Of which Retail – Other non-SMEs | 21,523 | 36.89 | 42.17 | 24.42 | |
| 5 | Equity | – | 1,244 | – | – | – |
| 6 | Other non-credit obligation assets | – | – | – | – | – |
| 17 | Total | 546,718 | 689,329 | 12.99 | 79.31 | 2.26 |
| 2024 | ||||||
|---|---|---|---|---|---|---|
| Exposure value as defined in Article 166 CRR for exposures subject to IRB approach \$million |
Total exposure value for exposures subject to the Standardised approach and to the IRB approach \$million |
Percentage of total exposure value subject to the permanent partial use of the SA % |
Percentage of total exposure value subject to IRB Approach % |
Percentage of total exposure value subject to a roll-out plan % |
||
| 1 | Central governments or central banks | 163,957 | 206,035 | 19.92 | 79.58 | – |
| 1.1 | Of which Regional governments or local authorities |
– | – | – | – | |
| 1.2 | Of which Public sector entities | 391 | – | – | – | |
| 2 | Institutions | 72,044 | 81,573 | 2.73 | 88.32 | – |
| 3 | Corporates | 191,202 | 225,678 | 10.20 | 84.72 | 2.19 |
| 3.1 | Of which Corporates – Specialised lending, excluding slotting approach |
19,341 | 0.14 | 99.86 | – | |
| 3.2 | Of which Corporates – Specialised lending under slotting approach |
8,363 | – | 100.00 | – | |
| 3.3 | Of which Corporates – SMEs | 3,181 | 19,862 | 72.01 | 16.02 | 15.76 |
| 4 | Retail | 99,646 | 120,678 | 5.24 | 82.57 | 9.01 |
| 4.1 | Of which Retail – Secured by real estate SMEs | 1,175 | 1.30 | 29.17 | – | |
| 4.2 | Of which Retail – Secured by real estate non-SMEs |
74,813 | 0.18 | 94.05 | 3.94 | |
| 4.3 | Of which Retail – Qualifying revolving | 16,374 | – | 97.78 | – | |
| 4.4 | Of which Retail – Other SMEs | 6,400 | 0.45 | 33.85 | 54.08 | |
| 4.5 | Of which Retail – Other non-SMEs | 21,916 | 28.05 | 49.11 | 20.36 | |
| 5 | Equity | – | 1,577 | – | – | – |
| 6 | Other non-credit obligation assets | – | – | – | – | – |
| 17 | Total | 526,849 | 635,542 | 11.43 | 82.90 | 2.49 |
1 Comparatives for UK CR6-A have been restated to reflect the exposure class of standardised exposures which would change when under the IRB approach.
3.5 Risk grade profile continued
Table 66 sets out the slotting approach that is applied to financing of individual projects where the repayment is highly dependent on the performance of the underlying pool or collateral, known as specialised lending. It uses a standard set of rules for the calculation of RWAs, based upon an assessment of factors such as the financial strength of the counterparty. The requirements for the application of the Slotting approach are detailed in CRR article 153.
Table 66: Specialised lending and equity exposures under the simple risk weighted approach (UK CR10.2)
| 2025 Income-producing real estate and high volatility commercial real estate (Slotting approach) Risk weighted On-balance Off-balance exposure sheet exposure sheet exposure Risk weight Exposure value amount \$million \$million % \$million \$million 4,619 823 50 4,869 3,047 904 1,007 70 1,248 849 991 323 70 1,001 832 187 527 90 410 367 479 38 115 499 553 |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Remaining maturity | Expected loss amount \$million |
|||||||||||
| Category 1 | Less than 2.5 years | 13 | ||||||||||
| Equal to or more than 2.5 years | 5 | |||||||||||
| Category 2 | Less than 2.5 years | 14 | ||||||||||
| Equal to or more than 2.5 years | 3 | |||||||||||
| Category 3 | Less than 2.5 years | 14 | ||||||||||
| Equal to or more than 2.5 years | 53 | – | 115 | 53 | 61 | 1 | ||||||
| Category 4 | Less than 2.5 years | 13 | – | 250 | 13 | 28 | 1 | |||||
| Equal to or more than 2.5 years | – | 107 | 250 | 57 | 142 | 5 | ||||||
| Category 5 | Less than 2.5 years | 443 | 16 | – | 448 | – | 224 | |||||
| Equal to or more than 2.5 years | 37 | – | – | 37 | – | 19 | ||||||
| Total | Less than 2.5 years | 6,544 | 1,201 | 6,829 | 4,459 | 266 | ||||||
| Equal to or more than 2.5 years | 1,181 | 1,642 | 1,806 | 1,419 | 33 |
2024
Income-producing real estate and high volatility commercial real estate (Slotting approach)
| Remaining maturity | On-balance sheet exposure \$million |
Off-balance sheet exposure \$million |
Risk weight % |
Exposure value \$million |
Risk weighted exposure amount \$million |
Expected loss amount \$million |
|
|---|---|---|---|---|---|---|---|
| Category 1 | Less than 2.5 years | 3,667 | 714 | 50 | 3,795 | 2,371 | – |
| Equal to or more than 2.5 years | 1,304 | 1,092 | 70 | 1,607 | 1,102 | 6 | |
| Category 2 | Less than 2.5 years | 988 | 302 | 70 | 1,042 | 1,114 | 4 |
| Equal to or more than 2.5 years | 258 | 423 | 90 | 297 | 257 | 2 | |
| Category 3 | Less than 2.5 years | 568 | 8 | 115 | 569 | 830 | 16 |
| Equal to or more than 2.5 years | 1 | 1 | 115 | 1 | 1 | – | |
| Category 4 | Less than 2.5 years | 89 | – | 250 | 89 | 208 | 7 |
| Equal to or more than 2.5 years | – | – | 250 | – | 1 | – | |
| Category 5 | Less than 2.5 years | 257 | 5 | – | 257 | – | 128 |
| Equal to or more than 2.5 years | – | – | – | – | – | – | |
| Total | Less than 2.5 years | 5,569 | 1,029 | 5,752 | 4,523 | 155 | |
| Equal to or more than 2.5 years | 1,563 | 1,516 | 1,904 | 1,360 | 9 |
3.6 Credit risk mitigation
Potential credit losses from any given account, customer or portfolio are mitigated using a range of tools such as collateral, netting agreements, credit insurance, credit derivatives and guarantees. For example, eligible financial collateral taken under eligible master netting agreements supported by a legal opinion may be netted against exposures. The reliance that can be placed on these mitigants is carefully assessed in light of issues such as legal certainty and enforceability, market valuation, correlation and credit risk of the guarantor. The presence of credit risk mitigation is not a substitute for the ability to pay, which is the primary consideration for any credit decision, but may influence credit limit sizing. Where appropriate, credit derivatives are used to reduce credit risks in the portfolio. Due to their potential impact on income volatility, such derivatives are used in a controlled manner with reference to their expected volatility. Collateral is held to mitigate credit risk exposures and risk mitigation policies determine the eligibility of collateral types. Potential concentration risk from the use of financial collaterals, guarantee and credit insurance is monitored through periodic risk reporting. The Group uses credit limits to record guarantees taken against each guarantor where a capital benefit is taken.
Our approach to credit risk mitigation can be found in the Risk management approach section of the 2025 Annual Report and Accounts on pages 226 to 227.
The table below shows the unfunded credit protection held by the Group, consisting of credit derivatives and guarantees, and funded credit protection, including financial collateral. Exposure class has been defined based on the guarantor of the exposure.
Table 67: CRM techniques overview: Disclosure of the use of credit risk mitigation techniques (UK CR3)
| 2025 | ||||||
|---|---|---|---|---|---|---|
| Exposures unsecured \$million |
Exposures secured \$million |
Of which secured by collateral \$million |
Of which secured by financial guarantees \$million |
Of which secured by credit derivatives \$million |
||
| 1 | Total loans | 353,419 | 139,861 | 130,853 | 9,007 | 320 |
| 2 | Total debt securities | 168,058 | 730 | 90 | 639 | |
| 3 | Total exposures | 521,477 | 140,591 | 130,943 | 9,647 | 320 |
| 4 | Of which non-performing exposures | 3,024 | 995 | 988 | 7 | 3 |
| 5 | Of which defaulted | 3,024 | 995 | |||
| 2024 | ||||||
| Exposures unsecured \$million |
Exposures secured \$million |
Of which secured by collateral \$million |
Of which secured by financial guarantees \$million |
Of which secured by credit derivatives \$million |
| 1 | Total loans | 351,126 | 123,741 | 115,423 | 8,318 | – |
|---|---|---|---|---|---|---|
| 2 | Total debt securities | 145,600 | 201 | 105 | 96 | |
| 3 | Total exposures | 496,726 | 123,942 | 115,528 | 8,414 | – |
| 4 | Of which non-performing exposures | 1,977 | 881 | 860 | 21 | – |
| 5 | Of which defaulted | 1,977 | 881 |
3.6 Credit risk mitigation continued
Table 68 presents the EAD before and after the effect of CRM, including credit substitution and financial collateral, with a further split into on-balance sheet and off-balance sheet exposures. Off-balance sheet exposures are presented before and after the application of standardised CCFs.
Table 68: Standardised approach – Credit risk exposure and CRM effects (UK CR4)
| 2025 | |||||||
|---|---|---|---|---|---|---|---|
| Exposures before CCF and CRM1 | Exposures post CCF and CRM | RWA and RWA density | |||||
| On-balance sheet \$million |
Off-balance sheet \$million |
On-balance sheet \$million |
Off-balance sheet \$million |
RWA \$million |
RWA density % |
||
| Standardised Exposure Class | |||||||
| 1 | Central governments or central banks |
26,274 | 272 | 27,356 | 754 | 1,777 | 6 |
| 2 | Multilateral development banks | 27,145 | 741 | 30,296 | 398 | 859 | 3 |
| 6 | Institutions | 15 | 356 | 7 | – | 4 | 57 |
| 7 | Corporates | 37,816 | 59,648 | 11,425 | 1,472 | 11,098 | 86 |
| 8 | Retail | 15,275 | 18,246 | 12,911 | 229 | 7,968 | 61 |
| 9 | Secured on real estate property | 8,633 | 270 | 8,538 | 128 | 3,967 | 46 |
| 10 | Exposures in default | 183 | 36 | 179 | 13 | 192 | 100 |
| 11 | Items belonging to regulatory high risk categories |
2,085 | 313 | 1,838 | 43 | 2,821 | 150 |
| 15 | Equity | 1,186 | – | 1,186 | – | 2,965 | 250 |
| 16 | Other items2 | 17,874 | 332 | 20,115 | 301 | 10,199 | 50 |
| 17 | Total Standardised3 | 136,486 | 80,214 | 113,851 | 3,338 | 41,850 | 36 |
| 2024 | |||||||
|---|---|---|---|---|---|---|---|
| Exposures before CCF and CRM1 | Exposures post CCF and CRM | RWA and RWA density | |||||
| On-balance sheet \$million |
Off-balance sheet \$million |
On-balance sheet \$million |
Off-balance sheet \$million |
RWA \$million |
RWA density % |
||
| Standardised Exposure Class | |||||||
| 1 | Central governments or central banks |
23,177 | 437 | 24,344 | 1,118 | 1,384 | 5 |
| 2 | Multilateral development banks | 20,430 | 1,075 | 23,462 | 157 | 1,058 | 4 |
| 6 | Institutions | 45 | 331 | 34 | – | 17 | 50 |
| 7 | Corporates | 18,691 | 35,946 | 11,513 | 1,063 | 9,451 | 75 |
| 8 | Retail | 14,777 | 20,994 | 10,641 | 254 | 7,825 | 72 |
| 9 | Secured on real estate property | 8,506 | 366 | 8,406 | 178 | 4,130 | 48 |
| 10 | Exposures in default | 198 | 51 | 195 | 28 | 223 | 100 |
| 11 | Items belonging to regulatory high risk categories |
1,254 | 566 | 1,203 | 64 | 1,901 | 150 |
| 15 | Equity | 868 | – | 868 | – | 2,169 | 250 |
| 16 | Other items2 | 17,374 | 354 | 11,954 | 349 | 9,275 | 75 |
| 17 | Total Standardised3 | 105,320 | 60,120 | 92,620 | 3,211 | 37,433 | 39 |
1 EAD before the effect of collateral and substitution.
2 Other items include public sector entities.
3 Refer to table 20 (OV1): Standardised approach \$37,456 million and amount below threshold for deduction \$4,395 million RWA.
3.6 Credit risk mitigation continued
Table 69: IRB approach – Effect on the RWEAs of credit derivatives used as CRM techniques (UK CR7)
| 2025 | 2024 | ||||
|---|---|---|---|---|---|
| Pre-credit derivatives risk weighted exposure amount \$million |
Actual risk weighted exposure amount \$million |
Pre-credit derivatives risk weighted exposure amount \$million |
Actual risk weighted exposure amount \$million |
||
| 6 | Central governments and central banks | 21,328 | 21,328 | 21,958 | 21,958 |
| 7 | Institutions | 12,143 | 12,143 | 12,902 | 12,902 |
| 8 | Corporates | 70,467 | 70,467 | 69,490 | 69,490 |
| 8.1 | Of Corporates – which SMEs | 1,238 | 1,238 | 1,355 | 1,355 |
| 8.1 | Of which Corporates – Specialised lending | 10,669 | 10,669 | 9,865 | 9,865 |
| 9 | Retail | 18,083 | 18,083 | 19,692 | 19,692 |
| 9.1 | Of which Retail – SMEs – Secured by immovable property collateral |
18 | 18 | 18 | 18 |
| 9.2 | Of which Retail – non-SMEs – Secured by immovable property collateral |
5,783 | 5,783 | 4,952 | 4,952 |
| 9.3 | Of which Retail – Qualifying revolving | 4,692 | 4,692 | 4,908 | 4,908 |
| 9.4 | Of which Retail – SMEs – Other | 1,198 | 1,198 | 1,181 | 1,181 |
| 9.5 | Of which Retail – Non-SMEs – Other | 6,392 | 6,392 | 8,634 | 8,634 |
| 10 | Total | 122,021 | 122,021 | 124,043 | 124,043 |
Table 70: IRB approach – Disclosure of the extent of the use of CRM techniques (UK CR7-A)
| 2025 | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Credit risk Mitigation techniques | Credit risk Mitigation methods in the calculation of RWEAs |
||||||||||||||
| Total | Funded credit Protection (FCP) | Unfunded credit Protection (UFCP) |
|||||||||||||
| exposures \$million |
Part of exposures covered by Financial Collaterals % |
Part of exposures covered by Other eligible collaterals % |
Part of exposures covered by Immovable property Collaterals % |
Part of exposures covered by Receiva bles % |
Part of exposures covered by Other physical collateral % |
Part of exposures covered by Other funded credit protection % |
Part of exposures covered by Cash on deposit % |
Part of exposures covered by Life insurance policies % |
Part of exposures covered by Instru ments held by a third party % |
Part of exposures covered by Guaran tees % |
Part of exposures covered by Credit Deriva tives % |
RWEA without sub stitution effects (reduction effects only) \$million |
RWEA with sub stitution effects (both reduction and sub stitution effects) \$million |
||
| IRB Exposure Class | |||||||||||||||
| 1 | Central governments and central banks |
180,287 | – | – | – | – | – | – | – | – | – | 5.3 | – | 21,825 | 21,328 |
| 2 | Institutions | 71,707 | 4.1 | 1.9 | – | – | 1.9 | 1.7 | – | – | – | 10.5 | – | 11,848 | 12,143 |
| 3 | Corporates | 191,728 | 1.8 | 7.8 | 2.9 | – | 4.8 | 1.0 | – | – | – | 10.6 | – | 67,651 | 70,467 |
| 3.1 | Of which Corporates – SMEs |
2,909 | 3.5 | 40.4 | 39.8 | – | 0.5 | – | – | – | – | 6.2 | – | 1,258 | 1,238 |
| 3.2 | Of which Corporates – Specialised lending |
32,332 | 0.5 | 15.9 | 0.3 | 0.1 | 15.4 | 1.1 | – | – | – | 19.0 | – | 11,541 | 10,669 |
| 3.3 | Of which Corporates – Other |
156,486 | 2.1 | 5.6 | 2.8 | – | 2.7 | 1.0 | – | – | – | 8.9 | – | 54,852 | 58,560 |
| 4 | Retail | 103,031 | 0.1 | 72.2 | 72.2 | – | – | – | – | – | – | 0.9 | – | 18,219 | 18,083 |
| 4.1 | Of which Retail – Immovable property SMEs |
366 | – | 90.6 | 90.6 | – | – | – | – | – | – | – | – | 18 | 18 |
| 4.2 | Of which Retail – Immovable property non-SMEs |
76,280 | – | 97.1 | 97.1 | – | – | – | – | – | – | – | – | 5,783 | 5,783 |
| 4.3 | Of which Retail – Qualifying revolving |
15,023 | – | – | – | – | – | – | – | – | – | – | – | 4,692 | 4,692 |
| 4.4 | Of which Retail – Other SMEs |
2,286 | 1.3 | 0.1 | – | – | 0.1 | – | – | – | – | 7.3 | – | 1,213 | 1,198 |
| 4.5 | Of which Retail – Other non-SMEs |
9,076 | 0.3 | – | – | – | – | – | – | – | – | 7.9 | – | 6,514 | 6,392 |
| 5 | Total | 546,753 | 1.2 | 16.6 | 14.6 | – | 1.9 | 0.6 | – | – | – | 7.0 | – | 119,543 | 122,021 |
3.6 Credit risk mitigation continued
Table 70: IRB approach – Disclosure of the extent of the use of CRM techniques (UK CR7-A) continued
| 2024 | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Credit risk Mitigation techniques | Credit risk Mitigation methods in the calculation of RWEAs |
||||||||||||||
| Total | Funded credit Protection (FCP) | Protection (UFCP) | Unfunded credit | RWEA | |||||||||||
| exposures1 \$million |
Part of exposures covered by Financial Collaterals % |
Part of exposures covered by Other eligible collaterals % |
Part of exposures covered by Immovable property Collaterals % |
Part of exposures covered by Receiva bles % |
Part of exposures covered by Other physical collateral % |
Part of exposures covered by Other funded credit protection % |
Part of exposures covered by Cash on deposit % |
Part of exposures covered by Life insurance policies % |
Part of exposures covered byInstru ments held by a third party % |
Part of exposures covered by Guaran tees % |
Part of exposures covered by Credit Derivatives % |
RWEA without sub stitution effects (reduction effects only) \$million |
with sub stitution effects (both reduction and sub stitution effects) \$million |
||
| IRB Exposure Class | |||||||||||||||
| 1 | Central governments and central banks |
163,957 | – | – | – | – | – | – | – | – | – | 4.9 | – | 21,236 | 21,958 |
| 2 | Institutions | 72,044 | 2.8 | 1.4 | – | – | 1.3 | 2.2 | – | – | – | 10.3 | – | 13,089 | 12,903 |
| 3 | Corporates | 191,202 | 1.9 | 8.3 | 3.3 | – | 4.9 | 0.9 | – | – | – | 17.6 | – | 68,865 | 69,490 |
| 3.1 | Of which Corporates – SMEs |
3,181 | 4.2 | 39.9 | 39.3 | – | 0.5 | – | – | – | – | 4.5 | – | 1,365 | 1,355 |
| 3.2 | Of which Corporates – Specialised lending |
27,676 | 0.7 | 16.1 | 0.4 | 0.2– | 15.5 | 1.6 | – | – | – | 20.6 | – | 10,730 | 9,865 |
| 3.3 | Of which Corporates – Other |
160,344 | 2.0 | 6.3 | 3.1 | – | 3.1 | 0.8 | – | – | – | 17.4 | – | 56,770 | 58,270 |
| 4 | Retail | 99,646 | – | 67.3 | 67.3 | – | – | – | – | – | – | 0.2 | – | 19,709 | 19,693 |
| 4.1 | Of which Retail – Immovable property SMEs |
343 | – | 89.5 | 89.5 | – | – | – | – | – | – | – | – | 18 | 18 |
| 4.2 | Of which Retail – Immovable property non-SMEs |
70,364 | – | 94.9 | 94.9 | – | – | – | – | – | – | – | – | 4,952 | 4,952 |
| 4.3 | Of which Retail – Qualifying revolving |
16,010 | – | – | – | – | – | – | – | – | – | – | – | 4,908 | 4,908 |
| 4.4 | Of which Retail – Other SMEs |
2,166 | 1.0 | – | – | – | – | – | – | – | – | 8.2 | – | 1,198 | 1,181 |
| 4.5 | Of which Retail – Other non-SMEs |
10,764 | – | – | – | – | – | – | – | – | – | – | – | 8,634 | 8,634 |
| 5 | Total | 526,849 | 1.1 | 15.9 | 13.9 | – | 1.9 | 0.6 | – | – | – | 9.4 | – | 122,898 124,044 |
1 2024 has been represented to show exposures on an obligor basis and for UFCP to include all exposures covered by UFCP and not just where the impact is taken through LGD.
3.7 Standardised risk weight profile
External ratings, where available, are used to assign risk weights for standardised approach (SA) exposures. These external ratings must come from EU approved rating agencies, known as External Credit Assessment Institutions (ECAI); which currently include Moody's, Standard & Poor's and Fitch. The Group uses the ECAI ratings from these agencies in its day-to-day business, which are tracked and kept updated. Assessments provided by approved ECAI are mapped to credit quality steps as prescribed by the CRR.
The following tables set out EAD and EAD after CRM associated with each risk weight as prescribed in Part Three, Title II, Chapter 2 of the CRR, including credit and counterparty credit risk regulatory risk weights based on the exposure classes applied to unrated exposures.
Standardised EAD post CRM and post CCF increased by \$21.4 billion driven by:
- Central governments or central banks increased by \$2.6 billion
- Public sector entities increased by \$8.4 billion
- Multilateral development banks increased by \$7.1 billion
- Retail increased by \$2.2 billion
3.7 Standardised risk weight profile continued Table 71: Standardised approach (UK CR5)
| 2025 | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Risk Weight | Of which | ||||||||||||||
| 0% | 2% | 4% | 20% | 35% | 50% | 75% | 100% | 150% | 250% | Others Deducted | Total | unrated | |||
| Standardised Exposure Class | |||||||||||||||
| 1 | Central governments or central banks |
27,191 | – | – | – | – | – | – | 347 | – | 572 | – | – | 28,110 | – |
| 3 | Public sector entities | – | – | – | 8,795 | – | – | – | – | – | – | – | – | 8,795 | – |
| 4 | Multilateral development | ||||||||||||||
| banks | 28,944 | – | – | 390 | – | 1,158 | – | 202 | – | – | – | – | 30,694 | – | |
| 6 | Institutions | – | – | – | – | – | 7 | – | – | – | – | – | – | 7 | – |
| 7 | Corporates | – | – | – | 1,580 | – | 196 | – | 11,120 | – | – | – | – | 12,896 | 11,083 |
| 8 | Retail | – | – | – | 2,891 | – | – | 10,248 | – | – | – | – | – | 13,139 | 10,525 |
| 9 | Secured on real estate property |
– | – | – | – | 7,045 | – | – | 1,621 | – | – | – | – | 8,666 | 8,666 |
| 10 | Exposures in default | – | – | – | – | – | – | – | 192 | – | – | – | – | 192 | 192 |
| 11 | Items belonging to regulatory high risk categories |
– | – | – | – | – | – | – | – | 1,881 | – | – | – | 1,881 | 1,189 |
| 15 | Equity | – | – | – | – | – | – | – | – | – | 1,186 | – | – | 1,186 | 1,186 |
| 16 | Other items1 | 3,208 | – | – | 3 | – | – | – | 8,354 | – | – | 58 | – | 11,623 | 3,064 |
| 17 | Total Standardised | 59,343 | – | – | 13,659 | 7,045 | 1,361 | 10,248 | 21,836 | 1,881 | 1,758 | 58 | – | 117,189 | 35,905 |
| 2024 | |||||||||||||||
| Risk Weight | Of which | ||||||||||||||
| 0% | 2% | 4% | 20% | 35% | 50% | 75% | 100% | 150% | 250% | Others Deducted | Total | unrated | |||
| Standardised Exposure Class | |||||||||||||||
| 1 | Central governments or central banks |
24,755 | – | – | 18 | – | 126 | – | 17 | 66 | 481 | – | – | 25,463 | – |
| 3 | Public sector entities | – | – | – | 393 | – | – | – | – | – | – | – | – | 393 | – |
| 4 | Multilateral development banks |
21,374 | – | – | 556 | – | 1,482 | – | 206 | – | – | – | – | 23,618 | – |
| 6 | Institutions | – | – | – | – | – | 34 | – | – | – | – | – | – | 34 | – |
| 7 | Corporates | – | – | – | 3,237 | – | 272 | – | 9,066 | – | – | – | – | 12,575 | 9,471 |
| 8 | Retail | – | – | – | – | – | – | 10,895 | – | – | – | – | – | 10,895 | 10,895 |
| 9 | Secured on real estate | ||||||||||||||
| property | – | – | – | – | 6,601 | – | – | 1,983 | – | – | – | – | 8,584 | 8,584 | |
| 10 | Exposures in default | – | – | – | – | – | – | – | 223 | – | – | – | – | 223 | 223 |
| 11 | Items belonging to regulatory high risk categories |
– | – | – | – | – | – | – | – | 1,267 | – | – | – | 1,267 | 909 |
15 Equity – – – – – – – – – 868 – – 868 868 16 Other items1 2,663 – – 68 – 3 – 8,898 – – 277 – 11,909 3,194 17 Total Standardised 48,792 – – 4,272 6,601 1,917 10,895 20,393 1,333 1,349 277 – 95,829 34,144
1 Other items include cash, fixed assets, prepayments and accrued income.
3.8 Securitisation
Securitisation is defined by the CRR as a transaction or scheme where the credit risk of an exposure or pool of exposures is tranched and where the payments arising from the transaction or scheme are dependent upon the performance of the underlying exposure(s) and where the subordination of tranches determine the distribution of losses during the ongoing life of the transaction or the scheme.
Securitisation can be categorised as either:
- Traditional securitisation: A securitisation involving the economic transfer of the exposures being securitised via the transfer of ownership of securitised exposures from the originator institution to a securitisation special purpose entity (SSPE), where the securitised assets are beyond the reach of the originator and its creditors. The purchase of the assets by the SSPE are usually funded via the issuance of securities where the payments obligations does not belong to the originator institution.
- Synthetic transaction: A securitisation where the originator retains the ownership of the underlying exposure(s) and transfer the associated credit risk of the securitised exposures to third party through the use of credit derivatives or guarantees.
The Group has undertaken securitisation of its own originated assets to diversify sources of funding and capital management and may play one or more of the following roles in a securitisation transaction:
Originator – The Group securitised assets (Corporate loans , revolving credit facilities and trade finance facilities) originated in its normal course of business for capital and risk management and diversification of its sources of funding. The Group may be exposed to credit and market risk on the underlying assets, particularly if the structure of the transaction does not transfer these risks to third parties.
Investor – To generate financial returns, the group may purchase securitised issued by third-party SSPE or purchased securities from SSPE which it originates for market making purpose.
Arranger – The Group may act as arranger for securitisation transactions it originates or by its customers, usually financial institution or large corporates.
Underwriter – The Group may underwrite the securities issued by a SSPE originated by the Group or for its customers.
Credit Event Monitor Agent – Monitor the credit quality of the underlying securitised assets on behalf of the SSPE or investors
Account Bank – The Group may hold the bank account of a SSPE originated by the Group on its own books
Program Manager – Report on the performance of the securitised assets of the SSPE to investors
Servicer – Manage and service the asset pool of the securitisation transactions
The Group has \$32.6. billion (2024: \$32.2 billion) of EAD classified as securitisation positions, as shown in Table 72 on page 86. These transactions meet the criteria to qualify as securitisation positions under the PRA's securitisation framework and the particulars of these transactions are discussed below.
Asset Backed Securities
The carrying value of asset backed securities (ABS) of \$15.4 billion (2024: \$16.2 billion), held either as investments or arranged for clients, represents 2 per cent of the Group's total assets (2024: 2 per cent). This portfolio only constitutes third party securitisations and does not include self-securitisation (retained positions).
The portfolio primarily comprises of two main strategies, firstly, a mix of client-based and market making trades booked in Markets, and portfolios of liquid ABS investments for the Treasury Markets (TM) book.
The credit quality of the ABS portfolio remains strong, with over 94.3 per cent of the overall portfolio rated Investment Grade, and 97.5 per cent of the overall portfolio is rated as AAA. The portfolio is diversified across asset classes and geographies. Residential mortgage-backed securities (RMBS) make up 17.5 per cent of the overall portfolio and have a weighted averaged credit rating of AAA.
Other ABS include Auto ABS, comprising 5.8 per cent of the overall portfolio, CLOs (58.6 per cent) The balance of Other ABS mainly includes securities backed by Credit Cards, consumer loans, diversified payment rights, and receivables ABS.
The notional and carrying values of the ABS purchased or retained by the Group are shown in the table below analysed by underlying asset type. ABS are accounted for as financial assets. For further details regarding recognition and impairment, refer to the note 33 to the financial statements of the 2025 Annual Report and Accounts, page 416. The ABS portfolio is assessed frequently for objective evidence of impairment.
Valuation of retained interest is initially and subsequently determined using market price quotations where available or internal pricing models that utilise variables such as yield curves, prepayment speeds, default rates, loss severity, interest rate volatilities and spreads. The assumptions used for valuation are based on observable transactions in similar securities and are verified by external pricing sources, where available.
The ABS portfolio is closely managed by a centralised dedicated team. The team has developed a detailed analysis and reporting framework of the underlying portfolio to allow senior management to make an informed holding decision with regards to specific assets, asset classes or parts of an asset class. These ABS portfolio reports are closely monitored by the Risk function in the Group.
The notional and carrying values of the ABS purchased or retained by the Group are shown below in the table analysed by underlying asset type.
Syndicate & Portfolio Management Balance Sheet Securitisation
Synthetic Securitisation – Significant Risk Transfer (SRT) trades
The Group via its Syndicate and Portfolio Management (SPM) Balance Sheet Securitisation unit buys synthetic protection for its banking book credit portfolio. Securitisation provides capacity for client-focused growth and improves efficiency of economic and regulatory capital. The Group as the originator performs multiple roles, including protection buyer, calculation agent and credit event monitor agent. The protection buyer executes and maintains securitisation transactions. The calculation agent computes periodic coupon payments and loss payouts. The credit event monitor agent validates and provides notifications of credit events.
Treasury Markets unit performs a different role, acting as deposit taker for funds collected from the credit protection providers. Deposits collected eliminate counterparty risk for transactions where the Group is the protection buyer.
The securitised assets consist of commercial loans , revolving credit facilities and trade finance facilities extended by the Group's branches and subsidiaries to borrowers from the Group's footprint markets, including the emerging markets in Asia, Africa and Middle East. The securitised assets are subject to changes in general economic conditions, performance of relevant financial markets, political events and developments or trends in a particular industry. Historically, the trading volume of loans in these emerging markets has been small relative to other more developed debt markets due to limited liquidity in the secondary loan market.
The securitised assets are originated by the Group in its ordinary course of business. Given the synthetic nature of securitisations originated by SPM Balance Sheet Securitisation unit, the securitised assets remain on the Group's balance sheet and continue to be subject to the Group's credit review and monitoring process and risk methodology. Accordingly retained positions for regulatory risk retention purpose are not hedged.
In its role as credit event monitor agent, SPM Balance Sheet Securitisation unit monitors the credit risk of the underlying securitised assets by leveraging on the Group's client and risk management system.
As of 31 December 2025, \$0 million of Trade Finance (2024: \$0 million) and \$113 million of Commercial Loans (2024: \$29 million) totalling \$113 million (2024: \$29 million) of securitised exposures were classified as impaired and past due.
The Group has eighteen synthetic securitisation transactions originated and managed by SPM Balance Sheet Securitisation unit, with an aggregate hedge capacity of \$26 billion (2024: \$25 billion). SPM Balance Sheet Securitisation unit as the originator has not acted as sponsor to securitise third-party exposures and does not manage or advise any third-party entity that invests in the securitisation positions. Table 72 provides details of current securitisation programmes originated and managed by the Group.
The Group transfer credit risk of underlying securitised assets (Refer to Table 72) to non-consolidated securitisation special purpose entity (SSPE) via credit derivatives or via credit-linked notes issued by the bank. In the transactions involving the use of SSPE structure, the underlying assets are not sold into the relevant SSPE. Instead, the credit risk of the underlying assets is transferred to the SSPE synthetically via credit default swaps whereby the SSPEs act as sellers of credit protection and receive premiums paid by the Group in return. The SSPE in turn issue credit-linked notes to third party investors who fund the credit protection in exchange for coupon on the notes purchased. The premium received by the SSPE and interest earned on the funded amount of the purchased notes are passed through to the third-party investors as coupon on the purchased notes. Payment to the third-party investors is made in accordance with the priority of payments stipulated in the transaction documents.
Traditional Securitisation
The Group entered into traditional securitisation transaction to diversify its sources of funding. The Group originated a revolving cashflow traditional trade finance and lending securitisation transaction, which consolidated the SSPE (Prunelli Issuer S.a.r.l) into the Group's financials as required under IFRS 10 as the Group was deemed to have control over the SSPE. Assets sold to the SSPE continue to remain on the Group's balance sheet as they did not satisfy derecognition criteria under the Group's accounting policy.
As of 31 December 2025, the outstanding securitised exposures were \$2,292 million (2024: \$2,714 million).
Governance of securitisation activities
Securitisation transactions proposed for funding and capital management must obtain support from the Corporate & Investment Banking Financial Risk Committee ("CIB FRC"), which manages the capital requirements of the Group. From 1 January 2026 onwards, the CIB FRC transactional level approvals are to be within Group Chief Financial Officer approval overall quantum for significant risk transfer given its capital implications. For a securitisation transaction that will lead to reduction in regulatory capital, it must be submitted to UK PRA for review one-month post deal close.
Execution of each securitisation transaction must either be approved through a Product Programme (PPG) or an individual Transaction Programme Approval (TPA) where approvals across all functions involved in the transaction are obtained. Specifically, Compliance covers issues like confidentiality of clients' information and insider information, Group Tax provides an opinion on taxation, Group Finance advises on the capital and accounting treatment.
Basel III for securitisation positions
The calculation of risk-weighted exposure amounts for securitisation positions is based on the following two calculation methods advised by the PRA:
- IRB method for third-party senior securitisation positions bought and securitisation positions originated and retained by the Group (including haircuts due to currency and collateral mismatch)
- Standardised Approach for the residual risk-weighted exposure amounts for all other securitisation positions originated by the Group and sold. For instance, risk-weight substitution under the Standardised Approach is adopted in unfunded transactions where cash collateral is with a third party
The Synthetic securitisation transactions originated by the Group in Table 72 meet the Significant risk transfer requirement ("SRT") under the CRR. Where securitisations do not achieve SRT (for instance when they are entered into for funding purpose), their associated exposures will be presented in other sections of the Pillar 3 report. Synthetic Securitisation transactions (Table 72) are unrated as the bank utilised SEC-IRBA for risk capital calculation under CRR IV.
Accounting
Accounting assessment takes place at the time of transaction closing. The Group consolidate structured entities (including SSPE) when the substance of the relationship indicates control over the SSPE. The Group controls an entity if it has all the three elements of control which are i) power over the entity; ii) the ability to use its power over the entity to affect the returns of the Group and iii) exposure to variable returns from its involvement with the entity. The consolidation treatment is initially assessed at inception and is reassessed if circumstances indicate that there are changes to one or more of the three elements of control.
A securitisation transaction is recognised as a sale or partial sale where derecognition is achieved. The difference between the carrying amount and the consideration received is recorded in the income statement. Securitisation transactions which do not achieve derecognition are treated as financing activity. In a synthetic securitisation transaction, the underlying assets are not sold into the securitisation special purpose entity (SSPE). Instead, the underlying assets' performance is transferred into the SSPE through a synthetic instrument such as a CDS, a credit-linked note or a financial guarantee. Synthetic securitisation are assessed using the same accounting approach summarised above, with the associated credit derivative accounted as a financial guarantee under IFRS 9. As of both 31 December 2025 and 31 December 2024, no securitised assets have been derecognised from the Group's balance sheet.
Financial assets awaiting for securitisation are valued using the Group's accounting policy for financial instrument. There are no assets classify as awaiting securitisation for both 31 December 2025 and 31 December 2024.
Any financial support or contractual arrangements provided to unconsolidated entities for securitised assets would be recognised as a liability on balance sheet if it met the relevant IFRS criteria. The Group has not provided support to any securitisation transactions beyond its contractual obligations.
The Group's approach to accounting for SSPEs can be found in the notes to the financial statements in the 2025 Annual Report and Accounts.
Assets securitised under the Significant risk transfer (SRT) program by the Group's in its capacity as originator decreased by \$0.6 billion to \$14.7 billion.
The following tables shows the distribution of the Group's securitisation exposures across risk-weights. The vast majority of the Group's exposure to securitisation programmes is to the lower risk weighted tranches.
Table 72: Securitisation exposures in the non-trading book (UK-SEC1)
| 2025 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Institution acts as originator | Institution acts as sponsor | Institution acts as investor | ||||||||||||||
| Traditional | Synthetic | Traditional | Traditional | |||||||||||||
| STS | Non-STS | |||||||||||||||
| \$ million | Of which SRT \$ million |
\$ million | Of which SRT \$ million |
\$ million | Of which SRT \$ million |
Sub-total \$ million |
STS \$ million |
Non-STS \$ million |
Synthetic \$ million |
Sub-total \$ million |
STS \$ million |
Non-STS \$ million |
Synthetic \$ million |
Sub-total \$ million |
||
| 1 | Total exposures | – | – | 664 | – | 14,717 | 14,717 | 15,381 | – | – | – | – | 254 | 16,934 | – | 17,188 |
| 2 | Retail (total) | – | – | – | – | – | – | – | – | – | – | – | 254 | 5,835 | – | 6,090 |
| 3 | residential mortgage |
– | – | – | – | – | – | – | – | – | – | – | – | 3,001 | – | 3,001 |
| 4 | credit card | – | – | – | – | – | – | – | – | – | – | – | 52 | 145 | – | 197 |
| 5 | other retail exposures |
– | – | – | – | – | – | – | – | – | – | – | 202 | 2,689 | – | 2,892 |
| 6 | re-securitisation | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 7 | Wholesale (total) | – | – | 664 | – | 14,717 | 14,717 | 15,381 | – | – | – | – | – | 11,099 | – | 11,099 |
| 8 | loans to corporates |
– | – | 664 | – | 13,324 | 13,324 | 13,988 | – | – | – | – | – | 9,716 | – | 9,716 |
| 9 | commercial mortgage |
– | – | – | – | – | – | – | – | – | – | – | – | 884 | – | 884 |
| 10 | lease and receivables |
– | – | – | – | 1,393 | 1,393 | 1,393 | – | – | – | – | – | 498 | – | 498 |
| 11 | other wholesale | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 12 | re-securitisation | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 2024 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Institution acts as originator | Institution acts as sponsor | Institution acts as investor | ||||||||||||||
| Traditional | Synthetic | Traditional | Traditional | |||||||||||||
| STS | Non-STS | |||||||||||||||
| \$ million | Of which SRT \$ million |
\$ million | Of which SRT \$ million |
\$ million | Of which SRT \$ million |
Sub-total \$ million |
STS \$ million |
Non-STS \$ million |
Synthetic \$ million |
Sub-total \$ million |
STS \$ million |
Non-STS \$ million |
Synthetic \$ million |
Sub-total \$ million |
||
| 1 | Total exposures | – | – | 862 | – | 15,292 | 15,292 | 16,154 | – | – | – | – | 267 | 15,768 | – | 16,035 |
| 2 | Retail (total) | – | – | – | – | – | – | – | – | – | – | – | 267 | 4,853 | – | 5,120 |
| 3 | residential | |||||||||||||||
| mortgage | – | – | – | – | – | – | – | – | – | – | – | 142 | 4,314 | – | 4,456 | |
| 4 | credit card | – | – | – | – | – | – | – | – | – | – | – | 125 | 88 | – | 213 |
| 5 | other retail exposures |
– | – | – | – | – | – | – | – | – | – | – | – | 451 | – | 451 |
| 6 | re-securitisation | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 7 | Wholesale (total) | – | – | 862 | – | 15,292 | 15,292 | 16,154 | – | – | – | – | – | 10,916 | – | 10,916 |
| 8 | loans to corporates |
– | – | 810 | – | 13,877 | 13,877 | 14,687 | – | – | – | – | – | 9,019 | – | 9,019 |
| 9 | commercial mortgage |
– | – | – | – | – | – | – | – | – | – | – | – | 669 | – | 669 |
| 10 | lease and receivables |
– | – | 52 | – | 1,415 | 1,415 | 1,467 | – | – | – | – | – | 1,228 | – | 1,228 |
| 11 | other wholesale | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 12 | re-securitisation | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Table 73: Securitisation exposures in the trading book (UK-SEC2)
| 2025 | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Institution acts as originator | Institution acts as sponsor | Institution acts as investor | |||||||||||
| Traditional | Traditional | Traditional | |||||||||||
| STS \$ million |
Non-STS \$ million |
Sub-total \$ million |
Sub-total \$ million |
STS \$ million |
Non-STS \$ million |
Sub-total \$ million |
Sub-total \$ million |
STS \$ million |
Non-STS \$ million |
Synthetic \$ million |
Sub-total \$ million |
||
| 1 | Total exposures | – | – | – | – | – | – | – | – | 109 | 1,257 | – | 1,366 |
| 2 | Retail (total) | – | – | – | – | – | – | – | – | 105 | 818 | – | 923 |
| 3 | residential mortgage | – | – | – | – | – | – | – | – | 8 | 294 | – | 302 |
| 4 | credit card | – | – | – | – | – | – | – | – | 10 | 7 | – | 17 |
| 5 | other retail exposures | – | – | – | – | – | – | – | – | 88 | 517 | – | 605 |
| 6 | re-securitisation | – | – | – | – | – | – | – | – | – | – | – | – |
| 7 | Wholesale (total) | – | – | – | – | – | – | – | – | 3 | 439 | – | 442 |
| 8 | loans to corporates | – | – | – | – | – | – | – | – | – | 255 | – | 255 |
| 9 | commercial mortgage | – | – | – | – | – | – | – | – | – | 46 | – | 46 |
| 10 | lease and receivables | – | – | – | – | – | – | – | – | 3 | 138 | – | 142 |
| 11 | other wholesale | – | – | – | – | – | – | – | – | – | – | – | – |
| 12 | re-securitisation | – | – | – | – | – | – | – | – | – | – | – | – |
| 2024 | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Institution acts as originator | Institution acts as sponsor | Institution acts as investor | |||||||||||
| Traditional | Traditional | Traditional | |||||||||||
| STS \$ million |
Non-STS \$ million |
Synthetic \$ million |
Sub-total \$ million |
STS \$ million |
Non-STS \$ million |
Synthetic \$ million |
Sub-total \$ million |
STS \$ million |
Non-STS \$ million |
Synthetic \$ million |
Sub-total \$ million |
||
| 1 | Total exposures | - | - | - | - | - | - | - | - | 16 | 781 | - | 797 |
| 2 | Retail (total) | - | - | - | - | - | - | - | - | 8 | 249 | - | 256 |
| 3 | residential mortgage | - | - | - | - | - | - | - | - | 8 | 216 | - | 224 |
| 4 | credit card | - | - | - | - | - | - | - | - | - | - | - | - |
| 5 | other retail exposures | - | - | - | - | - | - | - | - | - | 32 | - | 32 |
| 6 | re-securitisation | - | - | - | - | - | - | - | - | - | - | - | - |
| 7 | Wholesale (total) | - | - | - | - | - | - | - | - | 9 | 532 | - | 541 |
| 8 | loans to corporates | - | - | - | - | - | - | - | - | - | 357 | - | 357 |
| 9 | commercial mortgage | - | - | - | - | - | - | - | - | - | 27 | - | 27 |
| 10 | lease and receivables | - | - | - | - | - | - | - | - | 9 | 147 | - | 156 |
| 11 | other wholesale | - | - | - | - | - | - | - | - | - | - | - | - |
| 12 | re-securitisation | - | - | - | - | - | - | - | - | - | - | - | - |
Table 74: Securitisation exposures in the non-trading book and associated regulatory capital requirements – institution acting as originator or as sponsor (UK-SEC3)
| 2025 | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Exposure values (by RW bands/deductions) | Exposure values (by regulatory approach) | RWEA (by regulatory approach) | Capital charge after cap | |||||||||||||||
| ≤20% RW \$ million |
>20% to 50% RW \$ million |
>50% to 100% RW \$ million |
>100% to <1250% RW \$ million |
1250% RW/ deduc tions \$ million |
SEC-IR BA \$ million |
SEC ERBA (includ ing IAA) \$ million |
SEC-SA \$ million |
1250%/ deduc tions \$ million |
SEC-IR BA \$ million |
SEC ERBA (includ ing IAA) \$ million |
SEC-SA \$ million |
1250%/ deduc tions \$ million |
SEC-IR BA \$ million |
SEC ERBA (includ ing IAA) \$ million |
SEC-SA \$ million |
1250%/ deduc tions \$ million |
||
| 1 | Total exposures | 12,300 | 2,417 | – | – | – | 14,717 | – | – | – | 2,779 | – | – | – | 222 | – | – | – |
| 2 | Traditional transactions |
– | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 3 | Securitisation | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 4 | Retail underlying |
– | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 5 | Of which STS | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 6 | Wholesale | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 7 | Of which STS | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 8 | Re-securitisation | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 9 | Synthetic transactions |
12,300 | 2,417 | – | – | – | 14,717 | – | – | – | 2,779 | – | – | – | 222 | – | – | – |
| 10 | Securitisation | 12,300 | 2,417 | – | – | – | 14,717 | – | – | – | 2,779 | – | – | – | 222 | – | – | – |
| 11 | Retail underlying |
– | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 12 | Wholesale | 12,300 | 2,417 | – | – | – | 14,717 | – | – | – | 2,779 | – | – | – | 222 | – | – | – |
| 13 | Re-securitisation | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 2024 | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Exposure values (by RW bands/deductions) | Exposure values (by regulatory approach) | RWEA (by regulatory approach) | Capital charge after cap | |||||||||||||||
| ≤20% RW \$ million |
>20% to 50% RW \$ million |
>50% to 100% RW \$ million |
>100% to <1250% RW \$ million |
1250% RW/ deduc tions \$ million |
SEC-IRBA \$ million |
SEC-ERBA (includ ing IAA) \$ million |
SEC-SA \$ million |
1250%/ deduc tions \$ million |
SEC-IRBA \$ million |
SEC-ERBA (includ ing IAA) \$ million |
SEC-SA \$ million |
1250%/ deduc tions \$ million |
SEC-IRBA \$ million |
SEC-ERBA (includ ing IAA) \$ million |
SEC-SA \$ million |
1250%/ deduc tions \$ million |
||
| 1 | Total exposures | 11,015 | 3,891 | 386 | – | – | 15,292 | – | – | – | 3,096 | – | – | – | 227 | – | – | – |
| 2 | Traditional transactions |
– | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 3 | Securitisation | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 4 | Retail underlying |
– | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 5 | Of which STS | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 6 | Wholesale | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 7 | Of which STS | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 8 | Re-securitisation | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 9 | Synthetic transactions |
11,015 | 3,891 | 386 | – | – | 15,292 | – | – | – | 3,096 | – | – | – | 227 | – | – | – |
| 10 | Securitisation | 11,015 | 3,891 | 386 | – | – | 15,292 | – | – | – | 3,096 | – | – | – | 227 | – | – | – |
| 11 | Retail underlying |
– | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 12 | Wholesale | 11,015 | 3,891 | 386 | – | – | 15,292 | – | – | – | 3,096 | – | – | – | 227 | – | – | – |
| 13 | Re-securitisation | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Table 75: Securitisation exposures in the non-trading book and associated regulatory capital requirements – institution acting as investor (UK-SEC4)
| 2025 | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Exposure values (by RW bands/deductions) | Exposure values (by regulatory approach) | RWEA (by regulatory approach) | Capital charge after cap | |||||||||||||||
| ≤20% RW \$ million |
>20% to 50% RW \$ million |
>50% to 100% RW \$ million |
>100% to <1250% RW \$ million |
1250% RW/ deduc tions \$ million |
SEC-IR BA \$ million |
SEC ERBA (includ ing IAA) \$ million |
SEC-SA \$ million |
1250%/ deduct ions \$ million |
SEC-IR BA \$ million |
SEC ERBA (includ ing IAA) \$ million |
SEC-SA \$ million |
1250%/ deduct ions \$ million |
SEC-IR BA \$ million |
SEC ERBA (includ ing IAA) \$ million |
SEC-SA \$ million |
1250%/ deduct ions \$ million |
||
| 1 | Total exposures | 16,203 | 664 | 318 | 4 | – | – | 11,612 | 5,576 | 2 | – | 2,059 | 1,029 | – | – | 165 | 82 | – |
| 2 | Traditional transactions |
16,203 | 664 | 318 | 4 | – | – | 11,612 | 5,576 | 2 | – | 2,059 | 1,029 | – | – | 165 | 82 | – |
| 3 | Securitisation | 16,203 | 664 | 318 | 4 | – | – | 11,612 | 5,576 | 2 | – | 2,059 | 1,029 | – | – | 165 | 82 | – |
| 4 | Retail underlying |
5,554 | 219 | 318 | – | – | – | 3,424 | 2,666 | 1 | – | 590 | 552 | – | – | 47 | 44 | – |
| 5 | Of which STS | 254 | – | – | – | – | – | 120 | 135 | – | – | 12 | 13 | – | – | 1 | 1 | – |
| 6 | Wholesale | 10,649 | 445 | – | 4 | – | – | 8,188 | 2,910 | 1 | – | 1,470 | 477 | – | – | 118 | 38 | – |
| 7 | Of which STS | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 8 | Re-securitisation | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 9 | Synthetic transactions |
– | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 10 | Securitisation | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 11 | Retail underlying |
– | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 12 | Wholesale | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 13 | Re-securitisation | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 2024 | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Exposure values (by RW bands/deductions) | Exposure values (by regulatory approach) | RWEA (by regulatory approach) | Capital charge after cap | |||||||||||||||
| ≤20% RW \$ million |
>20% to 50% RW \$ million |
>50% to 100% RW \$ million |
>100% to <1250% RW \$ million |
1250% RW/ deduc tions \$ million |
SEC-IRBA \$ million |
SEC-ERBA (includ ing IAA) \$ million |
SEC-SA \$ million |
1250%/ deduct ions \$ million |
SEC-IRBA \$ million |
SEC-ERBA (includ ing IAA) \$ million |
SEC-SA \$ million |
1250%/ deduct ions \$ million |
SEC-IRBA \$ million |
SEC-ERBA (includ ing IAA) \$ million |
SEC-SA \$ million |
1250%/ deduct ions \$ million |
||
| 1 | Total exposures | 15,415 | 591 | 6 | 24 | – | – | 12,211 | 3,824 | – | – | 2,188 | 666 | – | – | 175 | 53 | – |
| 2 | Traditional transactions |
15,415 | 591 | 6 | 24 | – | – | 12,211 | 3,824 | – | – | 2,188 | 666 | – | – | 175 | 53 | – |
| 3 | Securitisation | 15,415 | 591 | 6 | 24 | – | – | 12,211 | 3,824 | – | – | 2,188 | 666 | – | – | 175 | 53 | – |
| 4 | Retail underlying |
4,852 | 267 | – | – | – | – | 3,152 | 1,968 | – | – | 519 | 362 | – | – | 42 | 29 | – |
| 5 | Of which STS | 267 | – | – | – | – | – | 142 | 125 | – | – | 14 | 13 | – | – | 1 | 1 | – |
| 6 | Wholesale | 10,563 | 324 | 6 | 24 | – | – | 9,059 | 1,856 | – | – | 1,669 | 304 | – | – | 134 | 24 | – |
| 7 | Of which STS | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 8 | Re-securitisation | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 9 | Synthetic transactions |
– | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 10 | Securitisation | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 11 | Retail underlying |
– | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 12 | Wholesale | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 13 | Re-securitisation | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Table 76: Exposures securitised by the institution – Exposures in default and specific credit risk adjustments (UK-SEC5)
| 2025 | 2024 | ||||||
|---|---|---|---|---|---|---|---|
| Exposures securitised by the institution – Institution acts as originator or as sponsor |
Exposures securitised by the institution – Institution acts as originator or as sponsor |
||||||
| Total outstanding nominal amount | Total amount of | Total outstanding nominal amount | Total amount of | ||||
| \$million | Of which exposures in default \$million |
specific credit risk adjustments made during the period \$million |
\$million | Of which exposures in default \$million |
specific credit risk adjustments made during the period \$million |
||
| 1 | Total exposures | 23,021 | 113 | – | 19,311 | 29 | – |
| 2 | Retail (total) | – | – | – | – | – | – |
| 3 | residential mortgage | – | – | – | – | – | – |
| 4 | credit card | – | – | – | – | – | – |
| 5 | other retail exposures | – | – | – | – | – | – |
| 6 | re-securitisation | – | – | – | – | – | – |
| 7 | Wholesale (total) | 23,021 | 113 | – | 19,311 | 29 | – |
| 8 | loans to corporates | 21,489 | 113 | – | 17,794 | 29 | – |
| 9 | commercial mortgage | 82 | – | – | 77 | – | – |
| 10 | lease and receivables | 1,450 | – | – | 1,440 | – | – |
| 11 | other wholesale | – | – | – | – | – | – |
| 12 | re-securitisation | – | – | – | – | – | – |
4. Traded risk
Our approach to Traded risk can be found in the Enterprise Risk Management approach section in the 2025 Annual Report and Accounts on pages 227 to 229.
4.1 Market risk
The primary categories of Market Risk for the Group are:
- Interest Rate Risk: arising from changes in yield curves and implied volatilities
- Foreign Exchange Rate Risk: arising from changes in currency exchange rates and implied volatilities
- Commodity Risk: arising from changes in commodity prices and implied volatilities
- Credit Spread Risk: arising from changes in the price of debt instruments and credit-linked derivatives, driven by factors other than the level of risk-free interest rates
- Equity Risk: arising from changes in the prices of equities and implied volatilities
Valuation framework
Valuation of financial assets and liabilities held at fair value is subject to an independent review by Valuation Methodology within the Finance function. For those financial assets and liabilities whose fair value is determined by reference to externally quoted prices or market observable pricing inputs or to a valuation model, an assessment is made by Valuation Methodology against external market data and consensus services. Valuation Methodology also ensures adherence to the valuation adjustment policies to incorporate bid/ask spreads, model risk and other reserves, and, where appropriate, to mark all positions in accordance with prevailing accounting and regulatory guidelines.
The Valuation and Benchmarks Committee (VBC), a sub-committee of the Corporate and Institutional Banking Risk Committee, provides oversight and governance over price testing and valuation adjustments and reviews the results on a monthly basis. In addition, the VBC also provides governance over the Group's benchmark rates review process.
Our approach to market risk can be found in the Risk management approach section in the 2025 Annual Report and Accounts on pages 227 to 229.
Regulatory VaR
Regulatory VaR is used to estimate the potential loss, from market movements, across trading book positions for which the Bank has received permission to apply the internal model approach (IMA). Regulatory VaR, including Stressed VaR and Risk Not in VaR (RNIV) measures, is used to calculate market risk RWAs for positions falling under the IMA permission.
The PRA has granted the Group permission to apply IMA for the following entities:
| Standard Chartered Bank | Solo and consolidated | |
|---|---|---|
| Standard Chartered Bank (Singapore) Ltd | Consolidated | |
| Standard Chartered Bank (Hong Kong) Ltd | Consolidated | |
| Standard Chartered Bank (China) Ltd | Consolidated | |
| Standard Chartered Bank Korea Ltd | Consolidated | |
| Standard Chartered Bank Malaysia Berhad | Consolidated | |
| Standard Chartered Bank (Taiwan) Ltd | Consolidated | |
| Standard Chartered Bank (Thai) PCL | Consolidated | |
| Standard Chartered Bank (Vietnam) Ltd | Consolidated | |
| Standard Chartered Bank AG | Consolidated |
Backtesting
Backtesting is performed to ensure that the VaR model is fit for purpose. It measures the ability of the model to correctly reflect the potential level of losses under normal trading conditions, for a certain confidence level.
A backtesting breach is recorded when the net trading P&L loss in one day is greater than the estimated VaR for the same day. For details see the further Pillar 3 disclosure on regulatory backtesting below.
Stressed VaR
Stressed VaR (sVaR) applies an equal-weighted (i.e., unscaled) model using a one-year historical stressed observation period relevant to the entity (i.e. Group or Solo). SCB has a quarterly sVaR window selection process which ensures that the stressed observation period is equivalent to the period that would maximise VaR given the entity's IMA portfolio. In Q1 and Q2 of 2025, the stressed period was the 260 business days ending 30 June 2009 reflecting the Global Financial Crisis. In Q3 and Q4 of 2025, the stressed period was the 260 business days ending 6 Jan 2017 reflecting the Chinese/African Stress Period.
4.1 Market risk continued
Stress testing
Group-wide stress testing is performed to measure the potential loss on a portfolio of financial positions due to low probability market events or risk to the Group posed by a breakdown of risk model assumptions.
Stress testing supplements the use of VaR as the primary measure of risk. The roles and responsibilities of the various business functions are set out in the Traded Risk Stress Testing standard.
Market risk changes
Value at Risk (VaR) allows the Group to manage Market Risk across the trading book and most of the fair valued non-trading books.
The average level of trading VaR in 2025 was \$25.4 million, 20 per cent higher than 2024 (\$21.1 million). The increase in trading average VaR was driven by an increase in market volatility combined with a VaR model enhancement to make the model more responsive to market volatility.
The average level of non-trading VaR in 2025 was \$47million, 37 per cent higher than 2024 (\$34.2 million). The increase in non-trading average VaR was driven by an increase in market volatility combined with a VaR model enhancement to make the model more responsive to market volatility, and larger US agency bonds inventory in the CIB non-trading portfolio.
Table 77: Market risk regulatory capital requirements
| 2025 | 2024 | ||||
|---|---|---|---|---|---|
| Market risk capital requirements for trading book | Risk Weighted Assets \$million |
Regulatory capital requirement \$million |
Risk Weighted Assets \$million |
Regulatory capital requirement \$million |
|
| Interest rate1 | 12,072 | 966 | 9,493 | 759 | |
| Equity | 121 | 10 | 20 | 2 | |
| Options | 93 | 7 | 69 | 6 | |
| Commodity | 507 | 41 | 479 | 38 | |
| Foreign exchange | 4,363 | 349 | 3,748 | 300 | |
| Internal Models Approach | 13,507 | 1,081 | 14,474 | 1,158 | |
| Total | 30,663 | 2,453 | 28,283 | 2,263 |
1 Where the risks are not within the approved scope of the internal models approach, they are captured in the relevant category above based on the Standardised Approach.
Table 78: Market risk under standardised approach (UK MR1)
| 2025 | 2024 | ||
|---|---|---|---|
| Risk Weighted Assets \$million |
Risk Weighted Assets \$million |
||
| Outright products | |||
| 1 | Interest rate risk (general and specific) | 12,072 | 9,493 |
| 2 | Equity risk (general and specific) | 121 | 20 |
| 3 | Foreign exchange risk | 4,363 | 3,748 |
| 4 | Commodity risk | 507 | 479 |
| Options | 93 | 69 | |
| 5 | Simplified approach | – | – |
| 6 | Delta-plus method | 18 | 21 |
| 7 | Scenario approach | 76 | 48 |
| 8 | Securitisation (specific risk)1 | 1,316 | 694 |
| 9 | Total | 17,156 | 13,810 |
1 Securitisation (specific risk) is included in the interest rate risk RWA number.
4.1 Market risk continued Table 79: IMA values for trading portfolios (UK MR3)
| 2025 \$million |
2024 \$million |
|
|---|---|---|
| VaR (10 day 99%)1 | ||
| Maximum value | 135 | 129 |
| Average value | 86 | 75 |
| Minimum value | 53 | 37 |
| Period end2 | 60 | 86 |
| Stressed VaR (10 day 99%)1 | ||
| Maximum value | 358 | 231 |
| Average value | 207 | 153 |
| Minimum value | 106 | 98 |
| Period end2 | 218 | 166 |
| Incremental Risk Charge (99.99%)1 | ||
| Maximum value | – | – |
| Average value | – | – |
| Minimum value | – | – |
| Period end2 | – | – |
| Comprehensive Risk capital charge (99.9%)1 | ||
| Maximum value | – | – |
| Average value | – | – |
| Minimum value | – | – |
| Period end2 | – | – |
1 Represents only the Group's portfolio covered by the IMA and calculated at the 99 per cent confidence level. Details of the Group's management VaR covering all non-structured market risk exposures, across the trading and non-trading books, calculated at the 97.5 per cent confidence level can be found in the Group's Year End Report 2025 on pages 277 to 278.
2 Actual one day VaR as at period end date.
Table 80: Market risk under the internal Model Approach (IMA) (UK MR2-A)
| 2025 | 2024 | ||||
|---|---|---|---|---|---|
| RWAs \$million |
Own funds requirements \$million |
RWAs \$million |
Own funds requirements \$million |
||
| 1 | VaR (higher of values a and b) | 2,572 | 206 | 3,984 | 319 |
| (a) | Previous day's VaR | 753 | 60 | 1,072 | 86 |
| (b) | Average of the daily VaR | 2,572 | 206 | 3,984 | 319 |
| 2 | SVaR (higher of values a and b) | 6,399 | 512 | 5,529 | 442 |
| (a) | Latest SVaR | 2,723 | 218 | 2,073 | 166 |
| (b) | Average of the SVaR | 6,399 | 512 | 5,529 | 442 |
| 3 | IRC (higher of values a and b) | – | – | – | – |
| (a) | Most recent IRC measure | – | – | – | – |
| (b) | 12 weeks average IRC measure | – | – | – | – |
| 4 | Comprehensive risk measure (higher of values a, b and c) | – | – | – | – |
| (a) | Most recent risk measure of comprehensive risk measure | – | – | – | – |
| (b) | 12 weeks average of comprehensive risk measure | – | – | – | – |
| (c) | Comprehensive risk measure Floor | – | – | – | – |
| 5 | Other1 | 4,536 | 363 | 4,960 | 397 |
| 6 | Total2 | 13,507 | 1,081 | 14,474 | 1,158 |
1 Other IMA capital add-ons for market risks not fully captured in either VaR or SVaR. More details on Risks not in VaR can be found in the Group's Year End Report 2025 on page 278.
2 Represents only the Group's portfolio covered by the IMA and calculated at the 99 per cent confidence level. Details of the Group's management VaR covering all non-structured market risk exposures, across the trading and non-trading books, calculated at the 97.5 per cent confidence level can be found in the Group's Year End Report 2025 on pages 277 to 278.
Backtesting
In 2025, there were no regulatory backtesting negative exceptions at Group level.
An enhancement to the VaR model implemented was from January 2025 to increase the model's responsiveness to abrupt upturns in market volatility.
4.1 Market risk continued
The graph below illustrates the performance of the VaR model used in capital calculations. It compares the 99 percentile profit and loss confidence level given by the VaR model with the hypothetical profit and loss of each day given the actual market movement ignoring any intra-day trading activity.
Table 81: 2025 Backtesting chart for Internal Model Approach regulatory trading book at Group level with hypothetical profit and loss (P&L) versus VaR (99 per cent, one day) (MR4)

Table 82: 2025 Backtesting chart for Internal Model Approach regulatory trading book at Group level with actual profit and loss (P&L) versus VaR (99 per cent, one day) (MR4)

4.2 Counterparty credit risk
Counterparty credit risk (CCR) is the risk that a counterparty in a foreign exchange, interest rate, commodity, equity or credit derivative or repo contract defaults prior to the maturity date of the contract, and that the Group at the time has a claim on the counterparty. CCR arises predominantly in the trading book, but also arises in the non-trading book when hedging with external counterparties is required.
CCR is managed within the overall credit risk appetite for corporate and financial institutions. CCR limits are set for individual counterparties, including central clearing counterparties, and for specific portfolios. Individual limits are calibrated to the credit grade and business model of the counterparties and are set on Potential Future Exposure (PFE). Portfolio limits are set to contain concentration risk across multiple dimensions and are set on PFE or other relevant CCR measures.
The Group reduces its credit exposures to counterparties by entering into contractual netting agreements which result in a single amount owed by or to the counterparty. The amount is calculated by netting the Mark-To-Market (MTM) owed by the counterparty to the Group and the MTM owed by the Group to the counterparty on the transactions covered by the netting agreement. In line with the International Accounting Standard (IAS) 32 principles, the Group's balance sheet will present assets and liabilities on a net basis provided there is a legally enforceable right to set off assets and liabilities, and the Group intends to settle on a net basis or realise the asset and liability simultaneously.
Wrong-way risk
Wrong-way risk occurs when an exposure increase is coupled with a decrease in the credit quality of the obligor. Specifically, as the MTM on a derivative or repo contract increases in favour of the Group, the driver of this MTM change also reduces the ability of the counterparty to meet its payment, margin call or collateral posting requirements. Wrong-way risk mostly arises from FX transactions and financing transactions. The Group employs various policies and procedures to ensure that wrong-way risk exposures are recognised upfront, monitored, and where required, contained by limits on country, tenor, collateral type and counterparty.
Stress testing
Stress testing is an integral part of CCR management, complementing PFE or other portfolio limits. Single and multi-factor scenarios are regularly applied to the CCR portfolio to identify and quantify exposures that could become a concern for the Group. The stressed exposures are monitored monthly at regional and global counterparty credit risk exposure forums. The relevance and severity of the stress scenarios are periodically reviewed with cross functional stakeholders.
Exposure value calculation
Exposure calculation used for risk management is based on a PFE measure (at 75% confidence interval). The PFE is mostly calculated from simulation models, and from PFE add-ons for the non-simulated products.
Derivatives exposures for capital calculation purposes are calculated using the Standard Approach Method (SA-CCR). Individual transactions are measured using the sum of current replacement cost and potential future credit exposure, and the benefit of netting agreements is applied as per the SA-CCR rules. This approach is used for all derivative products not covered by our Internal Models Method (IMM) permission. Under the IMM approach, EAD is calculated by multiplying the effective expected positive exposure by a factor stipulated by the regulator called alpha. The Group has been granted permission by the regulator to use the IMM approach for "vanilla" Interest Rate and Foreign Exchange over-the-counter derivatives. The IMM model is subject to model validation including regular model performance monitoring.
Exposure for repurchase transactions and securities lending or borrowing transactions for capital calculation purposes is calculated using the Financial Collateral Comprehensive Method. Supervisory volatility adjustments are applied to both collateral and exposure legs and the benefit of master netting agreements is taken into consideration.
The Group has credit policies and procedures setting out the criteria for collateral to be recognised as a credit risk mitigant, including requirements concerning legal certainty, priority, concentration, correlation, liquidity and valuation parameters such as frequency of review and independence. The Group seeks to negotiate Credit Support Annexes (CSA) with counterparties when collateral is deemed a necessary or desirable mitigant to the exposure. The credit terms of a CSA are specific to each legal document and determined by the credit risk approval unit responsible for the counterparty. The nature of the collateral is specified in the legal document and is typically cash or highly liquid securities.
The MTM of all trades captured under CSAs is calculated daily. Additional collateral will be called from the counterparty if total uncollateralised MTM exposure exceeds the threshold and minimum transfer amount specified in the CSA. Additional collateral may be required from the counterparty to provide an extra buffer to the daily variation margin process.
The Group also has policies and procedures in place setting out the criteria for guarantees to be recognised as a credit risk mitigant. Where guarantees meet regulatory criteria, the Group treats the exposure as guarantor risk from counterparty credit risk capital standpoint.
4.2 Counterparty credit risk continued
Credit valuation adjustments
CVA measures potential MTM loss associated with the deterioration in the creditworthiness of the counterparty. The Group applies standardised approach to calculate CVA capital charge on over-the-counter derivative contracts. Details on CVA are provided in note 13 of the 2025 Annual Report and Accounts on page 363.
Table 83 shows the credit exposure on derivative transactions after taking into account the benefits from legally enforceable netting agreements and collateral held, including transactions cleared through recognised trading exchanges.
Table 84 specifies the methods used by the Group to calculate counterparty credit risk regulatory requirements, followed by Table 85 which demonstrates the risk-weighted exposure amounts to central counterparties by derivative types.
Table 86 indicates the notional amounts of credit derivative transactions segregated between protection bought and sold within each product type.
Table 87 describes the exposure value subject to credit valuation adjustment charge and related RWA.
Table 83: Composition of collateral for CCR exposures (UK CCR5)
| 2025 | |||||||
|---|---|---|---|---|---|---|---|
| Collateral used in derivatives transactions | Collateral used in securities financing transactions (SFTs) |
||||||
| Fair value of collateral received | Fair value of collateral posted | Fair value of | Fair value of | ||||
| Segregated \$million |
Unsegregated \$million |
Segregated \$million |
Unsegregated \$million |
collateral received \$million |
collateral posted \$million |
||
| Collateral type | |||||||
| 1 | Cash | – | 12,281 | 2,320 | 14,196 | 669 | – |
| 2 | Debt | 522 | 8,906 | 8,897 | 5,976 | 146,451 | 161,572 |
| 3 | Equity | – | – | – | – | 11,902 | 488 |
| 4 | Other | – | – | – | – | 41,258 | 24 |
| 5 | Total | 522 | 21,187 | 11,216 | 20,172 | 200,281 | 162,084 |
| 2024 | |||||||
|---|---|---|---|---|---|---|---|
| Collateral used in derivatives transactions | Collateral used in securities financing transactions (SFTs) |
||||||
| Fair value of collateral received | Fair value of collateral posted | Fair value of | Fair value of | ||||
| Segregated \$million |
Unsegregated \$million |
Segregated \$million |
Unsegregated \$million |
collateral received \$million |
collateral posted \$million |
||
| Collateral type | |||||||
| 1 | Cash1 | – | 11,307 | 1,141 | 14,400 | 549 | |
| 2 | Debt | 430 | 4,665 | 4,044 | 1,734 | 122,674 | 116,667 |
| 3 | Equity | – | – | – | – | 14,577 | 985 |
| 4 | Other | – | – | – | – | 21,332 | 29 |
| 5 | Total | 430 | 15,972 | 5,185 | 16,133 | 159,132 | 117,681 |
1 2024 has been represented to show fair value of collateral received or posted (excluding initial margin and variation margin) for SFTs to only include security legs.
4.2 Counterparty credit risk continued Table 84: Analysis of CCR exposure by approach (UK CCR1)
| 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Replacement cost (RC) \$million |
Potential future exposure (PFE) \$million |
EEPE \$million |
Alpha used for computing regulatory exposure value |
Exposure value pre-CRM \$million |
Exposure value post-CRM \$million |
Exposure value \$million |
RWEA \$million |
||
| UK1 | Original Exposure Method (for derivatives) |
– | – | 1.4 | – | – | – | – | |
| UK2 | Simplified SA-CCR (for derivatives) | – | – | 1.4 | – | – | – | – | |
| 1 | SA-CCR (for derivatives) | 1,219 | 4,432 | 1.4 | 12,426 | 7,912 | 7,910 | 4,197 | |
| 2 | IMM (for derivatives and SFTs) | 18,561 | 1.4 | 33,276 | 25,986 | 25,978 | 10,667 | ||
| 2a | Of which securities financing transactions netting sets |
– | – | – | – | – | |||
| 2b | Of which derivatives and long settlement transactions netting sets |
18,561 | 33,276 | 25,986 | 25,978 | 10,667 | |||
| 2c | Of which from contractual cross-product netting sets |
– | – | – | – | – | |||
| 3 | Financial collateral simple method (for SFTs) |
– | – | – | – | ||||
| 4 | Financial collateral comprehensive method (for SFTs) |
260,602 | 206,783 | 206,783 | 3,806 | ||||
| 5 | VaR for SFTs | – | – | – | – | ||||
| 6 | Total | 306,304 | 240,681 | 240,671 | 18,670 |
| 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Replacement cost (RC) \$million |
Potential future exposure (PFE) \$million |
EEPE \$million |
Alpha used for computing regulatory exposure value |
Exposure value pre-CRM \$million |
Exposure value post-CRM \$million |
Exposure value \$million |
RWEA \$million |
||
| UK1 | Original Exposure Method (for derivatives) |
– | – | 1.4 | – | – | – | – | |
| UK2 | Simplified SA-CCR (for derivatives) | – | – | 1.4 | – | – | – | – | |
| 1 | SA-CCR (for derivatives) | 2,014 | 3,532 | 1.4 | 9,987 | 7,453 | 7,452 | 3,583 | |
| 2 | IMM (for derivatives and SFTs) | 18,269 | 1.6 | 42,806 | 29,227 | 29,222 | 11,322 | ||
| 2a | Of which securities financing transactions netting sets |
– | – | – | – | – | |||
| 2b | Of which derivatives and long settlement transactions netting sets |
18,269 | 42,806 | 29,227 | 29,222 | 11,322 | |||
| 2c | Of which from contractual cross-product netting sets |
– | – | – | – | – | |||
| 3 | Financial collateral simple method (for SFTs) |
– | – | – | – | ||||
| 4 | Financial collateral comprehensive method (for SFTs) |
210,101 | 171,607 | 171,607 | 3,467 | ||||
| 5 | VaR for SFTs | – | – | – | – | ||||
| 6 | Total | 262,893 | 208,287 | 208,281 | 18,372 |
4.2 Counterparty credit risk continued Table 85: Exposures to CCPs (UK CCR8)
| 2025 | 2024 | ||||
|---|---|---|---|---|---|
| Exposure value \$million |
RWA \$million |
Exposure value \$million |
RWA \$million |
||
| 1 | Exposures to QCCPs (total) | 1,018 | 950 | ||
| 2 | Trade exposure | 10,201 | 865 | 6,728 | 831 |
| 3 | Of which OTC derivatives | 7,169 | 728 | 4,042 | 703 |
| 4 | Of which exchange-traded derivatives | 1,739 | 112 | 1,576 | 106 |
| 5 | Of which SFTs | 1,293 | 26 | 1,111 | 22 |
| 6 | Of which collateral posted | – | – | – | – |
| 7 | Segregated initial margin | – | – | ||
| 8 | Non-segregated initial margin | – | – | – | – |
| 9 | Prefunded default fund contributions | 798 | 153 | 638 | 119 |
| 10 | Unfunded default fund contributions | – | – | – | – |
| 11 | Exposures to non-QCCPs (total) | 305 | 100 | ||
| 12 | Trade exposure | 307 | 295 | 93 | 91 |
| 13 | Of which OTC derivatives | 234 | 224 | 54 | 54 |
| 14 | Of which exchange-traded derivatives | 73 | 71 | 39 | 37 |
| 15 | Of which SFTs | – | – | – | – |
| 16 | Of which collateral posted | – | – | – | – |
| 17 | Segregated initial margin | – | – | ||
| 18 | Non-segregated initial margin | – | – | – | – |
| 19 | Prefunded default fund contributions | 1 | 9 | 1 | 9 |
| 20 | Unfunded default fund contributions | – | – | – | – |
Table 86: Credit derivatives exposures (UK CCR6)
| 2025 2024 |
|||||
|---|---|---|---|---|---|
| Protection bought \$million |
Protection sold \$million |
Protection bought \$million |
Protection sold \$million |
||
| Notionals | |||||
| 1 | Single-name credit default swaps | 14,893 | 12,191 | 40,847 | 36,116 |
| 2 | Index credit default swaps | 15,936 | 11,276 | 63,925 | 59,833 |
| 3 | Total return swaps | 45,432 | 1,365 | 41,031 | 1,669 |
| 4 | Credit options | – | – | – | – |
| 5 | Other Credit derivatives1 | – | – | – | – |
| Total notionals | 76,261 | 24,832 | 145,803 | 97,618 | |
| Fair values | |||||
| 6 | Positive fair value (asset) | 679 | 369 | 666 | 1,264 |
| 7 | Negative fair value (liability) | (2,506) | (260) | (2,625) | (225) |
1 2024 has been represented to exclude long settlement transactions reported in other credit derivatives.
Table 87: Transactions subject to own funds requirements for CVA risk (UK CCR2)
| 2025 | 2024 | ||||
|---|---|---|---|---|---|
| Exposure Value | RWA | Exposure Value | RWA | ||
| \$million | \$million | \$million | \$million | ||
| 1 | Total transactions subject to the Advanced method | – | – | – | – |
| 2 | (i) VaR component (including the 3× multiplier) | – | – | ||
| 3 | (ii) stressed VaR component (including the 3× multiplier) |
– | – | ||
| 4 | Transactions subject to the Standardised method | 22,327 | 2,413 | 23,756 | 2,706 |
| UK4 | Transactions subject to the Alternative approach (Based on the Original Exposure Method) |
– | – | – | – |
| 5 | Total transactions subject to own funds requirements for CVA risk |
22,327 | 2,413 | 23,756 | 2,706 |
4.2 Counterparty credit risk continued
Table 88 depicts EAD after the effect of collateral associated with each risk weight prescribed in Part Three, Title II, Chapter 2 of the CRR for counterparty credit risk.
Table 88: Standardised approach – CCR exposures by regulatory exposure class and risk weights (UK CCR3)
| 2025 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Risk Weight | ||||||||||||||
| 0% | 2% | 4% | 10% | 20% | 35% | 50% | 70% | 75% | 100% | 150% | Others | Total | ||
| Standardised Exposure Class | ||||||||||||||
| 1 | Central governments or central banks |
498 | – | – | – | 5 | – | – | – | – | – | – | – | 503 |
| 4 | Multilateral development banks | 232 | – | – | – | 31 | – | 7 | – | – | 1 | – | – | 271 |
| 6 | Institutions | – | 8,933 | 8 | – | 4 | – | – | – | – | – | – | – | 8,945 |
| 7 | Corporates | – | – | – | – | 63 | – | 6 | – | – | 4,073 | – | – | 4,142 |
| 8 | Retail | – | – | – | – | – | – | – | – | 1 | – | – | – | 1 |
| 10a | Secured on real estate property | – | – | – | – | – | 18 | – | – | – | – | – | – | 18 |
| 10b | Exposures in default | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 10c | Items belonging to regulatory high risk categories |
– | – | – | – | – | – | – | – | – | – | – | – | – |
| 10d | Other items | 127 | – | – | – | 3 | – | – | – | – | – | – | – | 130 |
| 11 | Total Standardised | 857 | 8,933 | 8 | – | 106 | 18 | 13 | – | 1 | 4,074 | – | – | 14,010 |
| 2024 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Risk Weight | ||||||||||||||
| 0% | 2% | 4% | 10% | 20% | 35% | 50% | 70% | 75% | 100% | 150% | Others | Total | ||
| Standardised Exposure Class | ||||||||||||||
| 1 | Central governments or central banks |
295 | – | – | – | 12 | – | – | – | – | – | – | – | 307 |
| 4 | Multilateral development banks | 361 | – | – | – | 30 | – | 1 | – | – | – | – | – | 392 |
| 6 | Institutions | – | 5,562 | 13 | – | 2 | – | – | – | – | – | – | – | 5,577 |
| 7 | Corporates | – | – | – | – | 76 | – | 4 | – | – | 2,484 | – | – | 2,564 |
| 8 | Retail | – | – | – | – | – | – | – | – | 1 | – | – | – | 1 |
| 10a | Secured on real estate property | – | – | – | – | – | 12 | – | – | – | – | – | – | 12 |
| 10b | Exposures in default | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 10c | Items belonging to regulatory high risk categories |
– | – | – | – | – | – | – | – | – | – | – | – | – |
| 10d | Other items | – | – | – | – | 4 | – | – | – | – | – | – | – | 4 |
| 11 | Total Standardised | 656 | 5,562 | 13 | – | 124 | 12 | 5 | – | 1 | 2,484 | – | – | 8,857 |
Exposures increased by \$5.0 billion mainly driven by a \$3.4 billion increase in exposures to institutions and a \$1.6 billion increase in corporates.
The following tables provide further detail on the exposure classes subject to counterparty credit risk, in particular for central governments or central banks, institutions, corporates. These have been split by internal credit grade which relate to the PD ranges presented.
- Central governments or central banks EAD increased by \$1.0 billion
- Institutions EAD increased by \$33.1 billion
- Corporates EAD and RWA decreased by \$3.3 billion and \$1.2 billion respectively
4.2 Counterparty credit risk continued Table 89: IRB – CCR exposures by exposure class
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| EAD post CRM and post CCF \$million |
Average PD1 % |
Number of obligors2 |
Average LGD1 % |
Average maturity1 years |
RWA \$million |
RWA density1 % |
|||||
| IRB exposure class | |||||||||||
| Central governments or central banks |
15,742 | 0.67 | 54 | 12 | 0.28 | 850 | 5 | ||||
| Institutions | 118,236 | 0.27 | 1,045 | 7 | 0.44 | 4,122 | 3 | ||||
| Corporates | 101,906 | 0.19 | 7,419 | 13 | 0.43 | 9,995 | 10 | ||||
| Of which specialised lending |
1,231 | 0.60 | 279 | 50 | 2.10 | 589 | 48 | ||||
| Of which SME | 19 | 1.94 | 25 | 85 | 2.12 | 30 | 159 | ||||
| Total IRB | 235,884 | 0.27 | 8,518 | 10 | 0.42 | 14,967 | 6 | ||||
| 2024 | |||||||||||
| EAD post CRM and post CCF \$million |
Average PD1 % |
Number of obligors2 |
Average LGD1 % |
Average maturity1 years |
RWA \$million |
RWA density1 % |
|||||
| IRB exposure class | |||||||||||
| Central governments or central banks |
14,715 | 0.51 | 48 | 9 | 0.30 | 637 | 4 | ||||
| Institutions | 85,164 | 0.21 | 1,025 | 9 | 0.51 | 4,223 | 5 | ||||
| Corporates | 105,227 | 0.25 | 7,842 | 14 | 0.46 | 11,179 | 11 | ||||
| Of which specialised lending |
996 | 0.60 | 338 | 49 | 1.89 | 461 | 46 | ||||
| Of which SME | 18 | 0.36 | 25 | 59 | 1.04 | 5 | 28 | ||||
| Total IRB | 205,106 | 0.25 | 8,915 | 12 | 0.47 | 16,039 | 8 |
1 Weighted averages are based on EAD.
2 Number of obligors is based on number of counterparties.
Table 90: IRB approach – CCR exposures by exposure class and PD scale for central governments or central banks (UK CCR4)
| 2025 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| PD range % | EAD post CRM and post CCF \$million |
Average PD1 % |
Number of obligors2 |
Average LGD1 % |
Average maturity1 years |
RWA \$million |
RWA density1 % |
|||
| 0.00 to < 0.15 | 14,411 | 0.06 | 41 | 9 | 0.16 | 261 | 2 | |||
| 0.15 to < 0.25 | 28 | 0.22 | 2 | 45 | 1.00 | 9 | 34 | |||
| 0.25 to < 0.50 | 11 | 0.39 | 1 | – | 1.00 | 5 | 48 | |||
| 0.50 to < 0.75 | 3 | 0.51 | 1 | 45 | 1.00 | 2 | 56 | |||
| 0.75 to < 2.50 | 135 | 1.18 | 2 | 45 | 1.09 | 113 | 84 | |||
| 2.50 to < 10.00 | 824 | 3.51 | 5 | 45 | 1.88 | 346 | 42 | |||
| 10.00 to < 100.00 | 305 | 13.77 | 1 | 36 | 1.08 | 12 | 4 | |||
| 100.00 (default) | 25 | 100.00 | 1 | 45 | 1.48 | 101 | 398 | |||
| Total | 15,742 | 0.67 | 54 | 12 | 0.28 | 850 | 5 |
| 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| PD range % | EAD post CRM and post CCF \$million |
Average PD1 % |
Number of obligors2 |
Average LGD1 % |
Average maturity1 years |
RWA \$million |
RWA density1 % |
||
| 0.00 to < 0.15 | 13,080 | 0.02 | 36 | 8 | 0.21 | 191 | 1 | ||
| 0.15 to < 0.25 | 25 | 0.22 | 1 | 45 | 1.78 | 10 | 42 | ||
| 0.25 to < 0.50 | – | 0.22 | – | – | – | – | 42 | ||
| 0.50 to < 0.75 | 1 | 0.51 | 2 | 45 | 1.00 | 1 | 56 | ||
| 0.75 to < 2.50 | 42 | 1.15 | 2 | 45 | 2.61 | 42 | 101 | ||
| 2.50 to < 10.00 | 1,532 | 4.25 | 5 | 16 | 0.99 | 312 | 20 | ||
| 10.00 to < 100.00 | 36 | 18.00 | 2 | 45 | 0.02 | 81 | 224 | ||
| 100.00 (default) | – | 18.00 | – | 45 | 0.02 | – | 20 | ||
| Total | 14,715 | 0.51 | 48 | 9 | 0.30 | 637 | 4 |
1 Weighted averages are based on EAD.
4.2 Counterparty credit risk continued
Table 91: IRB approach – CCR exposures by exposure class and PD scale for institutions (UK CCR4)
| 2025 | |||||||
|---|---|---|---|---|---|---|---|
| PD range % | EAD post CRM and post CCF \$million |
Average PD1 % |
Number of obligors2 |
Average LGD1 % |
Average maturity1 years |
RWA \$million |
RWA density1 % |
| 0.00 to < 0.15 | 106,683 | 0.05 | 646 | 7 | 0.44 | 2,829 | 3 |
| 0.15 to < 0.25 | 4,912 | 0.22 | 99 | 5 | 0.41 | 270 | 6 |
| 0.25 to < 0.50 | 774 | 0.39 | 48 | 6 | 0.36 | 70 | 9 |
| 0.50 to < 0.75 | 1,889 | 0.53 | 72 | 6 | 0.41 | 199 | 11 |
| 0.75 to < 2.50 | 3,644 | 1.30 | 113 | 8 | 0.36 | 645 | 18 |
| 2.50 to < 10.00 | 136 | 3.44 | 46 | 8 | 0.35 | 36 | 26 |
| 10.00 to < 100.00 | 9 | 13.88 | 15 | 45 | 1.02 | 22 | 244 |
| 100.00 (default) | 189 | 100.00 | 6 | 2 | 0.04 | 50 | 27 |
| Total | 118,236 | 0.27 | 1,045 | 7 | 0.44 | 4,122 | 3 |
| 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| PD range % | EAD post CRM and post CCF \$million |
Average PD1 % |
Number of obligors2 |
Average LGD1 % |
Average maturity1 years |
RWA \$million |
RWA density1 % |
||
| 0.00 to < 0.15 | 71,543 | 0.05 | 645 | 9 | 0.52 | 2,714 | 4 | ||
| 0.15 to < 0.25 | 6,173 | 0.22 | 93 | 7 | 0.64 | 403 | 7 | ||
| 0.25 to < 0.50 | 1,262 | 0.39 | 48 | 3 | 0.27 | 57 | 4 | ||
| 0.50 to < 0.75 | 2,431 | 0.55 | 84 | 6 | 0.24 | 232 | 10 | ||
| 0.75 to < 2.50 | 3,523 | 1.18 | 105 | 8 | 0.39 | 488 | 14 | ||
| 2.50 to < 10.00 | 90 | 5.05 | 28 | 22 | 0.80 | 67 | 74 | ||
| 10.00 to < 100.00 | 97 | 18.00 | 11 | 45 | 0.03 | 246 | 254 | ||
| 100.00 (default) | 45 | 100.00 | 11 | 3 | 0.18 | 16 | 37 | ||
| Total | 85,164 | 0.21 | 1,025 | 9 | 0.51 | 4,223 | 5 |
1 Weighted averages are based on EAD.
2 Number of obligors is based on number of counterparties within each PD grade.
Table 92: IRB approach – CCR exposures by exposure class and PD scale for corporates (UK CCR4)
| 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| PD range % | EAD post CRM and post CCF \$million |
Average PD1 % |
Number of obligors2 |
Average LGD1 % |
Average maturity1 years |
RWA \$million |
RWA density1 % |
||
| 0.00 to < 0.15 | 73,291 | 0.07 | 4,582 | 11 | 0.40 | 3,684 | 5 | ||
| 0.15 to < 0.25 | 14,541 | 0.22 | 1,163 | 13 | 0.45 | 1,760 | 12 | ||
| 0.25 to < 0.50 | 3,371 | 0.39 | 501 | 29 | 0.89 | 1,210 | 36 | ||
| 0.50 to < 0.75 | 6,374 | 0.54 | 530 | 15 | 0.41 | 1,443 | 23 | ||
| 0.75 to < 2.50 | 4,159 | 1.19 | 442 | 20 | 0.45 | 1,568 | 38 | ||
| 2.50 to < 10.00 | 114 | 3.92 | 125 | 61 | 1.95 | 201 | 176 | ||
| 10.00 to < 100.00 | 50 | 14.71 | 59 | 43 | 1.32 | 117 | 234 | ||
| 100.00 (default) | 6 | 100.00 | 17 | 36 | 2.39 | 12 | 200 | ||
| Total | 101,906 | 0.19 | 7,419 | 13 | 0.43 | 9,995 | 10 |
| 2024 |
|---|
| PD range % | EAD post CRM and post CCF \$million |
Average PD1 % |
Number of obligors2 |
Average LGD1 % |
Average maturity1 years |
RWA \$million |
RWA density1 % |
||
|---|---|---|---|---|---|---|---|---|---|
| 0.00 to < 0.15 | 80,313 | 0.07 | 4,445 | 12 | 0.42 | 4,251 | 5 | ||
| 0.15 to < 0.25 | 9,293 | 0.22 | 1,157 | 23 | 0.76 | 2,001 | 22 | ||
| 0.25 to < 0.50 | 3,506 | 0.39 | 499 | 22 | 0.68 | 934 | 27 | ||
| 0.50 to < 0.75 | 7,273 | 0.54 | 552 | 21 | 0.48 | 2,037 | 28 | ||
| 0.75 to < 2.50 | 4,125 | 1.26 | 465 | 19 | 0.40 | 1,463 | 35 | ||
| 2.50 to < 10.00 | 349 | 4.36 | 184 | 15 | 0.67 | 155 | 44 | ||
| 10.00 to < 100.00 | 365 | 16.48 | 425 | 19 | 0.51 | 325 | 89 | ||
| 100.00 (default) | 3 | 100.00 | 115 | 35 | 2.16 | 13 | 433 | ||
| Total | 105,227 | 0.25 | 7,842 | 14 | 0.46 | 11,179 | 11 |
1 Weighted averages are based on EAD.
4.2 Counterparty credit risk continued
Table 93: IRB approach – CCR exposures by exposure class and PD scale for corporates – specialised lending (UK CCR4)
| 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| PD range % | EAD post CRM and post CCF \$million |
Average PD1 % |
Number of obligors2 |
Average LGD1 % |
Average maturity1 years |
RWA \$million |
RWA density1 % |
||
| 0.00 to < 0.15 | 522 | 0.12 | 53 | 58 | 1.34 | 151 | 29 | ||
| 0.15 to < 0.25 | 188 | 0.22 | 67 | 37 | 3.61 | 81 | 43 | ||
| 0.25 to < 0.50 | 263 | 0.39 | 34 | 54 | 1.80 | 160 | 61 | ||
| 0.50 to < 0.75 | 112 | 0.54 | 40 | 40 | 3.30 | 70 | 63 | ||
| 0.75 to < 2.50 | 125 | 1.18 | 58 | 44 | 2.36 | 105 | 85 | ||
| 2.50 to < 10.00 | 16 | 3.41 | 18 | 30 | 3.24 | 14 | 90 | ||
| 10.00 to < 100.00 | 3 | 20.91 | 4 | 17 | 4.18 | 3 | 90 | ||
| 100.00 (default) | 2 | 100.00 | 5 | 19 | 4.35 | 4 | 180 | ||
| Total | 1,231 | 0.60 | 279 | 50 | 2.10 | 589 | 48 |
| 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| PD range % | EAD post CRM and post CCF \$million |
Average PD1 % |
Number of obligors2 |
Average LGD1 % |
Average maturity1 years |
RWA \$million |
RWA density1 % |
||
| 0.00 to < 0.15 | 386 | 0.10 | 79 | 52 | 1.61 | 92 | 24 | ||
| 0.15 to < 0.25 | 320 | 0.22 | 52 | 46 | 2.30 | 126 | 39 | ||
| 0.25 to < 0.50 | 81 | 0.38 | 43 | 51 | 1.86 | 48 | 59 | ||
| 0.50 to < 0.75 | 70 | 0.49 | 65 | 48 | 1.80 | 48 | 68 | ||
| 0.75 to < 2.50 | 109 | 1.05 | 64 | 48 | 1.58 | 95 | 87 | ||
| 2.50 to < 10.00 | 13 | 3.14 | 28 | 29 | 4.16 | 13 | 100 | ||
| 10.00 to < 100.00 | 15 | 10.54 | 4 | 59 | 1.00 | 38 | 248 | ||
| 100.00 (default) | 1 | 100.00 | 3 | 28 | 4.34 | 2 | 150 | ||
| Total | 996 | 0.60 | 338 | 49 | 1.89 | 461 | 46 |
1 Weighted averages are based on EAD.
2 Number of obligors is based on number of counterparties within each PD grade.
Table 94: IRB approach – CCR exposures by exposure class and PD scale for corporates – SME (UK CCR4)
| 2025 | ||||||||
|---|---|---|---|---|---|---|---|---|
| PD range % | EAD post CRM and post CCF \$million |
Average PD1 % |
Number of obligors2 |
Average LGD1 % |
Average maturity1 years |
RWA \$million |
RWA density1 % |
|
| 0.00 to < 0.15 | 1 | 0.10 | 5 | 49 | 1.00 | – | 13 | |
| 0.15 to < 0.25 | 1 | 0.25 | 2 | 87 | 1.00 | – | 53 | |
| 0.25 to < 0.50 | 3 | 0.39 | 4 | 66 | 1.00 | 2 | 51 | |
| 0.50 to < 0.75 | – | 0.67 | 2 | 66 | 1.00 | – | 69 | |
| 0.75 to < 2.50 | 2 | 1.15 | 5 | 62 | 1.00 | 1 | 67 | |
| 2.50 to < 10.00 | 12 | 2.83 | 7 | 97 | 2.84 | 26 | 227 | |
| 10.00 to < 100.00 | – | – | – | – | – | – | – | |
| 100.00 (default) | – | – | – | – | – | – | – | |
| Total | 1,231 | 0.60 | 279 | 50 | 2.10 | 589 | 48 |
| 2024 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PD range % | EAD post CRM and post CCF \$million |
Average PD1 % |
Number of obligors2 |
Average LGD1 % |
Average maturity1 years |
RWA \$million |
RWA density1 % |
||||
| 0.00 to < 0.15 | 12 | 0.05 | 1 | 54 | 1.00 | 1 | 10 | ||||
| 0.15 to < 0.25 | 2 | 0.23 | 5 | 76 | 1.37 | 1 | 48 | ||||
| 0.25 to < 0.50 | – | 0.44 | 1 | 87 | 1.00 | – | 63 | ||||
| 0.50 to < 0.75 | 3 | 0.67 | 3 | 61 | 1.00 | 2 | 54 | ||||
| 0.75 to < 2.50 | 1 | 1.53 | 3 | 71 | 1.00 | 1 | 92 | ||||
| 2.50 to < 10.00 | – | 3.52 | 10 | 82 | 1.00 | 1 | 145 | ||||
| 10.00 to < 100.00 | – | 18.00 | 2 | 70 | 1.00 | – | 270 | ||||
| 100.00 (default) | – | – | – | – | – | – | – | ||||
| Total | 18 | 0.36 | 25 | 59 | 1.04 | 5 | 28 |
1 Weighted averages are based on EAD.
5. Operational Risk
The Group applies the Standardised Approach for measuring the capital requirements for operational risk. The table below reflects the risk-weighted assets and capital requirements resultant from operational risk.
Table 95: Operational risk own funds requirements and risk-weighted exposure amounts (UK OR1)
| 2025 | ||||||
|---|---|---|---|---|---|---|
| Relevant indicator | Own funds | Risk weighted | ||||
| Year-3 | Year-2 | Last year | requirements | exposure amount | ||
| Banking activities | \$million | \$million | \$million | \$million | \$million | |
| 1 | Banking activities subject to basic indicator approach (BIA) |
– | – | – | – | – |
| 2 | Banking activities subject to standardised (TSA) / alternative standardised (ASA) approaches |
17,779 | 19,584 | 20,898 | 2,818 | 35,223 |
| 3 | Subject to TSA: | 17,779 | 19,584 | 20,898 | ||
| 4 | Subject to ASA: | – | – | – | ||
| 5 | Banking activities subject to advanced measurement approaches AMA |
– | – | – | – | – |
| 2024 | ||||||
| Relevant indicator | Own funds | Risk weighted | ||||
| Year-3 | Year-2 | Last year | requirements | exposure amount | ||
| Banking activities | \$million | \$million | \$million | \$million | \$million | |
| 1 | Banking activities subject to basic indicator approach (BIA) |
– | – | – | – | – |
| Banking activities subject to standardised (TSA) / | ||||||
| 2 | alternative standardised (ASA) approaches | 14,337 | 16,015 | 17,850 | 2,358 | 29,479 |
| 3 | Subject to TSA: | 14,337 | 16,015 | 17,850 | ||
| 4 | Subject to ASA: | – | – | – | ||
| 5 | Banking activities subject to advanced measurement approaches AMA |
– | – | – | – | – |
6. Interest rate risk in the banking book
The Group defines Interest Rate Risk in the Banking Book ('IRRBB') as the potential for loss of future earnings or economic value following adverse movements in interest rates, which arises from a mismatch in the re-pricing profile of assets, liabilities, and off-balance sheet items in the banking book.
Risk Control and Governance
Treasury is responsible for monitoring IRRBB through the Treasury Risk Type Framework, policies and Risk Appetite, subject to independent oversight and challenge from Risk and Internal Audit.
The Board delegates the management of IRRBB to the Group Asset & Liability Committee (GALCO), which provides oversight of Group-level IRRBB and works in conjunction with Country ALCOs to monitor IRRBB as per the Risk Type Framework. IRRBB is managed at a country level by the Country ALCO, chaired by the Country CFO.
IRRBB models and methodologies are defined for the Group by the Treasury function, independently validated and approved by the Risk function. Country modelling assumptions are derived locally using the Group's methodologies and are reviewed by Country ALCO.
The Group uses Funds Transfer Pricing (FTP) to transfer re-pricing risk from the business to Treasury, including that arising from structural positions such as non-maturity deposit balances. For non-maturity deposits (NMDs), the assumed duration is dependent on the portion that can be considered stable and the degree to which these balances are considered price sensitive. Certain structural balances have been approved by GALCO and Country ALCOs to be risk managed directly under the Group's structural hedging programme. Other re-pricing risks transferred to Treasury are managed on an integrated basis with a securities portfolio maintained for liquidity and investment management purposes. Basis risk where material (whether transferred to and managed by Treasury or remaining in the business) is reported and overseen at local ALCOs.
Re-pricing risk arising within Treasury is managed using a combination of on-balance sheet short and long tenor securities and derivative hedges. Derivative hedges are subject to Fair Value and Cash Flow Hedge accounting treatment where available. These interest rate risk positions and limits are independently monitored by the Risk function.
Key Risk Measures
The Group uses two key metrics for measuring IRRBB: Net Interest Income ('NII') Sensitivity, an income measure which quantifies the potential change in projected net interest income over a one-year horizon from defined movements in interest rates; and Economic Value of Equity ('EVE'), a value measure which estimates the potential change in the present value of the Group's Banking Book assets and liabilities from defined movements in interest rates. These measures differ in their coverage of the drivers of interest rate risk and the time horizon for these to materialise but used together they can provide a complementary and rounded view of the Group's risk profile. Both NII Sensitivity and EVE are monitored monthly against defined Risk Appetite limits, which are set at the Group level and, where appropriate, at a country level in compliance with local regulatory requirements.
NII Sensitivity and EVE are indicative stress tests calculated under various interest rate scenarios, including parallel and nonparallel shifts and a range of internally designed scenarios that assess vulnerabilities in the Group's business model and key behavioural assumptions under interest rate shocks and stresses. These stress tests are supplemented by internal NII forecasts which are used for financial planning purposes.
Stress tests are performed monthly to identify structural risks to Net Interest Income or the Economic Value of the Banking Book under adverse but plausible interest rate scenarios. Additionally, stress testing of IRRBB is covered as part of ICAAP and BoE concurrent stress testing exercises (more information on stress testing can be found on page 24). Stress testing of price risk on Fair Value instruments in the Banking Book is conducted by Traded Risk Management under the Traded Risk Framework.
Prescribed Regulatory Interest Rate Shock and Stress Scenarios
The following table shows the Group's NII sensitivity and EVE regulatory metrics under each of the interest rate shock scenarios prescribed by the PRA (Rule 9.4A of the PRA Rulebook: CRR Firms: Interest Rate Risk Arising from Non-Trading Activities Instrument 2020. The sensitivities are indicative and subject to standardised shocks and parametric assumptions that may differ to those used in the Group's own internal models; please see next section for more information. The sensitivities should not be considered an income or profit forecast. Furthermore, the regulatory EVE results should not be considered a proxy for expected income or capital impacts on a going concern basis.
Key modelling and parametric assumptions
Net Interest Income Sensitivity
For regulatory NII sensitivities, currency specific shocks are applied as follows:
• A parallel interest rate shock (up and down) to the current market-implied path of rates, across all yield curves, including +/- 200 bps immediate shock for USD and HKD; +/- 150 bps for SGD; +/- 250 bps for CNY and GBP; and +/- 300 bps for KRW. The assessment assumes that the size and mix of the balance sheet remain constant and that there are no specific management actions in response to the change in rates. No assumptions are made in relation to the impact on credit spreads in a changing rate environment. Significant modelling and behavioural assumptions are made regarding scenario simplification, market competition, pass-through rates, asset and liability re-pricing tenors, and price flooring.
Economic Value of Equity Sensitivity
The regulatory EVE sensitivities have been calculated under six standardised interest rate shock scenarios for measuring EVE under the standard outlier test, defined by the PRA.
For EVE, commercial margins and other spread components have been included in the modelled cashflows. The sensitivity represents a hypothetical impact to capital assuming a complete balance sheet run-off, assuming no new business. Balances are adjusted for assumed behavioural profiles, primarily non-maturity deposits, which reflect quantitative and qualitative assessments of the expected stability, rate sensitivity and run off of client balances under varying interest rate conditions.
In line with regulatory guidelines:
- all equity instruments that have no coupon or call dates have been excluded;
- market interest rate floors start at -1.0% for the overnight tenor on the yield curve and increase by 5bps per year to at the 20 year tenor point on the yield curve; and
- the aggregate EVE sensitivity for each interest rate shock scenario is calculated by adding together the negative and positive changes to EVE occurring in each currency. Positive values are weighted by 50%, but the full impact of negative values is included.
As at 31 December 2025, the average repricing maturity assigned to Non-Maturity Deposits was 6 months and the longest repricing maturity was 60 months.
Table 96: Quantitative information on IRRBB (UK IRRBB1)
| Change in EVE | Change in NII | Tier 1 capital | ||||||
|---|---|---|---|---|---|---|---|---|
| Banking activities | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 | ||
| 010 | Parallel shock up | (2,479) | (2,385) | 1,135 | 977 | |||
| 020 | Parallel shock down | 1,267 | 1,174 | (1,664) | (1,449) | |||
| 030 | Steepener shock | (352) | (426) | |||||
| 040 | Flattener shock | (314) | (234) | |||||
| 050 | Short rates shock up | (1,174) | (1,044) | |||||
| 060 | Short rates shock down | 511 | 451 | |||||
| 070 | Maximum | (2,479) | (2,385) | (1,664) | (1,449) | |||
| 080 | Tier 1 capital | 43,949 | 41,672 |
As at 31 December 2025, the maximum EVE decline was \$2,479 million under the parallel shock up. This does not represent the expected impact to capital. EVE sensitivity is driven by duration mismatches in the balance sheet. The magnitude of the result is largely due to the exclusion of equity, in line with regulatory guidelines, versus the inclusion of a structural hedge that is designed to stabilise the net interest income arising from the deployment of equity.
In addition, EVE sensitivity shows the theoretical reduction in the value of the structural hedge when rates rise but does not capture the benefit to future income that would result from rising interest rates as demonstrated by the NII Sensitivity.
Duration mismatches for the remainder of the balance sheet are largely immaterial; however, the sensitivity is amplified by large shocks to Emerging Markets currencies, and the impact of weighting positive values at the currency level by 50%. This 50% haircut on positive EVE values is also the main driver of asymmetry between EVE up and down shocks.
The most adverse impact to NII under the regulatory scenarios was a reduction of \$1,664 million under the parallel shock down. While the interest rate shocks used to compute the regulatory NII sensitivity are larger than the Group's NII sensitivities used for risk management, the drivers of the sensitivities and the limitations of these measures are consistent (please see page 285 of the 2025 Annual Report and Accounts for more information).
7. Liquidity risk
Liquidity & Funding risk management
For information on the Group's Liquidity & Funding risk management practices and risk profile we refer to the Principal Risks and Risk Profile sections of the 2025 Annual Report and Accounts on pages 283 and 287 respectively.
Liquidity Coverage Ratio (LCR) disclosure
The Liquidity Coverage Ratio (LCR) is a regulatory stress ratio measuring the proportion of High-Quality Liquid Assets (HQLA) against net outflows over 30 calendar days. An essential component of the Basel III reforms, the LCR was introduced in October 2015 with the goal of promoting the short-term resilience of a firm's liquidity risk profile.
The Group monitors and reports its LCR under UK onshored Commission Delegated Regulation 2015/61 (LCR Delegated Act rules) and is also subject to local prudential LCR requirements across our footprint, where applicable. The Prudential Regulation Authority (PRA), as the Group's competent authority, accelerated LCR implementation by setting an initial industry-wide minimum threshold of 80 per cent on 1 October 2015 before increasing to 90 per cent on 1 January 2017 ahead of full implementation (100 per cent) from 1 January 2018.
The LCR is a Pillar 1 regulatory requirement calculated by applying standardised haircuts, outflow and inflow factors to HQLA, liabilities and assets respectively. Risks not captured, or not fully captured, under the standardised Pillar 1 ratio (e.g. Intra-day risk or other risks specific to each firm) are known as Pillar 2 risks and are captured under a separate Pillar 2 regulatory framework. These Pillar 2 requirements are set in the form of fixed or variable add-ons to LCR Pillar 1 requirements. Therefore, it should be noted that the HQLA reported in the table below is held to meet Pillar 1 and Pillar 2 risks along with internal Board approved risk appetite.
HQLA
HQLA eligible securities, as defined under LCR Delegated Act rules, fall into three categories: Level 1, Level 2A, and Level 2B liquid assets. Level 1 liquid assets, which are of the highest quality and deemed the most liquid (e.g. central bank reserves or securities issued by the U.S. Treasury Department), are subject to no or little discount (or haircuts) to their market value and may be largely used without limit in the liquidity buffer, except for Level 1 covered bonds.
Level 2A and 2B securities are recognised as being relatively stable and reliable sources of liquidity, but not to the same extent as Level 1 assets. LCR rules therefore set a 40 per cent composition cap on the combined amount of Level 2A and Level 2B that firms may hold in their total eligible liquidity buffer. Level 2B liquid assets, which are considered less liquid and more volatile than Level 2A liquid assets, are subject to large and varying haircuts and may not exceed 15 per cent of the total eligible HQLA.
To be recognised as HQLA eligible, securities must also meet various operational and general requirements designed to ensure that such assets have robust liquidity characteristics and can be freely converted into cash within a short timeframe, without significant loss in value.
Outflows
Expected outflows are generally calculated as a percentage outflow of on-balance sheet items (e.g. funding received) and off-balance sheet commitments (e.g. credit and liquidity lines) made by firms. This outflow varies typically by counterparty. For example, the outflow expected on retail deposits is lower than the outflow expected on deposits provided by corporates or financial institutions.
Inflows
Expected inflows are also generally calculated as a percentage inflow on-balance sheet items and include inflows (e.g. from retail or corporate loans) that will be repaid within 30 days. To ensure a minimum level of liquid asset holdings, and to prevent firms from relying solely on anticipated inflows to meet their liquidity coverage ratio, the prescribed amount of inflows that can offset outflows is capped at 75 per cent of total expected outflows.
Calculated pursuant to LCR Delegated Act rules, the following table sets forth simple averages of month-end Group LCR observations over the 12-months preceding each quarter. For a period end Group LCR disclosure, refer to page 281 of the 2025 Annual Report and Accounts.
Table 97: Liquidity Coverage Ratio (LCR) (UK LIQ1)
| 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Total unweighted value (average) |
Total weighted value (average) |
||||||||
| 31.03.25 \$million |
30.06.25 \$million |
30.09.25 \$million |
31.12.25 \$million |
31.03.25 \$million |
30.06.25 \$million |
30.09.25 \$million |
31.12.25 \$million |
||
| Number of data points used in the calculation of averages |
12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | |
| High-Quality Liquid Assets | |||||||||
| 1 | Total High-Quality Liquid Assets (HQLA) |
177,586 | 180,147 | 182,646 | 185,262 | ||||
| Cash outflows | |||||||||
| 2 | Retail deposits and deposits from small business customers, of which: |
188,544 | 196,413 | 204,354 | 211,436 | 17,541 | 18,345 | 19,227 | 19,671 |
| 3 | Stable deposits | 29,423 | 33,815 | 38,809 | 43,228 | 1,471 | 1,691 | 1,940 | 2,161 |
| 4 | Less stable deposits | 159,121 | 162,598 | 165,545 | 168,207 | 16,070 | 16,654 | 17,287 | 17,509 |
| 5 | Unsecured wholesale funding, of which: | 268,878 | 273,127 | 276,536 | 281,690 | 117,376 | 118,768 | 119,322 | 121,234 |
| 6 | Operational deposits (all counterparties) and deposits in networks of cooperative banks |
109,512 | 113,024 | 116,321 | 119,083 | 27,361 | 28,239 | 29,045 | 29,718 |
| 7 | Non-operational deposits (all counterparties) |
155,354 | 155,636 | 155,582 | 158,131 | 86,002 | 86,062 | 85,645 | 87,041 |
| 8 | Unsecured debt | 4,012 | 4,467 | 4,633 | 4,476 | 4,012 | 4,467 | 4,633 | 4,476 |
| 9 | Secured wholesale funding | 6,848 | 7,339 | 7,290 | 7,246 | ||||
| 10 | Additional requirements | 106,994 | 109,191 | 110,451 | 111,343 | 32,782 | 33,637 | 32,668 | 30,576 |
| 11 | Outflows related to derivative exposures and other collateral requirements |
21,962 | 21,972 | 19,872 | 16,512 | 16,314 | 16,661 | 15,360 | 12,825 |
| 12 | Outflows related to loss of funding on debt products |
49 | 21 | 37 | 28 | 49 | 21 | 37 | 28 |
| 13 | Credit and liquidity facilities | 84,983 | 87,198 | 90,542 | 94,804 | 16,418 | 16,955 | 17,271 | 17,723 |
| 14 | Other contractual funding obligations | 12,786 | 13,060 | 13,730 | 15,534 | 9,209 | 9,280 | 9,699 | 11,260 |
| 15 | Other contingent funding obligations | 256,674 | 258,204 | 257,474 | 254,800 | 3,546 | 3,550 | 3,670 | 3,873 |
| 16 | Total cash outflows | 187,301 | 190,919 | 191,877 | 193,861 | ||||
| Cash inflows | |||||||||
| 17 | Secured lending (e.g. reverse repos) | 74,199 | 80,197 | 83,075 | 89,539 | 13,130 | 13,797 | 14,181 | 15,143 |
| 18 | Inflows from fully performing exposures | 52,089 | 51,250 | 50,851 | 51,729 | 36,249 | 35,716 | 35,407 | 36,143 |
| 19 | Other cash inflows | 30,028 | 31,465 | 33,173 | 34,449 | 18,973 | 20,287 | 21,908 | 22,764 |
| UK-19a | (Difference between total weighted inflows and total weighted outflows arising from transactions in third countries where there are transfer restrictions or which are denominated |
||||||||
| in non-convertible currencies) | – | – | – | – | |||||
| UK-19b | (Excess inflows from a related specialised credit institutions) |
– | – | – | – | ||||
| 20 | Total cash inflows | 156,316 | 162,912 | 167,099 | 175,717 | 68,352 | 69,800 | 71,495 | 74,049 |
| UK-20a Fully exempt inflows | – | – | – | – | – | – | – | – | |
| UK-20b Inflows subject to 90% cap | – | – | – | – | – | – | – | – | |
| UK-20c | Inflows subject to 75% cap | 149,270 | 155,246 | 159,337 | 167,334 | 68,352 | 69,800 | 71,495 | 74,049 |
| Total adjusted value | |||||||||
| 21 | Liquidity buffer | 177,586 | 180,147 | 182,646 | 185,262 | ||||
| 22 23 |
Total net cash outflows Liquidity coverage ratio (%) |
118,948 149% |
121,119 149% |
120,381 152% |
119,812 155% |
||||
Table 97: Liquidity Coverage Ratio (LCR) (UK LIQ1) continued
| 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Total unweighted value (average) |
Total weighted value (average) |
||||||||
| 31.03.24 \$million |
30.06.24 \$million |
30.09.24 \$million |
31.12.24 \$million |
31.03.24 \$million |
30.06.24 \$million |
30.09.24 \$million |
31.12.24 \$million |
||
| Number of data points used in the calculation of averages |
12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | |
| High-Quality Liquid Assets | |||||||||
| 1 | Total High-Quality Liquid Assets (HQLA) | 187,777 | 184,937 | 180,914 | 178,676 | ||||
| Cash outflows | |||||||||
| 2 | Retail deposits and deposits from small business customers, of which: |
160,852 | 166,820 | 174,527 | 182,277 | 16,641 | 16,545 | 16,667 | 16,984 |
| 3 | Stable deposits | 35,837 | 32,573 | 29,406 | 26,759 | 1,792 | 1,629 | 1,470 | 1,338 |
| 4 | Less stable deposits | 125,015 | 134,247 | 145,121 | 155,518 | 14,849 | 14,916 | 15,196 | 15,647 |
| 5 | Unsecured wholesale funding, of which: | 265,422 | 265,492 | 267,511 | 268,125 | 120,081 | 119,500 | 119,167 | 118,058 |
| 6 | Operational deposits (all counterparties) and deposits in networks of cooperative banks |
110,232 | 107,508 | 106,485 | 106,393 | 27,540 | 26,859 | 26,604 | 26,582 |
| 7 | Non-operational deposits (all counterparties) |
149,431 | 152,583 | 156,224 | 157,426 | 86,783 | 87,240 | 87,761 | 87,170 |
| 8 | Unsecured debt | 5,758 | 5,401 | 4,802 | 4,306 | 5,758 | 5,401 | 4,802 | 4,306 |
| 9 | Secured wholesale funding | 5,321 | 5,529 | 5,888 | 6,276 | ||||
| 10 | Additional requirements | 101,849 | 102,520 | 103,364 | 105,088 | 30,774 | 30,391 | 30,995 | 32,078 |
| 11 | Outflows related to derivative exposures and other collateral requirements |
18,005 | 18,993 | 20,116 | 21,430 | 15,074 | 14,554 | 15,042 | 15,933 |
| 12 | Outflows related to loss of funding | ||||||||
| on debt products | 2 | 32 | 32 | 50 | 2 | 32 | 32 | 50 | |
| 13 | Credit and liquidity facilities | 83,842 | 83,496 | 83,217 | 83,608 | 15,699 | 15,805 | 15,921 | 16,095 |
| 14 | Other contractual funding obligations | 11,172 | 11,067 | 11,986 | 12,098 | 8,192 | 8,457 | 9,098 | 8,908 |
| 15 | Other contingent funding obligations | 244,096 | 247,871 | 252,574 | 256,204 | 2,818 | 3,138 | 3,411 | 3,587 |
| 16 | Total cash outflows | 183,826 | 183,559 | 185,227 | 185,890 | ||||
| Cash inflows | |||||||||
| 17 | Secured lending (e.g. reverse repos) | 57,672 | 57,428 | 61,322 | 66,620 | 8,477 | 9,029 | 10,077 | 11,424 |
| 18 | Inflows from fully performing exposures | 56,103 | 55,383 | 54,576 | 52,650 | 39,969 | 39,109 | 38,220 | 36,776 |
| 19 | Other cash inflows | 27,989 | 28,215 | 29,188 | 29,751 | 17,591 | 17,536 | 18,175 | 18,695 |
| UK-19a | (Difference between total weighted inflows and total weighted outflows arising from transactions in third countries where there are transfer restrictions or which are denominated in non-convertible currencies) |
– | – | – | – | ||||
| UK-19b | (Excess inflows from a related specialised credit institutions) |
– | – | – | – | ||||
| 20 | Total cash inflows | 141,763 | 141,025 | 145,086 | 149,021 | 66,037 | 65,674 | 66,472 | 66,896 |
| UK-20a | Fully exempt inflows | – | – | – | – | – | – | – | – |
| UK-20b | Inflows subject to 90% cap | – | – | – | – | – | – | – | – |
| UK-20c | Inflows subject to 75% cap | 135,793 | 135,805 | 139,655 | 142,932 | 66,037 | 65,674 | 66,472 | 66,896 |
| Total adjusted value | |||||||||
| 21 | Liquidity buffer | 187,777 | 184,937 | 180,914 | 178,676 | ||||
| 22 | Total net cash outflows | 117,790 | 117,885 | 118,755 | 118,995 | ||||
| 23 | Liquidity coverage ratio (%) | 160% | 157% | 153% | 150% |
The ratios reported in the above table are simple averages of month-end Group LCR ratios over the twelve months preceding each quarter. Therefore, these ratios may not be equal to the implied LCR calculated when using the average component amounts reported under 'Liquidity buffer' and 'Total net cash outflows' in the above table.
Main drivers and changes in LCR
The Group continued to maintain a strong average LCR position over the reporting period with a prudent surplus to both Board approved risk appetite and regulatory requirements. LCR at 155% was higher compared to 2024. Increase is mainly driven by increase in HQLA with Net outflows (outflow minus inflow) remaining broadly stable.
Net Stable Funding Ratio
The Net Stable Funding Ratio (NSFR) is a regulatory ratio measuring Available Stable Funding ("ASF") compared to Required Stable Funding ("RSF") over the time horizon of one year.
Table 98: Net Stable Funding Ratio (UK LIQ2)
| 2025 | ||||||
|---|---|---|---|---|---|---|
| Unweighted value by residual maturity | ||||||
| No maturity \$million |
< 6 months \$million |
6 months to < 1yr \$million |
≥ 1yr \$million |
Weighted value (aver age) \$million |
||
| Available stable funding (ASF) Items | ||||||
| 1 | Capital items and instruments | 50,690 | 525 | 584 | 9,215 | 60,197 |
| 2 | Own funds | 50,690 | 525 | 584 | 9,215 | 60,197 |
| 3 | Other capital instruments | – | – | – | – | |
| 4 | Retail deposits | 201,300 | 9,751 | 1,678 | 194,416 | |
| 5 | Stable deposits | 53,045 | 2,781 | 60 | 53,095 | |
| 6 | Less stable deposits | 148,255 | 6,970 | 1,618 | 141,321 | |
| 7 | Wholesale funding: | 399,225 | 37,525 | 56,655 | 208,148 | |
| 8 | Operational deposits | 118,453 | – | – | 59,227 | |
| 9 | Other wholesale funding | 280,772 | 37,525 | 56,655 | 148,921 | |
| 10 | Interdependent liabilities | 2,816 | 52 | 48 | – | |
| 11 | Other liabilities: | 1,147 | 61,093 | 1,577 | 858 | 1,646 |
| 12 | NSFR derivative liabilities | 1,147 | ||||
| 13 | All other liabilities and capital instruments not included in the above categories |
61,093 | 1,577 | 858 | 1,646 | |
| 14 | Total available stable funding (ASF) | 464,406 | ||||
| Required stable funding (RSF) Items | ||||||
| 15 | Total high-quality liquid assets (HQLA) | 12,538 | ||||
| UK-15a | Assets encumbered for more than 12m in cover pool | – | – | – | – | |
| 16 | Deposits held at other financial institutions for operational purposes |
2,742 | – | – | 1,371 | |
| 17 | Performing loans and securities: | 189,484 | 61,192 | 216,751 | 262,570 | |
| 18 | Performing securities financing transactions with financial | |||||
| customers collateralised by Level 1 HQLA subject to 0% haircut |
27,126 | 1,596 | 2,165 | 5,671 | ||
| 19 | Performing securities financing transactions with financial customer collateralised by other assets and loans and advances to financial institutions |
68,638 | 29,217 | 26,712 | 48,825 | |
| 20 | Performing loans to non-financial corporate clients, loans to retail and small business customers, and loans to sovereigns, and PSEs, of which: |
47,760 | 14,981 | 85,796 | 104,299 | |
| 21 | With a risk weight of less than or equal to 35% under the Basel II Standardised Approach for credit risk |
2,748 | 1,643 | 1,525 | 3,490 | |
| 22 | Performing residential mortgages, of which: | 2,136 | 1,571 | 61,767 | 43,818 | |
| 23 | With a risk weight of less than or equal to 35% under the Basel II Standardised Approach for credit risk |
1,561 | 949 | 55,781 | 38,131 | |
| 24 | Other loans and securities that are not in default and do not qualify as HQLA, including exchange-traded equities and trade finance on-balance sheet products |
43,824 | 13,828 | 40,310 | 59,956 | |
| 25 | Interdependent assets | – | – | 2,917 | – | |
| 26 | Other assets: | – | 59,403 | 2,571 | 47,992 | 51,331 |
| 27 | Physical traded commodities | 18,178 | 15,451 | |||
| 28 | Assets posted as initial margin for derivative contracts and contributions to default funds of |
|||||
| CCPs | 420 | 9 | 11,990 | 10,557 | ||
| 29 | NSFR derivative assets | 559 | – | – | 559 | |
| 30 | NSFR derivative liabilities before deduction of variation margin posted |
19,703 | – | – | 985 | |
| 31 | All other assets not included in the above | |||||
| categories | 38,722 | 2,561 | 17,825 | 23,779 | ||
| 32 | Off-balance sheet items | 174,334 | 74,530 | 103,661 | 7,348 | |
| 33 | Total RSF | 335,158 | ||||
| 34 | Net Stable Funding Ratio (%) | 138.6% |
Table 98: Net Stable Funding Ratio (UK LIQ2) continued
| 2024 | ||||||
|---|---|---|---|---|---|---|
| Unweighted value by residual maturity | ||||||
| No maturity \$million |
< 6 months \$million |
6 months to < 1yr \$million |
≥ 1yr \$million |
Weighted value (average) \$million |
||
| Available stable funding (ASF) Items | ||||||
| 1 | Capital items and instruments | 48,085 | 1,164 | 1,802 | 10,456 | 59,442 |
| 2 | Own funds | 48,085 | 1,164 | 1,802 | 10,456 | 59,442 |
| 3 | Other capital instruments | – | – | – | – | |
| 4 | Retail deposits | 166,882 | 11,230 | 2,054 | 163,814 | |
| 5 | Stable deposits | 28,827 | 362 | 109 | 27,838 | |
| 6 | Less stable deposits | 138,055 | 10,869 | 1,945 | 135,976 | |
| 7 | Wholesale funding: | 379,391 | 38,297 | 50,552 | 192,931 | |
| 8 | Operational deposits | 102,808 | – | – | 51,404 | |
| 9 | Other wholesale funding | 276,583 | 38,297 | 50,552 | 141,527 | |
| 10 | Interdependent liabilities | 2,306 | 84 | 14 | – | |
| 11 | Other liabilities: | 588 | 60,130 | 833 | 1,099 | 1,471 |
| 12 | NSFR derivative liabilities | 588 | ||||
| 13 | All other liabilities and capital instruments not included in the above categories |
60,130 | 833 | 1,099 | 1,471 | |
| 14 | Total available stable funding (ASF) | 417,658 | ||||
| Required stable funding (RSF) Items | ||||||
| 15 | Total high-quality liquid assets (HQLA) | 11,340 | ||||
| UK-15a | Assets encumbered for more than 12m in cover pool | – | – | – | – | |
| 16 | Deposits held at other financial institutions for operational purposes |
2,749 | – | – | 1,375 | |
| 17 | Performing loans and securities: | 201,490 | 64,747 | 193,269 | 248,900 | |
| 18 | Performing securities financing transactions with financial customers collateralised by Level 1 HQLA subject to 0% haircut |
25,487 | 1,216 | 2,162 | 4,832 | |
| 19 | Performing securities financing transactions with financial customer collateralised by other assets and loans and advances to financial institutions |
74,512 | 25,983 | 21,063 | 43,318 | |
| 20 | Performing loans to non-financial corporate clients, loans to retail and small business customers, and loans to |
|||||
| sovereigns, and PSEs, of which: | 47,005 | 14,574 | 76,932 | 96,565 | ||
| 21 | With a risk weight of less than or equal to 35% under the Basel II Standardised Approach for credit risk |
938 | 1,184 | 1,590 | 2,492 | |
| 22 | Performing residential mortgages, of which: | 3,529 | 2,184 | 57,479 | 41,380 | |
| 23 | With a risk weight of less than or equal to 35% under the Basel II Standardised Approach for credit risk |
2,580 | 1,399 | 52,780 | 36,519 | |
| 24 | Other loans and securities that are not in default and do not qualify as HQLA, including exchange-traded equities and trade finance on-balance sheet products |
50,957 | 20,790 | 35,632 | 62,805 | |
| 25 | Interdependent assets | – | – | 2,404 | – | |
| 26 | Other assets: | – | 60,298 | 1,906 | 38,311 | 41,052 |
| 27 | Physical traded commodities | 7,247 | 6,160 | |||
| 28 | Assets posted as initial margin for derivative contracts and contributions to default funds of |
|||||
| CCPs | – | – | 12,784 | 10,866 | ||
| 29 | NSFR derivative assets | 693 | – | – | 693 | |
| 30 | NSFR derivative liabilities before deduction of | |||||
| variation margin posted | 17,274 | – | – | 864 | ||
| 31 | All other assets not included in the above | |||||
| categories | 42,331 | 1,906 | 18,280 | 22,469 | ||
| 32 | Off-balance sheet items1 | 164,524 | 72,517 | 104,556 | 6,282 | |
| 33 | Total RSF | 308,948 | ||||
| 34 | Net Stable Funding Ratio (%) | 135.2% |
1 During 2025, uncommitted facilities were included in the NSFR templates. To allow for meaningful year on year comparatives, Pillar 3 templates have been re-stated to account for this change.
HQLA composition
Figures reported in this section are simple averages of the 12 data points over the reporting period Jan 2025 to Dec 2025.
HQLA presented herein excludes excess liquidity held at certain subsidiaries that is not transferable within the Group.
Our liquidity management function in Treasury actively manages the size and composition of our eligible HQLA to ensure it is well diversified and reflects the Group's Board approved risk appetite and supporting risk measures, regulatory and internal stress testing requirements, the currency denomination of outflows, amongst other relevant considerations.
For a regional view of our HQLA liquidity pool, refer to page 281 of the 2025 Annual Report and Accounts.
Table 99: Total eligible high-quality liquid assets (HQLA)
| Average unweighted | Average weighted | |
|---|---|---|
| Level 1 reserves | 44% | 44% |
| Level 1 liquid securities | 53% | 53% |
| Level 2A liquid assets | 3% | 2% |
| Level 2B liquid assets | 1% | – |
Concentration of funding and liquidity sources
The Group's funding strategy is largely driven by its policy to maintain adequate liquidity at all times, in all geographic locations and in all currencies, and hence to be in a position to meet all obligations as they fall due.
With a sufficiently flexible funding strategy we are able to reduce liquidity risk by diversifying our liquidity resources. Our high degree of geographic diversification constitutes a material risk offset because of our ability to raise a variety of funding across a number of markets in which we operate.
The Group has established internal measures to closely monitor and highlight any build up in counterparty, industry and tenor concentrations to ensure it can meet liquidity needs under different stress scenarios and different time horizons.
Our funding profile over the reporting period was well diversified across different sources by product, business and tenor. Consistent with the Group's funding strategy, customer assets were largely funded out of customer deposits, which are considered a stable source of funding. Customer deposits are primarily sourced from Current Account Saving Account balances along with time deposits and these are further diversified across different customer segments, currencies, tenors and markets.
For further details on the Group's funding profile, refer to pages 281 to 282 of the 2025 Annual Report and Accounts.
Derivative exposures and potential collateral calls
In the normal course of business, the Group deals in the Over-the-counter (OTC) and exchange traded derivative markets with both collateralised and uncollateralised derivative counterparties. Trades are taken primarily to facilitate client activity or for hedging our own risk exposures; as such, derivatives are not generally held for position-taking.
The LCR Delegated Act requires HQLA to be held against net contractual and contingent outflows relating to derivative transactions. These include:
- Net Contractual outflows over a 30-day calendar period if subject to either legally enforceable master netting agreements and/or covered by collateral agreements (e.g. CSA), these cash flows can be netted at a counterparty level
- The impact of an adverse market scenario on the collateral requirements of the Group's derivatives portfolio
- Incremental collateral required to be posted in the event of a deterioration in the Group's own credit quality (e.g. a threenotch downgrade in the firm's long-term external credit rating)
- The counterparties' contractual right to substitute higher quality collateral with lower quality collateral
- The devaluation of existing collateral posted to counterparties
- Callable/due excess collateral that a firm may be contractually required to return to a counterparty
In addition to regulatory requirements, the Group employs various measures to actively reduce the risk of potential collateral calls on our derivative positions.
On average over the reporting period, weighted 'Outflows related to derivative exposures and other collateral requirements' made up only 6.6 per cent of the Group's total weighted outflows.
Currency mismatch in the LCR
The Group LCR is calculated and reported on a consolidated basis and in its reporting currency, US dollars. Although not required to meet minimum LCR requirements in other currencies, we report other significant currency LCRs to the PRA as part of the monthly LCR submission as well as to senior stakeholders in the form of internal monthly MI.
To minimise currency mismatch risk, the Group seeks to fund assets in the same currency, however, due to our global footprint, cross currency funding is utilised to appropriately manage currency gaps when it makes economic sense to do so.
To the extent mismatches arise, these are managed via the Group's currency convertibility framework. The framework identifies currencies that are expected to have limited convertibility during a stress, and sets thresholds on the amount of currency surplus that can be used to meet outflows in other currencies. HQLA amounts reported in Table 96 above therefore exclude surplus liquidity across the Group considered non-convertible in stress.
The implementation of liquidity metrics (such as ADR) at country level ensures that a large portion of assets is funded out of liabilities raised in the same currency. We also monitor closely, against set limits, the amount of foreign currency that can be swapped to local currency, and vice versa, in addition to currency mismatches by different tenor buckets.
7.1 Encumbered and unencumbered assets
The following disclosures of encumbered and unencumbered assets are based on the requirements in Part Eight of the CRR Article 443.
Standard Chartered's primary funding source is its customer deposit base. Given this structural unsecured funding position we have little requirement to fund ourselves in secured markets, and therefore our overall low level of encumbrance reflects this position. However, we do provide collateralised financing services to clients and these result in off-balance sheet encumbrance. The Group monitors the mix of secured and unsecured funding sources within the Group's funding plan and seeks to efficiently utilise available collateral to raise secured funding and meet other collateral requirements.
Table 100: Encumbered and unencumbered assets (UK AE1)
| 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Carrying amount of encumbered assets \$million |
Of which notionally eligible EHQLA and HQLA \$million |
Fair value of encumbered assets \$million |
Of which notionally eligible EHQLA and HQLA \$million |
Carrying amount of unencumbered assets \$million |
Of which notionally eligible EHQLA and HQLA \$million |
Fair value of unencumbered assets \$million |
Of which notionally eligible EHQLA and HQLA \$million |
||
| 010 | Assets of the reporting institution | 63,244 | 38,688 | 846,021 | 238,458 | ||||
| 030 | Equity instruments | – | - | - | - | 8,903 | 176 | 8,903 | 90 |
| 040 | Debt securities | 48,413 | 38,688 | 48,413 | 38,494 | 204,894 | 148,208 | 203,048 | 144,033 |
| 050 | Of which: covered bonds | 113 | 113 | 113 | 113 | 3,143 | 3,143 | 3,143 | 3,125 |
| 060 | Of which: securitisations | 3,966 | 193 | 3,966 | 193 | 20,976 | 8,110 | 19,984 | 8,110 |
| 070 | Of which: issued by general governments | 27,576 | 24,497 | 27,575 | 24,531 | 95,367 | 86,662 | 95,404 | 86,294 |
| 080 | Of which: issued by financial corporations | 17,671 | 11,950 | 17,671 | 11,910 | 68,326 | 30,122 | 66,720 | 28,242 |
| 090 | Of which: issued by non-financial corporations |
1,043 | 522 | 1,043 | 489 | 6,243 | 2,364 | 5,872 | 2,352 |
| 120 | Other assets | 14,831 | - | 632,224 | 90,074 |
| 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Carrying amount of encumbered assets \$million |
Of which notionally eligible EHQLA and HQLA \$million |
Fair value of encumbered assets \$million |
Of which notionally eligible EHQLA and HQLA \$million |
Carrying amount of unencumbered assets \$million |
Of which notionally eligible EHQLA and HQLA \$million |
Fair value of unencumbered assets \$million |
Of which notionally eligible EHQLA and HQLA \$million |
||
| 010 | Assets of the reporting institution | 46,526 | 21,089 | 803,388 | 223,192 | ||||
| 030 | Equity instruments | – | – | – | – | 6,254 | 155 | 6,256 | 10 |
| 040 | Debt securities | 32,881 | 21,089 | 32,881 | 21,089 | 194,839 | 140,630 | 194,656 | 140,559 |
| 050 | Of which: covered bonds | 337 | 337 | 337 | 337 | 4,355 | 4,313 | 4,355 | 4,313 |
| 060 | Of which: securitisations | 4,965 | 116 | 4,965 | 116 | 14,812 | 3,688 | 14,811 | 3,688 |
| 070 | Of which: issued by general governments | 21,903 | 17,434 | 21,903 | 17,321 | 85,764 | 77,364 | 85,675 | 77,222 |
| 080 | Of which: issued by financial corporations | 8,858 | 3,031 | 8,858 | 3,160 | 79,458 | 43,642 | 79,373 | 43,642 |
| 090 | Of which: issued by non-financial corporations |
978 | 181 | 978 | 181 | 5,107 | 2,653 | 4,952 | 2,653 |
| 120 | Other assets | 13,644 | – | 602,295 | 82,408 |
7.1 Encumbered and unencumbered assets continued Table 101: Collateral received and own debt securities issued (UK AE2)
| 2025 | ||||||
|---|---|---|---|---|---|---|
| Carrying amount of encumbered assets \$million |
Of which notionally eligible EHQLA and HQLA \$million |
Fair value of encumbered assets \$million |
Of which notionally eligible EHQLA and HQLA \$million |
|||
| 130 | Collateral received by the reporting institution | 57,440 | 35,035 | 43,488 | 14,625 | |
| 140 | Loans on Demand | - | - | - | - | |
| 150 | Equity Instruments | - | - | 9,381 | - | |
| 160 | Debt securities | 57,440 | 35,035 | 34,106 | 14,625 | |
| 170 | Of which: covered bonds | - | - | - | - | |
| 180 | Of which: Asset backed securities | 433 | - | 2,024 | - | |
| 190 | Of which: issued by General Governments | 28,048 | 22,044 | 15,375 | 8,653 | |
| 200 | Of which: issued by Financial Corporations | 18,086 | 5,193 | 9,361 | 3,647 | |
| 210 | Of which: issued by Non Financial Corporations | 5,743 | 2,510 | 4,549 | 1,339 | |
| 220 | Loans and Advances other than Loans on demand | - | - | - | - | |
| 230 | Other collateral received | - | - | - | - | |
| 240 | Own debt securities issued other than own covered bonds or securitisations |
- | - | - | - | |
| 241 | Own covered bonds and asset-backed securities issued and not yet pledged |
- | - | |||
| 250 | Total assets, collateral received and own debt securities issued | 120,684 | 73,723 |
| 2024 | ||||||
|---|---|---|---|---|---|---|
| Carrying amount of encumbered assets \$million |
Of which notionally eligible EHQLA and HQLA \$million |
Fair value of encumbered assets \$million |
Of which notionally eligible EHQLA and HQLA \$million |
|||
| 130 | Collateral received by the reporting institution | 73,824 | 47,736 | 35,380 | 17,129 | |
| 140 | Loans on Demand | – | – | – | – | |
| 150 | Equity Instruments | – | – | 9,069 | – | |
| 160 | Debt securities | 73,824 | 47,736 | 26,311 | 17,129 | |
| 170 | Of which: covered bonds | – | – | – | – | |
| 180 | Of which: Asset backed securities | 896 | – | 1,395 | – | |
| 190 | Of which: issued by General Governments | 35,370 | 29,558 | 10,115 | 7,400 | |
| 200 | Of which: issued by Financial Corporations | 20,479 | 5,573 | 10,925 | 4,493 | |
| 210 | Of which: issued by Non Financial Corporations | 7,094 | 3,492 | 2,828 | 2,477 | |
| 220 | Loans and Advances other than Loans on demand | – | – | – | – | |
| 230 | Other collateral received | – | – | – | – | |
| 240 | Own debt securities issued other than own covered bonds or securitisations |
– | – | – | – | |
| 241 | Own covered bonds and asset-backed securities issued and not yet pledged |
– | – | |||
| 250 | Total assets, collateral received and own debt securities issued | 120,350 | 68,825 |
7.1 Encumbered and unencumbered assets continued Table 102: Sources of encumbrance (UK AE3)
| 2025 | 2024 | |||
|---|---|---|---|---|
| Matching liabilities contingent liabilities or securities lent \$million |
Assets, collateral received and own debt securities issued other than covered bonds and ABSs encumbered \$million |
Matching liabilities contingent liabilities or securities lent \$million |
Assets, collateral received and own debt securities issued other than covered bonds and ABSs encumbered \$million |
|
| 010 Carrying amount of selected financial liabilities |
62,242 | 65,029 | 61,273 | 63,845 |
The Group's median asset encumbrance for 2025 was \$121 billion, which primarily related to cash collateral pledged against derivatives, and other securities.
Encumbered assets represent on-balance sheet assets pledged or subject to any form of arrangement to secure, collateralise or credit enhance any transaction from which it cannot be freely withdrawn. Debt securities are predominantly related to repurchase agreements. Furthermore, the unencumbered assets that cannot be encumbered also remain at low level and include goodwill, property and plant, unsettled trades, non-group acceptance and tax assets. Derivatives and Reverse Repos are not generally deemed available for encumbrance.
The Group provides collateralised security financing services to its clients, which is also used to manage the Group's own short-term cash and collateral needs. For securities accepted as collateral, mandates are credit rating driven with appropriate notional limits per rating, asset and individual bond concentration. The majority of collateral the Group uses in repo/reverse repo and stock lending/stock borrowing transactions is investment grade government issued. Information on over-collateralisation can be found in the Credit risk mitigation section of the 2025 Annual Report and Accounts on page 226.
8. Remuneration
The qualitative Pillar 3 remuneration disclosures for the 2025 performance year are set out on pages 180 to 206 of the Directors' remuneration report in the 2025 Annual Report and Accounts. Information is provided on the key components of our remuneration approach and how we develop our approach. The disclosures follow the requirements set out in Article 450 of chapter 4 of the 'Disclosure (CRR)' part of the PRA Rulebook.
Table 103: Remuneration awarded for the financial year (UK REM1)
| 2025 | 2024 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| MB Supervisory function \$million |
MB Management function \$million |
Other senior management \$million |
Other identified staff \$million |
MB Supervisory function \$million |
MB Management function \$million |
Other senior management \$million |
Other identified staff \$million |
||
| Fixed remuneration | |||||||||
| 1 | Number of identified staff | 10 | 2 | 13 | 666 | 11 | 2 | 16 | 671 |
| 2 | Total fixed remuneration | 5 | 5 | 24 | 372 | 4 | 6 | 33 | 365 |
| 3 | Of which: cash-based | 5 | 4 | 24 | 372 | 4 | 4 | 33 | 365 |
| UK-4a | Of which: shares or equivalent ownership interests |
- | 1 | - | - | – | 2 | – | – |
| 5 | Of which: share-linked instruments or equivalent non-cash instruments |
- | - | - | - | – | – | – | – |
| UK-5x | Of which: other instruments |
- | - | - | - | – | – | – | – |
| 7 | Of which: other forms | - | - | - | - | – | – | – | – |
| Variable remuneration | |||||||||
| 9 | Number of identified staff | 10 | 2 | 13 | 666 | 11 | 2 | 16 | 671 |
| 10 | Total variable remuneration | - | 14 | 62 | 438 | – | 18 | 46 | 399 |
| 11 | Of which: cash-based | - | 4 | 19 | 216 | – | 2 | 18 | 201 |
| 12 | Of which: deferred | - | - | - | 3 | – | 1 | 9 | 104 |
| UK-13a | Of which: shares or equivalent ownership interests |
- | 10 | 43 | 222 | – | 16 | 28 | 198 |
| UK-14a | Of which: deferred | - | 10 | 42 | 220 | – | 16 | 19 | 106 |
| UK-13b | Of which: share-linked instruments or equivalent non-cash instruments |
- | - | - | - | – | – | – | – |
| UK-14b | Of which: deferred | - | - | - | - | – | – | – | – |
| UK-14x | Of which: other instruments |
- | - | - | - | – | – | – | – |
| UK-14y | Of which: deferred | - | - | - | - | – | – | – | – |
| 15 | Of which: other forms | - | - | - | - | – | – | – | – |
| 16 | Of which: deferred | - | - | - | - | – | – | – | – |
| 17 | Total remuneration (2 + 10) | 5 | 19 | 86 | 810 | 4 | 24 | 79 | 764 |
Table 104: Special payments to staff whose professional activities have a material impact on institutions' risk profile (identified staff) (UK REM2)
| MB Supervisory function \$million |
MB Management function \$million |
Other senior management \$million |
Other identified staff \$million |
|
|---|---|---|---|---|
| Guaranteed variable remuneration awards | ||||
| Guaranteed variable remuneration awards – Number of identified staff |
– | – | – | 4 |
| Guaranteed variable remuneration awards – Total amount | – | – | – | 3 |
| Of which guaranteed variable remuneration awards paid during the financial year, that are not taken into account in the bonus cap |
– | – | – | – |
| Severance payments awarded in previous periods, that have been paid out during the financial year |
||||
| Severance payments awarded in previous periods, that have been paid out during the financial year – Number of identified staff |
– | – | – | – |
| Severance payments awarded in previous periods, that have been paid out during the financial year – Total amount |
– | – | – | – |
| Severance payments awarded during the financial year | ||||
| Severance payments awarded during the financial year – | – | |||
| Severance payments awarded during the financial year – | – | |||
| – | ||||
| Of which deferred | – | – | – | – |
| Of which severance payments paid during the financial year, | – | |||
| Of which highest payment that has been awarded to a single person |
– | – | – | – |
| Number of identified staff Total amount Of which paid during the financial year that are not taken into account in the bonus cap |
– – – – |
– – – – |
2025 – – – – |
| 2024 | |||||
|---|---|---|---|---|---|
| MB Supervisory function \$million |
MB Management function \$million |
Other senior management \$million |
Other identified staff \$million |
||
| Guaranteed variable remuneration awards | |||||
| 1 | Guaranteed variable remuneration awards – Number of identified staff |
– | – | – | 4 |
| 2 | Guaranteed variable remuneration awards – Total amount | – | – | – | 3 |
| 3 | Of which guaranteed variable remuneration awards paid during the financial year, that are not taken into account in the bonus cap |
– | – | – | – |
| Severance payments awarded in previous periods, that have been paid out during the financial year |
|||||
| 4 | Severance payments awarded in previous periods, that have been paid out during the financial year – Number of identified staff |
– | – | – | – |
| 5 | Severance payments awarded in previous periods, that have been paid out during the financial year – Total amount |
– | – | – | – |
| Severance payments awarded during the financial year | |||||
| 6 | Severance payments awarded during the financial year – Number of identified staff |
– | – | – | – |
| 7 | Severance payments awarded during the financial year – Total amount |
– | – | – | – |
| 8 | Of which paid during the financial year | – | – | – | – |
| 9 | Of which deferred | – | – | – | – |
| 10 | Of which severance payments paid during the financial year, that are not taken into account in the bonus cap |
– | – | – | – |
| 11 | Of which highest payment that has been awarded to a single person |
– | – | – | – |
Table 105: Deferred remuneration (UK REM3)
| 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Deferred and retained remuneration | Total amount of deferred remuneration awarded for previous performance periods \$million |
Of which due to vest in the financial year \$million |
Of which vesting in subsequent financial years \$million |
Amount of performance adjustment made in the financial year to deferred remuneration that was due to vest in the financial year \$million |
Amount of performance adjustment made in the financial year to deferred remuneration that was due to vest in future performance years \$million |
Total amount of adjustment during the financial year due to ex post implicit adjustments (i.e. changes of value of deferred remuneration due to the changes of prices of instruments) \$million |
Total amount of deferred remuneration awarded before the financial year actually paid out in the financial year \$million |
Total of amount of deferred remuneration awarded for previous performance period that has vested but is subject to retention periods \$million |
|
| 1 | MB Supervisory function | – | – | – | – | – | – | – | – |
| 2 | Cash-based | – | – | – | – | – | – | – | – |
| 3 | Shares or equivalent ownership interests |
– | – | – | – | – | – | – | – |
| 4 | Share-linked instruments or equivalent non-cash instruments |
– | – | – | – | – | – | – | – |
| 5 | Other instruments | – | – | – | – | – | – | – | – |
| 6 | Other forms | – | – | – | – | – | – | – | – |
| 7 | MB Management function | 100 | 10 | 90 | (2) | – | 46 | 8 | 8 |
| 8 | Cash-based | – | – | – | – | – | – | – | – |
| 9 | Shares or equivalent ownership interests |
100 | 10 | 90 | (2) | – | 46 | 8 | 8 |
| 10 | Share-linked instruments or equivalent non-cash instruments |
– | – | – | – | – | – | – | – |
| 11 | Other instruments | – | – | – | – | – | – | – | – |
| 12 | Other forms | – | – | – | – | – | – | – | – |
| 13 | Other senior management | 227 | 29 | 198 | (2) | – | 91 | 27 | 20 |
| 14 | Cash-based | 29 | 4 | 25 | – | – | – | 4 | – |
| 15 | Shares or equivalent ownership interests |
198 | 25 | 173 | (2) | – | 91 | 23 | 20 |
| 16 | Share-linked instruments or equivalent non-cash instruments |
– | – | – | – | – | – | – | – |
| 17 | Other instruments | – | – | – | – | – | – | – | – |
| 18 | Other forms | – | – | – | – | – | – | – | – |
| 19 | Other identified staff | 1,075 | 268 | 807 | – | – | 362 | 259 | 123 |
| 20 | Cash-based | 288 | 62 | 226 | – | – | – | 59 | – |
| 21 | Shares or equivalent ownership interests |
679 | 179 | 500 | – | – | 312 | 173 | 109 |
| 22 | Share-linked instruments or equivalent non-cash instruments |
108 | 27 | 81 | – | – | 50 | 27 | 14 |
| 23 | Other instruments | – | – | – | – | – | – | – | – |
| 24 | Other forms | – | – | – | – | – | – | – | – |
| 25 | Total amount | 1,402 | 307 | 1,095 | (4) | – | 499 | 294 | 151 |
Table 105: Deferred remuneration (UK REM3) continued
| 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Deferred and retained remuneration | Total amount of deferred remuneration awarded for previous performance periods \$million |
Of which due to vest in the financial year \$million |
Of which vesting in subsequent financial years \$million |
Amount of performance adjustment made in the financial year to deferred remuneration that was due to vest in the financial year \$million |
Amount of performance adjustment made in the financial year to deferred remuneration that was due to vest in future performance years \$million |
Total amount of adjustment during the financial year due to ex post implicit adjustments (i.e. changes of value of deferred remuneration due to the changes of prices of instruments) \$million |
Total amount of deferred remuneration awarded before the financial year actually paid out in the financial year \$million |
Total of amount of deferred remuneration awarded for previous performance period that has vested but is subject to retention periods \$million |
|
| 1 | MB Supervisory function | – | – | – | – | – | – | – | – |
| 2 | Cash-based | – | – | – | – | – | – | – | – |
| 3 | Shares or equivalent ownership interests |
– | – | – | – | – | – | – | – |
| Share-linked instruments or equivalent | |||||||||
| 4 | non-cash instruments | – | – | – | – | – | – | – | – |
| 5 | Other instruments | – | – | – | – | – | – | – | – |
| 6 | Other forms | – | – | – | – | – | – | – | – |
| 7 | MB Management function | 44 | 7 | 37 | (4) | – | 15 | 3 | 3 |
| 8 | Cash-based | – | – | – | – | – | – | – | – |
| 9 | Shares or equivalent ownership interests |
44 | 7 | 37 | (4) | – | 15 | 3 | 3 |
| 10 | Share-linked instruments or equivalent non-cash instruments |
– | – | – | – | – | – | – | – |
| 11 | Other instruments | – | – | – | – | – | – | – | – |
| 12 | Other forms | – | – | – | – | – | – | – | – |
| 13 | Other senior management | 185 | 43 | 142 | (9) | – | 50 | 18 | 11 |
| 14 | Cash-based | 34 | 6 | 28 | – | – | – | 4 | – |
| 15 | Shares or equivalent ownership interests |
151 | 37 | 114 | (9) | – | 50 | 14 | 11 |
| Share-linked instruments or | |||||||||
| 16 | equivalent non-cash instruments | – | – | – | – | – | – | – | – |
| 17 | Other instruments | – | – | – | – | – | – | – | – |
| 18 | Other forms | – | – | – | – | – | – | – | – |
| 19 | Other identified staff | 709 | 174 | 535 | (3) | – | 154 | 163 | 63 |
| 20 | Cash-based | 247 | 58 | 189 | – | – | – | 55 | – |
| 21 | Shares or equivalent ownership interests |
409 | 104 | 305 | (3) | – | 136 | 96 | 57 |
| Share-linked instruments or | |||||||||
| 22 | equivalent non-cash instruments | 53 | 12 | 41 | – | – | 18 | 12 | 6 |
| 23 | Other instruments | – | – | – | – | – | – | – | – |
| 24 | Other forms | – | – | – | – | – | – | – | – |
| 25 | Total amount | 938 | 224 | 714 | (16) | – | 219 | 184 | 77 |
Table 106: Remuneration of 1 million EUR or more per year (UK REM4)
| 2025 | 2024 | ||
|---|---|---|---|
| EUR | Identified staff that are high earners as set out in Article 450(i) CRR Number of employees |
Identified staff that are high earners as set out in Article 450(i) CRR Number of employees |
|
| 1 | 1,000,000 to below 1,500,000 | 157 | 164 |
| 2 | 1,500,000 to below 2,000,000 | 54 | 54 |
| 3 | 2,000,000 to below 2,500,000 | 33 | 25 |
| 4 | 2,500,000 to below 3,000,000 | 8 | 16 |
| 5 | 3,000,000 to below 3,500,000 | 6 | 10 |
| 6 | 3,500,000 to below 4,000,000 | 7 | 6 |
| 7 | 4,000,000 to below 4,500,000 | 2 | 4 |
| 8 | 4,500,000 to below 5,000,000 | 5 | 4 |
| 9 | 5,000,000 to below 6,000,000 | 1 | 2 |
| 10 | 6,000,000 to below 7,000,000 | 4 | 3 |
| 11 | 7,000,000 to below 8,000,000 | 1 | 2 |
| 12 | 8,000,000 to below 9,000,000 | 2 | 1 |
| 13 | 13,000,000 to below 14,000,000 | - | 1 |
| 14 | 14,000,000 to below 15,000,000 | 1 | 1 |
| 15 | 16,000,000 to below 17,000,000 | 1 | – |
| Total | 282 | 293 |
Table 107: Information on remuneration of staff whose professional activities have a material impact on institutions' risk profile (identified staff) (UK REM5)
| 2025 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Management body remuneration | Business areas | |||||||||||
| MB Supervisory function \$million |
MB Management \$million |
Total MB \$million |
Investment banking \$million |
Retail banking \$million |
Asset management \$million |
Corporate functions \$million |
Independent internal control functions \$million |
All other \$million |
Total \$million |
|||
| 1 | Total number of identified staff |
691 | ||||||||||
| 2 | Of which: members of the MB |
10 | 2 | 12 | ||||||||
| 3 | Of which: other senior management |
2 | 1 | - | 5 | 4 | 1 | |||||
| 4 | Of which: other identified staff |
383 | 59 | - | 95 | 118 | 11 | |||||
| 5 | Total remuneration of identified staff |
5 | 19 | 24 | 570 | 87 | - | 163 | 83 | 17 | ||
| 6 | Of which: variable remuneration |
- | 14 | 14 | 335 | 51 | - | 87 | 32 | 9 | ||
| 7 | Of which: fixed remuneration |
5 | 5 | 10 | 235 | 36 | - | 76 | 51 | 8 |
| 2024 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Management body remuneration | Business areas | |||||||||||
| MB Supervisory function \$million |
MB Management \$million |
Total MB \$million |
Investment banking \$million |
Retail banking \$million |
Asset management \$million |
Corporate functions \$million |
Independent internal control functions \$million |
All other \$million |
Total \$million |
|||
| 1 | Total number of identified staff |
700 | ||||||||||
| 2 | Of which: members of the MB |
11 | 2 | 13 | ||||||||
| 3 | Of which: other senior management |
3 | 1 | – | 8 | 3 | 1 | |||||
| 4 | Of which: other identified staff |
367 | 54 | – | 120 | 117 | 13 | |||||
| 5 | Total remuneration of identified staff |
4 | 24 | 28 | 503 | 76 | – | 197 | 80 | 15 | ||
| 6 | Of which: variable remuneration |
– | 18 | 18 | 283 | 43 | – | 98 | 31 | 7 | ||
| 7 | Of which: fixed remuneration |
4 | 6 | 10 | 220 | 33 | – | 99 | 49 | 8 |
9. Forward-looking statements
The information included in this document may contain 'forward-looking statements' based upon current expectations or beliefs as well as statements formulated with assumptions about future events. Forward-looking statements include, without limitation, projections, estimates, commitments, plans, approaches, ambitions and targets (including, without limitation, ESG commitments, ambitions and targets). Forward-looking statements often use words such as 'may', 'could', 'will', 'expect', 'intend', 'estimate', 'anticipate', 'believe', 'plan', 'seek', 'aim', 'continue' or other words of similar meaning to any of the foregoing. Forward-looking statements may also (or additionally) be identified by the fact that they do not relate only to historical or current facts.
By their very nature, forward-looking statements are subject to known and unknown risks and uncertainties and other factors that could cause actual results, and the Group's plans and objectives, to differ materially from those expressed or implied in the forward-looking statements. Readers should not place reliance on, and are cautioned about relying on, any forward-looking statements.
There are several factors which could cause the Group's actual results and its plans and objectives to differ materially from those expressed or implied in forward-looking statements. The factors include (but are not limited to): changes in global, political, economic, business, competitive and market forces or conditions, or in future exchange and interest rates; changes in environmental, geopolitical, social or physical risks; legal, regulatory and policy developments, including regulatory measures addressing climate change and broader sustainability-related issues; the development of standards and interpretations, including evolving requirements and practices in ESG reporting; the ability of the Group, together with governments and other stakeholders to measure, manage, and mitigate the impacts of climate change and broader sustainability-related issues effectively; risks arising out of health crises and pandemics; risks of cyber-attacks, data, information or security breaches or technology failures involving the Group; changes in tax rates or policy; future business combinations or dispositions; and other factors specific to the Group, including those identified in Standard Chartered PLC's Annual Report and the financial statements of the Group. To the extent that any forward-looking statements contained in this document are based on past or current trends and/or activities of the Group, they should not be taken as a representation that such trends or activities will continue in the future.
No statement in this document is intended to be, nor should be interpreted as, a profit forecast or to imply that the earnings of the Group for the current year or future years will necessarily match or exceed the historical or published earnings of the Group. Each forward-looking statement speaks only as of the date that it is made. Except as required by any applicable laws or regulations, the Group expressly disclaims any obligation to revise or update any forward-looking statement contained within this document, regardless of whether those statements are affected as a result of new information, future events or otherwise.
Please refer to Standard Chartered PLC's Annual Report and the financial statements of the Group for a discussion of certain of the risks and factors that could adversely impact the Group's actual results, and cause its plans and objectives, to differ materially from those expressed or implied in any forward-looking statements.
Annex 1
Standard Chartered Significant Subsidiaries Capital resources of significant subsidiaries
For local capital adequacy purposes, a range of approaches are applied in accordance with the regulatory requirements in force in each jurisdiction. Wherever possible, the approaches adopted at the Group level are applied locally.
Under Part 2, rule 2.3 of the CRR requires the application of disclosure requirements of Large subsidiaries of UK parent institutions, UK parent financial holding companies.
The capital resources of the Group's significant subsidiaries under CRR Part 2 are presented below. These subsidiaries are Standard Chartered – solo consolidated, a UK regulated banking entity, Standard Chartered Bank (Hong Kong) Limited, Standard Chartered Bank Korea Limited, and Standard Chartered Bank (Singapore) Limited.
The capital resources of these subsidiaries are calculated in accordance with the regulatory requirements applicable in the countries in which they are incorporated, and therefore cannot be aggregated, but are presented to align with the Group format.
The table below provides a summary view of the significant subsidiaries. The significant subsidiary data is subject to change due to local timing and local regulatory requirements.
Table 108: Capital resources of significant subsidiaries
| 2025 | ||||||||
|---|---|---|---|---|---|---|---|---|
| Standard Chartered – Solo consolidation \$million |
Standard Chartered Bank (HK) Ltd \$million |
Standard Chartered Bank Korea Ltd \$million |
Standard Chartered Bank (Singapore) Ltd \$million |
Standard Chartered – Solo consolidation \$million |
Standard Chartered Bank (HK) Ltd2 \$million |
Standard Chartered Bank Korea Ltd1 \$million |
Standard Chartered Bank (Singapore) Ltd1 \$million |
|
| Local Regulator | PRA | HKMA | FSS | MAS | PRA | HKMA | FSS | MAS |
| Common Equity Tier 1 capital before regulatory adjustments |
22,971 | 22,164 | 3,583 | 7,742 | 23,047 | 21,561 | 3,586 | 7,480 |
| Regulatory adjustments | (8,445) | (2,292) | (194) | (935) | (8,317) | (2,156) | (240) | (747) |
| Common Equity Tier 1 capital | 14,526 | 19,872 | 3,388 | 6,807 | 14,730 | 19,405 | 3,346 | 6,733 |
| Additional Tier 1 (AT1) capital: instruments |
4,152 | 4,820 | 208 | 1,430 | 4,273 | 3,018 | 204 | 1,392 |
| Tier 1 capital (T1 = CET1 + AT1) | 18,678 | 24,691 | 3,597 | 8,237 | 19,003 | 22,422 | 3,550 | 8,125 |
| Tier 2 capital | 5,697 | 2,123 | 427 | 2,968 | 8,183 | 1,361 | 559 | 2,942 |
| Total capital (TC = T1 + T2) | 24,375 | 26,815 | 4,023 | 11,205 | 27,186 | 23,784 | 4,109 | 11,067 |
| Total risk-weighted assets | 130,608 | 104,849 | 21,680 | 51,348 | 126,383 | 109,927 | 20,826 | 45,467 |
| Capital Ratios | ||||||||
| Common Equity Tier 1 | 11.1% | 19.0% | 15.6% | 13.3% | 11.7% | 17.7% | 16.1% | 14.8% |
| Tier 1 Capital | 14.3% | 23.5% | 16.6% | 16.0% | 15.0% | 20.4% | 17.0% | 17.9% |
| Total Capital | 18.7% | 25.6% | 18.6% | 21.8% | 21.5% | 21.6% | 19.7% | 24.3% |
1 2024 Capital resources have been re-presented to align with local regulatory returns, which included late adjustments for Standard Chartered Korea Ltd and Standard Chartered Bank (Singapore) Ltd.
2 2024 has been re-presented to show Standard Chartered Bank (HK) Ltd on a consolidated basis. This also includes Standard Chartered Bank Korea Ltd.
Capital management – Standard Chartered – Solo consolidated
The Risk management approach section of the 2025 Annual Report and Accounts sets out our approach to capital management (pages 222 to 234). Tables 109 to 131 summarise the consolidated capital position of Standard Chartered – solo consolidated, as well as a summary of exposures, credit quality and remuneration.
| 2025 \$million |
2024 \$million |
||
|---|---|---|---|
| Common Equity Tier 1 (CET1) capital: instruments and reserves | |||
| 1 | Capital instruments and the related share premium accounts | 20,893 | 20,893 |
| Of which: Share premium accounts | 296 | 296 | |
| 2 | Retained earnings1 | 3,543 | 3,815 |
| 3 | Accumulated other comprehensive income (and other reserves) | (3,766) | (3,804) |
| 5 | Minority interests (amount allowed in consolidated CET1) | – | – |
| 5a | Independently reviewed interim and year-end profits/(loss)2 | 2,493 | 2,336 |
| Foreseeable dividends3 | (192) | (193) | |
| 6 | Common Equity Tier 1 (CET1) capital before regulatory adjustments | 22,971 | 23,047 |
| Common Equity Tier 1 capital: regulatory adjustments | |||
| 7 | Additional value adjustments | (393) | (324) |
| 8 | Intangible assets (net of related tax liability) | (3,427) | (3,166) |
| 10 | Deferred tax assets that rely on future profitability excluding those arising from temporary | ||
| differences (net of related tax liability where the conditions in Article 38 (3) CRR are met) | (15) | (25) | |
| 11 | Fair value reserves related to gains or losses on cash flow hedges of financial instruments | ||
| that are not valued at fair value | (38) | 16 | |
| 12 | Negative amounts resulting from the calculation of expected loss amounts | (259) | (297) |
| 14 | Gains or losses on liabilities valued at fair value resulting from changes in own credit standing | 308 | 244 |
| 15 | Defined-benefit pension fund assets | (99) | (114) |
| Fair value gains and losses from own credit risk related to derivative liabilities | (60) | (84) | |
| 19 | Direct, indirect and synthetic holdings by the institution of the CET1 instruments of financial sector entities where the institution has a significant investment in those entities (amount |
||
| above 10% threshold and net of eligible short positions) (negative amount) | (4,447) | (4,456) | |
| UK-20a Exposure amount of the following items which qualify for a RW of 1250%, where the institution | |||
| opts for the deduction alternative | (13) | (111) | |
| UK-20c | Of which: securitisation positions | (5) | (4) |
| UK-20d | Of which: free deliveries | (8) | (107) |
| 22 | Amount exceeding the 17,65% threshold (negative amount) | – | |
| 27a | Other regulatory adjustments to CET1 capital (including IFRS 9 transitional adjustments | ||
| when relevant) | (2) | – | |
| 28 | Total regulatory adjustments to Common Equity Tier 1 (CET1) | (8,445) | (8,317) |
| 29 | Common Equity Tier 1 (CET1) capital | 14,526 | 14,730 |
| Additional Tier 1 (AT1) capital: instruments | |||
| 30 | Capital instruments and the related share premium accounts | 5,722 | 5,722 |
| 31 | Of which: classified as equity under applicable accounting standards | 5,722 | 5,722 |
| 32 | Of which: classified as liabilities under applicable accounting standards | – | – |
| 36 | Additional Tier 1 (AT1) capital before regulatory adjustments | 5,722 | 5,722 |
| Additional Tier 1 capital: regulatory adjustments | |||
| 37 | Direct, indirect and synthetic holdings by an institution of own AT1 instruments | ||
| (negative amount) | (20) | (20) | |
| 40 | Direct, indirect and synthetic holdings by the institution of the AT1 instruments of financial sector entities where the institution has a significant investment in those |
||
| entities (net of eligible short positions) (negative amount) | (1,550) | (1,429) | |
| 43 | Total regulatory adjustments to Additional Tier 1 (AT1) capital | (1,570) | (1,449) |
| 44 | Additional Tier 1 (AT1) capital | 4,152 | 4,273 |
| 45 | Tier 1 capital (T1 = CET1 + AT1) | 18,678 | 19,003 |
| Tier 2 (T2) capital: instruments and provisions | |||
| 46 | Capital instruments and the related share premium accounts | 8,909 | 11,117 |
| 47 | Amount of qualifying items referred to in Article 484 (5) CRR and the related share | ||
| premium accounts subject to phase out from T2 as described in Article 486(4) CRR | – | – | |
| 48 | Qualifying own funds instruments included in consolidated T2 capital (including minority | ||
| interests and AT1 instruments not included in rows 5 or 34) issued by subsidiaries and held | |||
| by third parties | – | – | |
| 51 | Tier 2 (T2) capital before regulatory adjustments | 8,909 | 11,117 |
| Tier 2 capital: regulatory adjustments | – | ||
| 52 | Direct, indirect and synthetic holdings by an institution of own T2 instruments and subordinated loans |
(30) | (30) |
Table 109: Composition of regulatory own funds (UK CC1) – Solo consolidation
Table 109: Composition of regulatory own funds (UK CC1) – Solo consolidation continued
| 55 | Direct, indirect and synthetic holdings by the institution of the T2 instruments and subordinated loans of financial sector entities where the institution has a significant |
||
|---|---|---|---|
| investment in those entities (net of eligible short positions) (negative amount) | (3,182) | (2,904) | |
| 57 | Total regulatory adjustments to Tier 2 (T2) capital | (3,212) | (2,934) |
| 58 | Tier 2 (T2) capital | 5,697 | 8,183 |
| 59 | Total capital (TC = T1 + T2) | 24,375 | 27,186 |
| 60 | Total Risk exposure amount | 130,608 | 126,383 |
| Capital ratios and buffers | |||
| 61 | Common Equity Tier 1 (as a percentage of total risk exposure amount) | 11.1% | 12.0% |
| 62 | Tier 1 (as a percentage of total risk exposure amount) | 14.3% | 15.2% |
| 63 | Total capital (as a percentage of total risk exposure amount) | 18.7% | 22.6% |
| 64 | Institution CET1 overall capital requirement (CET1 requirement in accordance with Article 92 (1) CRR, plus additional CET1 requirement which the institution is required to hold in accordance with point (a) of Article 104(1) CRD, plus combined buffer requirement in accordance with Article 128(6) CRD) expressed as a percentage of risk exposure amount) |
9.25% | 9.45% |
| 65 | Of which: capital conservation buffer requirement | 2.50% | 2.50% |
| 66 | Of which: countercyclical buffer requirement | 0.37% | 0.38% |
| 67 | Of which: systemic risk buffer requirement | – | – |
| UK-67a | Of which: Global Systemically Important Institution (G-SII) or Other Systemically Important Institution (O-SII) buffer |
– | – |
| 68 | Common Equity Tier 1 available to meet buffers (as a percentage of risk exposure amount) | 4.74% | 5.10% |
| Amounts below the thresholds for deduction (before risk weighting) | |||
| 72 | Direct and indirect holdings of own funds and eligible liabilities of financial sector entities where the institution does not have a significant investment in those entities (amount below 10% threshold and net of eligible short positions) |
1,153 | 1,400 |
| 73 | Direct and indirect holdings by the institution of the CET1 instruments of financial sector entities where the institution has a significant investment in those entities (amount below 17.65% thresholds and net of eligible short positions) |
6,345 | 6,245 |
| 75 | Deferred tax assets arising from temporary differences (amount below 17,65% threshold, net of related tax liability where the conditions in Article 38 (3) CRR are met) |
282 | 376 |
| Applicable caps on the inclusion of provisions in Tier 2 | |||
| 76 | Credit risk adjustments included in T2 in respect of exposures subject to standardised approach (prior to the application of the cap) |
– | – |
| 77 | Cap on inclusion of credit risk adjustments in T2 under standardised approach | 302 | 231 |
| 78 | Credit risk adjustments included in T2 in respect of exposures subject to internal ratings-based approach (prior to the application of the cap) |
– | – |
| 79 | Cap for inclusion of credit risk adjustments in T2 under internal ratings-based approach | 379 | 399 |
1 Retained earnings under CRD IV include the effect of regulatory consolidation adjustments.
2 Independently reviewed year-end profits are in accordance with regulatory consolidation rules.
3 Foreseeable dividends as at FY 2025 represent preference and AT1 securities dividends.
Table 110: Reconciliation of regulatory own funds to balance sheet in the audited financial statements (UK CC2) – Solo consolidation
| 2025 | 2024 | |||||
|---|---|---|---|---|---|---|
| Balance sheet as in published financial statements |
Under regulatory scope of consolidation |
Balance sheet as in published financial statements |
Under regulatory scope of consolidation |
|||
| \$million | \$million | \$million | \$million | |||
| Assets | ||||||
| Cash and balances at central banks | 52,348 | 52,348 | 45,233 | 45,233 | ||
| Financial assets held at fair value through profit or loss | 99,894 | 96,816 | 88,349 | 85,699 | ||
| Derivative financial instruments | 66,631 | 66,631 | 82,844 | 82,844 | ||
| Loans and advances to banks | 11,108 | 11,108 | 11,755 | 11,755 | ||
| Loans and advances to customers | 80,091 | 80,091 | 77,597 | 77,597 | ||
| Investment securities | 79,684 | 77,839 | 82,101 | 81,134 | ||
| Other assets | 35,105 | 33,074 | 31,584 | 30,859 | ||
| Current tax assets | 412 | 447 | 516 | 553 | ||
| Prepayments and accrued income | 1,392 | 1,392 | 1,535 | 1,535 | ||
| Interests in associates and joint ventures | 10,802 | 14,695 | 10,671 | 13,354 | ||
| Goodwill and intangible assets | 2,245 | 2,245 | 1,988 | 1,988 | ||
| Of which: goodwill | 2,251 | 2,244 | 1,991 | 1,988 | ||
| Of which: other intangibles (excluding MSRs) | (6) | 1 | (3) | – | ||
| Of which: MSRs | – | – | – | – | ||
| Property, plant and equipment | 714 | 714 | 659 | 659 | ||
| Deferred tax assets | 251 | 251 | 233 | 233 | ||
| 'Retirement benefit schemes in surplus | 104 | 104 | 118 | 118 | ||
| Assets classified as held for sale | 240 | 240 | 474 | 474 | ||
| Total assets | 441,021 | 437,995 | 435,656 | 434,034 | ||
| Liabilities | ||||||
| Deposits by banks | 20,607 | 20,607 | 17,824 | 17,824 | ||
| Customer accounts | 132,018 | 132,018 | 119,502 | 119,502 | ||
| Repurchase agreements and other similar secured borrowing | 4,828 | 4,828 | 9,845 | 9,845 | ||
| Financial liabilities held at fair value through profit or loss | 64,880 | 64,880 | 61,683 | 61,683 | ||
| Derivative financial instruments | 67,556 | 67,556 | 82,745 | 82,745 | ||
| Debt securities in issue | 37,849 | 37,849 | 36,081 | 36,081 | ||
| Other liabilities | 70,401 | 68,668 | 63,799 | 63,439 | ||
| Current tax liabilities | 254 | 254 | 294 | 294 | ||
| Accruals and deferred income | 2,620 | 2,627 | 2,441 | 2,447 | ||
| Subordinated liabilities and other borrowed funds | 8,158 | 8,158 | 9,801 | 9,801 | ||
| Of which: considered as Additional Tier 1 capital | – | – | – | – | ||
| Of which: considered as Tier 2 capital | 8,158 | 8,158 | 9,801 | 9,801 | ||
| Deferred tax liabilities | 358 | 358 | 308 | 309 | ||
| Of which: DTLs related to goodwill | 358 | 358 | 308 | 309 | ||
| Of which: DTLs related to intangible assets (excluding MSRs) | – | – | – | – | ||
| Of which: DTLs related to MSRs | – | – | – | – | ||
| Provisions for liabilities and charges | 191 | 191 | 186 | 186 | ||
| Retirement benefit obligations | 216 | 216 | 200 | 200 | ||
| Liabilities included in disposal groups held for sale | 150 | 150 | – | – | ||
| Total liabilities | 410,086 | 408,360 | 404,709 | 404,356 | ||
| Shareholders' Equity | ||||||
| Share capital and share premium account | 21,643 | 21,643 | 21,643 | 21,643 | ||
| Other reserves & Retained earnings | 3,570 | 2,270 | 3,582 | 2,313 | ||
| Total parent company shareholders' equity | 25,213 | 23,913 | 25,225 | 23,956 | ||
| Other equity instruments | 5,722 | 5,722 | 5,722 | 5,722 | ||
| Total equity excluding non-controlling interests | 30,935 | 29,635 | 30,947 | 29,678 | ||
| Non-controlling interest | – | – | – | – | ||
| Total equity | 30,935 | 29,635 | 30,947 | 29,678 | ||
| Total equity and liabilities | 441,021 | 437,995 | 435,656 | 434,034 |
Countercyclical capital buffer – Standard Chartered – Solo consolidated Table 111: Geographical distribution of credit exposures relevant for the calculation of the countercyclical buffer (UK CCyB1) – Solo consolidation
| 2025 | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| General credit exposures | Relevant credit exposures – Market risk |
Own funds requirements | |||||||||||
| Breakdown by country |
Exposure value under the standardised approach \$million |
Exposure value under the IRB approach \$million |
Sum of long and short positions of trading book exposures for SA \$million |
Value of trading book exposures for internal models \$million |
Securitisation exposures Exposure value for non-trading book \$million |
Total exposure value \$million |
Relevant credit risk exposures – Credit risk \$million |
Relevant credit exposures – Market risk \$million |
Relevant credit exposures – Securitisation positions in the non-trading book \$million |
Total \$million |
Risk weighted exposure amounts % |
Own fund requirements weights % |
Countercyclical buffer rate (%) % |
| Armenia | – | – | – | – | – | – | – | – | – | – | – | 0.0% | 1.5% |
| Australia | 245 | 3,093 | 286 | – | 286 | 3,910 | 88 | 21 | 4 | 113 | 1,415 | 1.9% | 1.0% |
| Belgium | – | 498 | 2 | – | 21 | 521 | 5 | – | – | 6 | 74 | ||
| Bulgaria | – | – | – | – | – | – | – | – | – | – | – | 0.0% | 2.0% |
| Chile | – | 77 | 91 | – | 3 | 171 | 3 | 4 | – | 7 | 82 | 0.1% | 0.5% |
| Croatia | – | 5 | – | – | – | 5 | – | – | – | – | 3 | 0.0% | 1.5% |
| Cyprus | – | 32 | – | – | – | 32 | – | – | – | – | 5 | 0.0% | 1.0% |
| Czech Republic |
– | – | 6 | – | – | 6 | – | 1 | – | 1 | 18 | 0.0% | 1.3% |
| Denmark | 12 | 590 | 3 | – | 144 | 749 | 4 | – | 2 | 6 | 74 | 0.1% | 2.5% |
| Estonia | – | – | 4 | – | – | 4 | – | – | – | – | – | 0.0% | 1.5% |
| France | 3 | 1,039 | 273 | – | 2 | 1,317 | 34 | 20 | – | 54 | 675 | 0.9% | 1.0% |
| Germany | 282 | 3,544 | 104 | – | 442 | 4,372 | 105 | 15 | 7 | 127 | 1,587 | 2.1% | 0.8% |
| Greece | – | 26 | 7 | – | – | 33 | – | 1 | – | 1 | 7 | 0.0% | 0.3% |
| Hong Kong | 349 | 3,081 | 237 | – | 109 | 3,776 | 72 | 11 | 2 | 85 | 1,061 | 1.4% | 0.5% |
| Hungary | – | 87 | 195 | – | – | 282 | 7 | 1 | – | 8 | 96 | 0.1% | 1.0% |
| Iceland | – | – | – | – | – | – | – | – | – | – | – | 0.0% | 2.5% |
| Ireland | 29 | 2,206 | 1,023 | – | 109 | 3,367 | 25 | 82 | 2 | 109 | 1,364 | 1.8% | 1.5% |
| Korea | 66 | 1,172 | 246 | – | 11 | 1,495 | 28 | 10 | – | 38 | 476 | 0.6% | 1.0% |
| Latvia | – | – | – | – | – | – | – | – | – | – | – | 0.0% | 1.0% |
| Lithuania | – | – | – | – | – | – | – | – | – | – | – | 0.0% | 1.0% |
| Luxembourg | 150 | 4,220 | 101 | – | 429 | 4,900 | 73 | 7 | 6 | 86 | 1,071 | 1.4% | 0.5% |
| Netherlands | – | 1,213 | 64 | – | 495 | 1,772 | 70 | 4 | 7 | 81 | 1,015 | 1.4% | 2.0% |
| Norway | – | 347 | 7 | – | 222 | 576 | 11 | – | 3 | 15 | 190 | 0.3% | 2.5% |
| Poland | – | 110 | 10 | – | – | 120 | 3 | – | – | 4 | 44 | 0.1% | 1.0% |
| Romania | – | – | – | – | – | – | – | – | – | – | – | 0.0% | 1.0% |
| Slovakia | 1 | 1 | – | – | – | 2 | – | – | – | – | 1 | 0.0% | 1.5% |
| Slovenia | – | – | 7 | – | – | 7 | – | 1 | – | 1 | 10 | 0.0% | 1.0% |
| Spain | 8 | 113 | 42 | – | 23 | 186 | 8 | 4 | – | 12 | 151 | 0.2% | 0.5% |
| Sweden | – | 227 | 52 | – | 181 | 460 | 9 | 5 | 3 | 17 | 214 | 0.3% | 2.0% |
| United Kingdom |
3,121 | 33,597 | 1,184 | – | 8,124 | 46,026 | 519 | 37 | 123 | 679 | 8,481 | 11.5% | 2.0% |
| Other countries |
18,275 | 127,973 | 9,849 | – | 7,768 163,865 | 4,041 | 311 | 115 | 4,464 | 55,805 | 87.3% | 0.0% |
Table 111: Geographical distribution of credit exposures relevant for the calculation of the countercyclical buffer (UK CCyB1) – Solo consolidation continued
| Relevant credit exposures – General credit exposures Market risk Own funds requirements Sum of long Securitisation Relevant credit Exposure and short Value of exposures exposures value Exposure positions of trading book Exposure Relevant Relevant – Securitisation Risk under the value under trading book exposures for value for Total credit risk credit positions in the weighted Own fund standardised the IRB exposures internal non-trading exposure exposures exposures non-trading exposure requirements Countercyclical Breakdown approach approach for SA models book value – Credit risk – Market risk book Total amounts weights buffer rate (%) by country \$million \$million \$million \$million \$million \$million \$million \$million \$million \$million % % % Armenia – – – – – – – – – – – – 1.5% Australia 156 2,333 144 – 34 2,667 82 11 – 94 1,170 0.7% 1.0% Belgium – 757 4 – – 761 4 – – 5 59 – 1.0% Bulgaria – – – – – – – – – – – – 2.0% Chile – 129 25 – – 154 3 3 – 6 78 – 0.5% Croatia – 7 – – – 7 – – – – 4 – 1.5% Cyprus 2 134 – – – 136 4 – – 4 55 – 1.0% Czech Republic – – 3 – – 3 – – – – 4 – 1.3% Denmark 6 665 1 – – 672 20 – – 20 248 0.2% 2.5% Estonia – – – – – – – – – – – – 1.5% France 14 4,117 221 – – 4,352 66 10 – 76 946 0.6% 1.0% Germany 31 6,709 329 – 3,152 10,220 85 8 47 140 1,747 1.1% 0.8% Greece 5,692 72,370 620 – 3,902 82,583 1,776 8 60 1,844 23,048 14.6% 0.5% Hong Kong – 553 196 – – 749 15 – – 15 190 0.1% 0.5% Hungary – – – – – – – – – – – – 2.5% Iceland 53 2,113 33 – 78 2,278 32 50 1 83 1,041 0.7% 1.5% Ireland 910 34,811 292 – – 36,014 789 3 – 792 9,895 6.3% 1.0% Korea – – – – – – – – – – – – 1.0% Latvia 134 6,519 12 – 332 6,997 110 2 4 116 1,450 0.9% 0.5% Lithuania 20 2,261 31 – – 2,312 86 2 – 88 1,099 0.7% 2.0% Luxembourg 1 239 4 – – 244 10 – – 11 131 0.1% 2.5% Netherlands 1 – – – – 1 – – – – – – 1.0% Norway – – – – – – – – – – – – 1.5% Poland – – – – – – – – – – – – 0.5% Romania – 1,229 8 – – 1,238 28 1 – 30 374 0.2% 2.0% Slovakia 3,780 41,306 1,054 – 18,348 64,487 822 27 265 1,114 13,926 8.8% 2.0% Slovenia 36,254 229,587 16,766 – 5,482 288,090 7,533 572 79 8,184 102,302 64.8% – Spain 8 113 42 – 23 186 8 4 – 12 151 0.2% 0.5% Sweden – 227 52 – 181 460 9 5 3 17 214 0.3% 2.0% United Kingdom 3,121 33,597 1,184 – 8,124 46,026 519 37 123 679 8,481 11.5% 2.0% Other countries 18,275 127,973 9,849 – 7,768 163,865 4,041 311 115 4,464 55,805 87.3% 0.0% |
2024 | ||||||
|---|---|---|---|---|---|---|---|
Table 112: Amount of institution-specific countercyclical capital buffer (UK CCyB2) – Solo consolidation
| 2025 \$million |
2024 \$million |
||
|---|---|---|---|
| 1 | Total risk exposure amount | 130,608 | 126,383 |
| 2 | Institution specific countercyclical capital buffer rate | 0.37% | 0.38% |
| 3 | Institution specific countercyclical capital buffer requirement | 483 | 479 |
Leverage ratio – Standard Chartered – Solo consolidated Table 113: LRSum: Summary reconciliation of accounting assets and leverage ratio exposures (UK LR1) – Solo consolidation
| 2025 \$million |
2024 \$million |
||
|---|---|---|---|
| 1 | Total assets as per published financial statements | 441,020 | 435,691 |
| 2 | Adjustment for entities which are consolidated for accounting purposes but are outside the scope of prudential consolidation |
(3,026) | (1,622) |
| 3 | (Adjustment for securitised exposures that meet the operational requirements for the recognition of risk transference) |
– | – |
| 4 | (Adjustment for exemption of exposures to central banks) | (48,691) | (43,583) |
| 5 | (Adjustment for fiduciary assets recognised on the balance sheet pursuant to the applicable accounting framework but excluded from the total exposure measure in accordance with point (i) of Article 429a(1) of the CRR) |
– | – |
| 6 | Adjustment for regular-way purchases and sales of financial assets subject to trade date accounting |
(493) | (48) |
| 7 | Adjustment for eligible cash pooling transactions | – | – |
| 8 | Adjustment for derivative financial instruments | 1,630 | (25,002) |
| 9 | Adjustment for securities financing transactions (SFTs) | 5,869 | 3,706 |
| 10 | Adjustment for off-balance sheet items (i.e. conversion to credit equivalent amounts of off-balance sheet exposures) |
69,910 | 68,672 |
| 11 | (Adjustment for prudent valuation adjustments and specific and general provisions which have reduced tier 1 capital (leverage)) |
(651) | (621) |
| UK-11a | (Adjustment for exposures excluded from the total exposure measure in accordance with point (c) of Article 429a(1) of the CRR) |
– | – |
| UK-11b | (Adjustment for exposures excluded from the total exposure measure in accordance with point (j) of Article 429a(1) of the CRR) |
– | – |
| 12 | Other adjustments1 | (17,238) | (15,415) |
| 13 | Total exposure measure | 448,330 | 421,778 |
1 Other Adjustments include Cash Collateral posted \$(7,674) million, Tier-1 Capital deduction other than disclosed in above row 12 \$(10,306) million, DTL \$91m million.
Table 114: LRCom: Leverage ratio common disclosure (UK LR2) – Solo consolidation
| 2025 \$million |
2024 \$million |
||
|---|---|---|---|
| On-balance sheet exposures (excluding derivatives and SFTs) | |||
| 1 | On-balance sheet items (excluding derivatives, SFTs, but including collateral) | 301,562 | 278,060 |
| 2 | Gross-up for derivatives collateral provided, where deducted from the balance sheet assets pursuant to the applicable accounting framework |
– | – |
| 3 | (Deductions of receivables assets for cash variation margin provided in derivatives transactions) |
(7,674) | (7,634) |
| 4 | (Adjustment for securities received under securities financing transactions that are recognised as an asset) |
– | – |
| 5 | (General credit risk adjustments to on-balance sheet items) | – | – |
| 6 | (Asset amounts deducted in determining tier 1 capital (leverage)) | (10,306) | (8,477) |
| 7 | Total on-balance sheet exposures (excluding derivatives and SFTs) | 283,582 | 261,949 |
| Derivative exposures | |||
| 8 | Replacement cost associated with SA-CCR derivatives transactions (i.e. net of eligible cash variation margin) |
12,716 | 15,567 |
| UK-8a | Derogation for derivatives: replacement costs contribution under the simplified standardised approach |
– | – |
| 9 | Add-on amounts for potential future exposure associated with SA-CCR derivatives transactions |
51,815 | 44,909 |
| UK-9a | Derogation for derivatives: potential future exposure contribution under the simplified standardised approach |
– | – |
| UK-9b | Exposure determined under the original exposure method | – | – |
| 10 | (Exempted CCP leg of client-cleared trade exposures) (SA-CCR) | (5,324) | (6,035) |
| UK-10a | (Exempted CCP leg of client-cleared trade exposures) (simplified standardised approach) | – | – |
| UK-10b | (Exempted CCP leg of client-cleared trade exposures) (original exposure method) | – | – |
| 11 | Adjusted effective notional amount of written credit derivatives | 34,871 | 103,787 |
| 12 | (Adjusted effective notional offsets and add-on deductions for written credit derivatives) | (25,817) | (100,386) |
| 13 | Total derivatives exposures | 68,261 | 57,842 |
| Securities financing transaction exposures | |||
| 14 | Gross SFT assets (with no recognition of netting), after adjustment for sales accounting transactions |
133,635 | 111,445 |
| 15 | (Netted amounts of cash payables and cash receivables of gross SFT assets) | (64,235) | (38,253) |
| 16 | Counterparty credit risk exposure for SFT assets | 5,869 | 3,706 |
| UK-16a | Derogation for SFTs: counterparty credit risk exposure in accordance with Articles 429e(5) and 222 of the CRR |
– | – |
| 17 | Agent transaction exposures | – | – |
| UK-17a | (Exempted CCP leg of client-cleared SFT exposures) | – | – |
| 18 | Total securities financing transaction exposures | 75,268 | 76,898 |
| Other off-balance sheet exposures | |||
| 19 | Off-balance sheet exposures at gross notional amount | 206,520 | 201,646 |
| 20 | (Adjustments for conversion to credit equivalent amounts) | (136,610) | (132,974) |
| 21 | (General provisions deducted in determining tier 1 capital (leverage) and specific provisions associated with off-balance sheet exposures) |
– | – |
| 22 | Off-balance sheet exposures | 69,910 | 68,672 |
| Excluded exposures | |||
| UK-22a | (Exposures excluded from the total exposure measure in accordance with point (c) of Article 429a(1) of the CRR) |
– | – |
| UK-22b | (Exposures exempted in accordance with point (j) of Article 429a(1) of the CRR (on- and off balance sheet)) |
– | – |
| UK-22g | (Excluded excess collateral deposited at triparty agents) | – | – |
| UK-22k | (Total exempted exposures) | – | – |
| Capital and total exposures | |||
| 23 | Tier 1 capital (leverage) | 18,678 | 19,003 |
| 24 | Total exposure measure including claims on central banks | 497,021 | 465,361 |
| UK-24a (-) Claims on central banks excluded | (48,691) | (43,583) | |
| UK-24b Total exposure measure excluding claims on central banks1 | 448,330 | 421,778 |
| 2025 \$million |
2024 \$million |
||
|---|---|---|---|
| Leverage ratio | |||
| 25 | Leverage ratio excluding claims on central banks (%) | 4.2% | 4.5% |
| UK-25a | Fully loaded ECL accounting model leverage ratio excluding claims on central banks (%) | 4.2% | 4.5% |
| UK-25b | Leverage ratio excluding central bank reserves as if the temporary treatment of unrealised gains and losses measured at fair value through other comprehensive income had not been |
||
| applied (%) | 4.2% | 4.5% | |
| UK-25c | Leverage ratio including claims on central banks (%) | 3.8% | 4.1% |
| 26 | Regulatory minimum leverage ratio requirement (%) | 3.3% | 3.3% |
| Additional leverage ratio disclosure requirements – leverage ratio buffers | |||
| 27 | Leverage ratio buffer (%) | 0.1% | 0.1% |
| UK-27a Of which: G-SII or O-SII additional leverage ratio buffer (%) | – | – | |
| UK-27b | Of which: countercyclical leverage ratio buffer (%) | 0.1% | 0.1% |
| Additional leverage ratio disclosure requirements – disclosure of mean values | |||
| 28 | Mean of daily values of gross SFT assets, after adjustment for sale accounting transactions and netted of amounts of associated cash payables and cash receivable |
75,241 | 78,234 |
| 29 | Quarter-end value of gross SFT assets, after adjustment for sale accounting transactions and netted of amounts of associated cash payables and cash receivables |
69,399 | 73,192 |
| UK-31 | Average total exposure measure including claims on central banks | 519,731 | 492,115 |
| UK-32 | Average total exposure measure excluding claims on central banks | 466,499 | 439,529 |
| UK-33 | Average leverage ratio including claims on central banks | 3.6% | 3.8% |
| UK-34 | Average leverage ratio excluding claims on central banks | 4.1% | 4.3% |
Table 114: LRCom: Leverage ratio common disclosure (UK LR2) – Solo consolidation continued
Table 115: LRSpl: Split-up of on balance sheet exposures (excluding derivatives, SFTs and exempted exposures) (UK LR3) – Solo consolidation
| 2025 \$million |
2024 \$million |
||
|---|---|---|---|
| UK-1 | Total on-balance sheet exposures (excluding derivatives, SFTs, and exempted exposures), | ||
| of which: | 293,888 | 270,426 | |
| UK-2 | Trading book exposures | 41,455 | 30,380 |
| UK-3 | Banking book exposures, of which: | 252,433 | 240,046 |
| UK-4 | Covered bonds | 3,019 | 3,781 |
| UK-5 | Exposures treated as sovereigns | 110,937 | 104,829 |
| UK-6 | Exposures to regional governments, MDB, international organisations and PSE not treated | ||
| as sovereigns | 9,975 | 9,002 | |
| UK-7 | Institutions | 17,794 | 18,197 |
| UK-8 | Secured by mortgages of immovable properties | 6,391 | 6,368 |
| UK-9 | Retail exposures | 3,925 | 4,394 |
| UK-10 | Corporates | 63,620 | 56,150 |
| UK-11 | Exposures in default | 2,150 | 2,082 |
| UK-12 | Other exposures (e.g. equity, securitisations, and other non-credit obligation assets) | 34,621 | 35,242 |
Credit Risk quality – Standard Chartered – Solo consolidated
Table 116: Performing and non-performing exposures and related provisions (UK CR1) – Solo consolidation
| 2025 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross carrying amount/nominal amount | Accumulated impairment, accumulated negative changes in fair value due to credit risk and provisions |
Collateral and financial guarantees received |
||||||||||||||
| Performing exposures | Non-performing exposures |
Performing exposures – accumulated impairment and provisions |
Non-performing exposures – accumulated impairment, accumulated negative changes in fair value due to credit risk and provisions |
|||||||||||||
| \$million | Of which stage 1 \$million |
Of which stage 2 \$million |
\$million | Of which stage 2 \$million |
Of which stage 3 \$million |
\$million | Of which stage 1 \$million |
Of which stage 2 \$million |
\$million | Of which stage 2 \$million |
Of which stage 3 \$million |
Accumulated partial write-off \$million |
On performing exposures \$million |
On non performing exposures \$million |
||
| 005 Cash balances at central banks and other demand deposits |
54,111 | 53,987 | 123 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 010 | Loans and advances |
156,527 | 152,542 | 3,985 | 2,698 | – | 2,698 | (237) | (125) | (112) | (1,443) | – | (1,443) | (3,377) | 23,144 | 325 |
| 020 Central banks | 4,266 | 4,266 | – | – | – | – | – | – | – | – | – | – | – | 6 | – | |
| 030 General governments |
1,676 | 1,601 | 75 | 339 | – | 339 | (1) | – | – | (25) | – | (25) | (0) | 733 | – | |
| 040 Credit institutions |
43,871 | 43,751 | 120 | 9 | – | 9 | (1) | (1) | – | (4) | – | (4) | (27) | 1,442 | – | |
| 050 Other financial corporations |
54,901 | 54,550 | 351 | 18 | – | 18 | (11) | (4) | (7) | (12) | – | (12) | (59) | 6,818 | – | |
| 060 Non-financial corporations |
42,986 | 39,834 | 3,152 | 1,795 | – | 1,795 | (136) | (48) | (88) (1,312) | – | (1,312) | (3,291) | 7,538 | 76 | ||
| 070 | Of which SMEs | 3,721 | 3,646 | 75 | 142 | – | 142 | (14) | (12) | (2) | (112) | – | (112) | – | 444 | 4 |
| 080 Households | 8,827 | 8,540 | 287 | 537 | – | 537 | (89) | (72) | (17) | (89) | – | (89) | – | 6,607 | 249 | |
| 090 Debt securities | 78,211 | 77,820 | 391 | – | – | – | (36) | (34) | (2) | – | – | – | – | 120 | – | |
| 100 | Central banks | 7,984 | 7,984 | – | – | – | – | (8) | (8) | – | – | – | – | – | – | – |
| 110 | General governments |
37,858 | 37,565 | 293 | – | – | – | (14) | (13) | (1) | – | – | – | – | 30 | – |
| 120 | Credit institutions |
23,550 | 23,550 | – | – | – | – | (6) | (6) | – | – | – | – | – | 9 | – |
| 130 | Other financial corporations |
8,004 | 7,906 | 98 | – | – | – | (8) | (7) | (1) | – | – | – | – | 5 | – |
| 140 | Non-financial corporations |
816 | 816 | – | – | – | – | – | – | – | – | – | – | – | 77 | – |
| 150 | Off-balance sheet exposures |
170,826 | 167,693 | 3,133 | 523 | – | 523 | (64) | (36) | (28) | (90) | – | (90) | 4,140 | 48 | |
| 160 | Central banks | 391 | 391 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 170 | General governments |
1,905 | 1,873 | 32 | – | – | – | (1) | (1) | – | – | – | – | 213 | – | |
| 180 | Credit institutions |
9,664 | 9,506 | 158 | 6 | – | 6 | (1) | (1) | – | – | – | – | 148 | – | |
| 190 | Other financial corporations |
72,144 | 71,368 | 776 | 1 | – | 1 | (3) | (3) | (1) | – | – | – | 235 | – | |
| 200 Non-financial corporations |
83,413 | 81,295 | 2,118 | 515 | – | 515 | (58) | (31) | (27) | (90) | – | (90) | 3,509 | 48 | ||
| 210 | Households | 3,308 | 3,259 | 50 | 1 | – | 1 | – | – | – | – | – | – | 35 | – | |
| 220 Total | 459,675 452,042 | 7,632 | 3,221 | – | 3,221 | (337) | (195) | (142) | (1,533) | – | (1,533) | (3,377) | 27,404 | 374 |
Table 116: Performing and non-performing exposures and related provisions (UK CR1) – Solo consolidation continued
| 2024 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross carrying amount/nominal amount | Accumulated impairment, accumulated negative changes in fair value due to credit risk and provisions |
Collateral and financial guarantees received |
||||||||||||||
| Performing exposures | Non-performing exposures |
Performing exposures – accumulated impairment and provisions |
Non-performing exposures – accumulated impairment, accumulated negative changes in fair value due to credit risk and provisions |
|||||||||||||
| \$million | Of which stage 1 \$million |
Of which stage 2 \$million |
\$million | Of which stage 1 \$million |
Of which stage 2 \$million |
\$million | Of which stage 1 \$million |
Of which stage 2 \$million |
\$million | Of which stage 2 \$million |
Of which stage 3 \$million |
Accumulated partial write-off \$million |
On performing exposures \$million |
On non performing exposures \$million |
||
| 005 Cash balances at central banks and other demand deposits |
46,333 | 46,193 | 140 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 010 | Loans and advances |
156,961 | 152,708 | 4,253 | 2,688 | – | 2,688 | (213) | (115) | (98) | (1,580) | – | (1,580) | (3,339) | 26,147 | 367 |
| 020 Central banks 030 General |
3,102 | 3,102 | – | – | – | – | – | – | – | – | – | – | – | 10 | – | |
| governments 040 Credit institutions |
10,776 36,609 |
10,392 36,502 |
384 107 |
94 8 |
– – |
94 8 |
(1) (1) |
– (1) |
(1) – |
(41) (6) |
– – |
(41) (6) |
– (27) |
911 2,046 |
5 – |
|
| 050 Other financial corporations |
58,250 | 57,803 | 447 | 19 | – | 19 | (6) | (5) | (1) | (19) | – | (19) | (59) | 9,445 | – | |
| 060 Non-financial corporations |
39,521 | 36,345 | 3,176 | 2,177 | – | 2,177 | (128) | (53) | (75) | (1,426) | – | (1,426) | (3,253) | 7,697 | 118 | |
| 070 | Of which SMEs | 3,922 | 3,822 | 100 | 209 | – | 209 | (13) | (10) | (3) | (123) | – | (123) | – | 572 | 2 |
| 080 Households | 8,703 | 8,564 | 139 | 390 | – | 390 | (77) | (56) | (21) | (88) | – | (88) | – | 6,038 | 244 | |
| 090 Debt securities | 81,450 | 81,205 | 245 | – | – | – | (18) | (17) | (1) | – | – | – | – | 51 | – | |
| 100 | Central banks | 6,783 | 6,783 | – | – | – | – | (3) | (3) | – | – | – | – | – | 1 | – |
| 110 | General governments |
34,313 | 34,068 | 245 | – | – | – | (8) | (7) | (1) | – | – | – | – | – | – |
| 120 | Credit institutions |
21,396 | 21,396 | – | – | – | – | (1) | (1) | – | – | – | – | – | 14 | – |
| 130 | Other financial corporations |
18,097 | 18,097 | – | – | – | – | (5) | (5) | – | – | – | – | – | – | – |
| 140 | Non-financial corporations |
861 | 861 | – | – | – | – | (1) | (1) | – | – | – | – | – | 36 | – |
| 150 | Off-balance sheet exposures |
137,886 | 134,056 | 3,830 | 445 | – | 445 | (47) | (25) | (22) | (102) | – | (102) | 2,227 | 20 | |
| 160 | Central banks | 111 | 111 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 170 | General governments |
4,142 | 4,124 | 18 | – | – | – | – | – | – | – | – | – | 123 | – | |
| 180 | Credit institutions |
8,569 | 8,282 | 287 | 17 | – | 17 | (2) | (1) | (1) | (4) | – | (4) | 47 | – | |
| 190 | Other financial corporations |
52,391 | 52,083 | 308 | 1 | – | 1 | (3) | (3) | – | – | – | – | 610 | – | |
| 200 Non-financial corporations |
69,706 | 66,545 | 3,161 | 427 | – | 427 | (41) | (20) | (21) | (98) | – | (98) | 1,296 | 20 | ||
| 210 | Households | 2,967 | 2,911 | 56 | – | – | – | (1) | (1) | – | – | – | – | 151 | – | |
| 220 Total | 422,630 | 414,162 | 8,468 | 3,133 | – | 3,133 | (278) | (157) | (121) | (1,682) | – | (1,682) | (3,339) | 28,425 | 387 |
Table 117: Maturity of exposures (UK CR1-A) – Solo consolidation
| 2025 | |||||||
|---|---|---|---|---|---|---|---|
| Net exposure value | |||||||
| On demand \$million |
<= 1 year \$million |
> 1 year <= 5 years \$million |
> 5 years \$million |
No stated maturity \$million |
Total \$million |
||
| 1 | Loans and advances | 7,967 | 96,792 | 30,372 | 25,972 | – | 161,102 |
| 2 | Debt securities | 1 | 35,294 | 28,390 | 45,566 | – | 109,251 |
| 3 | Total | 7,968 | 132,086 | 58,762 | 71,537 | – | 270,353 |
| 2024 | |||||||
| Net exposure value | |||||||
| On demand \$million |
<= 1 year \$million |
> 1 year <= 5 years \$million |
> 5 years \$million |
No stated maturity \$million |
Total \$million |
||
| 1 | Loans and advances | 7,412 | 101,739 | 26,002 | 21,496 | – | 156,649 |
| 2 | Debt securities | 139 | 27,849 | 27,908 | 45,785 | – | 101,681 |
3 Total 7,551 129,588 53,910 67,281 – 258,330 Table 118: Changes in the stock of non-performing loans and advances (UK CR2) – Solo consolidation
| 2025 | 2024 | ||
|---|---|---|---|
| Gross carrying amount \$million |
Gross carrying amount \$million |
||
| 010 | Initial stock of non-performing loans and advances | 2,688 | 3,767 |
| 020 | Inflows to non-performing portfolios | 1,221 | 601 |
| 030 | Outflows from non-performing portfolios | (1,212) | (1,680) |
| 040 | Outflows due to write-offs | (207) | (433) |
| 050 | Outflow due to other situations | (1,005) | (1,247) |
| 060 | Final stock of non-performing loans and advances | 2,697 | 2,688 |
Table 119: Credit quality of forborne exposures (UK CQ1) – Solo consolidation
| 2025 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Gross carrying amount/nominal amount of exposures with forbearance measures |
Accumulated impairment, accumulated negative changes in fair value due to credit risk and provisions |
Collateral received and financial guarantees received on forborne exposures |
||||||||
| Non-performing forborne | On performing | On non-performing |
Of which collateral and financial guarantees received on non-performing |
|||||||
| Performing forborne \$million |
\$million | Of which defaulted \$million |
Of which impaired \$million |
forborne exposures \$million |
forborne exposures \$million |
\$million | exposures with forbearance measures \$million |
|||
| 005 | Cash balances at central banks and other demand deposits |
– | – | – | – | – | – | – | – | |
| 010 | Loans and advances | 61 | 596 | 596 | 596 | (2) | (310) | 33 | 23 | |
| 020 | Central banks | – | – | – | – | – | – | – | – | |
| 030 | General governments | – | 27 | 27 | 27 | – | (1) | – | – | |
| 040 | Credit institutions | – | – | – | – | – | – | – | – | |
| 050 | Other financial corporations | 48 | 18 | 18 | 18 | – | (18) | – | – | |
| 060 | Non-financial corporations | 10 | 551 | 551 | 551 | (1) | (291) | 30 | 23 | |
| 070 | Households | 3 | – | – | – | – | – | 2 | – | |
| 080 | Debt Securities | – | – | – | – | – | – | – | – | |
| 090 | Loan commitments given | – | – | – | – | – | – | – | – | |
| 100 | Total | 61 | 596 | 596 | 596 | (2) | (310) | 33 | 23 |
Table 119: Credit quality of forborne exposures (UK CQ1) – Solo consolidation continued
| 2024 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| with forbearance measures | Gross carrying amount/nominal amount of exposures | Accumulated impairment, accumulated negative changes in fair value due to credit risk and provisions |
Collateral received and financial guarantees received on forborne exposures |
|||||||
| Non-performing forborne | Of which collateral | |||||||||
| Performing forborne \$million |
\$million | Of which defaulted \$million |
Of which impaired \$million |
On performing forborne exposures \$million |
On non-performing forborne exposures \$million |
\$million | and financial guarantees received on non-performing exposures with forbearance measures \$million |
|||
| 005 | Cash balances at central banks and other demand deposits |
– | – | – | – | – | – | – | – | |
| 010 | Loans and advances | 15 | 708 | 708 | 708 | – | (397) | 95 | 81 | |
| 020 | Central banks | – | – | – | – | – | – | – | – | |
| 030 | General governments | – | – | – | – | – | – | – | – | |
| 040 | Credit institutions | – | – | – | – | – | – | – | – | |
| 050 | Other financial corporations | – | 19 | 19 | 19 | – | (19) | – | – | |
| 060 | Non-financial corporations | 11 | 688 | 688 | 688 | – | (378) | 92 | 81 | |
| 070 | Households | 4 | 1 | 1 | 1 | – | – | 3 | – | |
| 080 | Debt Securities | – | – | – | – | – | – | – | – | |
| 090 | Loan commitments given | – | – | – | – | – | – | – | – | |
| 100 | Total | 15 | 708 | 708 | 708 | – | (397) | 95 | 81 |
Table 120: Credit quality of performing and non-performing exposures by past due days (UK CQ3) – Solo consolidation
| 2025 | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross carrying amount/nominal amount | |||||||||||||
| Performing exposures | Non-performing exposures | ||||||||||||
| \$million | Not past due or past due ≤ 30 days \$million |
Past due > 30 days ≤ 90 days \$million |
\$million | Unlikely to pay that are not past due or are past due ≤ 90 days \$million |
Past due > 90 days ≤ 180 days \$million |
Past due > 180 days ≤ 1 year \$million |
Past due > 1 year ≤ 2 years \$million |
Past due > 2 years ≤ 5 years \$million |
Past due > 5 years ≤ 7 years \$million |
Past due > 7 years \$million |
Of which defaulted \$million |
||
| 005 | Cash balances at central banks and other demand deposits |
54,111 | 54,111 | – | – | – | – | – | – | – | – | – | – |
| 010 | Loans and advances | 156,527 | 156,179 | 348 | 2,698 | 1,234 | 361 | 4 | 165 | 161 | 290 | 483 | 2,698 |
| 020 | Central banks | 4,266 | 4,266 | – | – | – | – | – | – | – | – | – | – |
| 030 | General governments | 1,677 | 1,677 | – | 339 | 290 | – | – | 1 | 11 | 37 | – | 339 |
| 040 | Credit institutions | 43,871 | 43,870 | 1 | 9 | 8 | 1 | – | – | – | – | – | 9 |
| 050 | Other financial corporations |
54,901 | 54,802 | 99 | 18 | – | – | – | – | 3 | – | 15 | 18 |
| 060 | Non-financial corporations |
42,986 | 42,791 | 196 | 1,795 | 792 | – | – | 140 | 143 | 252 | 468 | 1,795 |
| 070 | Of which SMEs | 3,721 | 3,716 | 4 | 142 | – | – | – | 12 | 40 | 32 | 58 | 142 |
| 080 | Households | 8,827 | 8,774 | 53 | 537 | 145 | 360 | 4 | 24 | 4 | 1 | – | 537 |
| 090 | Debt securities | 78,211 | 78,211 | – | – | – | – | – | – | – | – | – | – |
| 100 | Central banks | 7,984 | 7,984 | – | – | – | – | – | – | – | – | – | – |
| 110 | General governments | 37,858 | 37,858 | – | – | – | – | – | – | – | – | – | – |
| 120 | Credit institutions | 23,550 | 23,550 | – | – | – | – | – | – | – | – | – | – |
| 130 | Other financial corporations |
8,004 | 8,004 | – | – | – | – | – | – | – | – | – | – |
| 140 | Non-financial corporations |
816 | 816 | – | – | – | – | – | – | – | – | – | – |
| 150 | Off-balance-sheet exposures |
170,826 | 523 | 523 | |||||||||
| 160 | Central banks | 391 | – | – | |||||||||
| 170 | General governments | 1,905 | 0 | 0 | |||||||||
| 180 | Credit institutions | 9,665 | 6 | 6 | |||||||||
| 190 | Other financial corporations |
72,144 | 1 | 1 | |||||||||
| 200 | Non-financial corporations |
83,413 | 515 | 515 | |||||||||
| 210 | Households | 3,308 | 1 | 1 | |||||||||
| 220 | Total | 459,675 | 288,501 | 348 | 3,221 | 1,234 | 361 | 4 | 165 | 161 | 290 | 483 | 3,221 |
Table 120: Credit quality of performing and non-performing exposures by past due days (UK CQ3) – Solo consolidation continued
| 2024 | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross carrying amount/nominal amount | |||||||||||||
| Performing exposures | Non-performing exposures | ||||||||||||
| \$million | Not past due or past due ≤ 30 days \$million |
Past due > 30 days ≤ 90 days \$million |
\$million | Unlikely to pay that are not past due or are past due ≤ 90 days \$million |
Past due > 90 days ≤ 180 days \$million |
Past due > 180 days ≤ 1 year \$million |
Past due > 1 year ≤ 2 years \$million |
Past due > 2 years ≤ 5 years \$million |
Past due > 5 years ≤ 7 years \$million |
Past due > 7 years \$million |
Of which defaulted \$million |
||
| 005 | Cash balances at central banks and other demand deposits |
46,333 | 46,333 | – | – | – | – | – | – | – | – | – | – |
| 010 | Loans and advances | 156,961 | 156,875 | 86 | 2,688 | 997 | 370 | 124 | 200 | 393 | 178 | 426 | 2,688 |
| 020 | Central banks | 3,102 | 3,102 | – | – | – | – | – | – | – | – | – | – |
| 030 | General governments | 10,776 | 10,776 | – | 94 | 50 | 1 | – | – | 43 | – | – | 94 |
| 040 | Credit institutions | 36,609 | 36,609 | – | 8 | 7 | 1 | – | – | – | – | – | 8 |
| 050 | Other financial corporations |
58,250 | 58,250 | – | 19 | 1 | – | – | 3 | – | – | 15 | 19 |
| 060 | Non-financial corporations |
39,521 | 39,496 | 25 | 2,177 | 939 | 23 | 120 | 163 | 344 | 177 | 411 | 2,177 |
| 070 | Of which SMEs | 3,922 | 3,917 | 5 | 209 | 51 | 5 | 3 | 8 | 45 | 62 | 35 | 209 |
| 080 | Households | 8,703 | 8,642 | 61 | 390 | – | 345 | 4 | 34 | 6 | 1 | – | 390 |
| 090 | Debt securities | 81,450 | 81,450 | – | – | – | – | – | – | – | – | – | – |
| 100 | Central banks | 6,783 | 6,783 | – | – | – | – | – | – | – | – | – | – |
| 110 | General governments | 34,313 | 34,313 | – | – | – | – | – | – | – | – | – | – |
| 120 | Credit institutions | 21,396 | 21,396 | – | – | – | – | – | – | – | – | – | – |
| 130 | Other financial corporations |
18,097 | 18,097 | – | – | – | – | – | – | – | – | – | – |
| 140 | Non-financial corporations |
861 | 861 | – | – | – | – | – | – | – | – | – | – |
| 150 | Off-balance-sheet exposures |
137,886 | 445 | 445 | |||||||||
| 160 | Central banks | 111 | – | – | |||||||||
| 170 | General governments | 4,142 | – | – | |||||||||
| 180 | Credit institutions | 8,569 | 17 | 17 | |||||||||
| 190 | Other financial corporations |
52,391 | 1 | 1 | |||||||||
| 200 | Non-financial corporations |
69,706 | 427 | 427 | |||||||||
| 210 | Households | 2,967 | – | – | |||||||||
| 220 | Total | 422,630 | 284,658 | 86 | 3,133 | 997 | 370 | 124 | 200 | 393 | 178 | 426 | 3,133 |
Table 121: Quality of non-performing exposures by geography (UK CQ4) – Solo consolidation
| 2025 | ||||||||
|---|---|---|---|---|---|---|---|---|
| Gross carrying amount | ||||||||
| Of which non-performing |
Provisions on | Accumulated negative changes in fair value due to credit risk on non-performing exposures \$million |
||||||
| \$million | \$million | Of which defaulted \$million |
Of which loans and advances subject to impairment \$million |
Accumulated impairment \$million |
off-balance-sheet commitments and financial guarantees given \$million |
|||
| 010 | On-balance-sheet exposures |
291,547 | 2,698 | (1,716) | – | |||
| 020 | United Kingdom | 33,705 | 9 | (26) | – | |||
| 030 | United States | 82,503 | 71 | (33) | – | |||
| 040 | India | 20,355 | 301 | (310) | – | |||
| 050 | Japan | 13,471 | – | (1) | – | |||
| 060 | Other countries | 141,513 | 2,317 | (1,347) | – | |||
| 070 | Off-balance-sheet exposures |
171,348 | 523 | (154) | ||||
| 080 | United Kingdom | 70,568 | 2 | (7) | ||||
| 090 | United States | 45,935 | 11 | (18) | ||||
| 100 | India | 10,163 | 59 | (53) | ||||
| 110 | Japan | 1,710 | – | (1) | ||||
| 120 | Other countries | 42,972 | 451 | (75) | ||||
| 130 | Total | 462,895 | 3,221 | (1,716) | (154) | – |
| Gross carrying amount | ||||||||
|---|---|---|---|---|---|---|---|---|
| Of which non-performing |
Provisions on | Accumulated negative | ||||||
| \$million | \$million | Of which defaulted \$million |
Of which loans and advances subject to impairment \$million |
Accumulated impairment \$million |
off-balance-sheet commitments and financial guarantees given \$million |
changes in fair value due to credit risk on non-performing exposures \$million |
||
| 010 | On-balance-sheet exposures |
287,432 | 2,688 | (1,810) | – | |||
| 020 | United Kingdom | 33,133 | 13 | (26) | – | |||
| 030 | United States | 77,305 | 2 | (7) | – | |||
| 040 | India | 22,645 | 409 | (364) | – | |||
| 050 | Japan | 15,915 | – | (11) | – | |||
| 060 | Other countries | 138,434 | 2,264 | (1,402) | – | |||
| 070 | Off-balance-sheet exposures |
138,331 | 445 | (149) | ||||
| 080 | United Kingdom | 17,380 | 5 | (6) | ||||
| 090 | United States | 49,251 | – | (9) | ||||
| 100 | India | 9,992 | 77 | (56) | ||||
| 110 | Japan | 1,591 | – | (1) | ||||
| 120 | Other countries | 60,117 | 363 | (77) | ||||
| 130 | Total | 425,763 | 3,133 | (1,810) | (149) | – |
2024
Table 122: Credit quality of loans and advances to non-financial corporations by industry (UK CQ5) – Solo consolidation
| 2025 | |||||||
|---|---|---|---|---|---|---|---|
| Gross carrying amount | |||||||
| Of which non-performing |
Accumulated negative changes in fair value |
||||||
| \$million | \$million | Of which defaulted \$million |
Of which loans and advances subject to impairment \$million |
Accumulated impairment \$million |
due to credit risk on non-performing exposures \$million |
||
| 005 | Cash balances at central banks and other demand deposits |
52,191 | – | – | – | ||
| 010 | Agriculture, forestry and fishing | 66 | 2 | (4) | – | ||
| 020 | Mining and quarrying | 2,384 | 15 | (23) | – | ||
| 030 | Manufacturing | 13,905 | 746 | (566) | – | ||
| 040 | Electricity, gas, steam and air conditioning supply |
4,354 | 230 | (79) | – | ||
| 050 | Water supply | 164 | – | – | – | ||
| 060 | Construction | 854 | 63 | (74) | – | ||
| 070 | Wholesale and retail trade | 10,335 | 373 | (343) | – | ||
| 080 | Transport and storage | 1,777 | 62 | (3) | – | ||
| 090 | Accommodation and food service activities | 856 | 66 | (40) | – | ||
| 100 | Information and communication | 1,595 | 33 | (49) | – | ||
| 110 | Financial and insurance activities | 67 | – | – | – | ||
| 120 | Real estate activities | 5,581 | 135 | (103) | – | ||
| 130 | Professional, scientific and technical activities | 254 | 6 | (5) | – | ||
| 140 | Administrative and support service activities | 316 | 2 | (4) | – | ||
| 150 | Public administration and defence, compulsory social security |
– | – | – | – | ||
| 160 | Education | 41 | – | – | – | ||
| 170 | Human health services and social work activities |
167 | – | – | – | ||
| 180 | Arts, entertainment and recreation | 30 | – | – | – | ||
| 190 | Other services | 2,036 | 61 | (155) | – | ||
| 200 | Total | 44,782 | 1,795 | (1,449) | – | ||
| 210 | Households | 9,364 | 537 | (178) | – | ||
| 220 | Total | 106,337 | 2,332 | (1,627) | – | ||
| 2024 |
| Gross carrying amount | |||||||
|---|---|---|---|---|---|---|---|
| Of which non-performing |
Accumulated negative | ||||||
| \$million | \$million | Of which defaulted \$million |
Of which loans and advances subject to impairment \$million |
Accumulated impairment \$million |
changes in fair value due to credit risk on non-performing exposures \$million |
||
| 005 | Cash balances at central banks and other demand deposits |
45,066 | – | – | – | ||
| 010 | Agriculture, forestry and fishing | 144 | 6 | (7) | – | ||
| 020 | Mining and quarrying | 3,037 | 218 | (200) | – | ||
| 030 | Manufacturing | 15,395 | 920 | (547) | – | ||
| 040 | Electricity, gas, steam and air conditioning supply |
3,415 | 187 | (61) | – | ||
| 050 | Water supply | 116 | – | (1) | – | ||
| 060 | Construction | 717 | 90 | (93) | – | ||
| 070 | Wholesale and retail trade | 9,941 | 436 | (294) | – | ||
| 080 | Transport and storage | 1,835 | 61 | (29) | – | ||
| 090 | Accommodation and food service activities | 685 | 65 | (11) | – | ||
| 100 | Information and communication | 1,251 | 32 | (77) | – | ||
| 110 | Financial and insurance activities | – | – | – | – | ||
| 120 | Real estate activities | 4,215 | 140 | (84) | – | ||
| 130 | Professional, scientific and technical activities | 361 | 6 | (6) | – | ||
| 140 | Administrative and support service activities | 343 | 16 | (12) | – | ||
| 150 | Public administration and defence, compulsory social security |
– | – | – | – | ||
| 160 | Education | 11 | – | – | – | ||
| 170 | Human health services and social work activities |
196 | – | – | – | ||
| 180 | Arts, entertainment and recreation | 22 | – | – | – | ||
| 190 | Other services | 14 | – | (132) | – | ||
| 200 | Total | 41,698 | 2,177 | (1,554) | – | ||
| 210 | Households | 9,093 | 390 | (165) | – | ||
| 220 | Total | 95,857 | 2,567 | (1,719) | – |
Table 123: CRM techniques overview: Disclosure of the use of credit risk mitigation techniques (UK CR3) – Solo consolidation
| 2025 | ||||||
|---|---|---|---|---|---|---|
| Exposures unsecured \$million |
Exposures secured \$million |
Of which secured by collateral \$million |
Of which secured by financial guarantees \$million |
Of which secured by credit derivatives \$million |
||
| 1 | Total loans | 188,186 | 23,469 | 19,104 | 4,366 | 123 |
| 2 | Total debt securities | 78,055 | 120 | 70 | 50 | |
| 3 | Total exposures | 266,241 | 23,589 | 19,174 | 4,416 | 123 |
| 4 | Of which non-performing exposures | 930 | 325 | 325 | – | – |
| 5 | Of which defaulted | 930 | 325 | |||
| 2024 |
| Exposures unsecured \$million |
Exposures secured \$million |
Of which secured by collateral \$million |
Of which secured by financial guarantees \$million |
Of which secured by credit derivatives \$million |
||
|---|---|---|---|---|---|---|
| 1 | Total loans | 177,675 | 26,514 | 22,163 | 4,351 | – |
| 2 | Total debt securities | 81,382 | 51 | 31 | 20 | |
| 3 | Total exposures | 259,057 | 26,565 | 22,194 | 4,371 | – |
| 4 | Of which non-performing exposures | 741 | 367 | 367 | – | – |
| 5 | Of which defaulted | 741 | 367 |
Table 124: Standardised approach – Credit risk exposure and CRM effects (UK CR4) – Solo consolidation
| 2025 | |||||||
|---|---|---|---|---|---|---|---|
| Exposures before CCF and CRM1 | Exposures post CCF and CRM | RWA and RWA density | |||||
| On-balance sheet \$million |
Off-balance sheet \$million |
On-balance sheet \$million |
Off-balance sheet \$million |
RWA \$million |
RWA density % |
||
| Standardised Exposure Class | |||||||
| 1 | Central governments or central banks |
14,726 | 240 | 15,634 | 554 | 704 | 4 |
| 2 | Multilateral development banks | 19,898 | 608 | 21,810 | 318 | 84 | – |
| 6 | Institutions | 8 | 165 | – | – | – | – |
| 7 | Corporates | 18,156 | 20,760 | 4,259 | 957 | 4,235 | 81 |
| 8 | Retail | 3,040 | 1,282 | 2,874 | 59 | 2,051 | 70 |
| 9 | Secured on real estate property | 5,005 | 137 | 5,005 | 78 | 2,410 | 47 |
| 10 | Exposures in default | 96 | 7 | 96 | 3 | 99 | 100 |
| 11 | Items belonging to regulatory high risk categories |
376 | 141 | 167 | 2 | 253 | 150 |
| 15 | Equity | 2,446 | – | 2,446 | – | 6,115 | 250 |
| 16 | Other items2 | 11,828 | – | 13,447 | – | 4,664 | 35 |
| 17 | Total Standardised3 | 75,579 | 23,340 | 65,738 | 1,971 | 20,615 | 30 |
| 2024 | |||||||
|---|---|---|---|---|---|---|---|
| Exposures before CCF and CRM1 | Exposures post CCF and CRM | RWA and RWA density | |||||
| On-balance sheet \$million |
Off-balance sheet \$million |
On-balance sheet \$million |
Off-balance sheet \$million |
RWA \$million |
RWA density % |
||
| Standardised Exposure Class | |||||||
| 1 | Central governments or central banks |
14,116 | 189 | 14,926 | 718 | 746 | 4.77 |
| 2 | Multilateral development banks | 15,028 | 806 | 17,241 | 46 | 70 | 0.40 |
| 6 | Institutions | 6 | 138 | – | – | – | – |
| 7 | Corporates | 4,949 | 4,430 | 3,259 | 622 | 3,167 | 81.60 |
| 8 | Retail | 2,959 | 1,435 | 2,889 | 68 | 2,059 | 69.63 |
| 9 | Secured on real estate property | 4,799 | 183 | 4,799 | 105 | 2,509 | 51.16 |
| 10 | Exposures in default | 123 | 9 | 123 | 6 | 128 | 99.22 |
| 11 | Items belonging to regulatory high risk categories |
163 | 248 | 149 | 25 | 260 | 149.43 |
| 15 | Equity | 1,865 | – | 1,865 | – | 4,661 | 249.92 |
| 16 | Other items2 | 10,787 | 10 | 5,080 | 10 | 3,125 | 61.39 |
| 17 | Total Standardised3 | 54,795 | 7,448 | 50,331 | 1,600 | 16,725 | 32.21 |
1 EAD before the effect of collateral and substitution.
2 Other items include public sector entities.
3 Refer to table 132 (OV1): Standardised approach \$13,796 million and amount below threshold for deduction \$6,819 million RWA.
Table 125: Liquidity Coverage Ratio (LCR) (UK LIQ1) – Solo consolidation
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total unweighted value (average) |
Total weighted value (average) |
||||||||||
| 31.03.25 \$million |
30.06.25 \$million |
30.09.25 \$million |
31.12.25 \$million |
31.03.25 \$million |
30.06.25 \$million |
30.09.25 \$million |
31.12.25 \$million |
||||
| Number of data points used in the calculation of averages |
12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | |||
| High-Quality Liquid Assets | |||||||||||
| 1 | Total High-Quality Liquid Assets (HQLA) |
88,828 | 88,491 | 89,813 | 89,647 | ||||||
| Cash outflows | |||||||||||
| 2 | Retail deposits and deposits from small business customers, of which: |
14,484 | 15,181 | 15,759 | 16,318 | 1,763 | 1,944 | 2,092 | 2,189 | ||
| 3 | Stable deposits | 601 | 579 | 554 | 572 | 30 | 29 | 28 | 29 | ||
| 4 | Less stable deposits | 13,882 | 14,603 | 15,206 | 15,746 | 1,733 | 1,915 | 2,064 | 2,161 | ||
| 5 | Unsecured wholesale funding, of which: |
113,592 | 115,048 | 115,358 | 115,333 | 57,654 | 58,183 | 58,013 | 57,977 | ||
| 6 | Operational deposits (all counterparties) and deposits in networks of cooperative banks |
36,093 | 37,647 | 38,888 | 39,443 | 9,022 | 9,410 | 9,719 | 9,856 | ||
| 7 | Non-operational deposits (all counterparties) |
74,836 | 74,454 | 73,363 | 72,908 | 45,969 | 45,825 | 45,186 | 45,139 | ||
| 8 | Unsecured debt | 2,663 | 2,948 | 3,108 | 2,982 | 2,663 | 2,948 | 3,108 | 2,982 | ||
| 9 | Secured wholesale funding | 7,972 | 8,636 | 8,719 | 8,448 | ||||||
| 10 | Additional requirements | 67,588 | 68,290 | 66,968 | 65,541 | 22,463 | 22,942 | 21,493 | 19,256 | ||
| 11 | Outflows related to derivative exposures and other collateral requirements |
19,107 | 19,049 | 16,293 | 12,509 | 13,016 | 13,187 | 11,499 | 8,811 | ||
| 12 | Outflows related to loss of | ||||||||||
| funding on debt products | – | – | – | – | – | – | – | – | |||
| 13 | Credit and liquidity facilities | 48,481 | 49,241 | 50,675 | 53,032 | 9,447 | 9,755 | 9,994 | 10,445 | ||
| 14 | Other contractual funding obligations |
5,656 | 5,799 | 6,275 | 7,383 | 3,134 | 3,105 | 3,482 | 4,545 | ||
| 15 | Other contingent funding obligations |
99,077 | 98,545 | 97,109 | 95,846 | 749 | 733 | 658 | 637 | ||
| 16 | Total cash outflows | 93,734 | 95,543 | 94,456 | 93,052 | ||||||
| Cash inflows | |||||||||||
| 17 | Secured lending (e.g. reverse repos) |
69,993 | 75,273 | 77,107 | 82,151 | 10,486 | 10,898 | 11,058 | 11,507 | ||
| 18 | Inflows from fully | ||||||||||
| performing exposures | 17,200 | 17,955 | 18,293 | 19,165 | 14,836 | 15,377 | 15,633 | 16,382 | |||
| 19 | Other cash inflows | 12,196 | 12,524 | 12,576 | 13,241 | 10,244 | 10,798 | 11,090 | 11,794 | ||
| UK-19a | (Difference between total weighted inflows and total weighted outflows arising from transactions in third countries where there are transfer restrictions or which are denominated in non convertible currencies) |
– | – | – | – | ||||||
| UK-19b | (Excess inflows from a related | ||||||||||
| specialised credit institutions) | – | – | – | – | |||||||
| 20 | Total cash inflows | 99,390 | 105,752 | 107,975 | 114,557 | 35,566 | 37,073 | 37,781 | 39,682 | ||
| UK-20a Fully exempt inflows | – | – | – | – | – | – | – | – | |||
| UK-20b Inflows subject to 90% cap | – | – | – | – | – | – | – | – | |||
| UK-20c Inflows subject to 75% cap | 90,138 | 96,157 | 98,619 | 105,600 | 35,566 | 37,073 | 37,781 | 39,682 | |||
| Total adjusted value | |||||||||||
| 21 | Liquidity buffer | 88,828 | 88,491 | 89,813 | 89,647 | ||||||
| 22 | Total net cash outflows | 58,168 | 58,470 | 56,675 | 53,370 | ||||||
| 23 | Liquidity coverage ratio (%) | 153.4% | 151.8% | 159.7% | 169.2% |
Table 125: Liquidity Coverage Ratio (LCR) (UK LIQ1) – Solo consolidation continued
| 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Total unweighted value (average) |
Total weighted value (average) |
||||||||
| 31.03.25 \$million |
30.06.25 \$million |
30.09.25 \$million |
31.12.25 \$million |
31.03.25 \$million |
30.06.25 \$million |
30.09.25 \$million |
31.12.25 \$million |
||
| Number of data points used in the calculation of averages |
12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | |
| High-Quality Liquid Assets | |||||||||
| 1 | Total High-Quality Liquid Assets (HQLA) |
103,106 | 98,688 | 92,637 | 90,026 | ||||
| Cash outflows | |||||||||
| 2 | Retail deposits and deposits from small business customers, of which: |
13,172 | 13,420 | 13,713 | 14,048 | 1,433 | 1,462 | 1,518 | 1,629 |
| 3 | Stable deposits | 605 | 669 | 692 | 649 | 30 | 33 | 35 | 32 |
| 4 | Less stable deposits | 12,567 | 12,752 | 13,021 | 13,399 | 1,403 | 1,429 | 1,483 | 1,597 |
| 5 | Unsecured wholesale funding, of which: |
114,034 | 111,473 | 111,342 | 112,986 | 61,167 | 59,585 | 58,323 | 58,065 |
| 6 | Operational deposits (all counterparties) and deposits in networks of cooperative banks |
33,856 | 32,836 | 33,261 | 34,455 | 8,462 | 8,207 | 8,314 | 8,612 |
| 7 | Non-operational deposits (all counterparties) |
75,679 | 74,484 | 74,635 | 75,603 | 48,208 | 47,224 | 46,564 | 46,525 |
| 8 | Unsecured debt | 4,498 | 4,153 | 3,445 | 2,928 | 4,498 | 4,153 | 3,445 | 2,928 |
| 9 | Secured wholesale funding | 6,068 | 6,324 | 6,693 | 7,165 | ||||
| 10 | Additional requirements | 63,961 | 64,425 | 65,300 | 66,789 | 21,547 | 20,849 | 21,170 | 22,193 |
| 11 | Outflows related to derivative exposures and other collateral requirements |
15,433 | 16,353 | 17,495 | 18,820 | 12,126 | 11,609 | 12,012 | 12,900 |
| 12 | Outflows related to loss of funding on debt products |
– | – | – | – | – | – | – | – |
| 13 | Credit and liquidity facilities | 48,528 | 48,072 | 47,805 | 47,969 | 9,421 | 9,240 | 9,158 | 9,293 |
| 14 | Other contractual funding obligations |
4,966 | 4,751 | 5,087 | 5,363 | 2,682 | 2,975 | 3,105 | 3,140 |
| 15 | Other contingent funding obligations |
96,129 | 97,467 | 98,917 | 99,574 | 455 | 567 | 706 | 745 |
| 16 | Total cash outflows | 93,354 | 91,762 | 91,515 | 92,938 | ||||
| Cash inflows | |||||||||
| 17 | Secured lending (e.g. reverse repos) |
53,322 | 53,445 | 57,577 | 62,593 | 6,135 | 6,843 | 7,913 | 8,892 |
| 18 | Inflows from fully | ||||||||
| performing exposures | 16,408 | 15,854 | 16,320 | 16,894 | 14,693 | 14,067 | 14,357 | 14,706 | |
| 19 UK-19a |
Other cash inflows (Difference between total weighted inflows and total weighted outflows arising from transactions in third countries where there are transfer restrictions or which are denominated in non |
10,615 | 11,366 | 11,806 | 12,433 | 8,407 | 9,097 | 9,473 | 10,220 |
| UK-19b | convertible currencies) (Excess inflows from a related |
– | – | – | – | ||||
| specialised credit institutions) | – | – | – | – | |||||
| 20 | Total cash inflows | 80,346 | 80,666 | 85,703 | 91,919 | 29,235 | 30,007 | 31,742 | 33,818 |
| UK-20a Fully exempt inflows | – | – | – | – | – | – | – | – | |
| UK-20b Inflows subject to 90% cap | – | – | – | – | – | – | – | – | |
| UK-20c Inflows subject to 75% cap | 73,980 | 74,661 | 78,900 | 84,084 | 29,235 | 30,007 | 31,742 | 33,818 | |
| Total adjusted value | |||||||||
| 21 | Liquidity buffer | 103,106 | 98,688 | 92,637 | 90,026 | ||||
| 22 23 |
Total net cash outflows Liquidity coverage ratio (%) |
64,119 161% |
61,755 160% |
59,773 155% |
59,120 153% |
||||
Table 126: Net Stable Funding Ratio (UK LIQ2) – Solo consolidation
| 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Unweighted value by residual maturity | |||||||||
| No maturity | < 6 months | 6 months to < 1yr | ≥ 1yr | Weighted value (aver age) |
|||||
| \$million | \$million | \$million | \$million | \$million | |||||
| Available stable funding (ASF) Items | |||||||||
| 1 | Capital items and instruments | 28,964 | 267 | 9 | 9,067 | 38,036 | |||
| 2 | Own funds | 28,964 | 267 | 9 | 9,067 | 38,036 | |||
| 3 | Other capital instruments | – | – | – | – | ||||
| 4 | Retail deposits | 15,525 | 770 | 197 | 14,891 | ||||
| 5 | Stable deposits | 558 | 21 | 11 | 560 | ||||
| 6 | Less stable deposits | 14,968 | 750 | 186 | 14,331 | ||||
| 7 | Wholesale funding: | 214,953 | 23,681 | 43,573 | 105,228 | ||||
| 8 | Operational deposits | 39,233 | – | – | 19,616 | ||||
| 9 | Other wholesale funding | 175,720 | 23,681 | 43,573 | 85,612 | ||||
| 10 | Interdependent liabilities | 4,357 | 200 | 159 | – | ||||
| 11 | Other liabilities: | 134 | 23,655 | 766 | 373 | 756 | |||
| 12 | NSFR derivative liabilities | 134 | |||||||
| 13 | All other liabilities and capital instruments not included in the above categories |
23,655 | 766 | 373 | 756 | ||||
| 14 | Total available stable funding (ASF) | 158,911 | |||||||
| Required stable funding (RSF) Items | |||||||||
| 15 | Total high-quality liquid assets (HQLA) | 3,711 | |||||||
| UK-15a | Assets encumbered for more than 12m in cover pool | – | – | – | – | ||||
| 16 | Deposits held at other financial institutions for operational | ||||||||
| purposes | 1,384 | – | – | 692 | |||||
| 17 | Performing loans and securities: | 95,061 | 25,248 | 65,160 | 88,426 | ||||
| 18 | Performing securities financing transactions with financial customers collateralised by Level 1 HQLA subject to 0% |
||||||||
| haircut | 24,124 | 1,254 | 1,575 | 4,477 | |||||
| 19 | Performing securities financing transactions with financial customer collateralised by other assets and loans and advances to financial institutions |
41,124 | 14,274 | 18,238 | 28,639 | ||||
| 20 | Performing loans to non-financial corporate clients, loans to retail and small business customers, and loans to sovereigns, and PSEs, of which: |
13,486 | 4,982 | 24,837 | 30,460 | ||||
| 21 | With a risk weight of less than or equal to 35% under the Basel II Standardised Approach for credit risk |
2,748 | 1,643 | – | 2,305 | ||||
| 22 | Performing residential mortgages, of which: | 230 | 145 | 2,201 | 1,618 | ||||
| 23 | With a risk weight of less than or equal to 35% under the Basel II Standardised Approach for credit risk |
230 | 145 | 2,201 | 1,618 | ||||
| 24 | Other loans and securities that are not in default and do not qualify as HQLA, including exchange-traded equities and trade finance on-balance sheet products |
16,097 | 4,592 | 18,308 | 23,230 | ||||
| 25 | Interdependent assets | – | – | 4,716 | – | ||||
| 26 | Other assets: | – | 29,563 | 1,989 | 30,360 | 31,978 | |||
| 27 | Physical traded commodities | 3,452 | 2,934 | ||||||
| 28 | Assets posted as initial margin for derivative contracts and contributions to default funds of CCPs |
412 | 8 | 9,501 | 8,433 | ||||
| 29 | NSFR derivative assets | 119 | – | – | 119 | ||||
| 30 | NSFR derivative liabilities before deduction of variation margin posted |
13,481 | – | – | 674 | ||||
| 31 | All other assets not included in the above categories | 15,552 | 1,981 | 17,406 | 19,818 | ||||
| 32 | Off-balance sheet items | 58,912 | 27,759 | 64,150 | 4,724 | ||||
| 33 | Total RSF | 129,531 | |||||||
| 34 | Net Stable Funding Ratio (%) | 122.7% | |||||||
Table 126: Net Stable Funding Ratio (UK LIQ2) – Solo consolidation continued
| 2024 | ||||||
|---|---|---|---|---|---|---|
| Unweighted value by residual maturity | ||||||
| No maturity \$million |
< 6 months \$million |
6 months to < 1yr \$million |
≥ 1yr \$million |
Weighted value (average) \$million |
||
| Available stable funding (ASF) Items | ||||||
| 1 | Capital items and instruments | 28,457 | 771 | 1,044 | 9,349 | 38,327 |
| 2 | Own funds | 28,457 | 771 | 1,044 | 9,349 | 38,327 |
| 3 | Other capital instruments | – | – | – | – | |
| 4 | Retail deposits | 11,618 | 1,419 | 945 | 12,707 | |
| 5 | Stable deposits | 494 | 69 | 68 | 603 | |
| 6 | Less stable deposits | 11,123 | 1,350 | 878 | 12,104 | |
| 7 | Wholesale funding: | 205,334 | 24,064 | 37,116 | 96,853 | |
| 8 | Operational deposits | 33,626 | – | – | 16,813 | |
| 9 | Other wholesale funding | 171,708 | 24,064 | 37,116 | 80,040 | |
| 10 | Interdependent liabilities | 3,302 | 123 | 13 | – | |
| 11 | Other liabilities: | 266 | 22,686 | 367 | 618 | 802 |
| 12 | NSFR derivative liabilities | 266 | ||||
| 13 | All other liabilities and capital instruments not included in the above categories |
22,686 | 367 | 618 | 802 | |
| 14 | Total available stable funding (ASF) | 148,690 | ||||
| Required stable funding (RSF) Items | ||||||
| 15 | Total high-quality liquid assets (HQLA) | 4,173 | ||||
| UK-15a | Assets encumbered for more than 12m in cover pool | – | – | – | – | |
| 16 | Deposits held at other financial institutions for operational purposes |
1,028 | – | – | 514 | |
| 17 | Performing loans and securities: | 105,046 | 26,635 | 57,981 | 86,348 | |
| 18 | Performing securities financing transactions with financial customers collateralised by Level 1 HQLA subject to 0% haircut |
20,656 | 920 | 1,913 | 3,859 | |
| 19 | Performing securities financing transactions with financial customer collateralised by other assets and loans and advances to financial institutions |
48,466 | 13,751 | 13,476 | 25,400 | |
| 20 | Performing loans to non-financial corporate clients, loans to retail and small business customers, and loans to sovereigns, and PSEs, of which: |
14,155 | 5,154 | 22,420 | 28,941 | |
| 21 | With a risk weight of less than or equal to 35% under the Basel II Standardised Approach for credit risk |
938 | 1,184 | – | 1,131 | |
| 22 | Performing residential mortgages, of which: | 683 | 66 | 1,858 | 1,593 | |
| 23 | With a risk weight of less than or equal to 35% under the Basel II Standardised Approach for credit risk |
681 | 61 | 1,806 | 1,545 | |
| 24 | Other loans and securities that are not in default and do not qualify as HQLA, including exchange-traded equities and trade finance on-balance sheet products |
21,085 | 6,743 | 18,315 | 26,555 | |
| 25 | Interdependent assets | – | – | 3,438 | – | |
| 26 | Other assets: | – | 28,906 | 1,055 | 27,891 | 27,419 |
| 27 | Physical traded commodities | 2,087 | 1,774 | |||
| 28 | Assets posted as initial margin for derivative contracts and contributions to default funds of CCPs |
– | – | 8,220 | 6,987 | |
| 29 | NSFR derivative assets | 56 | – | – | 56 | |
| 30 | NSFR derivative liabilities before deduction of variation margin posted |
12,557 | – | – | 628 | |
| 31 | All other assets not included in the above categories | 16,293 | 1,055 | 17,584 | 17,975 | |
| 32 | Off-balance sheet items1 | 60,688 | 25,750 | 61,067 | 4,045 | |
| 33 | Total RSF | 122,499 | ||||
| 34 | Net Stable Funding Ratio (%) | 121.4% |
1 During 2025, uncommitted facilities were included in the NSFR templates. To allow for meaningful year on year comparatives, Pillar 3 templates have been re-stated to account for this change.
| 2025 | 2024 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| MB Supervisory function \$million |
MB Management function \$million |
Other senior management \$million |
Other identified staff \$million |
MB Supervisory function \$million |
MB Management function \$million |
Other senior management \$million |
Other identified staff \$million |
||
| Fixed remuneration | |||||||||
| 1 | Number of identified staff | 10 | 2 | 13 | 658 | 10 | 2 | 16 | 666 |
| 2 | Total fixed remuneration | 5 | 5 | 24 | 368 | 4 | 6 | 33 | 364 |
| 3 | Of which: cash-based | 5 | 4 | 24 | 368 | 4 | 6 | 33 | 364 |
| UK-4a | Of which: shares or equivalent ownership interests |
– | 1 | – | – | – | – | – | – |
| 5 | Of which: share-linked instruments or equivalent non-cash instruments |
– | – | – | – | – | – | – | – |
| UK-5x | Of which: other instruments |
– | – | – | – | – | – | – | – |
| 7 | Of which: other forms | – | – | – | – | – | – | – | – |
| Variable remuneration | |||||||||
| 9 | Number of identified staff | 10 | 2 | 13 | 658 | 10 | 2 | 16 | 666 |
| 10 | Total variable remuneration | – | 14 | 62 | 437 | – | 18 | 46 | 397 |
| 11 | Of which: cash-based | – | 4 | 19 | 215 | – | 2 | 18 | 200 |
| 12 | Of which: deferred | – | – | – | 3 | – | 1 | 9 | 104 |
| UK-13a | Of which: shares or equivalent ownership interests |
– | 10 | 43 | 222 | – | 16 | 28 | 197 |
| UK-14a | Of which: deferred | – | 10 | 42 | 220 | – | 16 | 19 | 106 |
| UK-13b | Of which: share-linked instruments or equivalent non-cash instruments |
– | – | – | – | – | – | – | – |
| UK-14b | Of which: deferred | – | – | – | – | – | – | – | – |
| UK-14x | Of which: other instruments |
– | – | – | – | – | – | – | – |
| UK-14y | Of which: deferred | – | – | – | – | – | – | – | – |
| 15 | Of which: other forms | – | – | – | – | – | – | – | – |
| 16 | Of which: deferred | – | – | – | – | – | – | – | – |
| 17 | Total remuneration (2 + 10) | 5 | 19 | 86 | 805 | 4 | 24 | 79 | 761 |
Table 127: Remuneration awarded for the financial year – Solo consolidation (UK REM1)
Table 128: Special payments to staff whose professional activities have a material impact on institutions' risk profile (identified staff) – Solo consolidation (UK REM2)
| 2025 | |||||
|---|---|---|---|---|---|
| MB Supervisory function \$million |
MB Management function \$million |
Other senior management \$million |
Other identified staff \$million |
||
| Guaranteed variable remuneration awards | |||||
| 1 | Guaranteed variable remuneration awards – Number of identified staff |
– | – | – | 4 |
| 2 | Guaranteed variable remuneration awards – Total amount | – | – | – | 3 |
| 3 | Of which guaranteed variable remuneration awards paid during the financial year, that are not taken into account in the bonus cap |
– | – | – | – |
| Severance payments awarded in previous periods, that have been paid out during the financial year |
|||||
| 4 | Severance payments awarded in previous periods, that have been paid out during the financial year – Number of identified staff |
– | – | – | – |
| 5 | Severance payments awarded in previous periods, that have been paid out during the financial year – Total amount |
– | – | – | – |
| Severance payments awarded during the financial year | |||||
| 6 | Severance payments awarded during the financial year – Number of identified staff |
– | – | – | – |
| 7 | Severance payments awarded during the financial year – Total amount |
– | – | – | – |
| 8 | Of which paid during the financial year | – | – | – | – |
| 9 | Of which deferred | – | – | – | – |
| 10 | Of which severance payments paid during the financial year, that are not taken into account in the bonus cap |
– | – | – | – |
| 11 | Of which highest payment that has been awarded to a single person |
– | – | – | – |
| 2024 |
| MB Supervisory function \$million |
MB Management function \$million |
Other senior management \$million |
Other identified staff \$million |
||
|---|---|---|---|---|---|
| Guaranteed variable remuneration awards | |||||
| 1 | Guaranteed variable remuneration awards – Number of identified staff |
– | – | – | 4 |
| 2 | Guaranteed variable remuneration awards – Total amount | – | – | – | 3 |
| 3 | Of which guaranteed variable remuneration awards paid during the financial year, that are not taken into account in the bonus cap |
– | – | – | – |
| Severance payments awarded in previous periods, that have been paid out during the financial year |
|||||
| 4 | Severance payments awarded in previous periods, that have been paid out during the financial year – Number of identified staff |
– | – | – | – |
| 5 | Severance payments awarded in previous periods, that have been paid out during the financial year – Total amount |
– | – | – | – |
| Severance payments awarded during the financial year | |||||
| 6 | Severance payments awarded during the financial year – Number of identified staff |
– | – | – | – |
| 7 | Severance payments awarded during the financial year – Total amount |
– | – | – | – |
| 8 | Of which paid during the financial year | – | – | – | – |
| 9 | Of which deferred | – | – | – | – |
| 10 | Of which severance payments paid during the financial year, that are not taken into account in the bonus cap |
– | – | – | – |
| 11 | Of which highest payment that has been awarded to a single person |
– | – | – | – |
Table 129: Deferred remuneration – Solo Consolidation (UK REM3)
| 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Deferred and retained remuneration | Total amount of deferred remuneration awarded for previous performance periods \$million |
Of which due to vest in the financial year \$million |
Of which vesting in subsequent financial years \$million |
Amount of performance adjustment made in the financial year to deferred remuneration that was due to vest in the financial year \$million |
Amount of performance adjustment made in the financial year to deferred remuneration that was due to vest in future performance years \$million |
Total amount of adjustment during the financial year due to ex post implicit adjustments (i.e. changes of value of deferred remuneration due to the changes of prices of instruments) \$million |
Total amount of deferred remuneration awarded before the financial year actually paid out in the financial year \$million |
Total of amount of deferred remuneration awarded for previous performance period that has vested but is subject to retention periods \$million |
|
| 1 | MB Supervisory function | 2 | 1 | 1 | – | – | 1 | 1 | – |
| 2 | Cash-based | – | – | – | – | – | – | – | – |
| 3 | Shares or equivalent ownership interests |
2 | 1 | 1 | – | – | 1 | 1 | – |
| 4 | Share-linked instruments or equivalent non-cash instruments |
– | – | – | – | – | – | – | – |
| 5 | Other instruments | – | – | – | – | – | – | – | – |
| 6 | Other forms | – | – | – | – | – | – | – | – |
| 7 | MB Management function | 100 | 10 | 90 | (2) | – | 46 | 8 | 8 |
| 8 | Cash-based | – | – | – | – | – | – | – | – |
| 9 | Shares or equivalent ownership interests |
100 | 10 | 90 | (2) | – | 46 | 8 | 8 |
| 10 | Share-linked instruments or equivalent non-cash instruments |
– | – | – | – | – | – | – | – |
| 11 | Other instruments | – | – | – | – | – | – | – | – |
| 12 | Other forms | – | – | – | – | – | – | – | – |
| 13 | Other senior management | 227 | 29 | 198 | (2) | – | 91 | 27 | 20 |
| 14 | Cash-based | 29 | 4 | 25 | – | – | – | 4 | – |
| 15 | Shares or equivalent ownership interests |
198 | 25 | 173 | (2) | – | 91 | 23 | 20 |
| 16 | Share-linked instruments or equivalent non-cash instruments |
– | – | – | – | – | – | – | – |
| 17 | Other instruments | – | – | – | – | – | – | – | – |
| 18 | Other forms | – | – | – | – | – | – | – | – |
| 19 | Other identified staff | 1,073 | 268 | 805 | – | – | 361 | 259 | 123 |
| 20 | Cash-based | 287 | 62 | 225 | – | – | – | 59 | – |
| 21 | Shares or equivalent ownership interests |
678 | 179 | 499 | – | – | 311 | 173 | 109 |
| 22 | Share-linked instruments or equivalent non-cash instruments |
108 | 27 | 81 | – | – | 50 | 27 | 14 |
| 23 | Other instruments | – | – | – | – | – | – | – | – |
| 24 | Other forms | – | – | – | – | – | – | – | – |
| 25 | Total amount | 1,402 | 308 | 1,094 | (4) | – | 499 | 295 | 151 |
Table 129: Deferred remuneration – Solo consolidation (UK REM3) continued
| 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Deferred and retained remuneration | Total amount of deferred remuneration awarded for previous performance periods \$million |
Of which due to vest in the financial year \$million |
Of which vesting in subsequent financial years \$million |
Amount of performance adjustment made in the financial year to deferred remuneration that was due to vest in the financial year \$million |
Amount of performance adjustment made in the financial year to deferred remuneration that was due to vest in future performance years \$million |
Total amount of adjustment during the financial year due to ex post implicit adjustments (i.e. changes of value of deferred remuneration due to the changes of prices of instruments) \$million |
Total amount of deferred remuneration awarded before the financial year actually paid out in the financial year \$million |
Total of amount of deferred remuneration awarded for previous performance period that has vested but is subject to retention periods \$million |
|
| 1 | MB Supervisory function | 1 | – | 1 | – | – | – | – | – |
| 2 | Cash-based | – | – | – | – | – | – | – | – |
| 3 | Shares or equivalent ownership interests |
1 | – | 1 | – | – | – | – | – |
| Share-linked instruments or | |||||||||
| 4 | equivalent non-cash instruments | – | – | – | – | – | – | – | – |
| 5 | Other instruments | – | – | – | – | – | – | – | – |
| 6 | Other forms | – | – | – | – | – | – | – | – |
| 7 | MB Management function | 44 | 7 | 37 | (4) | – | 15 | 3 | 3 |
| 8 | Cash-based | – | – | – | – | – | – | – | – |
| 9 | Shares or equivalent ownership interests |
44 | 7 | 37 | (4) | – | 15 | 3 | 3 |
| 10 | Share-linked instruments or equivalent non-cash instruments |
– | – | – | – | – | – | – | – |
| 11 | Other instruments | – | – | – | – | – | – | – | – |
| 12 | Other forms | – | – | – | – | – | – | – | – |
| 13 | Other senior management | 185 | 43 | 142 | (9) | – | 50 | 18 | 11 |
| 14 | Cash-based | 34 | 6 | 28 | – | – | – | 4 | – |
| 15 | Shares or equivalent ownership interests |
151 | 37 | 114 | (9) | – | 50 | 14 | 11 |
| 16 | Share-linked instruments or equivalent non-cash instruments |
– | – | – | – | – | – | – | – |
| 17 | Other instruments | – | – | – | – | – | – | – | – |
| 18 | Other forms | – | – | – | – | – | – | – | – |
| 19 | Other identified staff | 709 | 175 | 534 | (3) | – | 154 | 164 | 63 |
| 20 | Cash-based | 247 | 58 | 189 | – | – | – | 55 | – |
| 21 | Shares or equivalent ownership interests |
408 | 104 | 304 | (3) | – | 136 | 96 | 57 |
| Share-linked instruments or | |||||||||
| 22 | equivalent non-cash instruments | 54 | 13 | 41 | – | – | 18 | 13 | 6 |
| 23 | Other instruments | – | – | – | – | – | – | – | – |
| 24 | Other forms | – | – | – | – | – | – | – | – |
| 25 | Total amount | 939 | 225 | 714 | (16) | – | 219 | 185 | 77 |
| 2025 | 2024 | ||
|---|---|---|---|
| EUR | Identified staff that are high earners as set out in Article 450(i) CRR Number of employees |
Identified staff that are high earners as set out in Article 450(i) CRR Number of employees |
|
| 1 | 1,000,000 to below 1,500,000 | 157 | 164 |
| 2 | 1,500,000 to below 2,000,000 | 54 | 54 |
| 3 | 2,000,000 to below 2,500,000 | 33 | 25 |
| 4 | 2,500,000 to below 3,000,000 | 8 | 16 |
| 5 | 3,000,000 to below 3,500,000 | 6 | 10 |
| 6 | 3,500,000 to below 4,000,000 | 7 | 6 |
| 7 | 4,000,000 to below 4,500,000 | 2 | 4 |
| 8 | 4,500,000 to below 5,000,000 | 5 | 4 |
| 9 | 5,000,000 to below 6,000,000 | 1 | 2 |
| 10 | 6,000,000 to below 7,000,000 | 4 | 3 |
| 11 | 7,000,000 to below 8,000,000 | 1 | 2 |
| 12 | 8,000,000 to below 9,000,000 | 2 | 1 |
| 13 | 13,000,000 to below 14,000,000 | – | 1 |
| 14 | 14,000,000 to below 15,000,000 | 1 | 1 |
| 15 | 16,000,000 to below 17,000,000 | 1 | – |
| Total | 282 | 293 |
Table 130: Remuneration of 1 million EUR or more per year – Solo consolidation (UK REM4)
Table 131: Information on remuneration of staff whose professional activities have a material impact on institutions' risk profile (identified staff) – Solo consolidation (UK REM5)
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Management body remuneration | Business areas | ||||||||||
| MB Supervisory function \$million |
MB Management \$million |
Total MB \$million |
Investment banking \$million |
Retail banking \$million |
Asset management \$million |
Corporate functions \$million |
Independent internal control functions \$million |
All other \$million |
Total \$million |
||
| 1 | Total number of identified staff |
683 | |||||||||
| 2 | Of which: members of the MB |
10 | 2 | 12 | |||||||
| 3 | Of which: other senior management |
2 | 1 | – | 5 | 4 | 1 | ||||
| 4 | Of which: other identified staff |
384 | 59 | – | 92 | 114 | 9 | ||||
| 5 | Total remuneration of identified staff |
5 | 19 | 24 | 571 | 87 | – | 160 | 81 | 16 | |
| 6 | Of which: variable remuneration |
– | 14 | 14 | 335 | 51 | – | 86 | 32 | 9 | |
| 7 | Of which: fixed remuneration |
5 | 5 | 10 | 236 | 36 | – | 74 | 49 | 7 |
| 2024 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Management body remuneration | Business areas | ||||||||||
| MB Supervisory function \$million |
MB Management \$million |
Total MB \$million |
Investment banking \$million |
Retail banking \$million |
Asset management \$million |
Corporate functions \$million |
Independent internal control functions \$million |
All other \$million |
Total \$million |
||
| 1 | Total number of identified staff |
694 | |||||||||
| 2 | Of which: members of the MB |
10 | 2 | 12 | |||||||
| 3 | Of which: other senior management |
3 | 1 | – | 8 | 3 | 1 | ||||
| 4 | Of which: other identified staff |
365 | 52 | 2 | 120 | 114 | 13 | ||||
| 5 | Total remuneration of identified staff |
4 | 24 | 28 | 501 | 74 | 2 | 197 | 79 | 15 | |
| 6 | Of which: variable remuneration |
– | 18 | 18 | 282 | 43 | – | 98 | 31 | 7 | |
| 7 | Of which: fixed remuneration |
4 | 6 | 10 | 219 | 31 | 2 | 98 | 48 | 8 |
Table 132: Overview of RWA – Significant Subsidiaries
| 2025 | ||||||||
|---|---|---|---|---|---|---|---|---|
| Standard Chartered – Solo consolidation |
Standard Chartered Bank (HK) Ltd1 |
Standard Chartered Bank Korea Ltd |
Standard Chartered Bank (Singapore) Ltd |
|||||
| Risk weighted assets |
Regulatory capital requirement |
Risk weighted assets |
Regulatory capital requirement |
Risk weighted assets |
Regulatory capital requirement |
Risk weighted assets |
Regulatory capital requirement |
|
| \$million | \$million | \$million | \$million | \$million | \$million | \$million | \$million | |
| Local Regulator | PRA | HKMA | FSS | MAS | ||||
| Credit risk (excluding CCR)2 | 65,489 | 5,239 | 66,944 | 5,356 | 13,997 | 1,120 | 24,495 | 1,960 |
| Of which the standardised | ||||||||
| approach | 13,796 | 1,104 | 5,427 | 434 | 4,977 | 398 | 14,896 | 1,192 |
| Of which slotting approach | 2,842 | 227 | 3,431 | 275 | – | – | – | – |
| Of which the advanced IRB (AIRB) | ||||||||
| approach | 48,851 | 3,908 | 23,340 | 1,867 | 9,020 | 722 | – | – |
| Of which the foundation IRB | ||||||||
| (FIRB) approach | – | – | 34,746 | 2,780 | – | – | 9,599 | 768 |
| Counterparty credit risk – CCR3 | 16,773 | 1,342 | 8,603 | 687 | 4,023 | 321 | 3,677 | 294 |
| Of which the standardised | ||||||||
| approach | 2,891 | 231 | 4,492 | 359 | 2,753 | 220 | 1,467 | 117 |
| Of which internal model method (IMM) |
7,840 | 627 | – | – | – | – | – | – |
| Of which exposures to a CCP | 1,022 | 82 | – | – | 5 | – | – | – |
| Of which credit valuation | ||||||||
| adjustment – CVA | 1,639 | 131 | 3,317 | 265 | 1,265 | 101 | 1,666 | 133 |
| Of which other CCR | 3,382 | 271 | 794 | 63 | – | – | 544 | 44 |
| Settlement risk | – | – | – | – | – | – | – | – |
| Securitisation exposures in the | ||||||||
| banking book | 3,429 | 274 | 1,094 | 87 | – | – | 286 | 23 |
| Of which SEC-IRBA approach | 1,722 | 138 | – | – | – | – | 49 | 4 |
| Of which SEC-ERBA (including IAA) |
929 | 74 | 934 | 75 | – | – | 211 | 17 |
| Of which SEC-SA approach | 779 | 62 | 160 | 13 | – | – | 26 | 2 |
| Of which 1250%/deduction | – | – | – | – | – | – | – | – |
| Position, foreign exchange and | ||||||||
| commodities risks (Market risk) | 22,466 | 1,797 | 13,032 | 1,043 | 1,099 | 88 | 9,218 | 737 |
| Of which the standardised | ||||||||
| approach | 10,859 | 869 | 13,032 | 1,043 | 1,099 | 88 | 9,218 | 737 |
| Of which IMA | 11,607 | 929 | – | – | – | – | – | – |
| Large exposures | – | – | – | – | – | – | – | – |
| Operational risk | 15,632 | 1,251 | 12,348 | 988 | 2,560 | 205 | 5,587 | 447 |
| Of which standardised approach | 15,632 | 1,251 | 12,348 | 988 | 2,560 | 205 | 5,587 | 447 |
| Amounts below the thresholds for deduction (subject to 250% |
||||||||
| risk weight) | 6,819 | 546 | 2,874 | 230 | 1 | – | 4 | – |
| Floor Adjustment | – | – | – | – | – | – | – | – |
| Total | 130,608 | 10,449 | 104,896 | 8,392 | 21,680 | 1,734 | 51,348 | 3,328 |
1 Standard Chartered Bank (Hong Kong) Ltd follows local disclosure rules for the OV1 table above, the net impact is \$(47) million. Total RWA: \$104,896 million (\$104,849 million + \$(47) million).
2 Credit risk (including counterparty credit risk) includes Non-credit obligation assets.
3 Counterparty credit risk includes assets which are assessed under both IRB and Standardised approaches.
Table 132: Overview of RWA – Significant Subsidiaries continued
| 2024 | ||||||||
|---|---|---|---|---|---|---|---|---|
| Standard Chartered – Solo consolidation |
Standard Chartered Bank (HK) Ltd4 |
Standard Chartered Bank Korea Ltd |
Standard Chartered Bank (Singapore) Ltd |
|||||
| Risk weighted assets \$million |
Regulatory capital requirement \$million |
Risk weighted assets \$million |
Regulatory capital requirement \$million |
Risk weighted assets \$million |
Regulatory capital requirement \$million |
Risk weighted assets \$million |
Regulatory capital requirement \$million |
|
| Local Regulator | PRA | HKMA | FSS | MAS | ||||
| Credit risk (excluding CCR)2 | 65,425 | 5,234 | 67,255 | 5,380 | 13,097 | 1,048 | 32,632 | 2,610 |
| Of which the standardised | ||||||||
| approach | 11,425 | 914 | 4,722 | 378 | 4,372 | 350 | 13,687 | 1,095 |
| Of which slotting approach | 2,313 | 185 | 4,204 | 336 | – | – | – | – |
| Of which the advanced IRB (AIRB) | ||||||||
| approach | 51,688 | 4,135 | – | 8,725 | 698 | 8,273 | 662 | |
| Of which the foundation IRB | ||||||||
| (FIRB) approach | – | – | 58,329 | 4,666 | – | – | 10,672 | 854 |
| Counterparty credit risk – CCR3 | 15,638 | 1,251 | 8,694 | 696 | 4,762 | 380 | 1,686 | 135 |
| Of which the standardised | ||||||||
| approach | 2,435 | 195 | 5,467 | 437 | 3,317 | 265 | 1,607 | 129 |
| Of which internal model method (IMM) |
7,798 | 624 | – | – | – | – | – | – |
| Of which exposures to a CCP | 717 | 57 | – | – | 5 | – | – | – |
| Of which credit valuation | ||||||||
| adjustment – CVA | 1,824 | 146 | 2,560 | 205 | 1,440 | 115 | 856 | 68 |
| Of which other CCR | 2,864 | 229 | 666 | 53 | – | – | 80 | 6 |
| Settlement risk | – | – | 1 | – | – | – | – | – |
| Securitisation exposures in the | ||||||||
| banking book | 3,712 | 297 | 783 | 63 | – | – | 155 | 12 |
| Of which SEC-IRBA approach | 1,671 | 134 | 140 | 11 | – | – | – | – |
| Of which SEC-ERBA (including IAA) |
1,599 | 128 | 538 | 43 | – | – | 143 | 11 |
| Of which SEC-SA approach | 442 | 35 | 105 | 8 | – | – | 12 | 1 |
| Of which 1250%/deduction | – | – | – | – | – | – | – | – |
| Position, foreign exchange and commodities risks (Market risk) |
21,914 | 1,753 | 13,110 | 1,049 | 945 | 76 | 5,140 | 411 |
| Of which the standardised | ||||||||
| approach | 7,905 | 632 | 5,253 | 420 | 945 | 76 | 5,140 | 411 |
| Of which IMA | 14,008 | 1,121 | 7,857 | 629 | – | – | – | – |
| Large exposures | – | – | – | – | – | – | – | – |
| Operational risk | 14,258 | 1,141 | 13,868 | 1,109 | 1,957 | 157 | 4,998 | 400 |
| Of which standardised approach | 14,258 | 1,141 | 13,868 | 1,109 | 1,957 | 157 | 4,998 | 400 |
| Amounts below the thresholds for deduction (subject to 250% |
||||||||
| risk weight) | 5,427 | 434 | 2,093 | 167 | 64 | 5 | – | – |
| Floor Adjustment | – | – | – | – | – | – | – | – |
| Total | 126,375 | 10,110 | 105,803 | 8,464 | 20,826 | 1,666 | 45,468 | 3,569 |
1 Standard Chartered Bank (Hong Kong) Ltd follows local disclosure rules for the OV1 table above, the net impact is \$2,284 million. Total RWA: \$105,803 million (\$109,927 million + (4,124) million).
2 Credit risk (including counterparty credit risk) includes Non-credit obligation assets.
3 Counterparty credit risk includes assets which are assessed under both IRB and Standardised approaches.
4 2024 has been re-presented to show Standard Chartered Bank (HK) Ltd on a consolidated basis. This also includes Standard Chartered Bank Korea Ltd.
| 2025 | 2024 | |||||||
|---|---|---|---|---|---|---|---|---|
| Capital and total exposures | Standard Chartered – Solo consolidation \$million |
Standard Chartered Bank (HK) Ltd \$million |
Standard Chartered Bank Korea Ltd \$million |
Standard Chartered Bank (Singapore) Ltd \$million |
Standard Chartered – Solo consolidation \$million |
Standard Chartered Bank (HK) Ltd2 \$million |
Standard Chartered Bank Korea Ltd1 \$million |
Standard Chartered Bank (Singapore) Ltd1 \$million |
| Tier 1 capital | 18,678 | 24,691 | 3,597 | 8,237 | 19,003 | 22,422 | 3,550 | 8,125 |
| Total leverage ratio exposures |
448,330 | 381,427 | 64,684 | 176,923 | 421,778 | 337,126 | 55,578 | 154,989 |
| Leverage ratio | 4.2% | 6.5% | 5.6% | 4.7% | 4.5% | 6.7% | 6.4% | 5.2% |
Table 133: Leverage ratio common disclosure – Significant Subsidiaries
1 2024 has been re-presented to align with local regulatory returns, which included late adjustments for Standard Chartered Bank Korea Ltd and Standard Chartered Bank (Singapore) Ltd.
2 2024 has been re-presented to show Standard Chartered Bank (HK) Ltd on a consolidated basis. This also includes Standard Chartered Bank Korea Ltd.
Table 134: Market risk regulatory capital requirements for significant subsidiaries
| 2025 | 2024 | |||||||
|---|---|---|---|---|---|---|---|---|
| Market Risk regulatory capital Requirements for Trading Book |
Standard Chartered – Solo consolidation \$million |
Standard Chartered Bank (HK) Ltd \$million |
Standard Chartered Bank Korea Ltd \$million |
Standard Chartered Bank (Singapore) Ltd \$million |
Standard Chartered – Solo consolidation \$million |
Standard Chartered Bank (HK) Ltd1 \$million |
Standard Chartered Bank Korea Ltd \$million |
Standard Chartered Bank (Singapore) Ltd \$million |
| Local Regulators | PRA | HKMA | FSS | MAS | PRA | HKMA | FSS | MAS |
| Interest rate | 606 | 660 | 81 | 248 | 385 | 208 | 65 | 99 |
| Equity | 7 | 2 | – | – | 1 | – | – | – |
| Options | 5 | 206 | 4 | 5 | 4 | 163 | 3 | 9 |
| Commodity | 38 | 26 | – | 1 | 37 | 34 | – | 7 |
| Foreign exchange | 212 | 148 | 3 | 481 | 205 | 15 | 8 | 296 |
| Internal Models Approach | 929 | – | – | – | 1,121 | 629 | – | – |
| Total | 1,797 | 1,043 | 88 | 735 | 1,753 | 1,049 | 76 | 411 |
| Market Risk – RWA | 22,466 | 13,032 | 1,100 | 9,182 | 21,914 | 13,110 | 945 | 5,138 |
1 2024 has been re-presented to show Standard Chartered Bank (HK) Ltd on a consolidated basis. This also includes Standard Chartered Bank Korea Ltd.
Acronyms
| ABS | Asset Backed Securities | IRB | Internal Ratings Based |
|---|---|---|---|
| AIRB | Advanced Internal Rating Based approach | IRC | Incremental Risk Charge |
| ALCO | Asset and Liability Committee | IRR | Interest Rate Risk |
| ALM | Asset and Liability Management | LCR | Liquidity Coverage Ratio |
| AT1 | Additional Tier 1 | LGD | Loss Given Default |
| BCBS | Basel Committee on Banking Supervision | MAC | Model Assessment Committee |
| BOU | Bank of Uganda | MAS | Monetary Authority of Singapore |
| BRC | Board Risk Committee | MDB | Multilateral Development Banks |
| CCF | Credit Conversion Factor | MR | Market Risk |
| CCP | Central Counterparty | MREL | Minimum requirements for own funds and eligible |
| CCR | Counterparty Credit Risk | liabilities | |
| CCyB | Countercyclical capital buffer | MTM | Mark-To-Market |
| CDOs | Collateralised Debt Obligations | NII | Net Interest Income |
| CDS | Credit Default Swap | NSFR | Net Stable Funding Ratio |
| CET1 | Common Equity Tier 1 | O-SII | Other Systemically Important Institution |
| CMBS | Commercial Mortgage Backed Securities | OBSC | Operational Balance Sheet Committee |
| CQS | Credit Quality Step | OTC | Over the counter |
| CPM | Credit & Portfolio Management | PD | Probability of Default |
| CRD | Capital Requirements Directive | PFE | Potential Future Exposure |
| CRM | Credit Risk Mitigation | PIT | Point in Time |
| CRO | Chief Risk Officer | PM | Portfolio Management |
| CRR | Capital Requirements Regulation | PRA | Prudential Regulation Authority |
| CSA | Credit Support Annex | PV01 | Present Value 01 |
| CSDG | Capital Structuring & Distribution Group | PVA | Prudent Valuation Adjustment |
| CVA | Credit Valuation Adjustment | QCCP | Qualifying Central Counterparty |
| D-SIB | Domestic Systemically Important Bank | QRRE | Qualifying Revolving Retail Exposure |
| DVA | Debit Valuation Adjustment | RMB | Renminbi |
| EAD | Exposure at default | RMBS | Residential Mortgage Backed Securities |
| EBA | European Banking Authority | RNIV | Risk not in VaR |
| ECAI | External Credit Assessment Institutions | RTS | Regulatory Technical Standards |
| EL | Expected loss | RWAs | Risk-Weighted Assets |
| FCA | Financial Conduct Authority | SA | Standardised Approach |
| FIRB | Foundation Internal Ratings Based approach | SFT | Securities Financing Transactions |
| FPC | Financial Policy Committee | SIF | Significant Influence Function |
| FSB | Financial Stability Board | SME | Small and Medium – sized Enterprise |
| FSS | Financial Supervisory Service (South Korea) | SPE | Special Purpose Entity |
| FVA | Funding valuation adjustments | SVAR | Stressed VaR |
| GCRO | Group Chief Risk Officer | T1 | Tier 1 capital |
| G-SIB | Global Systemically Important Bank | T2 | Tier 2 capital |
| G-SII | Global Systemically Important Institutions | TC | Total capital |
| HKMA | Hong Kong Monetary Authority | TLAC | Total loss-absorbing capacity |
| IAS | International Accounting Standard | TM | Treasury Markets |
| ICAAP | Internal Capital Adequacy Assessment Process | TRS | Total Return Swap |
| ILAAP | Internal Liquidity Adequacy Assessment Process | TTC | Through the cycle |
| IFRS | International Financial Reporting Standards | VaR | Value at Risk |
| IMA | Internal Model Approach | VBC | Valuation and Benchmarks Committee |
| IMM | Internal model Method | XVA | Credit and Funding Valuation Adjustment |
Glossary
| Additional Tier 1 (AT1) capital | Additional Tier 1 capital consists of instruments issued by the bank and related share premium other than Common Equity Tier 1 that meet the Capital Requirement Regulation (CRR) criteria for inclusion in Tier 1 capital. |
|---|---|
| Advanced Internal Rating Based (AIRB) approach |
The AIRB approach under the Basel framework is used to calculate credit risk capital based on the Group's own estimates of prudential parameters. |
| Africa & Middle East (AME) | Africa & Middle East (AME) includes Bahrain, Egypt, Iraq, Jordan, Lebanon, Oman, Pakistan, Qatar, Saudi Arabia and the United Arab Emirates (UAE). |
| Arrears | A debt or other financial obligation is considered to be in a state of arrears when payments are overdue. Loans and advances are considered to be delinquent when consecutive payments are missed. Also known as 'delinquency'. |
| Available-for-Sale | Non-derivative financial assets that are designated as available-for-sale or are not classified as loans and receivables; held to maturity investments, or financial assets at fair value through profit or loss. |
| ASEAN | Association of South East Asian Nations (ASEAN) which includes the Group's operation in Brunei, Indonesia, Malaysia, Philippines, Singapore, Thailand and Vietnam. |
| ASEAN & South Asia (ASA) | ASEAN & South Asia (ASA) includes Australia, Bangladesh, Brunei, Cambodia, India, Indonesia, Laos, Malaysia, Myanmar, Nepal, Philippines, Singapore, Sri Lanka, Thailand and Vietnam. |
| Asset Backed Securities (ABS) |
Securities that represent an interest in an underlying pool of referenced assets. The referenced pool can comprise any assets which attract a set of associated cash flows but are commonly pools of residential or commercial mortgages and in the case of Collateralised Debt Obligations (CDOs), the reference pool may be ABS. |
| Attributable profit to ordinary shareholders |
Profit for the year after non-controlling interests and the declaration of dividends on preference shares classified as equity. |
| Backtesting | A statistical technique used to monitor and assess the accuracy of a model, and how that model would have performed had it been applied in the past. |
| Basel II | The capital adequacy framework issued by the Basel Committee on Banking Supervision (BCBS) in June 2006 in the form of the 'International Convergence of Capital Measurement and Capital Standards'. |
| Basel III | In December 2010, the BCBS issued the Basel III rules text, which were updated in June 2011, and represents the details of strengthened global regulatory standards on bank capital adequacy and liquidity. The new requirements have been fully implemented. In December 2017, the BCBS published a document setting out the finalisation of the Basel III framework. The new requirements issued in December 2017 will be implemented by 2023. |
| Basis point (bps) | One hundredth of a per cent (0.01 per cent); 100 basis points is 1 per cent. Used in quoting movements e.g. in interest rates or yields on securities. |
| Capital conservation buffer |
A capital buffer prescribed by regulators under Basel III and designed to ensure banks build up capital buffers outside periods of stress which can be drawn down as losses are incurred. Should a bank's CET1 capital fall within the capital conservation buffer range, capital distributions will be constrained by the regulators. |
| Capital Requirements Directive (CRD) |
A capital adequacy legislative package adopted by EU member states. CRD IV comprises the recast Capital Requirements Directive and the Capital Requirements Regulation (CRR). The package implements the Basel III framework together with transitional arrangements for some of its requirements. CRD IV came into force on 1 January 2014. CRR II and CRD V amending the existing package came into force in June 2019 with most changes starting to apply from 28 June 2021. |
| Central Counterparty (CCP) |
A CCP is a clearing house that acts as an intermediary between counterparties for certain products that are traded in one or more financial markets. |
| Common Equity Tier 1 (CET1) capital |
Common Equity Tier 1 capital consists of the common shares issued by the bank and related share premium, retained earnings, accumulated other comprehensive income and other disclosed reserves, eligible non-controlling interests and regulatory adjustments required in the calculation of Common Equity Tier 1. |
| Common Equity Tier 1 ratio |
Common Equity Tier 1 capital as a percentage of risk-weighted assets. |
| Countercyclical capital buffer (CCyB) |
The countercyclical capital buffer is part of a set of macroprudential instruments, designed to help counter pro-cyclicality in the financial system. CCyB as defined in the Basel III standard provides for an additional capital requirement of up to 2.5 per cent of risk-weighted assets in a given jurisdiction. The Bank of England's Financial Policy Committee has the power to set CCyB rate for the United Kingdom. Each bank must calculate its 'institution-specific' CCyB rate, defined as the weighted average of the CCyB rates in effect across the jurisdictions in which it has credit exposures. The institution-specific CCyB rate is then applied to a bank's total risk weighted assets. |
| Counterparty credit risk (CCR) |
The risk that a counterparty defaults before satisfying its obligations under a derivative, a securities financing transaction (SFT) or a similar contract. |
| Credit Conversion Factor (CCF) | Either prescribed by CRR or modelled by the bank, an estimate of the amount the Group expects a customer to have drawn further on a facility limit at the point of default. |
| Credit Default Swap (CDS) |
A derivative contract where a buyer pays a fee to a seller in return for receiving a payment in the event of a credit event (for example bankruptcy, payment default on a reference asset or assets, or downgrades by an rating agency) on an underlying obligation. |
|---|---|
| Credit quality step (CQS) |
Credit Quality Steps (CQS) are used to derive the risk-weight to be applied to exposures treated under the Standardised approach to credit risk. |
| Credit risk | Credit risk is the potential for loss due to the failure of a counterparty to meet its obligations to pay the Group in accordance with agreed terms. |
| Credit risk mitigation (CRM) |
Credit risk mitigation is a process to mitigate potential credit losses from any given account, customer or portfolio by using a range of tools such as collateral, netting agreements, credit insurance, credit derivatives and guarantees. |
| Credit support annex (CSA) |
A legal document that regulates the exchange of collateral between the parties of OTC derivative transactions. |
| Credit Valuation Adjustment (CVA) |
In the context of prudential requirements, additional regulatory capital charge that covers the risk of mark-to-market losses associated with changes in the credit worthiness of counterparties to derivative transactions. |
| Debit Valuation Adjustment (DVA) |
In the context of prudential requirements, adjustment required to Tier 1 capital to derecognise any unrealised fair value gains and losses associated with fair valued liabilities that are attributable to the market's perception of the Group's credit worthiness. |
| Domestic systemically important banks (D-SIB) |
Domestic systemically important banks are deemed systemically relevant for the domestic financial system in which they operate. The FSB and the BCBS have developed a framework for identifying and dealing with D-SIBs. The D-SIB framework has been implemented in the EU via CRD IV which refers to D-SIBs as Other Systemically Important Institutions ('O-SIIs'). |
| Equity price risk | The financial risk involved in holding equity in a particular investment. Arises from changes in the prices of equities, equity indices, equity baskets and implied volatilities on related options. |
| Expected Loss (EL) | The Group measure of anticipated loss for exposures captured under an internal ratings based credit risk approach for capital adequacy calculations. It is measured as the Group-modelled view of anticipated loss based on Probability of Default (PD), Loss Given Default (LGD) and Exposure at Default (EAD), with a one-year time horizon. |
| Exposure | Credit exposures represent the amount lent to a customer, together with any undrawn commitment. |
| Exposure at default (EAD) |
The estimation of the extent to which the Group may be exposed to a customer or counterparty in the event of, and at the time of, that counterparty's default. At default, the customer may not have drawn the loan fully or may already have repaid some of the principal, so that exposure is typically less than the approved loan limit. |
| External Credit Assessment Institutions (ECAI) |
For the Standardised Approach to credit risk for sovereigns, corporates and institutions, external ratings are used to assign risk-weights. These external ratings must come from credit rating agencies that are registered or certified in accordance with the credit rating agencies (CRA) regulation or from a central bank issuing credit ratings which is exempt from the application this regulation. |
| Fair value | The value of an asset or liability when it is transacted on an arm's length basis between knowledgeable and willing parties. |
| Financial Policy Committee (FPC) |
The Financial Policy Committee is an independent committee at the Bank of England that has the primary objective of identifying, monitoring and taking action to remove or reduce systemic risks with a view to protecting and enhancing the resilience of the UK financial system. The FPC's secondary objective is to support the economic policy of the Government. |
| Foreseeable dividends net of scrip |
Includes both ordinary and preference share dividends reasonably expected to be paid out of any future residual interim or year-end profits. In the case of ordinary dividends, the amount of foreseeable dividends deducted from the interim or year-end profits is equal to the amount of interim or year-end profits multiplied by the dividend payout ratio. In the case of preference share dividends, the amount of foreseeable dividends is equal to the amount accrued during the relevant reporting period payable at a future date. |
| Foundation Internal Ratings Based (FIRB) Approach |
A method of calculating credit risk capital requirements using internal PD models but with supervisory estimates of LGD and conversion factors for the calculation of EAD. |
| Free delivery | When a bank takes receipt of a debt or equity security, a commodity or foreign exchange without making immediate payment, or where a bank delivers a debt or equity security, a commodity or foreign exchange without receiving immediate payment. |
| Funding valuation adjustments (FVA) |
FVA reflects an adjustment to fair value in respect of derivative contracts associated with the funding costs that the market participant would incorporate when determining an exit price. |
| Greater China | Greater China includes the Group's operation in the People's Republic of China, the Hong Kong Special Administrative Region of the People's Republic of China and Taiwan. |
| Greater China & North Asia (GCNA) | Greater China & North Asia (GCNA) includes China, Hong Kong, Japan, Korea, Macau and Taiwan. |
| Global Systemically Important Bank (G-SIB) |
Global financial institutions whose size, complexity and systemic interconnectedness mean that their distress or failure would cause significant disruption to the wider financial system and economic activity. The Financial Stability Board (FSB) and the Basel Committee on Banking Supervision (BCBS) have established a methodology to identify G-SIBs based on 12 principal indicators. The list of G-SIBs is re-assessed through annual re-scoring of banks and a triennial review of the methodology. The G-SIB framework established by the FSB and the BCBS is implemented in the EU via CRD IV and G-SIBs are referred to as Global Systemically Important Institutions ('G-SIIs'). |
|---|---|
| G-SIB buffer | A CET1 capital buffer which results from designation as a G-SIB. The G-SIB buffer is between 1 per cent and 3.5 per cent, dependent on the allocation to one of five buckets based on the annual scoring. In the EU, the G-SIB buffer is implemented via CRD IV as Global Systemically Important Institutions ('G-SII') buffer requirement. |
| Haircut | A haircut, or volatility adjustment, ensures the value of exposures and collateral are adjusted to account for the volatility caused by foreign exchange or maturity mismatches, when the currency and maturity of an exposure differ materially to the currency and maturity of the associated collateral. |
| Held-to-maturity | Held-to-maturity assets are non-derivative financial assets with fixed or determinable payments and fixed maturities that the Group's management has the intention and ability to hold to maturity. |
| Impaired loans | Loans where individually identified impairment provisions have been raised. Also includes loans which are collateralised or where indebtedness has already been written down to the expected realisable value. The impaired loan category may include loans, which, while impaired, are still performing. |
| Individually assessed loan impairment provisions (IIP) |
Impairment is measured for assets that are individually significant to the Group. Typically assets within the Corporate & Institutional Banking segment of the Group are assessed individually. |
| Individual capital guidance |
Guidance given by the PRA to the Group about the amount and quality of capital resources to maintain. |
| Individual impairment charge |
The amount of individually assessed loan impairment provisions that are charged to the income statement in the reporting period. |
| Individual liquidity guidance |
Guidance given by the PRA to the Group about the amount, quality and funding profile of liquidity resources to maintain. |
| Institution | A credit institution or an investment firm as defined under the Capital Requirement Regulation (CRR). |
| Internal Capital Adequacy Assessment Process (ICAAP) |
A requirement on institutions under Pillar 2 of the Basel framework to undertake a comprehensive assessment of their risks and to determine the appropriate amounts of capital to be held against these risks. |
| Internal Liquidity Adequacy Assessment Process (ILAAP) |
A requirement on institutions under Pillar 2 of the Basel framework to undertake a comprehensive assessment of their risks and to determine the appropriate amounts of liquidity to be held against these risks. |
| Internal Model Approach (IMA) |
The approach used to calculate market risk capital and RWA with an internal market risk model approved by the PRA under the terms of CRD IV/CRR. |
| Internal Model Method (IMM) |
One of three approaches defined in the Basel Framework to determine exposure values for counterparty credit risk. |
| Interest Rate Risk (IRR) |
Interest rate risk arises due to the investment into rate-sensitive assets, as well as from mismatches between debt issuance and placements. |
| Internal ratings based approach ('IRB') |
Risk-weighting methodology in accordance with the Basel Capital Accord where capital requirements are based on a firm's own estimates of prudential parameters. |
| Items belonging to regulatory high-risk categories |
In relation to the Standardised Approach to credit risk, items which attract a risk-weight of 150 per cent. This includes exposures arising from venture capital business and certain positions in collective investment schemes. |
| Leverage ratio | A ratio introduced under Basel III / CRD IV that compares Tier 1 capital to total exposures, including certain exposures held off-balance sheet as adjusted by stipulated credit conversion factors. Intended to be a simple, non-risk based backstop measure. |
| Liquidity Coverage Ratio (LCR) | The ratio of the stock of high quality liquid assets to expected net cash outflows over the following 30 days. High quality liquid assets should be unencumbered, liquid in markets during a time of stress and, ideally, be central bank eligible. |
| Loans and advances | This represents lending made under bilateral agreements with customers entered into in the normal course of business and is based on the legal form of the instrument. |
| Loss Given Default (LGD) | The percentage of an exposure that a lender expects to lose in the event of obligor default. |
| Mark-to-market approach |
One of the approaches available to banks to calculate the exposure value associated with derivative transactions. The approach calculates the current replacement cost of derivative contracts, by determining the market value of the contract and considering any potential future exposure. |
| Market risk | The potential for loss of earnings or economic value due to adverse changes in financial market rates or prices. |
|---|---|
| Maturity | The time from the reporting date to the contractual maturity date of an exposure, capped at five years. Maturity is considered as part of the calculation of risk-weights for the Group's exposures treated under the IRB approach to credit risk. |
| Minimum capital requirement |
Minimum capital required to be held for credit, market and operational risk. |
| Model validation | The process of assessing how well a model performs using a predefined set of criteria including the discriminatory power of the model, the appropriateness of the inputs, and expert opinion. |
| MREL or minimum requirement for own fund and eligible liabilities |
A requirement under the Bank Recovery and Resolution Directive for EU resolution authorities to set a minimum requirement for own funds and eligible liabilities for banks, implementing the FSB's Total Loss-Absorbing Capacity (TLAC) standard. MREL is intended to ensure there is sufficient equity and specific types of liabilities to facilitate an orderly resolution that minimises any impact on financial stability and ensures the continuity of critical functions and avoids exposing taxpayers to loss. |
| Multilateral Development Banks (MDB) |
An institution created by a group of countries to provide financing for the purpose of development. Under the Standardised approach to credit risk, eligible multilateral development banks attract a zero per cent risk-weight. |
| Net stable funding ratio (NSFR) | The ratio of available stable funding to required stable funding over a one year time horizon, assuming a stressed scenario. It is a longer-term liquidity measure designed to restrain the amount of wholesale borrowing and encourage stable funding over a one year time horizon. |
| North East (NE) Asia | North East (NE) Asia includes the Group's operation in the Republic of Korea and Japan. |
| Operational risk | The potential for loss arising from the failure of people, process, or technology, or the impact of external events. |
| Over-the-Counter (OTC) traded products/OTC derivatives |
A bilateral transaction that is not exchange traded and is valued using valuation models. |
| Pillar 1 | The first Pillar of the three pillars of Basel framework which provides the approach to the calculation of the minimum capital requirements for credit, market and operational risk. Minimum capital requirements are 8 per cent of the Group's risk-weighted assets. |
| Pillar 2 | The second pillar of the three pillars of Basel framework which requires banks to undertake a comprehensive assessment of their risks and to determine the appropriate amounts of capital to be held against these risks where other suitable mitigants are not available. |
| Pillar 3 | The third pillar of the three pillars of Basel framework which aims to provide a consistent and comprehensive disclosure framework that enhances comparability between banks and further promotes improvements in risk practices. |
| Point in time (PIT) | Considers the economic conditions at the point in the economic cycle at which default occurs when estimating the probability of default. |
| Portfolio Impairment Provision (PIP) | The amount of loan impairment provisions assessed on the collective portfolio that are charged to the income statement in the reporting period. |
| Potential Future Exposure (PFE) | An estimate of the potential increase in exposure that may arise on a derivative contract prior to default, used to derive the exposure amount. |
| Probability of Default (PD) | PD is an internal estimate for each borrower grade of the likelihood that an obligor will default on an obligation within 12 months. |
| Present Value 01 (PV01) | This represents the change in present value of an asset or liability for a 1 basis point change in the nominal yield curve. |
| Prudential Regulatory Authority (PRA) |
The Prudential Regulation Authority is the statutory body responsible for the prudential supervision of banks, building societies, credit unions, insurers and a small number of significant investment firms in the UK. The PRA is a part of the Bank of England. |
| Prudent Valuation Adjustment (PVA) |
An adjustment to CET1 capital, to reflect the difference between the accounting fair value and the regulatory prudent value of positions, where the application of prudence results in a lower absolute carrying value than recognised in the financial statements. |
| Qualifying Central Counterparty (QCCP) |
Central counterparty that is either authorised (when established in the EU) or recognised (when established in a third-country) in accordance with the rules laid down in the European Market Infrastructure Regulation (EMIR). |
| Qualifying Revolving Retail Exposure (QRRE) |
Retail IRB exposures that are revolving, unsecured, and, to the extent they are not drawn, immediately and unconditionally cancellable, such as credit cards. |
| Regulatory capital | Sum of Tier 1 and Tier 2 capital after regulatory adjustments. |
| Repurchase agreement (repo) / reverse repurchase agreement (reverse repo) |
A short term funding agreement which allows a borrower to sell a financial asset, such as ABS or Government bonds as collateral for cash. As part of the agreement the borrower agrees to repurchase the security at some later date, usually less than 30 days, repaying the proceeds of the loan. For the party on the other end of the transaction (buying the security and agreeing to sell in the future) it is a reverse repurchase agreement or reverse repo. |
| Residential Mortgage-Backed Securities (RMBS) |
Securities that represent interests in a group of residential mortgages. Investors in these securities have the right to cash received from future mortgage payments (interest and/or principal). |
|---|---|
| Residual maturity | The remaining maturity of a facility from the reporting date until either the contractual maturity of the facility or the effective maturity date. |
| Retail Internal Ratings Based (Retail IRB) Approach |
In accordance with the PRA handbook and CRR, the approach to calculating credit risk capital requirements for eligible retail exposures. |
| Risk Appetite | Risk Appetite is defined by the Group and approved by the Board. It is the maximum amount and type of risk the Group is willing to assume in pursuit of its strategy. |
| Risk Capacity | The maximum level of risk the Group can assume, given its current capabilities and resources, before breaching constraints determined by capital and liquidity requirements and internal operational capability (including but not limited to technical infrastructure, risk management capabilities, expertise), or otherwise failing to meet the expectations of regulators and law enforcement agencies. |
| Risk-weighted assets (RWA) | A measure of a bank's assets adjusted for their associated risks, expressed as a percentage of an exposure value in accordance with the applicable Standardised or IRB approach provisions. |
| RWA density | The risk-weighted asset as a percentage of exposure at default (EAD). |
| Scrip dividends | Dividends paid to existing shareholders in securities instead of cash payment. |
| Securities Financing Transactions (SFT) |
Securities Financing Transactions are secured (i.e. collateralised) transactions that involve the temporary exchange of cash against securities, or securities against other securities, e.g. stock lending or stock borrowing or the lending or borrowing of other financial instruments, a repurchase or reverse repurchase transaction, or a buy-sell back or sell-buy back transaction. |
| Securitisation | Securitisation is a process by which credit exposures are aggregated into a pool, which is used to back new securities. Under traditional securitisation transactions, assets are sold to a special purpose entity (SPE) who then issues new securities to investors at different level of seniority (credit tranching). This allows the credit quality of the assets to be separated from the credit rating of the originating institution and transfers risk to external investors in a way that meets their risk appetite. Under synthetic securitisation transactions, the transfer of risk is achieved by the use of credit derivatives or guarantees, and the exposures being securitized remain exposures of the originating institution. |
| Securitisation position(s) | The positions assumed by the Group following the purchase of securities issued by Asset Backed Securitisation programmes or those retained following the origination of a securitisation programme. |
| Specialised lending | Specialised lending exposures are defined as an exposure to an entity which was created specifically to finance and/or operate physical assets, where the contractual arrangements given the lender a substantial degree of control over the assets and the income that they generate and the primary source of repayment of the obligation is the income generated by the assets being financed, rather than the independent capacity of a broader commercial enterprise. |
| Special Purpose Entities (SPEs) | SPEs are entities that are created to accomplish a narrow and well defined objective. There are often specific restrictions or limits around their ongoing activities. Transactions with SPEs take a number of forms, including: the provision of financing to fund asset purchases, or commitments to provide financing for future purchases; derivative transactions to provide investors in the SPE with a specified exposure; the provision of liquidity or backstop facilities which may be drawn upon if the SPE experiences future funding difficulties; and direct investment in the notes or equity issued by SPEs. |
| Standardised Approach (SA) | In relation to credit risk, a method for calculating credit risk capital requirements using External Credit Assessment Institutions (ECAI) ratings and supervisory risk-weights. In relation to operational risk, a method of calculating the operational risk capital requirement by the application of a supervisory defined percentage charge to the gross income of eight specified business lines. |
| Stressed Value at Risk (SVAR) |
A regulatory market risk measure based on potential market movements for a continuous one-year period of stress for a trading portfolio. |
| Through the cycle (TTC) |
Reduces the volatility in the estimation of the probability of default by considering the average conditions over the economic cycle at the point of default, versus the point in time (PIT) approach, which considers economic conditions at the point of the economic cycle at which default occurs. |
| Tier 1 capital | Tier 1 capital comprises Common Equity Tier 1 capital plus Additional Tier 1 securities and related share premium accounts. |
| Tier 1 capital ratio | Tier 1 capital as a percentage of risk-weighted assets. |
| Tier 2 capital | Tier 2 capital comprises qualifying subordinated liabilities and related share premium accounts. |
| Total Loss | An international standard for TLAC issued by the FSB, which requires G-SIBs to have sufficient |
| Absorbing | loss-absorbing and recapitalisation capacity available in resolution, to minimise impacts on |
| Capacity | financial stability, maintain the continuity of critical functions and avoid exposing public funds |
| (TLAC) | to loss. |
| Total Return Swap (TRS) |
A derivative transaction that swaps the total return on a financial instrument, including cash flows and capital gains or losses, for an interest rate return. |
|---|---|
| Trading book | The trading book consists of all positions in CRD financial instrument and commodities which are fair valued through the profit and loss account for accounting purposes, which are held either with trading intent or in order to hedge other elements of the trading book and which are either free of any restrictive covenants on their tradability or ability to be hedged. |
| Value at Risk (VAR) | A quantitative measure of market risk estimating the potential loss that will not be exceeded in a set time period at a set statistical confidence level. |
| Write downs | After an advance has been identified as impaired and is subject to an impairment allowance, the stage may be reached whereby it is concluded that there is no realistic prospect of further recovery. Write downs will occur when and to the extent that, the whole or part of a debt is considered irrecoverable. |
| Wrong way risk | Wrong way risk occurs when an exposure increase is coupled with a decrease in the credit quality of the obligor. |
| CRR article ref. | Requirement summary | Disclosure | |
|---|---|---|---|
| Scope of disclosure requirement | |||
| 431 | (1) | Institutions shall publicly disclose the information referred to in Titles II and III in accordance with the provisions laid down in this Title, subject to the exceptions referred to in Article 432. |
The Group publishes Pillar 3 disclosures |
| (2) | Institutions that have been granted permission by the competent authorities under Part Three for the instruments and methodologies referred to in Title III of this Part shall publicly disclose the information laid down therein. |
The Group applies the standardised approach, RWAs and capital requirements for operational risk are shown in Table 20: (OV1) on page 30 and in the 2025 Annual Reports and Accounts on page 306. |
|
| (3) | The management body or senior management shall adopt formal policies to comply with the disclosure requirements laid down in this Part and put in place and maintain internal processes, systems and controls to verify that the institution's disclosures are appropriate and in compliance with the requirements laid down in this Part. At least one member of the management body or senior management shall attest in writing that the relevant institution has made the disclosures required under this Part in accordance with the formal policies and internal processes, systems and controls. The written attestation and the key elements of the institution's formal policies to comply with the disclosure requirements shall be included in the institutions' disclosures. Information to be disclosed in accordance with this Part shall be subject to the same level of internal verification as |
The Group has a dedicated policy governing prudential disclosure requirements in place. |
|
| that applicable to the management report included in the institution's financial report. Institutions shall also have policies in place to verify that their disclosures convey their risk profile comprehensively to market participants. Where institutions find that the disclosures required under this Part do not convey the risk profile comprehensively to market participants, they shall publicly disclose information in addition to the information required to be disclosed under this Part. Nonetheless, institutions shall only be required to disclose information that is material and not proprietary or confidential in accordance with Article 432. |
|||
| (4) | All quantitative disclosures shall be accompanied by a qualitative narrative and any other supplementary information that may be necessary in order for the users of that information to understand the quantitative disclosures, noting in particular any significant change in any given disclosure compared to the information contained in the previous disclosures. |
||
| (5) | Institutions shall, if requested, explain their rating decisions to SMEs and other corporate applicants for loans, providing an explanation in writing when asked. The administrative costs of the explanation shall be proportionate to the size of the loan. |
The Group provides ratings decisions to SMEs and corporates upon request. |
|
| Non-material, proprietary or confidential information | |||
| 432 | (1) | With the exception of the disclosures laid down in point (c) of Article 435(2) and in Articles 437 and 450, institutions may omit one or more of the disclosures listed in Titles II and III where the information provided by those disclosures is not regarded as material. Information in disclosures shall be regarded as material where its omission or misstatement could change or influence the assessment or decision of a user of that information relying on it for the purpose of making economic decisions. |
Items omitted from disclosure are listed in section 1.4. Regulatory disclosure – Framework on page 2. |
| CRR article ref. | Requirement summary | Disclosure | |
|---|---|---|---|
| (2) | Institutions may also omit one or more items of information referred to in Titles II and III where those items include information that is regarded as proprietary or confidential in accordance with this paragraph, except for the disclosures laid down in Articles 437 and 450. Information shall be regarded as proprietary to institutions where disclosing it publicly would undermine their competitive position. Proprietary information may include information on products or systems that would render the investments of institutions therein less valuable, if shared with competitors. Information shall be regarded as confidential where the institutions are obliged by customers or other counterparty relationships to keep that information confidential. |
See Article 432(1) above | |
| (3) | In the exceptional cases referred to in paragraph 2, the institution concerned shall state in its disclosures the fact that the specific items of information are not disclosed and the reason for not disclosing those items, and publish more general information about the subject matter of the disclosure requirement, except where that subject matter is, in itself, proprietary or confidential. |
All material, non-confidential and non-proprietary information is disclosed by the Group in its 2025 Pillar 3 and 2025 Annual Report and Accounts. |
|
| Frequency of disclosure | |||
| 433 | Institutions shall publish the disclosures required under Titles II and III in the manner set out in Articles 433a, 433b and 433c. Annual disclosures shall be published on the same date as the date on which institutions publish their financial statements or as soon as possible thereafter. Semi-annual and quarterly disclosures shall be published on the same date as the date on which the institutions publish their financial reports for the corresponding period where applicable or as soon as possible thereafter. Any delay between the date of publication of the disclosures required under this Part and the relevant financial statements shall be reasonable. |
Section 1.4 Regulatory disclosure – Framework sub-section on Frequency on page 4. |
|
| Means of disclosure | |||
| 434 | (1) | Institutions shall disclose all the information required under Titles II and III in electronic format and in a single medium or location. The single medium or location shall be a standalone document that provides a readily accessible source of prudential information for users of that information or a distinctive section included in or appended to the institutions' financial statements or financial reports containing the required disclosures and being easily identifiable to those users. |
Section 1.4 Regulatory disclosure – Framework, sub-section on Verification on page 4. The 2025 Pillar 3 document is made publicly available on the Group website with the 2025 Annual Report and Accounts and other public disclosures. |
| (2) | Institutions shall make available on their website or, in the absence of a website, in any other appropriate location an archive of the information required to be disclosed in accordance with this Part. That archive shall be kept accessible for a period of time that shall be no less than the storage period set by national law for information included in the institutions' financial reports. |
The Group discharges parts of the prudential disclosure requirements in the 2025 Annual Reports and Accounts, in Main Features and GSIB disclosures, with cross references to exact locations provided in its Pillar 3 document. |
|
| Risk management objectives and policies | |||
| 435 | (1) | Institutions shall disclose their risk management objectives and policies for each separate category of risk, including the risks referred to in this Title. These disclosures shall include: |
See below |
| (1)(a) | The strategies and processes to manage those categories of risks |
Section 1.5 Risk management on pages 4 to 5. Risk management approach section in the 2025 Annual Report and Accounts on pages 222 to 234. |
|
| (1)(b) | The structure and organisation of the relevant risk management function including information on the basis of its authority, its powers and accountability in accordance with the institution's incorporation and governing documents |
See Article 435 (1)(a) above |
| CRR article ref. | Requirement summary | Disclosure | |
|---|---|---|---|
| (1)(c) | The scope and nature of risk reporting and measurement systems |
See Article 435 (1)(a) above | |
| (1)(d) | The policies for hedging and mitigating risk, and the strategies and processes for monitoring the continuing effectiveness of hedges and mitigants |
See Article 435 (1)(a) above | |
| (1)(e) | A declaration approved by the management body on the adequacy of risk management arrangements of the institution providing assurance that the risk management systems put in place are adequate with regard to the institution's profile and strategy |
||
| (1)(f) | A concise risk statement approved by the management body succinctly describing the relevant institution's overall risk profile associated with the business strategy; that statement shall include: (i) key ratios and figures providing external stakeholders with a comprehensive view of the institution's management of risk, including how the risk profile of the institution interacts with the risk tolerance set by the management body; (ii) information on intragroup transactions and transactions with related parties that may have a material impact of the risk profile of the consolidated group. |
See Article 435 (1)(a) above Key ratios and figures are highlighted in section 1.3 on pages 2 to 3 and in the 2025 Annual Report and Accounts on page 12. |
|
| (2) | Institutions shall disclose the following information regarding governance arrangements: |
See below | |
| (2)(a) | The number of directorships held by members of the management body |
2025 Annual Reports and Accounts, Board of Directors, on page 130 to 133 |
|
| (2)(b) | The recruitment policy for the selection of members of the management body and their actual knowledge, skills and expertise |
2025 Annual Reports and Accounts, Board of Directors, on pages 130 to 133 and Governance and Nomination Committee on pages 176 to 181. |
|
| (2)(c) | The policy on diversity with regard to selection of members of the management body, its objectives and any relevant targets set out in that policy, and the extent to which those objectives and targets have been achieved |
2025 Annual Reports and Accounts, Governance and Nomination Committee, on pages 176 to 181. Further information published on the Group website sc.com/boarddiversitypolicy. |
|
| (2)(d) | Whether or not the institution has set up a separate risk committee and the number of times the risk committee has me |
2025 Annual Reports and Accounts, Corporate Governance, on pages 116 to 122 |
|
| (2)(e) | The description of the information flow on risk to the management body |
2025 Annual Reports and Accounts, Risk management, on pages 222 to 234 |
|
| Scope of application | |||
| 436 | Institutions shall disclose the following information regarding the scope of application of the CRR as follows: |
See below | |
| (a) | The name of the institution to which the CRR applies. | Name of the Group and the Group logo are displayed on the cover page of the disclosures. |
|
| (b) (c) |
A reconciliation between the consolidated financial statements prepared in accordance with the applicable accounting framework and the consolidated financial statements prepared in accordance with the requirements on regulatory consolidation pursuant to Sections 2 and 3 of Title II of Part One; that reconciliation shall outline the differences between the accounting and regulatory scopes of consolidation and the legal entities included within the regulatory scope of consolidation where it differs from the accounting scope of consolidation; the outline of the legal entities included within the regulatory scope of consolidation shall describe the method of regulatory consolidation where it is different from the accounting consolidation method, whether those entities are fully or proportionally consolidated and whether the holdings in those legal entities are deducted from own funds. A breakdown of assets and liabilities of the consolidated |
Table 3: Regulatory Consolidation on page 5. Table 4: Outline of the differences in the scope of consolidation (LI3) on page 6. Table 5: Differences between accounting and |
|
| financial statements prepared in accordance with the requirements on regulatory consolidation pursuant to Sections 2 and 3 of Title II of Part One, broken down by type of risks as referred to under this Part. |
regulatory scopes of consolidation and the mapping of financial statement categories with regulatory risk categories (UK LI1) on page 7 |
| Table 6: Main sources of differences between regulatory exposure amounts and carrying values in Table 7: Prudent valuation adjustments (PVA) (UK |
|---|
| Table 9: Composition of regulatory own funds (UK Table 10: Reconciliation of regulatory own funds to balance sheet in the audited financial statements (UK |
| Details of the Group's capital instruments are set out in the Group's Main Features of Capital Instruments document available on the Group's website at https://www.sc.com/en/investors/credit-ratings |
| Table 9: Composition of regulatory own funds (UK Table 10: Reconciliation of regulatory own funds to balance sheet in the audited financial statements (UK |
| There were no restrictions applied to the calculation |
| The Group follows own funds calculation set out in the CRR, in the format set out by the below implementing |
| CRR article ref. | Requirement summary | Disclosure | |
|---|---|---|---|
| (a) | The composition of their own funds and eligible liabilities, their maturity and their main features. |
Details of the Group's capital instruments are set out in the Group's Main Features of Capital Instruments document available on the Group's website at https://www.sc.com/en/investors/credit-ratings fixed-income/#capitalsecurities |
|
| (b) | The ranking of eligible liabilities in the creditor hierarchy. | Table 12: Resolution entity – creditor ranking at legal entity level (TLAC3) on page 17 Table 13: Standard Chartered Bank – creditor ranking (TLAC2) on page 18 Table 14: Standard Chartered Bank (Hong Kong) Limited – creditor ranking (TLAC2) on page 19 Table 15: Standard Chartered Bank Korea Limited – creditor ranking (TLAC2) on page 20 Table 16: Standard Chartered Bank (Singapore) Limited – creditor ranking (TLAC2) on page 21 Table 17: Standard Chartered Bank (China) Limited – creditor ranking (TLAC2) on page 22 |
|
| (c) | The total amount of each issuance of eligible liabilities instruments referred to in Article 72b and the amount of those issuances that is included in eligible liabilities items within the limits specified in Article 72b(3) and (4). |
Table 12: TLAC composition for G-SIBs (TLAC1) on page 17 |
|
| (d) | The total amount of excluded liabilities referred to in Article 72a(2). |
Table 12: Resolution entity – creditor ranking at legal entity level (TLAC3) on page 17 |
|
| Own Funds Requirements and Risk-Weighted Exposure Amounts | |||
| 438 | Institutions shall disclose the following information regarding their compliance with Article 92 and rules 3.1(1) (a) and 3.4 of the Internal Capital Adequacy Assessment Part of the PRA Rulebook: |
See below | |
| (a) | A summary of their approach to assessing the adequacy of their internal capital to support current and future activities. |
Section 2.1 Capital management on page 11 Capital planning on page 303 of the 2025 Annual Reports and Accounts |
|
| (b) | The amount of the additional own funds requirements based on the supervisory review and evaluation process (within the meaning of regulation 34A of the Capital Requirements Regulations) and its composition in terms of Common Equity Tier 1, additional Tier 1 and Tier 2 instruments. |
Table 1: Key metrics template (UK KM1) on page 2 | |
| (c) | The result of the institution's internal capital adequacy assessment process. |
Section 2.1 Capital management on page 11. Capital planning on page 303 of the 2025 Annual Reports and Accounts |
|
| (d) | The total risk-weighted exposure amount and the corresponding total own funds requirement determined in accordance with Article 92, to be broken down by the different risk categories set out in Part Three and, where applicable, an explanation of the effect on the calculation of own funds and risk-weighted exposure amounts that results from applying capital floors and not deducting items from own funds. |
Table 20: Overview of risk weighted exposure amounts (UK OV1) on page 25 |
|
| (e) | The on- and off-balance-sheet exposures, the risk weighted exposure amounts and associated expected losses for each category of specialised lending referred to in Table 1 of Article 153(5) and the on- and off-balance sheet exposures and risk-weighted exposure amounts for the categories of equity exposures set out in Article 155(2). |
Excluded on the grounds of materiality | |
| (f) | The exposure value and the risk-weighted exposure amount of own funds instruments held in any insurance undertaking, reinsurance undertaking or insurance holding company that the institutions do not deduct from their own funds in accordance with Article 49 when calculating their capital requirements on an individual, sub-consolidated and consolidated basis. |
Not applicable | |
| (g) | The supplementary own funds requirement and the capital adequacy ratio of the financial conglomerate calculated in accordance with the provisions implementing Article 6 of Directive 2002/87/EC and Annex I to that Directive where method 1 or 2 set out in that Annex is applied. |
Table 24: RWA flow statements of market risk exposures under the IMA (UK MR2-B) on page 27 |
| CRR article ref. | Requirement summary | Disclosure |
|---|---|---|
| (h) | The variations in the risk-weighted exposure amounts of the current disclosure period compared to the immediately preceding disclosure period that result from the use of internal models, including an outline of the key drivers explaining those variations. |
Table 22: RWEA flow statements of credit risk exposures under the IRB approach (UK CR8) on page 26 Table 23: RWEA flow statements of CCR exposures under the IMM (UK CCR7) on page 27 |
| Exposure to counterparty credit risk | ||
| 439 | Institutions shall disclose the following information regarding their exposure to counterparty credit risk as referred to in Chapter 6 of Title II of Part Three: |
See below |
| (a) | A description of the methodology used to assign internal capital and credit limits for counterparty credit exposures, including the methods to assign those limits to exposures to central counterparties. |
Section 4.2. Counterparty credit risk on page 95 |
| (b) | A description of policies related to guarantees and other credit risk mitigants, such as the policies for securing collateral and establishing credit reserves. |
Section 4.2. Counterparty credit risk on page 95 |
| (c) | A description of policies with respect to General Wrong Way risk and Specific Wrong-Way risk as defined in Article 291. |
Section 4.2. Counterparty credit risk on page 95 |
| (d) | The amount of collateral the institution would have to provide if its credit rating were downgraded. |
Section 4.2. Counterparty credit risk on page 95 |
| (e) | For derivative transactions, the amount of segregated and unsegregated collateral received and posted per type of collateral; and for securities financing transactions, the total amount of collateral received and posted per type of collateral; provided in each case that: (i) institutions shall not disclose such amounts unless both the fair value of collateral posted in the form of debt securities and the fair value of collateral received in that form exceed GBP 125 billion; and (ii) for the purposes of subparagraph (i), institutions shall use the twelve month rolling arithmetic mean of the fair value of collateral received or posted (as the case may be) in the form of debt securities, determined using quarterly data calculated in a manner consistent with data reported under Article 430(g) and covering the twelve months immediately preceding the disclosure reference date; |
Table 86: Credit derivatives exposures (UK CCR6) on page 98 |
| (f) | For derivative transactions, the exposure values before and after the effect of the credit risk mitigation as determined under the methods set out in Sections 3 to 6 of Chapter 6 of Title II of Part Three, whichever method is applicable, and the associated risk exposure amounts broken down by applicable method. |
Table 84: Analysis of CCR exposure by approach (UK CCR1) on page 97 |
| (g) | For securities financing transactions, the exposure values before and after the effect of the credit risk mitigation as determined under the methods set out in Chapters 4 and 6 of Title II of Part Three, whichever method is used, and the associated risk exposure amounts broken down by applicable method. |
Table 84: Analysis of CCR exposure by approach (UK CCR1) on page 97 |
| (h) | The exposure values after credit risk mitigation effects and the associated risk exposures for credit valuation adjustment capital charge, separately for each method as set out in Title VI of Part Three. |
Table 87: Transactions subject to own funds requirements for CVA risk (UK CCR2) on page 98 |
| (i) | The exposure value to central counterparties and the associated risk exposures within the scope of Section 9 of Chapter 6 of Title II of Part Three, separately for qualifying and non-qualifying central counterparties, and broken down by types of exposures. |
Table 85: Exposures to CCPs (UK CCR8) on page 98 |
| (j) | The notional amounts and fair value of credit derivative transactions; credit derivative transactions shall be broken down by product type; within each product type, credit derivative transactions shall be broken down further by credit protection bought and credit protection sold. |
|
| (k) | The estimate of alpha where the institution has received the permission of the competent authorities to use its own estimate of alpha in accordance with Article 284(9). |
Table 84: Analysis of CCR exposure by approach (UK CCR1) on page 97 |
| CRR article ref. | Requirement summary | Disclosure | |
|---|---|---|---|
| (m) | for institutions using the methods set out in Sections 4 to 5 of Chapter 6 of Title II Part Three, the size of their on- and off-balance-sheet derivative business as calculated in accordance with Article 273a(1) or (2), as applicable. |
Table 84: Analysis of CCR exposure by approach (UK CCR1) on page 97 |
|
| Countercyclical capital buffers | |||
| 440 | Institutions shall disclose the following information in relation to their compliance with the requirement for a countercyclical capital buffer referred to in regulation 2 of the Capital Requirements (Capital Buffers and Macro prudential Measures) Regulations 2014: |
See below | |
| (a) | The geographical distribution of the exposure amounts and risk-weighted exposure amounts of its credit exposures used as a basis for the calculation of their countercyclical capital buffer. |
Table 18: Geographical distribution of credit exposures relevant for the calculation of the countercyclical buffer (UK CCyB1) on page 23 |
|
| (b) | The amount of their institution-specific countercyclical capital buffer. |
Table 19: Amount of institution-specific countercyclical capital buffer (UK CCyB2) on page 24 |
|
| Indicators of global systemic importance | |||
| 441 | (1) | G-SIIs shall disclose, on an annual basis, the values of the indicators used for determining their score in accordance with the identification methodology referred to in regulation 23 of Part 4 of Capital Requirements (Capital Buffers and Macro-prudential Measures) Regulations 2014. |
Discussed in Section 1.3. Regulatory disclosure framework on page 2 |
| Exposures to Credit Risk and Dilution Risk | |||
| 442 | Institutions shall disclose the following information regarding their exposure to credit risk and dilution risk: |
See below | |
| (a) | The scope and definitions that they use for accounting purposes of 'past due' and 'impaired' and the differences, if any, between the definitions of 'past due' and 'default' for accounting and regulatory purposes. |
Glossary sections of Pillar 3 and the Annual Report and Accounts on pages 151 to 156 and 470 to 478 respectively Credit risk section of the 2025 Annual Report and Accounts on page 233 |
|
| (b) | A description of the approaches and methods adopted for determining specific and general credit risk adjustments. |
Section 3.4. Exposure values on page 62 Note 8 of the 2025 Annual Report and Account on pages 342 to 346 |
|
| (c) | Information on the amount and quality of performing, non-performing and forborne exposures for loans, debt securities and off-balance-sheet exposures, including their related accumulated impairment, provisions and negative fair value changes due to credit risk and amounts of collateral and financial guarantees received. |
Table 44: Performing and non-performing exposures and related provisions (UK CR1) on page 55 Table 47: Credit quality of forborne exposures (UK CQ1) on page 57 Table 49: Quality of non-performing exposures by geography (UK CQ4) on page 59 Table 50: Credit quality of loans and advances to non-financial corporations by industry (UK CQ5) on page 60 |
|
| (d) | An ageing analysis of accounting past due exposures. | Table 48: Credit quality of performing and non performing exposures by past due days (UK CQ3) on page 58 |
|
| (e) | The gross carrying amounts of both defaulted and non-defaulted exposures, the accumulated specific and general credit risk adjustments, the accumulated write-offs taken against those exposures and the net carrying amounts and their distribution by geographical area and industry type and for loans, debt securities and off balance-sheet exposures. |
Table 44: Performing and non-performing exposures and related provisions (UK CR1) on page 55 Table 47: Credit quality of forborne exposures (UK CQ1) on page 57 Table 49: Quality of non-performing exposures by geography (UK CQ4) on page 59 Table 50: Credit quality of loans and advances to non-financial corporations by industry (UK CQ5) on page 60 |
|
| (f) | Any changes in the gross amount of defaulted on- and off-balance-sheet exposures, including, as a minimum, information on the opening and closing balances of those exposures, the gross amount of any of those exposures reverted to non-defaulted status or subject to a write-off. |
Table 44: Performing and non-performing exposures and related provisions (UK CR1) on page 55 Table 47: Credit quality of forborne exposures (UK CQ1) on page 57 Table 49: Quality of non-performing exposures by geography (UK CQ4) on page 59 Table 50: Credit quality of loans and advances to non-financial corporations by industry (UK CQ5) on page 60 |
|
| (g) | The breakdown of loans and debt securities by residual maturity. |
Table 45: Maturity of exposures (UK CR1-A) on page 56 |
| CRR article ref. | Requirement summary | Disclosure | |
|---|---|---|---|
| Encumbered and unencumbered assets | |||
| 443 | Institutions shall disclose information concerning their encumbered and unencumbered assets. For those purposes, institutions shall use the carrying amount per exposure class broken down by asset quality and the total amount of the carrying amount that is encumbered and unencumbered. Disclosure of information on encumbered and unencumbered assets shall not reveal emergency liquidity assistance provided by central banks. |
Table 100: Encumbered and unencumbered assets (UK AE1) on page 112 Table 101: Collateral received and own debt securities issued (UK AE2) on page 113 Table 102: Sources of encumbrance (UK AE3) on page 114 |
|
| Use of the Standardised Approach | |||
| 444 | Chapter 2 of Title II of Part Three shall disclose the following information for each of the exposure classes set out in Article 112: |
See below | |
| (a) | The names of the nominated ECAIs and export credit agencies and the reasons for any changes in those nominations over the disclosure period. |
Section 3.7. standardised risk weight profile on page 81 |
|
| (b) | The exposure classes for which each ECAI or export credit agency is used. |
Section 3.7. standardised risk weight profile on page 81 |
|
| (c) | A description of the process used to transfer the issuer and issue credit ratings onto items not included in the trading book. |
Section 3.7. standardised risk weight profile on page 81 |
|
| (d) | The association of the external rating of each nominated ECAI or export credit agency with the risk weights that correspond to the credit quality steps as set out in Chapter 2 of Title II of Part Three taking into account that it is not necessary to disclose that information where the institutions comply with the standard association published by the competent authority. |
Section 3.7. standardised risk weight profile on page 81 |
|
| (e) | The exposure values and the exposure values after credit risk mitigation associated with each credit quality step as set out in Chapter 2 of Title II of Part Three, by exposure class, as well as those deducted from own funds. |
Table 49: Quality of non-performing exposures by geography (UK CQ4) on page 59 Table 50: Credit quality of loans and advances to non-financial corporations by industry (UK CQ5) on page 60 |
|
| Exposure to market risk | |||
| 445 | Institutions calculating their own funds requirements in accordance with points (b) and (c) of Article 92(3) shall disclose those requirements separately for each risk referred to in those provisions. In addition, own funds requirements for the specific interest rate risk of securitisation positions shall be disclosed separately. |
Table 78: Market risk under standardised approach (UK MR1) on page 92 |
|
| Operational risk management | |||
| 446 | Institutions shall disclose the following information about their operational risk management: |
The Group applies STD approach for measuring capital requirements, described in section 1.5. Risk management under Operational Risk on page 4 |
|
| (a) | The approaches for the assessment of own funds requirements for operational risk that the institution qualifies for. |
Table 95: Operational risk own funds requirements and risk-weighted exposure amounts (UK OR1) on page 103 |
|
| (b) | Where the institution makes use of it, a description of the methodology set out in Article 312(2), which shall include a discussion of relevant internal and external factors being considered in the institution's advanced measurement approach. |
Not applicable | |
| (c) | In the case of partial use, the scope and coverage of the different methodologies used. |
Not applicable | |
| Key metrics | |||
| 447 | Institutions shall disclose the following key metrics in a tabular format: |
See below | |
| (a) | The composition of their own funds and their own funds requirements as calculated in accordance with Article 92. |
Table 1: Key metrics template (UK KM1) on page 2 | |
| (b) | The total risk exposure amount as calculated in accordance with Article 92(3). |
Table 1: Key metrics template (UK KM1) on page 2 | |
| (c) | Where applicable, the amount and composition of additional own funds which the institutions are required to hold in accordance with regulation 34(1) of the Capital Requirements Regulations. |
Table 1: Key metrics template (UK KM1) on page 2 |
| CRR article ref. | Requirement summary | Disclosure | |
|---|---|---|---|
| (d) | Their combined buffer requirement which the institutions are required to hold in accordance with regulation 35 of the Capital Requirements (Capital Buffers and Macro prudential Measures) Regulations 2014. |
Table 1: Key metrics template (UK KM1) on page 2 | |
| (e) | The following information in relation to their leverage ratio: (i) for all institutions, their leverage ratio and total exposure measure; (ii) for LREQ firms, the information in Article 451(1)(b) and (g) and Article 451(2)(b) to (d); |
Table 1: Key metrics template (UK KM1) on page 2 | |
| (f) | The following information in relation to their liquidity coverage ratio as calculated in accordance with Chapter 2 of the Liquidity Coverage Ratio (CRR) Part of the PRA Rulebook: (i) the average or averages, as applicable, of their liquidity coverage ratio based on end-of-the-month observations over the preceding 12 months for each quarter of the relevant disclosure period; (ii) the average or averages, as applicable, of their total liquid assets, after applying the relevant haircuts, included in the liquidity buffer pursuant to the Chapter 2 of the Liquidity Coverage Ratio (CRR) Part of the PRA Rulebook, based on end-of-the-month observations over the preceding 12 months for each quarter of the relevant disclosure period; (iii) the averages of their liquidity outflows, inflows and net liquidity outflows as calculated pursuant to Chapter 2 of the Liquidity Coverage Ratio (CRR) Part of the PRA Rulebook, based on end-of-the-month observations over the preceding 12 months for each quarter of the relevant disclosure period; |
Table 1: Key metrics template (UK KM1) on page 2 | |
| (g) | The following information in relation to their net stable funding requirement as calculated in accordance with Title IV of Part Six: (i) the average or averages, as applicable, of their net stable funding ratio based on end-of-the-quarter observations over the preceding four quarters, for each quarter of the relevant disclosure period; (ii) the average or averages, as applicable, of their available stable funding based on end-of-the-quarter observations over the preceding four quarters, for each quarter of the relevant disclosure period; (iii) the average or averages, as applicable, of their required stable funding based on end-of-the-quarter observations over the preceding four quarters, for each quarter of the relevant disclosure period; |
Table 1: Key metrics template (UK KM1) on page 2 | |
| (h) | Their own funds and eligible liabilities ratios and their components, numerator and denominator, as calculated in accordance with Articles 92a and 92b and broken down at the level of each resolution group, where applicable. |
||
| Exposure to interest rate risk on positions not included in the trading book | |||
| 448 | (1) | Institutions shall disclose the following quantitative and qualitative information on the risks arising from potential changes in interest rates that affect both the economic value of equity and the net interest income of their non-trading book activities referred to in in Chapter 9 of the Internal Capital Adequacy Assessment (ICAA) Part of the PRA Rulebook: |
See below |
| CRR article ref. | Requirement summary | Disclosure |
|---|---|---|
| (1)(a) | The changes in the economic value of equity calculated under the following six supervisory shock scenarios referred to in Rule 9.7 of the ICAA Part of the PRA Rulebook for the current and previous disclosure periods: (i) parallel shock up; (ii) parallel shock down; (iii) steepener shock (short rates down and long rates up); (iv) flattener shock (short rates up and long rates down); (v) short rates shock up; (vi) short rates shock down; |
Table 96: Quantitative information on IRRBB (UK IRRBB1) on page 104. |
| (1)(b) | The changes in the net interest income calculated under the following two supervisory shock scenarios referred to in Rule 9.7 of the ICAA Part of the PRA Rulebook for the current and previous disclosure periods: (i) parallel shock up; (ii) parallel shock down; |
Table 96: Quantitative information on IRRBB (UK IRRBB1) on page 104. |
| (1)(c) | A description of key modelling and parametric assumptions used to calculate changes in the economic value of equity and in the net interest income required under points (a) and (b) of this paragraph. |
Section 6 on Interest rate risk in the banking book on pages 104 to 105. |
| (1)(d) | An explanation of the significance of the risk measures disclosed under points (a) and (b) of this paragraph and of any significant variations of those risk measures since the previous disclosure reference date. |
Section 6 on Interest rate risk in the banking book on pages 104 to 105. |
| (1)(e) | The description of how institutions define, measure, mitigate and control the interest rate risk of their non trading book activities for the purposes of the competent authorities' review in accordance with Chapter 9 of the ICAA Part of the PRA Rulebook, including: (i) a description of the specific risk measures that the institutions use to evaluate changes in their economic value of equity and in their net interest income; (ii) a description of the key modelling and parametric assumptions used in the institutions' internal measurement systems for the purpose of calculating changes in the economic value of equity and in net interest income, as required under points (a) and (b) of this paragraph, if those assumptions differ from those used for the purposes of Chapter 9 of the ICAA Part of the PRA Rulebook or from those specified in Annex XXXVIII of Chapter 6 of this Disclosure (CRR) Part of the PRA Rulebook, including the rationale for those differences; (iii) a description of the interest rate shock scenarios that institutions use to estimate the interest rate risk; (iv) the recognition of the effect of hedges against those interest rate risks, including internal hedges that meet the requirements laid down in Article 106(3); (v) an outline of how often the evaluation of the interest rate risk occurs; |
Section 6 on Interest rate risk in the banking book on pages 104 to 105. |
| (1)(f) | The description of the overall risk management and mitigation strategies for those risks. |
Section 6 on Interest rate risk in the banking book on pages 104 to 105. |
| (1)(g) | Average and longest repricing maturity assigned to non-maturing deposits. |
Section 6 on Interest rate risk in the banking book on pages 104 to 105. |
| 2 | By way of derogation from paragraph 1 of this Article, the requirements set out in points (c) and (e)(i) to (e)(iv) of paragraph 1 of this Article for descriptions relating to economic value of equity shall not apply to institutions that use the standardised framework referred to in Rule 9.1B of the ICAA Part of the PRA Rulebook. |
|
| Exposure to securitisation position | ||
| 449 | Institutions calculating risk-weighted exposure amounts in accordance with Chapter 5 of Title II of Part Three or own funds requirements in accordance with Article 337 or 338 shall disclose the following information separately for their trading and non-trading book activities: |
See below |
| CRR article ref. | Requirement summary | Disclosure |
|---|---|---|
| (a) | A description of their securitisation and re-securitisation activities, including their risk management and investment objectives in connection with those activities, their role in securitisation and re-securitisation transactions, whether they use the simple, transparent and standardised securitisation (STS) as defined in point (10) of Article 242, and the extent to which they use securitisation transactions to transfer the credit risk of the securitised exposures to third parties with, where applicable, a separate description of their synthetic securitisation risk transfer policy. |
Section 3.8 Securitisation on pages 83 to 85 |
| (b) | The type of risks they are exposed to in their securitisation and re-securitisation activities by level of seniority of the relevant securitisation positions providing a distinction between STS and non-STS positions and: (i) the risk retained in own-originated transactions; (ii) the risk incurred in relation to transactions originated by third parties |
Section 3.8 Securitisation on pages 83 to 85 |
| (c) | Their approaches for calculating the risk-weighted exposure amounts that they apply to their securitisation activities, including the types of securitisation positions to which each approach applies and with a distinction between STS and non-STS positions. |
Section 3.8 Securitisation on pages 83 to 85 |
| (d) | A list of SSPEs falling into any of the following categories, with a description of their types of exposures to those SSPEs, including derivative contracts: (i) SSPEs which acquire exposures originated by the institutions; (ii) SSPEs sponsored by the institutions; (iii) SSPEs and other legal entities for which the institutions provide securitisation-related services, such as advisory, asset servicing or management services; (iv) SSPEs included in the institutions' regulatory scope of consolidation. |
Section 3.8 Securitisation on page 83 |
| (e) | A list of any legal entities in relation to which the institutions have disclosed that they have provided support in accordance with Chapter 5 of Title II of Part Three. |
Section 3.8 Securitisation on page 83 |
| (f) | A list of legal entities affiliated with the institutions and that invest in securitisations originated by the institutions or in securitisation positions issued by SSPEs sponsored by the institutions. |
Section 3.8 Securitisation on page 83 |
| (g) | A summary of their accounting policies for securitisation activity, including where relevant a distinction between securitisation and re-securitisation positions. |
Section 3.8 Securitisation on page 84 |
| (h) | The names of the ECAIs used for securitisations and the types of exposure for which each agency is used. |
Section 3.8 Securitisation on pages 83 to 85 |
| (i) | Where applicable, a description of the Internal Assessment Approach as set out in Chapter 5 of Title II of Part Three, including the structure of the internal assessment process and relation between internal assessment and external ratings of the relevant ECAI disclosed in accordance with point (h), the control mechanisms for the internal assessment process including discussion of independence, accountability, and internal assessment process review, the exposure types to which the internal assessment process is applied and the stress factors used for determining credit enhancement levels. |
Section 3.8 Securitisation on pages 83 to 85 |
| (j) | Separately for the trading book and the non-trading book, the carrying amount of securitisation exposures, including information on whether institutions have transferred significant credit risk in accordance with Articles 244 and 245, for which institutions act as originator, sponsor or investor, separately for traditional and synthetic securitisations, and for STS and non-STS transactions and broken down by type of securitisation exposures. |
Table 72: Securitisation exposures in the non-trading book (UK-SEC1) on page 86 Table 73: Securitisation exposures in the trading book (UK-SEC2) on page 87 |
| CRR article ref. | Requirement summary | Disclosure |
|---|---|---|
| (k) | For the trading and the non-trading book activities, the following information: (i) the aggregate amount of securitisation positions where institutions act as originator or sponsor and the associated risk-weighted assets and capital requirements by regulatory approaches, including exposures deducted from own funds or risk weighted at 1250%, broken down between traditional and synthetic securitisations and between securitisation and re-securitisation exposures, separately for STS and non-STS positions, and further broken down into a meaningful number of risk-weight or capital requirement bands and by approach used to calculate the capital requirements ; (ii) the aggregate amount of securitisation positions where institutions act as investor and the associated risk weighted assets and capital requirements by regulatory approaches, including exposures deducted from own funds or risk weighted at 1250%, broken down between traditional and synthetic securitisations, securitisation and re-securitisation positions, and STS and non-STS positions, and further broken down into a meaningful number of risk weight or capital requirement bands and by approach used to calculate the capital requirements; |
Table 74: Securitisation exposures in the non-trading book and associated regulatory capital requirements – institution acting as originator or as sponsor (UK-SEC3) on page 88 Table 75: Securitisation exposures in the non-trading book and associated regulatory capital requirements – institution acting as investor (UK-SEC4) on page 89 |
| (l) | For exposures securitised by the institution, the amount of exposures in default and the amount of the specific credit risk adjustments made by the institution during the current period, both broken down by exposure type. |
Table 76: Exposures securitised by the institution – Exposures in default and specific credit risk adjustments (UK-SEC5) on page 90 |
| Remuneration policy | ||
| 450 | Institutions shall disclose the following information regarding their remuneration policy and practices for those categories of staff whose professional activities have a material impact on risk profile of the institutions: |
|
| (1)(a) | Information concerning the decision-making process used for determining the remuneration policy, as well as the number of meetings held by the main body overseeing remuneration during the financial year, including, where applicable, information about the composition and the mandate of a remuneration committee, the external consultant whose services have been used for the determination of the remuneration policy and the role of the relevant stakeholders. |
2025 Annual Reports and Accounts on pages 180 to 206 |
| (1)(b) | Information about the link between pay of the staff and their performance. |
2025 Annual Reports and Accounts on pages 180 to 206 |
| (1)(c) | The most important design characteristics of the remuneration system, including information on the criteria used for performance measurement and risk adjustment, deferral policy and vesting criteria. |
2025 Annual Reports and Accounts on page 180 |
| (1)(d) | The ratios between fixed and variable remuneration set in accordance with rules 15.9 to 15.13 of the Remuneration Part of the PRA Rulebook. |
2025 Annual Reports and Accounts on page 180 |
| (1)(e) | Information on the performance criteria on which the entitlement to shares, options or variable components of remuneration is based. |
2025 Annual Reports and Accounts on page 180 |
| (1)(f) | The main parameters and rationale for any variable component scheme and any other non-cash benefits. |
2025 Annual Reports and Accounts on pages 180 to 206 |
| (1)(g) | Aggregate quantitative information on remuneration, broken down by business area. |
2025 Annual Reports and Accounts on page 180 |
| CRR article ref. | Requirement summary | Disclosure |
|---|---|---|
| (1)(h) | Aggregate quantitative information on remuneration, broken down by senior management and members of staff whose professional activities have a material impact on the risk profile of the institutions, indicating the following: (i) the amounts of remuneration for the financial year, split into fixed remuneration including a description of the fixed components, and variable remuneration, and the number of beneficiaries; (ii) the amounts and forms of awarded variable remuneration, split into cash, shares, share-linked instruments and other types separately for the part paid upfront and the deferred part; (iii) the amounts of deferred remuneration awarded for previous performance periods, split into the amount due to vest in the financial year and the amount due to vest in subsequent years; (iv) the amount of deferred remuneration due to vest in the financial year, and the number of beneficiaries of those awards; (v) the guaranteed variable remuneration awards during the financial year, and the number of beneficiaries of those awards; (vi) severance payments awarded in previous periods, that have been paid out during the financial year; (vii) the amounts of severance payments awarded during the financial year, split into paid upfront and deferred, the number of beneficiaries of those payments and highest payment that has been awarded to a single person; |
2025 Annual Reports and Accounts on pages 180 to 206 |
| (1)(i) | The number of individuals that have been remunerated EUR 1 million or more per financial year, with the remuneration between EUR 1 million and EUR 5 million broken down into pay bands of EUR 500 000 and with the remuneration of EUR 5 million and above broken down into pay bands of EUR 1 million. |
See Article 450 (1)(h)(i) above |
| (1)(k) | Information on whether the institution benefits from a derogation laid down in the Remuneration Part of the PRA Rulebook at 5.3, and/or 12.2 (second subparagraph), and 15.A1(3). For the purposes of point (k) of the first subparagraph of this paragraph, institutions that benefit from such a derogation shall indicate whether they benefit from that derogation on the basis of the Remuneration Part of the PRA Rulebook at 5.3, and/or 12.2 (second subparagraph), and 15.A1(3). They shall also indicate for which of the remuneration principles they apply the derogation(s), the number of staff members that benefit from the derogation(s) and their total remuneration, split into fixed and variable remuneration. |
See Article 450 (1)(h)(i) above |
| (2) | For large institutions, the quantitative information on the remuneration of institutions' collective management body referred to in this Article shall also be made available to the public, differentiating between executive and non executive members. Institutions shall comply with the requirements set out in this Article in a manner that is appropriate to their size, internal organisation and the nature, scope and complexity of their activities and without prejudice to the GDPR. |
2025 Annual Reports and Accounts on pages 180 to 206 |
| Leverage 451 |
Institutions shall disclose the following information regarding their leverage ratio as calculated in accordance with Article 429 of Chapter 3 of the Leverage Ratio (CRR) Part and their management of the risk of excessive leverage: |
See below |
| CRR article ref. | Requirement summary | Disclosure |
|---|---|---|
| (1)(a) | The leverage ratio. | Table 26: LRSum: Summary reconciliation of accounting assets and leverage ratio exposures (UK LR1) on page 29 Table 27: LRCom: Leverage ratio common disclosure (UK LR2) on page 30 Table 28: LRSpl: Split-up of on balance sheet exposures (excluding derivatives, SFTs and exempted exposures) (UK LR3) on page 31 |
| (1)(b) | The leverage ratio calculated as if central bank claims were required to be included in the total exposure measure. |
Table 26: LRSum: Summary reconciliation of accounting assets and leverage ratio exposures (UK LR1) on page 29 Table 27: LRCom: Leverage ratio common disclosure (UK LR2) on page 30 Table 28: LRSpl: Split-up of on balance sheet exposures (excluding derivatives, SFTs and exempted exposures) (UK LR3) on page 31 |
| (1)(c) | A breakdown of the total exposure measure, as well as a reconciliation of the total exposure measure with the relevant information disclosed in published financial statements. |
Table 26: LRSum: Summary reconciliation of accounting assets and leverage ratio exposures (UK LR1) on page 29 Table 27: LRCom: Leverage ratio common disclosure (UK LR2) on page 30 Table 28: LRSpl: Split-up of on balance sheet exposures (excluding derivatives, SFTs and exempted exposures) (UK LR3) on page 31 |
| (1)(d) | A description of the processes used to manage the risk of excessive leverage. |
Section 2.6 Leverage Ratio on page 28 |
| (1)(e) | A description of the factors that had an impact on the leverage ratio during the period to which the disclosed leverage ratio refers. |
Section 2.6 Leverage ratio on page 28 |
| (1)(f) | In relation to the quarterly periods up to 31 December 2025, the leverage ratio calculated as if Article 468 of the CRR did not apply for purposes of the capital measure under Article 429(3) of Chapter 3 of the Leverage Ratio (CRR) Part. |
|
| (1)(g) | In relation to the quarterly periods up to 31 December 2025, the leverage ratio calculated as if Article 473a of the CRR did not apply for purposes of the capital measure under Article 429(3) of Chapter 3 of the Leverage Ratio (CRR) Part. |
|
| (2) | An LREQ firm must disclose each of the following | See below |
| (2)(a) | The average exposure measure. | Table 27: LRCom: Leverage ratio common disclosure (UK LR2) on page 30 |
| (2)(b) | The average leverage ratio. | Table 27: LRCom: Leverage ratio common disclosure (UK LR2) on page 30 |
| (2)(c) | The average leverage ratio calculated as if central bank claims were required to be included in the total exposure measure; and |
Table 27: LRCom: Leverage ratio common disclosure (UK LR2) on page 30 |
| (2)(d) | The countercyclical leverage ratio buffer. | Table 27: LRCom: Leverage ratio common disclosure (UK LR2) on page 30 |
| (3) | An LREQ firm must disclose such information as is necessary to enable users to understand changes in the firm's total exposure measure and tier 1 capital (leverage) over the quarter that have affected the firm's average leverage ratio. |
|
| (4) | Subject to paragraph 5 | See below |
| (4)(a) | For the purposes of paragraph 2(a) an LREQ firm must calculate its average exposure measure for a quarter as the sum of: (i) the arithmetic mean of the firm's total exposure measure in relation to on-balance sheet assets and securities financing transactions on each day in the quarter; and (ii) the arithmetic mean of the firm's total exposure measure excluding on-balance sheet assets and securities financing transactions on the last day of each month in the quarter; and |
| CRR article ref. | Requirement summary | Disclosure | |
|---|---|---|---|
| 4(b) | For the purposes of paragraphs 2(a) and 3, an LREQ firm must calculate its average leverage ratio for a quarter as its capital measure divided by its exposure measure where the: (i) capital measure is the arithmetic mean of the firm's tier 1 capital (leverage) on the last day of each month in the quarter; and (ii) exposure measure is the sum derived in accordance with (a), unless paragraph 5 applies in which case it shall be the sum derived in accordance with that paragraph. |
||
| (5) | In relation to the quarterly periods up to 1 January 2025 an LREQ firm must calculate its average exposure measure for a quarter as the sum of: |
||
| (5)(a) | The arithmetic mean of the firm's total exposure measure in relation to on-balance sheet assets on each day in the quarter; and |
||
| (5)(b) | The arithmetic mean of the firm's total exposure measure excluding on-balance sheet assets on the last day of each month in the quarter. |
||
| Liquidity Requirements | |||
| 451a | (1) | Institutions that are subject to Part Six shall disclose information on their liquidity coverage ratio, net stable funding ratio and liquidity risk management in accordance with this Article. |
Section 7 Liquidity Risk on pages 106 to 111 |
| (2) | Institutions shall disclose the following information in relation to their liquidity coverage ratio as calculated in accordance with the Chapter 2 of the Liquidity Coverage Ratio (CRR) Part of the PRA Rulebook: |
See below | |
| (2)(a) | The average or averages, as applicable, of their liquidity coverage ratio based on end-of-the-month observations over the preceding 12 months for each quarter of the relevant disclosure period. |
Table 97: Liquidity Coverage Ratio (LCR) (UK LIQ1) on page 107 |
|
| (2)(b) | The average or averages, as applicable, of their total liquid assets, after applying the relevant haircuts, included in the liquidity buffer pursuant to the Chapter 2 of the Liquidity Coverage Ratio (CRR) Part of the PRA Rulebook, based on end-of-the-month observations over the preceding 12 months for each quarter of the relevant disclosure period, and a description of the composition of that liquidity buffer. |
Table 97: Liquidity Coverage Ratio (LCR) (UK LIQ1) on page 107 |
|
| (2)(c) | The averages of their liquidity outflows, inflows and net liquidity outflows as calculated in accordance with the Chapter 2 of the Liquidity Coverage Ratio (CRR) Part of the PRA Rulebook, based on end-of-the-month observations over the preceding 12 months for each quarter of the relevant disclosure period and the description of their composition. |
Table 97: Liquidity Coverage Ratio (LCR) (UK LIQ1) on page 107 |
|
| (3) | Institutions shall disclose the following information in relation to their net stable funding ratio as calculated in accordance with Title IV of Part Six: |
See below | |
| (3)(a) | Averages of their net stable funding ratio calculated in accordance with Chapter 2 of Title IV of Part Six for each quarter of the relevant disclosure period, based on end-of-the-quarter observations over the preceding four quarters. |
Table 98: Net Stable Funding Ratio (UK LIQ2) on page 109. |
|
| (3)(b) | An overview of the amount of available stable funding calculated in accordance with Chapter 3 of Title IV of Part Six for each quarter of the relevant disclosure period, comprising averages based on end-of-the-quarter observations over the preceding four quarters. |
Table 98: Net Stable Funding Ratio (UK LIQ2) on page 109. |
| CRR article ref. | Requirement summary | Disclosure | |
|---|---|---|---|
| (3)(c) | An overview of the amount of required stable funding calculated in accordance with Chapter 4 of Title IV of Part Six for each quarter of the relevant disclosure period, comprising averages based on end-of-the-quarter observations over the preceding four quarters. |
Table 98: Net Stable Funding Ratio (UK LIQ2) on page 109. |
|
| (4) | Institutions shall disclose the arrangements, systems, processes and strategies put in place to identify, measure, manage and monitor their liquidity risk in accordance with the Internal Liquidity Adequacy Assessment Part of the PRA Rulebook. |
Section 7 Liquidity Risk on pages 106 to 111 | |
| Use of the IRB Approach to credit risk | |||
| 452 | Institutions calculating the risk-weighted exposure amounts under the IRB Approach to credit risk shall disclose the following information: |
See below | |
| (a) | The competent authority's permission of the approach or approved transition. |
Section 3.3 Internal Ratings Based models on pages 33 to 54 Table 65: Scope of the use of IRB and SA approaches (UK CR6-A) on page 76 |
|
| (b) | For each exposure class referred to in Article 147, the percentage of the total exposure value of each exposure class subject to the Standardised Approach laid down in Chapter 2 of Title II of Part Three or to the IRB Approach laid down in Chapter 3 of Title II of Part Three, as well as the part of each exposure class subject to a roll-out plan; where institutions have received permission to use own LGDs and conversion factors for the calculation of risk-weighted exposure amounts, they shall disclose separately the percentage of the total exposure value of each exposure class subject to that permission. |
Section 3.3 Internal Ratings Based models on pages 33 to 54 Table 65: Scope of the use of IRB and SA approaches (UK CR6-A) on page 76 Table 52: Internal default grade probabilities and mapping to external ratings on page 63 |
|
| (c) | The control mechanisms for rating systems at the different stages of model development, controls and changes, which shall include information on: (i) the relationship between the risk management function and the internal audit function; (ii) the rating system review; (iii) the procedure to ensure the independence of the function in charge of reviewing the models from the functions responsible for the development of the models; (iv) the procedure to ensure the accountability of the functions in charge of developing and reviewing the models; |
Section 3.3 Internal Ratings Based models on pages 33 to 54 Table 65: Scope of the use of IRB and SA approaches (UK CR6-A) on page 76 |
|
| (d) | The role of the functions involved in the development, approval and subsequent changes of the credit risk models. |
Section 3.3 Internal Ratings Based models on pages 33 to 54 Table 65: Scope of the use of IRB and SA approaches (UK CR6-A) on page 76 |
|
| (e) | The scope and main content of the reporting related to credit risk models. |
Section 3.3 Internal Ratings Based models on pages 33 to 54 Table 65: Scope of the use of IRB and SA approaches (UK CR6-A) on page 76 |
| CRR article ref. | Requirement summary | Disclosure |
|---|---|---|
| (f) | A description of the internal ratings process by exposure class, including the number of key models used with respect to each portfolio and a brief discussion of the main differences between the models within the same portfolio, covering: (i) the definitions, methods and data for estimation and validation of PD, which shall include information on how PDs are estimated for low default portfolios, whether there are regulatory floors and the drivers for differences observed between PD and actual default rates at least for the last three periods; (ii) where applicable, the definitions, methods and data for estimation and validation of LGD, such as methods to calculate downturn LGD, how LGDs are estimated for low default portfolio and the time lapse between the default event and the closure of the exposure; (iii) where applicable, the definitions, methods and data for estimation and validation of conversion factors, including assumptions employed in the derivation of those variables; |
Section 3.3 Internal Ratings Based models on pages 33 to 54 Table 65: Scope of the use of IRB and SA approaches (UK CR6-A) on page 76 |
| (g) | As applicable, the following information in relation to each exposure class referred to in Article 147: (i) their gross on-balance-sheet exposure; (ii) their off-balance-sheet exposure values prior to the relevant conversion factor; (iii) their exposure after applying the relevant conversion factor and credit risk mitigation; (iv) any model, parameter or input relevant for the understanding of the risk weighting and the resulting risk exposure amounts disclosed across a sufficient number of obligor grades (including default) to allow for a meaningful differentiation of credit risk; (v) separately for those exposure classes in relation to which institutions have received permission to use own LGDs and conversion factors for the calculation of risk-weighted exposure amounts, and for exposures for which the institutions do not use such estimates, the values referred to in points (i) to (iv) subject to that permission; |
Tables 53 to 64: IRB approach – Credit risk exposures by exposure class and PD range on pages 64 to 75 |
| (h) | Institutions' estimates of PDs against the actual default rate for each exposure class over a longer period, with separate disclosure of the PD range, the external rating equivalent, the weighted average and arithmetic average PD, the number of obligors at the end of the previous year and of the year under review, the number of defaulted obligors, including the new defaulted obligors, and the annual average historical default rate. |
Tables 29 to 38: IRB approach – Back-testing of PD per exposure class (UK CR9) on pages 35 to 44 Tables 39 to 43: IRB – Backtesting of probability of default (PD) (UK CR9.1) on pages 45 to 53 |
| Use of credit risk mitigation techniques | ||
| 453 | Institutions using credit risk mitigation techniques shall disclose the following information: |
See below |
| (a) | The core features of the policies and processes for on- and off-balance-sheet netting and an indication of the extent to which institutions make use of balance sheet netting. |
Section 3.6. Credit risk mitigation on page 78 |
| (b) | The core features of the policies and processes for eligible collateral evaluation and management. |
See 453(a) above |
| (c) | A description of the main types of collateral taken by the institution to mitigate credit risk. |
See 453(a) above |
| (d) | For guarantees and credit derivatives used as credit protection, the main types of guarantor and credit derivative counterparty and their creditworthiness used for the purpose of reducing capital requirements, excluding those used as part of synthetic securitisation structures. |
See 453(a) above |
| (e) | Information about market or credit risk concentrations within the credit mitigation taken. |
See 453(a) above |
| CRR article ref. | Requirement summary | Disclosure | |
|---|---|---|---|
| (f) | For institutions calculating risk-weighted exposure amounts under the Standardised Approach or the IRB Approach, the total exposure value not covered by any eligible credit protection and the total exposure value covered by eligible credit protection after applying volatility adjustments; the disclosure set out in this point shall be made separately for loans and debt securities and including a breakdown of defaulted exposures. |
Table 67: CRM techniques overview: Disclosure of the use of credit risk mitigation techniques (UK CR3) on page 78 |
|
| (g) | The corresponding conversion factor and the credit risk mitigation associated with the exposure and the incidence of credit risk mitigation techniques with and without substitution effect. |
Table 68: UK CR4 – Credit risk exposure and CRM effects on page 79 |
|
| (h) | For institutions calculating risk-weighted exposure amounts under the Standardised Approach, the on- and off balance-sheet exposure value by exposure class before and after the application of conversion factors and any associated credit risk mitigation. |
Table 68: UK CR4 – Credit risk exposure and CRM effects on page 79 |
|
| (i) | For institutions calculating risk-weighted exposure amounts under the Standardised Approach, the risk-weighted exposure amount and the ratio between that risk-weighted exposure amount and the exposure value after applying the corresponding conversion factor and the credit risk mitigation associated with the exposure; the disclosure set out in this point shall be made separately for each exposure class. |
Table 68: UK CR4 – Credit risk exposure and CRM effects on page 79 |
|
| (j) | The institutions using the Advanced Measurement Approaches set out in Articles 321 to 324 for the calculation of their own funds requirements for operational risk shall disclose a description of their use of insurance and other risk transfer mechanisms for the purpose of mitigating that risk. |
Table 69: UK CR7 – IRB approach – Effect on the RWEAs of credit derivatives used as CRM techniques on page 80 Table 70: UK CR7-A – IRB approach – Disclosure of the extent of the use of CRM techniques on page 80 |
|
| Use of the Advanced Measurement Approaches to operational risk | |||
| 454 | The institutions using the Advanced Measurement Approaches set out in Articles 321 to 324 for the calculation of their own funds requirements for operational risk shall disclose a description of their use of insurance and other risk transfer mechanisms for the purpose of mitigating that risk. |
The Group does not hold a permission to use the advanced measurement approach for operational risk |
|
| Use of Internal Market Risk Models | |||
| 455 | Institutions calculating their capital requirements in accordance with Article 363 shall disclose the following information: |
See below | |
| (a) | For each sub-portfolio covered: (i) the characteristics of the models used; (ii) where applicable, for the internal models for incremental default and migration risk and for correlation trading, the methodologies used and the risks measured through the use of an internal model including a description of the approach used by the institution to determine liquidity horizons, the methodologies used to achieve a capital assessment that is consistent with the required soundness standard and the approaches used in the validation of the model; (iii) a description of stress testing applied to the sub portfolio; (iv) a description of the approaches used for back-testing and validating the accuracy and consistency of the internal models and modelling processes; |
The Group does not have IMA approval for incremental default and migration risk for correlation trading. |
|
| (b) | The scope of permission by the competent authority. | Section 4.1 under the heading Regulatory VaR and Regulatory VaR vs. management VaR on page 91 |
|
| (c) | A description of the extent and methodologies for compliance with the requirements set out in Articles 104 and 105. |
Section 4.1 under the heading Trading book and Valuation framework on page 91 |
| CRR article ref. | Requirement summary | Disclosure |
|---|---|---|
| (d) | The highest, the lowest and the mean of the following: (i) the daily value-at-risk measures over the reporting period and at the end of the reporting period; (ii) the stressed value-at-risk measures over the reporting period and at the end of the reporting period; (iii) the risk numbers for incremental default and migration risk and for the specific risk of the correlation trading portfolio over the reporting period and at the end of the reporting period. |
Table 79 IMA values for trading portfolios (UK MR3) on page 93 |
| (e) | The elements of the own funds requirement as specified in Article 364. |
Table 80 Market risk under the internal Model Approach (IMA) (UK MR2-A) on page 93 |
| (f) | The weighted average liquidity horizon for each sub portfolio covered by the internal models for incremental default and migration risk and for correlation trading. |
The Group has no model permissions for specific rate and comprehensive risk measure. |
| (g) | A comparison of the daily end-of-day value-at-risk measures to the one-day changes of the portfolio's value by the end of the subsequent business day together with an analysis of any important overshooting during the reporting period. |
Backtesting overshooting are shown in tables 81 and 82 (UK MR4) on page 94 |
Summary of differences between Pillar 3 Disclosures and the Risk and capital review section of the Annual Report and Accounts
The Group's Pillar 3 Disclosures for 31 December 2025 provide details from a regulatory perspective on certain aspects of credit risk, market risk and operational risk. The quantitative disclosures in the Pillar 3 Disclosures will not; however, be directly comparable to those in the Risk and capital review section of the Annual Report and Accounts as they are largely based on internally modelled risk metrics such as PD, LGD and EAD under Basel framework, whereas the quantitative disclosures in the Risk review are based on IFRS. EAD differs from the IFRS exposure primarily due to the inclusion of undrawn credit lines and off-balance sheet commitments. In addition, a number of the credit risk disclosures within the Pillar 3 Disclosures are only provided for the internal ratings based portfolio.
| Topic | Annual Report and Accounts | Pillar 3 Disclosures |
|---|---|---|
| Basis of requirements |
• The Group's Annual Report and Accounts are prepared in accordance with the requirements of IFRS as endorsed by the EU, the UK Companies Act 2006, and the UK, Hong Kong and India Listing rules |
• The Group's Pillar 3 Disclosures provide details on risk from a regulatory perspective to fulfil Basel III / CRD V requirements which have been implemented in the UK by the Prudential Regulatory Authority (PRA) via the 'Disclosure (CRR)' part of the PRA Rulebook. |
| Basis of preparation |
• The quantitative credit risk disclosures in the Risk review are based on IFRS • Loans and advances are analysed between the four client segments of Corporate & Institutional, Commercial, Private and Retail Banking (split by industry classification codes) • Market risk disclosures are presented using VaR methodology for the trading and non- trading books |
• Provides details from a regulatory perspective on certain aspects of credit risk, market risk and operational risk. For credit risk this is largely based on internally modelled risk metrics such as PD, LGD and EAD under Basel rules • Loans and advances are analysed between those that are internal ratings basis (IRB) and standardised, split by standard CRR categories • Market risk and operational risk disclosures are based on the capital required |
| Coverage | • All external assets which have an exposure to credit risk • Market risk exposure is the trading and non-trading books • Liquidity risk analysis of contractual maturities, liquid assets and encumbered assets |
• The credit risk disclosures are provided for approved portfolios as per the IRB approach and remaining portfolios are assessed as per Standardised rules as prescribed in the CRR • The PRA has granted the Group permission to use the internal model approach (IMA) covering the majority of market risk in the trading book. Positions outside the IMA scope are assessed according to standard CRR rules • The Standardised Approach consistent with the CRR requirements is used to assess its regulatory operational risk capital requirement |
| Credit rating and measurement |
• Overview of credit risk management credit grading and the use of IRB models is on page 264 • Maximum exposure to credit risk set out on page 234 • Internal credit grading analysis provided by business segment for both performing and non-performing loans and advances on pages 237 to 246 • External credit grading analysis for unimpaired debt securities and treasury bills is set out on pages 237 to 246 |
• Details of IRB and Standardised approach to credit risk is set out on pages 32 to 33 • For the IRB portfolio, page 63 provides an indicative mapping of the Group's credit grades in relation to Standard & Poor's credit ratings. • Minimum regulatory capital requirements for credit risk on page 25 • Credit grade analysis provided for the IRB portfolio only. EAD within the IRB portfolio after CRM, Undrawn commitments, exposure weighted average LGD and weighted average risk-weight internal credit grade on pages 64 to 75 and 100 to 102 • Credit quality step analysis for Standardised portfolio is provided on pages 88 to 89 |
Summary of differences
| Topic | Annual Report and Accounts | Pillar 3 Disclosures |
|---|---|---|
| Credit risk mitigation |
• CRM approach is set out on page 226 • Overview of collateral held and other credit risk mitigants provided on page 226. Quantitative overview of other risk mitigants including: • Securitisations, where the Group transfers the rights to collect principal and interest on client loan assets to third parties • Master netting agreements, CSAs and cash collateral for derivatives |
• Provides details on CRM from a regulatory perspective by providing EAD after CRM by IRB exposure class. Explanation is given on what constitutes eligible collateral including explanations of funded and unfunded protection. The main type of collateral for the Group's Standardised portfolio is also disclosed. Please refer to pages 88 to 89 • Extensive disclosures on securitisation including notional and carrying amounts, details of securitisation programmes where the Group is an originator, the accounting and governance of securitisation activities and retained exposures and carrying value by risk weight band. Please refer to pages 86 to 90 • EAD for items subject to CCR risk pre and post credit mitigation is disclosed. The products that are covered under CCR include 'repo style' transactions and derivative transactions. Please refer to pages 97 |
| Market risk | • Details of the VaR methodology, and VAR (trading and non trading) is disclosed by risk type on pages 277 to 278 • Details on Group Treasury's market risk, including a table showing a parallel shift in the yield curves, on page 285 |
• Provides details of the internal model approvals, such as the CAD2 granted by the PRA and the extension of the CAD2 scope to include coal market risk. • Market risk capital requirements for the trading book disclosed by risk type on page 92 |


www.sc.com